Craig Mayer, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

_See the full regCOVID repository with detailed results at https://github.com/lhncbc/r-snippets-bmi/tree/master/regCOVID

_regCOVID Published Paper

_See the regCOVIDpublications repository for publications from COVID-19 clinical studies: User friendly landing page


##  Data as of 2022-01-31

Study Status

overall_status Study_Count
Recruiting 2797
Completed 1975
Not yet recruiting 974
Active, not recruiting 720
Withdrawn 205
Terminated 193
Enrolling by invitation 191
Suspended 28
No longer available 17
Available 13
Approved for marketing 2
Temporarily not available 2
Unknown status 1

Study Types

Type Study_count
Total_Studies 5876
interventional 3167
Observational 2350
Registry 359

Studies over Time

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 620
Drug|placebo 518
Other 365
Biological 358
Behavioral 256
Biological|placebo 203
Device 171
Diagnostic Test 121
Drug|Other 92
Procedure 54
Biological|Other 45
Dietary Supplement|placebo 43
Dietary Supplement 42
Biological|Drug 35
Behavioral|Other 22
Dietary Supplement|Drug 20
Device|Other 19
Drug|Other|placebo 14
Combination Product 13
Radiation 13
Biological|Drug|placebo 11
Combination Product|Drug 10
Other|placebo 9
Diagnostic Test|Other 8
Dietary Supplement|Other 7
Behavioral|placebo 5
Combination Product|placebo 5
Device|Drug 5
Device|Drug|placebo 5
Drug|Procedure 5
Behavioral|Biological 4
Device|placebo 4
Other|Procedure 4
Behavioral|Device 3
Device|Drug|Procedure 3
Device|Procedure 3
Dietary Supplement|Drug|placebo 3
Behavioral|Drug 2
Biological|Device|Other 2
Biological|Other|placebo 2
Combination Product|Dietary Supplement 2
Combination Product|Procedure 2
Device|Drug|Radiation 2
Dietary Supplement|Drug|Other 2
Drug|placebo|Procedure 2
Genetic 2
placebo|Radiation 2
Behavioral|Combination Product 1
Behavioral|Diagnostic Test 1
Biological|Combination Product 1
Biological|Combination Product|Drug|placebo 1
Biological|Device 1
Biological|Device|Diagnostic Test 1
Biological|Device|Diagnostic Test|Other 1
Biological|Diagnostic Test 1
Biological|Dietary Supplement|placebo 1
Biological|Drug|Other 1
Biological|Drug|Other|placebo 1
Biological|Drug|Procedure 1
Biological|Genetic|Other 1
Combination Product|Device 1
Device|Diagnostic Test 1
Device|Drug|Other 1
Diagnostic Test|Dietary Supplement 1
Diagnostic Test|Dietary Supplement|Other 1
Diagnostic Test|Drug 1
Diagnostic Test|Drug|Other|placebo 1
Diagnostic Test|Drug|Other|placebo|Procedure 1
Diagnostic Test|Genetic|Other 1
Dietary Supplement|Drug|Other|placebo 1
Dietary Supplement|Other|placebo 1
Drug|placebo|Radiation 1
Drug|Radiation 1
Other|Radiation 1
placebo 1
placebo|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Weekly studies for each intervention

Studies by Country

Country Study_Count
United States 810
France 216
China 142
Brazil 126
Canada 126
Spain 118
Turkey 104
United Kingdom 102
Egypt 88
Italy 88
Mexico 71
Germany 59
Russian Federation 58
Belgium 52
Pakistan 45
India 40
Israel 37
Argentina 31
Indonesia 31
Korea, Republic of 31
Sweden 29
Denmark 26
Hong Kong 26
Netherlands 25
Iran, Islamic Republic of 23
Switzerland 22
Taiwan 22
Australia 21
Japan 20
Bangladesh 19
Greece 17
Saudi Arabia 17
Colombia 15
South Africa 15
Poland 13
Austria 12
Singapore 12
Vietnam 12
Chile 11
Norway 9
Thailand 9
United States|Canada 9
Hungary 8
Iraq 8
Qatar 8
Malaysia 7
Tunisia 7
United States|Puerto Rico 7
Kazakhstan 6
Peru 6
Ukraine 6
United Arab Emirates 6
Philippines 5
Bahrain 4
Czechia 4
Finland 4
Jordan 4
New Zealand 4
Paraguay 4
Romania 4
United States|Brazil 4
France|Monaco 3
French Guiana 3
Ireland 3
Uganda 3
Azerbaijan 2
Belarus 2
Belgium|France 2
Brazil|Canada 2
Brazil|Italy 2
Costa Rica 2
Georgia 2
Guinea 2
Guinea-Bissau 2
Honduras 2
Kenya 2
Kuwait 2
Lebanon 2
2
Nigeria 2
North Macedonia 2
Portugal 2
Puerto Rico 2
Rwanda 2
Slovakia 2
United States|Argentina 2
United States|Argentina|Brazil 2
United States|Argentina|Brazil|Mexico|Peru 2
United States|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom 2
United States|Italy 2
United States|Russian Federation 2
United States|Singapore 2
United States|Spain 2
United States|United Kingdom 2
Argentina|Belgium|Brazil|Bulgaria|Chile|Colombia|Costa Rica|Croatia|Denmark|France|Germany|Greece|Hungary|India|Italy|Japan|Mexico|Peru|Poland|Portugal|Romania|Russian Federation|Serbia|South Africa|Spain|Switzerland|Turkey|Ukraine|United Kingdom 1
Argentina|Belgium|Colombia|Dominican Republic|Germany|Mexico|Netherlands|Panama|Peru|Spain 1
Argentina|Brazil|Bulgaria|Colombia|France|Greece|Mexico|Peru|Portugal|Romania|South Africa|Spain|Turkey 1
Argentina|Brazil|Bulgaria|Germany|Greece|Hungary|Moldova, Republic of|Poland|Romania|South Africa|Ukraine 1
Argentina|Brazil|Canada|Chile|France|Germany|Israel|Italy|Japan|Russian Federation|Spain 1
Argentina|Brazil|Chile|France|Germany|India|Italy|Japan|Mexico|Peru|Poland|Russian Federation|South Africa|Turkey 1
Argentina|Brazil|Chile|Mexico|Russian Federation 1
Argentina|Brazil|Colombia|India|Mexico|Philippines|South Africa|Thailand 1
Argentina|Brazil|Denmark|Germany|Hungary|India|Mexico|Netherlands|Peru|Russian Federation|South Africa|Spain 1
Argentina|Chile|Mexico|Pakistan|Russian Federation 1
Argentina|Egypt 1
Argentina|Spain 1
Australia|Belgium|South Africa 1
Australia|Brazil|Netherlands|Spain|United Kingdom 1
Australia|India 1
Austria|Belgium|Brazil|Denmark|France|Germany|Italy|Netherlands|Portugal|Russian Federation|Spain 1
Austria|Belgium|France|Luxembourg|Norway|Portugal 1
Austria|Denmark|Germany|Russian Federation|United Kingdom 1
Austria|Germany 1
Austria|Ukraine 1
Bahrain|Egypt|Jordan|United Arab Emirates 1
Bangladesh|China|India|Indonesia|Spain 1
Belarus|Russian Federation 1
Belgium|Brazil|France|Germany|Italy|Mexico|Spain|United Kingdom 1
Belgium|Brazil|France|Germany|Mexico|Netherlands|Peru|Russian Federation|South Africa 1
Belgium|France|Monaco 1
Belgium|Germany 1
Belgium|Hungary|Poland|Russian Federation 1
Belgium|Italy 1
Belgium|Italy|Spain|Switzerland 1
Benin|Ethiopia|Indonesia|Kenya|Lao People’s Democratic Republic|Mali|Niger|Pakistan|Thailand|United Kingdom|Zambia 1
Bosnia and Herzegovina 1
Botswana|Kenya|Malawi|South Africa|Swaziland|Uganda|Zambia|Zimbabwe 1
Brazil|Canada|Colombia|Ecuador|Egypt|India|Nepal|Pakistan|Philippines|Russian Federation|Rwanda|South Africa|United Arab Emirates 1
Brazil|Canada|Hungary|Mexico|Serbia 1
Brazil|Canada|Mexico 1
Brazil|Chile|Colombia 1
Brazil|France|Russian Federation|Spain 1
Brazil|Malaysia 1
Brazil|Mexico|Switzerland 1
Brazil|Mexico|United Kingdom 1
Brazil|Poland|South Africa|United Kingdom 1
Brazil|Switzerland 1
Brazil|Thailand 1
Bulgaria 1
Bulgaria|Canada|Greece|Ireland|Latvia|Lithuania|Poland|Spain|United Kingdom 1
Bulgaria|Germany 1
Bulgaria|Greece|Romania|Spain|Turkey 1
Bulgaria|Israel|Romania 1
Burkina Faso|Guinea 1
Burkina Faso|Kenya 1
Côte D’Ivoire 1
Cameroon 1
Canada|India|Thailand 1
Canada|Israel 1
Canada|Mexico 1
Canada|Mongolia 1
Canada|South Africa 1
Cape Verde|Guinea-Bissau|Mozambique 1
Chile|Malaysia|Philippines|South Africa|Turkey 1
China|Ecuador|Indonesia|Pakistan|Uzbekistan 1
China|Italy 1
Croatia 1
Cyprus 1
Czechia|Romania|United Kingdom 1
Denmark|India|Sweden|Switzerland 1
Denmark|Norway|Switzerland 1
Denmark|Sweden 1
Dominican Republic 1
Ecuador 1
Estonia 1
France|French Guiana 1
France|Italy|Spain 1
France|Martinique|Réunion 1
France|Morocco|Serbia 1
France|Russian Federation|South Africa 1
French Guiana|Guadeloupe|New Caledonia 1
Gambia 1
Germany|India|Netherlands|Poland|Romania|South Africa|Spain 1
Germany|Israel 1
Germany|Netherlands|Spain|United Kingdom 1
Germany|Spain 1
Germany|Sweden 1
Germany|Switzerland 1
Ghana 1
Ghana|India|Indonesia|Nepal|South Africa|Sri Lanka|United Kingdom|Vietnam 1
Greece|Italy 1
Greece|Italy|Poland|Portugal|Spain|Turkey 1
Greece|Mexico 1
Iceland 1
India|Israel 1
India|South Africa 1
India|United Kingdom 1
Indonesia|Kenya|Mexico|Philippines 1
Indonesia|Mexico 1
Indonesia|Philippines|Russian Federation 1
Italy|Russian Federation 1
Jamaica 1
Jordan|Kenya|Lebanon 1
Korea, Republic of|New Zealand|Philippines|Thailand|Ukraine|Vietnam 1
Kuwait|Qatar 1
Kyrgyzstan 1
Malaysia|Pakistan 1
Mali 1
Moldova, Republic of 1
Monaco 1
Nepal 1
New Caledonia 1
Oman 1
Panama 1
Panama|Peru 1
Romania|Spain 1
Russian Federation|Slovakia 1
Russian Federation|Spain 1
Senegal 1
Slovenia 1
South Africa|United Kingdom 1
Spain|United Kingdom 1
Taiwan|Vietnam 1
United States|Argentina|Belgium|Brazil|Canada|Chile|Colombia|France|India|Italy|Japan|Mexico|Netherlands|Peru|Poland|Russian Federation|South Africa|Spain|United Kingdom 1
United States|Argentina|Belgium|Brazil|Colombia|France|Germany|India|Israel|Italy|Mexico|Netherlands|Portugal|Romania|Serbia|Spain|United Kingdom 1
United States|Argentina|Belgium|Brazil|Egypt|Moldova, Republic of|Romania|South Africa|Spain|Ukraine 1
United States|Argentina|Brazil|Bulgaria|Colombia|Czechia|Hungary|India|Japan|Korea, Republic of|Malaysia|Mexico|Poland|Puerto Rico|Russian Federation|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine 1
United States|Argentina|Brazil|Bulgaria|Colombia|Czechia|Hungary|Japan|Korea, Republic of|Malaysia|Mexico|Poland|Puerto Rico|Russian Federation|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine 1
United States|Argentina|Brazil|Bulgaria|Colombia|Mexico 1
United States|Argentina|Brazil|Bulgaria|Czechia|Germany|Hungary|Italy|Japan|Mexico|Peru|Poland|Russian Federation|Spain|Ukraine|United Kingdom 1
United States|Argentina|Brazil|Canada|Chile|Colombia|Egypt|France|Germany|Guatemala|Israel|Italy|Japan|Mexico|Philippines|Poland|Russian Federation|South Africa|Spain|Sweden|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Brazil|Canada|Chile|Colombia|Germany|Italy|Mexico|Peru|Spain|Ukraine 1
United States|Argentina|Brazil|Canada|Costa Rica|Guatemala|Mexico|Philippines|Puerto Rico|South Africa 1
United States|Argentina|Brazil|Canada|India|Mexico|United Kingdom 1
United States|Argentina|Brazil|Canada|Mexico|United Kingdom 1
United States|Argentina|Brazil|Chile|Colombia|Mexico|Peru 1
United States|Argentina|Brazil|Chile|Colombia|Mexico|Peru|South Africa 1
United States|Argentina|Brazil|Chile|Mexico|Russian Federation|South Africa|Ukraine 1
United States|Argentina|Brazil|Colombia|Czechia|India|Peru|Philippines|Ukraine 1
United States|Argentina|Brazil|Colombia|Dominican Republic|France|Guatemala|Hungary|Japan|Malaysia|Mexico|Philippines|Romania|Russian Federation|South Africa|Spain|Thailand|Turkey|Ukraine 1
United States|Argentina|Brazil|Colombia|France|Germany|Mexico|Peru|Russian Federation|Spain|Turkey|United Kingdom 1
United States|Argentina|Brazil|Colombia|India|Mexico|Peru|Philippines|Ukraine 1
United States|Argentina|Brazil|Czechia|Hungary|Japan|Korea, Republic of|Malaysia|Mexico|Poland|Puerto Rico|Russian Federation|South Africa|Taiwan|Thailand|Turkey|Ukraine 1
United States|Argentina|Brazil|Germany|India|Italy|Japan|Korea, Republic of|Mexico|Puerto Rico|Russian Federation|Spain|United Kingdom 1
United States|Argentina|Brazil|Germany|South Africa|Turkey 1
United States|Argentina|Brazil|Moldova, Republic of|Philippines|Romania|Ukraine|United Kingdom 1
United States|Argentina|Czechia|Georgia|Germany|Moldova, Republic of|Poland|Romania|Ukraine 1
United States|Argentina|Denmark|Georgia|Greece|India|Mexico|Mozambique|Nigeria|Poland|Singapore|Spain|Switzerland|Uganda|United Kingdom 1
United States|Argentina|Peru 1
United States|Argentina|Puerto Rico 1
United States|Australia 1
United States|Australia|Belgium|Brazil|Colombia|France|Mexico|Poland|Portugal|South Africa|Spain 1
United States|Australia|Brazil|Honduras 1
United States|Australia|Brazil|Mexico|South Africa 1
United States|Australia|France|Honduras|Kenya|Spain|United Kingdom 1
United States|Australia|Philippines|Romania 1
United States|Austria|Belgium 1
United States|Austria|Brazil|Canada|Peru|Spain|United Kingdom 1
United States|Austria|France|Israel|Spain|United Kingdom 1
United States|Belgium 1
United States|Belgium|Brazil|Colombia|France|Germany|Philippines|South Africa|Spain|United Kingdom 1
United States|Belgium|Brazil|France|Puerto Rico 1
United States|Belgium|Brazil|Mexico|Spain 1
United States|Belgium|Brazil|Spain 1
United States|Belgium|Canada|France|Japan|Spain 1
United States|Belgium|France|Netherlands 1
United States|Belgium|France|Spain|United Kingdom 1
United States|Belgium|Italy 1
United States|Belgium|Poland 1
United States|Brazil|Canada 1
United States|Brazil|Canada|Chile|Colombia|France|Israel|Italy|Korea, Republic of|Mexico|Philippines|Poland|Russian Federation|South Africa|Spain|Ukraine|United Kingdom 1
United States|Brazil|Canada|Greece|South Africa|Spain 1
United States|Brazil|Canada|Mexico 1
United States|Brazil|Canada|South Africa 1
United States|Brazil|Chile|Colombia|Mexico 1
United States|Brazil|Chile|Mexico|Moldova, Republic of|Romania 1
United States|Brazil|Chile|Mexico|Puerto Rico|Spain 1
United States|Brazil|Chile|Peru|South Africa 1
United States|Brazil|Colombia|India|Mexico 1
United States|Brazil|Colombia|Israel|Italy|Mexico|Peru|Poland|Russian Federation|United Kingdom 1
United States|Brazil|Colombia|Mexico|Philippines 1
United States|Brazil|Finland|Moldova, Republic of|Romania|Ukraine|United Kingdom 1
United States|Brazil|Germany|Mexico 1
United States|Brazil|Germany|Poland|South Africa 1
United States|Brazil|Italy|Spain 1
United States|Brazil|Kenya|Mexico|Peru|South Africa 1
United States|Brazil|Mexico 1
United States|Brazil|Mexico|Peru 1
United States|Brazil|Mexico|Spain 1
United States|Brazil|Philippines 1
United States|Brazil|Russian Federation|Spain 1
United States|Brazil|South Africa 1
United States|Brazil|South Africa|Spain|United Kingdom 1
United States|Bulgaria|North Macedonia|Puerto Rico 1
United States|Canada|Colombia 1
United States|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
United States|Canada|Italy|Korea, Republic of|Spain 1
United States|Canada|Kuwait|Saudi Arabia 1
United States|Canada|Turkey 1
United States|Chile|Mexico|Romania 1
United States|Chile|Peru 1
United States|Colombia 1
United States|Colombia|Ghana|Honduras|India|Japan|Kenya|Mexico|Nepal|Sri Lanka 1
United States|Denmark 1
United States|Denmark|Germany|Greece|Indonesia|Japan|Korea, Republic of|Mexico|Poland|Singapore|Spain|United Kingdom 1
United States|Denmark|Germany|Greece|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom 1
United States|Denmark|Greece|Japan|Nigeria|Spain|United Kingdom 1
United States|Denmark|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom 1
United States|Denmark|Spain|United Kingdom 1
United States|Finland|Poland|Spain 1
United States|France|Italy|Russian Federation|Spain|United Kingdom 1
United States|France|Japan|Spain|United Kingdom 1
United States|France|Ukraine 1
United States|Ghana|South Africa|United Kingdom|Zambia 1
United States|Hungary|India|Netherlands|Poland|South Africa 1
United States|Hungary|Israel|Netherlands|Puerto Rico 1
United States|India|Ukraine 1
United States|Israel 1
United States|Italy|Spain|United Kingdom 1
United States|Italy|United Kingdom 1
United States|Japan|Korea, Republic of|Mexico|Singapore 1
United States|Korea, Republic of 1
United States|Mexico 1
United States|Mexico|Pakistan 1
United States|Mexico|Puerto Rico 1
United States|Moldova, Republic of|Romania 1
United States|Netherlands|Switzerland 1
United States|New Zealand 1
United States|Nigeria|Spain|Switzerland|Uganda 1
United States|Philippines|Ukraine 1
United States|Portugal|Spain|United Kingdom 1
United States|Russian Federation|Ukraine 1
United States|South Africa 1
United States|Sweden 1
United States|Uganda 1
Zambia 1

Sites per Study

Site_count Study_Count
1 2060
2 267
3 131
4 110
5 62
6 50
7 37
8 39
9 28
10 25
11 28
12 30
13 17
14 16
15 5
16 11
17 12
18 16
19 6
20 5
21 13
22 9
23 7
24 8
25 9
26 5
27 5
28 5
29 7
30 3
31 9
32 2
33 3
34 2
35 4
36 5
37 3
38 1
39 4
40 5
41 3
42 3
43 4
45 1
47 3
48 1
50 3
51 1
52 1
53 3
54 1
55 2
56 1
57 4
58 2
59 2
60 3
61 3
62 4
63 2
64 2
65 1
66 1
68 1
69 1
71 2
73 1
74 2
76 1
79 1
84 3
86 1
87 1
89 1
91 4
94 1
95 2
96 1
99 1
100 1
102 1
104 1
107 1
112 1
115 1
116 1
120 1
121 1
123 1
125 1
134 1
141 1
145 2
156 1
164 1
166 1
173 1
174 1
183 1
184 1
202 1
220 1
225 1
256 1
292 1
366 1

Phase

Phase Study_Count
Not Applicable 1244
Phase 2 671
Phase 3 435
Phase 1 222
Phase 2/Phase 3 193
Phase 1/Phase 2 188
Phase 4 178
Early Phase 1 36

Number of Arms

Number_of_Arms Count_of_Studies
1 529
2 1876
3 337
4 198
5 46
6 55
7 17
8 26
9 15
10 9
11 1
12 12
14 4
15 6
16 3
17 3
18 2
19 1
20 2
21 1
22 2
29 1
32 1
20

Number of Updates

Count of Versions Count of Studies
1 556
2 665
3 555
4 426
5 284
6 172
7 129
8 90
9 56
10 45
11 19
12 16
13 20
14 10
15 16
16 15
17 10
18 7
19 10
20 11
21 7
22 10
23 4
24 1
25 3
26 2
27 3
28 2
30 1
31 3
32 2
34 1
35 1
36 3
38 1
39 1
48 3
59 1
62 1
64 1
73 1
95 1
374 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 11075 2610 4.243295
Contacts/Locations 6086 2170 2.804608
Recruitment Status 3244 2094 1.549188
None (earliest Version on record) 3166 3166 1.000000
Study Design 2132 1521 1.401709
Outcome Measures 1907 1247 1.529270
Eligibility 1580 976 1.618853
Study Description 1381 964 1.432573
Study Identification 1160 887 1.307779
Interventions 1151 780 1.475641
Arms 1150 780 1.474359
Oversight 902 848 1.063679
Sponsor/Collaborators 519 411 1.262774
Conditions 353 299 1.180602
Document Section 301 236 1.275424
References 211 161 1.310559
IPDSharing 163 148 1.101351
Results 85 85 1.000000
Adverse Events 70 54 1.296296
2021 Outcome Measures 68 44 1.545454
Results Submission Events 56 56 1.000000
Baseline Characteristics 51 41 1.243902
Participant Flow 44 37 1.189189
2021 Study Status 26 25 1.040000
2021Recruitment Status 18 18 1.000000
2021 Document Section 8 6 1.333333
More Information 8 8 1.000000
2021 Adverse Events 6 5 1.200000
2022 Study Status 6 6 1.000000
Quality Control Review has not concludedReturned: November 23 6 6 1.000000
Quality Control Review has not concludedReturned: November 24 6 6 1.000000
2021 Baseline Characteristics 5 5 1.000000
2022 Outcome Measures 5 4 1.250000
2020Recruitment Status 4 3 1.333333
Quality Control Review has not concludedReturned: November 5 4 4 1.000000
2022Recruitment Status 3 3 1.000000
Quality Control Review has not concludedReturned: December 1 3 3 1.000000
Quality Control Review has not concludedReturned: December 29 3 3 1.000000
Quality Control Review has not concludedReturned: March 8 3 3 1.000000
Quality Control Review has not concludedReturned: May 11 3 3 1.000000
Quality Control Review has not concludedReturned: October 4 3 3 1.000000
2021 IPDSharing 2 2 1.000000
Quality Control Review has not concludedReturned: April 12 2 2 1.000000
Quality Control Review has not concludedReturned: April 13 2 2 1.000000
Quality Control Review has not concludedReturned: April 20 2 2 1.000000
Quality Control Review has not concludedReturned: April 27 2 2 1.000000
Quality Control Review has not concludedReturned: April 30 2 2 1.000000
Quality Control Review has not concludedReturned: August 12 2 2 1.000000
Quality Control Review has not concludedReturned: August 18 2 2 1.000000
Quality Control Review has not concludedReturned: August 24 2 2 1.000000
Quality Control Review has not concludedReturned: August 25 2 2 1.000000
Quality Control Review has not concludedReturned: August 4 2 2 1.000000
Quality Control Review has not concludedReturned: December 17 2 2 1.000000
Quality Control Review has not concludedReturned: December 7 2 2 1.000000
Quality Control Review has not concludedReturned: December 8 2 2 1.000000
Quality Control Review has not concludedReturned: January 10 2 2 1.000000
Quality Control Review has not concludedReturned: January 14 2 2 1.000000
Quality Control Review has not concludedReturned: January 18 2 2 1.000000
Quality Control Review has not concludedReturned: January 24 2 2 1.000000
Quality Control Review has not concludedReturned: June 24 2 2 1.000000
Quality Control Review has not concludedReturned: June 7 2 2 1.000000
Quality Control Review has not concludedReturned: May 5 2 2 1.000000
Quality Control Review has not concludedReturned: November 15 2 2 1.000000
Quality Control Review has not concludedReturned: November 2 2 2 1.000000
Quality Control Review has not concludedReturned: November 4 2 2 1.000000
Quality Control Review has not concludedReturned: November 9 2 2 1.000000
Quality Control Review has not concludedReturned: October 14 2 2 1.000000
Quality Control Review has not concludedReturned: September 10 2 2 1.000000
Quality Control Review has not concludedReturned: September 24 2 2 1.000000
2020 Adverse Events 1 1 1.000000
2020 IPDSharing 1 1 1.000000
2020 Outcome Measures 1 1 1.000000
2021 Contacts/Locations 1 1 1.000000
2022 Arms 1 1 1.000000
Quality Control Review has not concludedReturned: April 1 1 1 1.000000
Quality Control Review has not concludedReturned: April 2 1 1 1.000000
Quality Control Review has not concludedReturned: April 28 1 1 1.000000
Quality Control Review has not concludedReturned: April 29 1 1 1.000000
Quality Control Review has not concludedReturned: April 6 1 1 1.000000
Quality Control Review has not concludedReturned: April 8 1 1 1.000000
Quality Control Review has not concludedReturned: August 10 1 1 1.000000
Quality Control Review has not concludedReturned: August 11 1 1 1.000000
Quality Control Review has not concludedReturned: August 13 1 1 1.000000
Quality Control Review has not concludedReturned: August 23 1 1 1.000000
Quality Control Review has not concludedReturned: August 26 1 1 1.000000
Quality Control Review has not concludedReturned: August 5 1 1 1.000000
Quality Control Review has not concludedReturned: August 6 1 1 1.000000
Quality Control Review has not concludedReturned: August 9 1 1 1.000000
Quality Control Review has not concludedReturned: December 14 1 1 1.000000
Quality Control Review has not concludedReturned: December 2 1 1 1.000000
Quality Control Review has not concludedReturned: December 27 1 1 1.000000
Quality Control Review has not concludedReturned: December 30 1 1 1.000000
Quality Control Review has not concludedReturned: December 9 1 1 1.000000
Quality Control Review has not concludedReturned: February 19 1 1 1.000000
Quality Control Review has not concludedReturned: January 11 1 1 1.000000
Quality Control Review has not concludedReturned: January 13 1 1 1.000000
Quality Control Review has not concludedReturned: January 20 1 1 1.000000
Quality Control Review has not concludedReturned: January 25 1 1 1.000000
Quality Control Review has not concludedReturned: January 26 1 1 1.000000
Quality Control Review has not concludedReturned: January 6 1 1 1.000000
Quality Control Review has not concludedReturned: January 7 1 1 1.000000
Quality Control Review has not concludedReturned: July 16 1 1 1.000000
Quality Control Review has not concludedReturned: July 21 1 1 1.000000
Quality Control Review has not concludedReturned: July 22 1 1 1.000000
Quality Control Review has not concludedReturned: July 27 1 1 1.000000
Quality Control Review has not concludedReturned: July 29 1 1 1.000000
Quality Control Review has not concludedReturned: July 7 1 1 1.000000
Quality Control Review has not concludedReturned: June 11 1 1 1.000000
Quality Control Review has not concludedReturned: June 14 1 1 1.000000
Quality Control Review has not concludedReturned: June 16 1 1 1.000000
Quality Control Review has not concludedReturned: June 29 1 1 1.000000
Quality Control Review has not concludedReturned: June 3 1 1 1.000000
Quality Control Review has not concludedReturned: June 4 1 1 1.000000
Quality Control Review has not concludedReturned: June 8 1 1 1.000000
Quality Control Review has not concludedReturned: March 17 1 1 1.000000
Quality Control Review has not concludedReturned: March 18 1 1 1.000000
Quality Control Review has not concludedReturned: March 22 1 1 1.000000
Quality Control Review has not concludedReturned: March 24 1 1 1.000000
Quality Control Review has not concludedReturned: May 18 1 1 1.000000
Quality Control Review has not concludedReturned: May 19 1 1 1.000000
Quality Control Review has not concludedReturned: May 21 1 1 1.000000
Quality Control Review has not concludedReturned: May 24 1 1 1.000000
Quality Control Review has not concludedReturned: May 26 1 1 1.000000
Quality Control Review has not concludedReturned: May 27 1 1 1.000000
Quality Control Review has not concludedReturned: May 3 1 1 1.000000
Quality Control Review has not concludedReturned: November 10 1 1 1.000000
Quality Control Review has not concludedReturned: November 16 1 1 1.000000
Quality Control Review has not concludedReturned: November 17 1 1 1.000000
Quality Control Review has not concludedReturned: November 19 1 1 1.000000
Quality Control Review has not concludedReturned: November 29 1 1 1.000000
Quality Control Review has not concludedReturned: November 3 1 1 1.000000
Quality Control Review has not concludedReturned: November 30 1 1 1.000000
Quality Control Review has not concludedReturned: October 12 1 1 1.000000
Quality Control Review has not concludedReturned: October 19 1 1 1.000000
Quality Control Review has not concludedReturned: October 20 1 1 1.000000
Quality Control Review has not concludedReturned: October 22 1 1 1.000000
Quality Control Review has not concludedReturned: October 25 1 1 1.000000
Quality Control Review has not concludedReturned: October 5 1 1 1.000000
Quality Control Review has not concludedReturned: October 6 1 1 1.000000
Quality Control Review has not concludedReturned: October 7 1 1 1.000000
Quality Control Review has not concludedReturned: October 8 1 1 1.000000
Quality Control Review has not concludedReturned: September 1 1 1 1.000000
Quality Control Review has not concludedReturned: September 13 1 1 1.000000
Quality Control Review has not concludedReturned: September 27 1 1 1.000000
Quality Control Review has not concludedReturned: September 3 1 1 1.000000

Enrollment Metrics by Phase

Measure Early.Phase.1 Not.Applicable Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 3.0 1.00 1.00000 1.0000 1.0000 3.000 1.000 1.000
1st Qu. 19.0 46.00 21.00000 35.7500 47.5000 120.000 146.000 66.000
Median 33.0 101.00 40.00000 90.0000 100.0000 310.000 400.000 200.000
Mean 99.5 36969.95 63.73423 271.1862 240.2683 2019.803 4939.007 2044.326
3rd Qu. 100.0 328.50 69.50000 246.5000 200.0000 722.000 1240.500 633.750
Max. 1000.0 40000000.00 974.00000 5394.0000 10000.0000 50000.000 500000.000 121000.000

Trial Group Type

group_type Group_Count
Experimental 4328
Active Comparator 1267
Placebo Comparator 1177
No Intervention 600
Other 398
Sham Comparator 47
20

Intervention Model

intervention_model Study_Count
Parallel Assignment 2288
Single Group Assignment 596
Sequential Assignment 163
Crossover Assignment 74
Factorial Assignment 46

Primary Purpose

primary_purpose Study_Count
Treatment 1846
Prevention 637
Supportive Care 177
Other 164
Diagnostic 161
Health Services Research 88
Basic Science 47
Screening 41
Device Feasibility 6

Has Results

nct_id brief_title link
NCT04382053 Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04382053
NCT04331899 Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04331899
NCT04347954 PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19) https://ClinicalTrials.gov/show/NCT04347954
NCT04349098 Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04349098
NCT04353037 PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine https://ClinicalTrials.gov/show/NCT04353037
NCT04355767 Convalescent Plasma in Outpatients With COVID-19 https://ClinicalTrials.gov/show/NCT04355767
NCT04358068 Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 https://ClinicalTrials.gov/show/NCT04358068
NCT04317040 CD24Fc (MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) https://ClinicalTrials.gov/show/NCT04317040
NCT04435184 Crizanlizumab for Treating COVID-19 Vasculopathy https://ClinicalTrials.gov/show/NCT04435184
NCT04388826 COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 https://ClinicalTrials.gov/show/NCT04388826
NCT04484207 Addressing COVID-19 Mental Health Problems Among US Veterans https://ClinicalTrials.gov/show/NCT04484207
NCT04401293 Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients https://ClinicalTrials.gov/show/NCT04401293
NCT04492475 Adaptive COVID-19 Treatment Trial 3 (ACTT-3) https://ClinicalTrials.gov/show/NCT04492475
NCT04497948 Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04497948
NCT04501952 Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734â„¢) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting https://ClinicalTrials.gov/show/NCT04501952
NCT04504032 A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) https://ClinicalTrials.gov/show/NCT04504032
NCT04507867 Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III https://ClinicalTrials.gov/show/NCT04507867
NCT04411628 A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 https://ClinicalTrials.gov/show/NCT04411628
NCT04418947 Project Resurgence Communication Trial https://ClinicalTrials.gov/show/NCT04418947
NCT04420273 Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access https://ClinicalTrials.gov/show/NCT04420273
NCT04523831 Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection https://ClinicalTrials.gov/show/NCT04523831
NCT04701658 A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04701658
NCT04706416 N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19) https://ClinicalTrials.gov/show/NCT04706416
NCT04502056 Covid-19 Messaging to Underserved Communities - 2nd Experiment https://ClinicalTrials.gov/show/NCT04502056
NCT04491994 Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression https://ClinicalTrials.gov/show/NCT04491994
NCT04491240 Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia. https://ClinicalTrials.gov/show/NCT04491240
NCT04463004 Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation https://ClinicalTrials.gov/show/NCT04463004
NCT04475588 Efficacy and Safety of Itolizumab in COVID-19 Complications https://ClinicalTrials.gov/show/NCT04475588
NCT04452435 Safety and Efficacy of C21 in Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04452435
NCT04435808 Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19 https://ClinicalTrials.gov/show/NCT04435808
NCT04402970 Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) https://ClinicalTrials.gov/show/NCT04402970
NCT04410159 Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients https://ClinicalTrials.gov/show/NCT04410159
NCT04392141 Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04392141
NCT04422561 Prophylactic Ivermectin in COVID-19 Contacts https://ClinicalTrials.gov/show/NCT04422561
NCT04421404 Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04421404
NCT04411667 Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04411667
NCT04409886 Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04409886
NCT04407507 Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms https://ClinicalTrials.gov/show/NCT04407507
NCT04392219 COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04392219
NCT04390022 Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial https://ClinicalTrials.gov/show/NCT04390022
NCT04401202 Nigella Sativa in COVID-19 https://ClinicalTrials.gov/show/NCT04401202
NCT04382066 Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04382066
NCT04380688 Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. https://ClinicalTrials.gov/show/NCT04380688
NCT04401579 Adaptive COVID-19 Treatment Trial 2 (ACTT-2) https://ClinicalTrials.gov/show/NCT04401579
NCT04399980 Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation https://ClinicalTrials.gov/show/NCT04399980
NCT04372186 A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04372186
NCT04371419 COVID-19 Health Messaging to Underserved Communities https://ClinicalTrials.gov/show/NCT04371419
NCT04370834 Tocilizumab for Patients With Cancer and COVID-19 Disease https://ClinicalTrials.gov/show/NCT04370834
NCT04363736 A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04363736
NCT04358081 Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04358081
NCT04356937 Efficacy of Tocilizumab on Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04356937
NCT04365699 Cardiovascular Effects of COVID-19 https://ClinicalTrials.gov/show/NCT04365699
NCT04340557 Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04340557
NCT04365153 Canakinumab in Covid-19 Cardiac Injury (The Three C Study) https://ClinicalTrials.gov/show/NCT04365153
NCT04362137 Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm https://ClinicalTrials.gov/show/NCT04362137
NCT04346199 Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. https://ClinicalTrials.gov/show/NCT04346199
NCT04354870 COVID-19 PrEP HCW HCQ Study https://ClinicalTrials.gov/show/NCT04354870
NCT04338009 Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04338009
NCT04334876 Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers https://ClinicalTrials.gov/show/NCT04334876
NCT04333225 Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers https://ClinicalTrials.gov/show/NCT04333225
NCT04332991 Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease https://ClinicalTrials.gov/show/NCT04332991
NCT04345653 Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers https://ClinicalTrials.gov/show/NCT04345653
NCT04343261 Convalescent Plasma in the Treatment of COVID 19 https://ClinicalTrials.gov/show/NCT04343261
NCT04343092 Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management https://ClinicalTrials.gov/show/NCT04343092
NCT04342663 A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04342663
NCT04342897 A Study of LY3127804 in Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04342897
NCT04329923 The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) https://ClinicalTrials.gov/show/NCT04329923
NCT04328467 Pre-exposure Prophylaxis for SARS-Coronavirus-2 https://ClinicalTrials.gov/show/NCT04328467
NCT04327388 Sarilumab COVID-19 https://ClinicalTrials.gov/show/NCT04327388
NCT04332081 Hyperbaric Oxygen for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04332081
NCT04332107 Azithromycin for COVID-19 Treatment in Outpatients Nationwide https://ClinicalTrials.gov/show/NCT04332107
NCT04322396 Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04322396
NCT04322682 Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) https://ClinicalTrials.gov/show/NCT04322682
NCT04338074 TXA and Corona Virus 2019 (COVID19) in Outpatients https://ClinicalTrials.gov/show/NCT04338074
NCT04335136 Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04335136
NCT04320615 A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04320615
NCT04335552 Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04335552
NCT04315298 Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04315298
NCT04308668 Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 https://ClinicalTrials.gov/show/NCT04308668
NCT04280705 Adaptive COVID-19 Treatment Trial (ACTT) https://ClinicalTrials.gov/show/NCT04280705
NCT04292899 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04292899
NCT04292730 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment https://ClinicalTrials.gov/show/NCT04292730
NCT04558125 Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism https://ClinicalTrials.gov/show/NCT04558125
NCT04381988 A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy https://ClinicalTrials.gov/show/NCT04381988
NCT04353271 Trial of Hydroxychloroquine In Covid-19 Kinetics https://ClinicalTrials.gov/show/NCT04353271
NCT04706403 Views on COVID-19 and Vaccination https://ClinicalTrials.gov/show/NCT04706403
NCT04502472 Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma https://ClinicalTrials.gov/show/NCT04502472
NCT04377711 A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04377711
NCT04494646 BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04494646
NCT04497415 The COVID-19 and Healthcare Workers: An Active Intervention https://ClinicalTrials.gov/show/NCT04497415
NCT04389333 Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04389333
NCT04386616 A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04386616
NCT04572399 UVA Light Device to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04572399
NCT04583592 Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT) https://ClinicalTrials.gov/show/NCT04583592
NCT04377620 Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) https://ClinicalTrials.gov/show/NCT04377620
NCT04579549 Repeat Testing for SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04579549
NCT04460690 Rapid, Onsite COVID-19 Detection https://ClinicalTrials.gov/show/NCT04460690
NCT04374019 Novel Agents for Treatment of High-risk COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04374019
NCT04357730 Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04357730
NCT04685213 Electrical Stimulation for Critically Ill Covid-19 Patients https://ClinicalTrials.gov/show/NCT04685213
NCT04425720 Use of Remote Monitoring for COVID-19 Patient https://ClinicalTrials.gov/show/NCT04425720
NCT04409509 Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04409509
NCT04380519 Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04380519
NCT04362813 Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia https://ClinicalTrials.gov/show/NCT04362813
NCT04365985 Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 https://ClinicalTrials.gov/show/NCT04365985
NCT05087524 BinaxNOW for Evaluating Children for Infection With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT05087524
NCT04532294 Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants https://ClinicalTrials.gov/show/NCT04532294
NCT04524507 Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04524507
NCT04382924 Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease https://ClinicalTrials.gov/show/NCT04382924
NCT04425538 A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19). https://ClinicalTrials.gov/show/NCT04425538
NCT04355728 Use of UC-MSCs for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04355728
NCT04344535 Convalescent Plasma vs. Standard Plasma for COVID-19 https://ClinicalTrials.gov/show/NCT04344535
NCT04446429 Anti-Androgen Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04446429
NCT04331366 Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19 https://ClinicalTrials.gov/show/NCT04331366
NCT04372017 Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection https://ClinicalTrials.gov/show/NCT04372017
NCT04876274 Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04876274
NCT04524598 A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19 https://ClinicalTrials.gov/show/NCT04524598
NCT04456153 Atovaquone for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04456153
NCT04351243 A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) https://ClinicalTrials.gov/show/NCT04351243
NCT04328961 Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) https://ClinicalTrials.gov/show/NCT04328961
NCT04644328 The Doctors for Coronavirus Prevention Project Thanksgiving / Christmas Messaging Campaign https://ClinicalTrials.gov/show/NCT04644328
NCT05057923 The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores https://ClinicalTrials.gov/show/NCT05057923
NCT04632706 Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19 https://ClinicalTrials.gov/show/NCT04632706
NCT04498247 A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) https://ClinicalTrials.gov/show/NCT04498247
NCT04359797 COVID-19 Patient Positioning Pragmatic Trial https://ClinicalTrials.gov/show/NCT04359797
NCT04569786 Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) https://ClinicalTrials.gov/show/NCT04569786
NCT04871815 Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers. https://ClinicalTrials.gov/show/NCT04871815
NCT04732819 Improving COVID-19 Vaccine Uptake in Nursing Homes https://ClinicalTrials.gov/show/NCT04732819
NCT04728802 Proxalutamide Treatment for Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04728802
NCT04728594 Emails Promoting COVID-19 Vaccination Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04728594
NCT04724538 Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19 https://ClinicalTrials.gov/show/NCT04724538
NCT04716426 APTâ„¢ T3X on the COVID-19 Contamination Rate https://ClinicalTrials.gov/show/NCT04716426
NCT04698993 Dräger COVID-19 Antigen Test Clinical Performance Study https://ClinicalTrials.gov/show/NCT04698993
NCT04674644 Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales https://ClinicalTrials.gov/show/NCT04674644
NCT04673214 Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment https://ClinicalTrials.gov/show/NCT04673214
NCT04646109 Ivermectin for Severe COVID-19 Management https://ClinicalTrials.gov/show/NCT04646109
NCT04634903 Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04634903
NCT04610489 Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04610489
NCT04599959 COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR https://ClinicalTrials.gov/show/NCT04599959
NCT04596085 Study to Evaluate Efficacy and Safety of “VIRACIDE” IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04596085
NCT04542694 Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04542694
NCT04432272 ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS) https://ClinicalTrials.gov/show/NCT04432272
NCT05017493 Treatment of Covid-19 With a Herbal Compound, Xagrotin https://ClinicalTrials.gov/show/NCT05017493
NCT04374149 Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS https://ClinicalTrials.gov/show/NCT04374149
NCT04348500 Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04348500
NCT04347941 Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE https://ClinicalTrials.gov/show/NCT04347941

Vaccines

nct_id brief_title link
NCT05175625 Immunogenicity and Safety of a Booster Dose of the SpikoGen COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05175625
NCT05148091 The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults https://ClinicalTrials.gov/show/NCT05148091
NCT05158855 Oral Neutralizing Antibody Booster for Post-vaccinated People With COVID19 Vaccine https://ClinicalTrials.gov/show/NCT05158855
NCT05142553 Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against the Virus That Cause COVID-19, Know as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2) in Healthy Adults Volunteers Fully Vaccinated https://ClinicalTrials.gov/show/NCT05142553
NCT04952402 SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine https://ClinicalTrials.gov/show/NCT04952402
NCT04944368 Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen) https://ClinicalTrials.gov/show/NCT04944368
NCT05005559 Phase III Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen) https://ClinicalTrials.gov/show/NCT05005559
NCT04954287 Phase 1 Study of Intranasal PIV5-vectored COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults https://ClinicalTrials.gov/show/NCT04954287
NCT04761822 COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations https://ClinicalTrials.gov/show/NCT04761822
NCT04895449 Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19 https://ClinicalTrials.gov/show/NCT04895449
NCT04805125 Immunocompromised Swiss Cohorts Based Trial Platform https://ClinicalTrials.gov/show/NCT04805125
NCT04706403 Views on COVID-19 and Vaccination https://ClinicalTrials.gov/show/NCT04706403
NCT05181709 A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study. https://ClinicalTrials.gov/show/NCT05181709
NCT05156723 The Objectives of This Study Are Study the Immunogenicity, Safety and Tolerability of the Coronavirus Vaccine in Healthy Adult Volunteer Aged 18 to 60 Years. https://ClinicalTrials.gov/show/NCT05156723
NCT04973449 Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04973449
NCT04673149 GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04673149
NCT05185687 Public Support for COVID-19 Test Allocation https://ClinicalTrials.gov/show/NCT05185687
NCT05160766 Assessing Immune Response of Different COVID-19 Vaccines in Older Adults https://ClinicalTrials.gov/show/NCT05160766
NCT05157230 Evaluation of Deltoid Exercises on Injection Site Pain After (BNT162b2) COVID - 19 Vaccination https://ClinicalTrials.gov/show/NCT05157230
NCT05148962 Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers https://ClinicalTrials.gov/show/NCT05148962
NCT05012943 The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01) https://ClinicalTrials.gov/show/NCT05012943
NCT04742842 The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04742842
NCT04686773 Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention https://ClinicalTrials.gov/show/NCT04686773
NCT04336410 Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04336410
NCT04560881 Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19) https://ClinicalTrials.gov/show/NCT04560881
NCT05191394 IMPACT OF THERAPEUTIC PLASMA EXCHANGE ON ACQUIRED VACCINAL ANTI-SARS-CoV-2 ANTIBODIES. https://ClinicalTrials.gov/show/NCT05191394
NCT05050474 Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) https://ClinicalTrials.gov/show/NCT05050474
NCT04894435 Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity https://ClinicalTrials.gov/show/NCT04894435
NCT04847050 A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy, Including Boost… https://ClinicalTrials.gov/show/NCT04847050
NCT05175742 PTX-COVID19-B, an mRNA Humoral Vaccine, Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Demonstrate the Safety, Tolerability, and Immunogenicity of PTX-COVID19-B in Comparison to the Pfizer-BioNTech COVID-19 Vaccine. https://ClinicalTrials.gov/show/NCT05175742
NCT04649151 A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04649151
NCT04639466 A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04639466
NCT05182554 COVID-19 Messaging for Vaccination https://ClinicalTrials.gov/show/NCT05182554
NCT05085613 Does Framing and Humor Improve the Effectiveness of Messages About COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05085613
NCT05065879 Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes https://ClinicalTrials.gov/show/NCT05065879
NCT04951336 RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT04951336
NCT04754594 Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older https://ClinicalTrials.gov/show/NCT04754594
NCT04611802 A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years) at Risk for SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04611802
NCT04449276 A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults https://ClinicalTrials.gov/show/NCT04449276
NCT05096845 Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III https://ClinicalTrials.gov/show/NCT05096845
NCT05096832 Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study https://ClinicalTrials.gov/show/NCT05096832
NCT05057182 Third Dose of mRNA Vaccination to Boost COVID-19 Immunity (mBoost Study) https://ClinicalTrials.gov/show/NCT05057182
NCT05033847 Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above https://ClinicalTrials.gov/show/NCT05033847
NCT04537949 A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04537949
NCT04508075 Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine https://ClinicalTrials.gov/show/NCT04508075
NCT04380701 A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults https://ClinicalTrials.gov/show/NCT04380701
NCT05132855 The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05132855
NCT05091307 A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults https://ClinicalTrials.gov/show/NCT05091307
NCT04954469 B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency https://ClinicalTrials.gov/show/NCT04954469
NCT04792567 Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC) https://ClinicalTrials.gov/show/NCT04792567
NCT04546841 Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults https://ClinicalTrials.gov/show/NCT04546841
NCT04535453 A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents https://ClinicalTrials.gov/show/NCT04535453
NCT04646590 A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04646590
NCT04283461 Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04283461
NCT05198336 Immunogenicity of an Inactivated COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05198336
NCT05198102 ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization https://ClinicalTrials.gov/show/NCT05198102
NCT04878211 A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab https://ClinicalTrials.gov/show/NCT04878211
NCT04864548 COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection Study https://ClinicalTrials.gov/show/NCT04864548
NCT05137236 A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters https://ClinicalTrials.gov/show/NCT05137236
NCT05069623 A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT05069623
NCT04813796 A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04813796
NCT04889274 Investigation of the Effects of Dietary Nitrate and Sex on COVID-19 Vaccine Induced Vascular Dysfunction in Healthy Men and Women (DiNOVasc-COVID-19) https://ClinicalTrials.gov/show/NCT04889274
NCT04400838 Investigating a Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04400838
NCT04324606 A Study of a Candidate COVID-19 Vaccine (COV001) https://ClinicalTrials.gov/show/NCT04324606
NCT05205746 Phase II Immunogenicity Study of AVX/COVID-12 (Patria) Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence https://ClinicalTrials.gov/show/NCT05205746
NCT05205096 Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac https://ClinicalTrials.gov/show/NCT05205096
NCT05205083 Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV https://ClinicalTrials.gov/show/NCT05205083
NCT05204589 Heterologous Boost Immunization With an Aerosolised Ad5-nCoV After Two-dose Priming With an Inactivated SARS-CoV-2 Vaccine https://ClinicalTrials.gov/show/NCT05204589
NCT05168813 Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern https://ClinicalTrials.gov/show/NCT05168813
NCT05043311 The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine. https://ClinicalTrials.gov/show/NCT05043311
NCT05043285 The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine. https://ClinicalTrials.gov/show/NCT05043285
NCT05049226 Third Dose Vaccination With AstraZeneca or Pfizer COVID-19 Vaccine Among Adults Received Sinovac COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05049226
NCT05047692 Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers https://ClinicalTrials.gov/show/NCT05047692
NCT04379336 BCG Vaccination for Healthcare Workers in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04379336
NCT05022329 COVID-19 Vaccine Boosters in Patients With CKD https://ClinicalTrials.gov/show/NCT05022329
NCT04327206 BCG Vaccination to Protect Healthcare Workers Against COVID-19 https://ClinicalTrials.gov/show/NCT04327206
NCT05213000 Health Factors and Immune Response to Coronavirus Disease 2019 (COVID-19) Vaccine https://ClinicalTrials.gov/show/NCT05213000
NCT05210179 Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19 https://ClinicalTrials.gov/show/NCT05210179
NCT05158140 Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911) https://ClinicalTrials.gov/show/NCT05158140
NCT05132907 Safety And Immunogenicity Of HDT-301 Targeting A SARS-CoV-2 Variant Spike Protein https://ClinicalTrials.gov/show/NCT05132907
NCT05102643 A Study to Evaluate Safety & Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19 https://ClinicalTrials.gov/show/NCT05102643
NCT04889209 Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines https://ClinicalTrials.gov/show/NCT04889209
NCT04776317 Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults https://ClinicalTrials.gov/show/NCT04776317
NCT04785144 Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults https://ClinicalTrials.gov/show/NCT04785144
NCT04762680 Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older https://ClinicalTrials.gov/show/NCT04762680
NCT05075499 Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab https://ClinicalTrials.gov/show/NCT05075499
NCT05074368 Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT05074368
NCT04821674 Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects https://ClinicalTrials.gov/show/NCT04821674
NCT04852978 COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT04852978
NCT04961541 Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine https://ClinicalTrials.gov/show/NCT04961541
NCT04368988 Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant https://ClinicalTrials.gov/show/NCT04368988
NCT04583995 A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom https://ClinicalTrials.gov/show/NCT04583995
NCT05077176 Phase 3 Booster Vaccination Against COVID-19 https://ClinicalTrials.gov/show/NCT05077176
NCT05007275 A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT05007275
NCT04515147 A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 https://ClinicalTrials.gov/show/NCT04515147
NCT05148845 Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study. https://ClinicalTrials.gov/show/NCT05148845
NCT04992260 Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents https://ClinicalTrials.gov/show/NCT04992260
NCT05047640 COVID-19 3rd Dose Vaccine in Transplant Patients https://ClinicalTrials.gov/show/NCT05047640
NCT04936997 Immune Response to the COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04936997
NCT04818801 Safety, Reactogenicity and Immunogenicity Study of ReCOV https://ClinicalTrials.gov/show/NCT04818801
NCT04715997 Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04715997
NCT04445389 Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04445389
NCT05124171 Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination https://ClinicalTrials.gov/show/NCT05124171
NCT05047770 A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine https://ClinicalTrials.gov/show/NCT05047770
NCT05157178 Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses. https://ClinicalTrials.gov/show/NCT05157178
NCT05112913 Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 Years https://ClinicalTrials.gov/show/NCT05112913
NCT05137418 Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years https://ClinicalTrials.gov/show/NCT05137418
NCT04904744 Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT04904744
NCT05030974 RECOVAC Third Vaccination Study https://ClinicalTrials.gov/show/NCT05030974
NCT05022472 Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California https://ClinicalTrials.gov/show/NCT05022472
NCT04967742 A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04967742
NCT05000216 COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders https://ClinicalTrials.gov/show/NCT05000216
NCT04690387 Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection https://ClinicalTrials.gov/show/NCT04690387
NCT05067933 A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05067933
NCT05163743 Diet and COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT05163743
NCT04969250 Vaccination for Recovered Inpatients With COVID-19 (VATICO) https://ClinicalTrials.gov/show/NCT04969250
NCT04816669 A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04816669
NCT04681092 Anti-COVID19 AKS-452 Fusion Protein Vaccine - ACT Study https://ClinicalTrials.gov/show/NCT04681092
NCT04588480 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults https://ClinicalTrials.gov/show/NCT04588480
NCT05165966 Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT05165966
NCT04904471 A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells) https://ClinicalTrials.gov/show/NCT04904471
NCT04788459 Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT04788459
NCT04860297 A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants https://ClinicalTrials.gov/show/NCT04860297
NCT04796896 A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age https://ClinicalTrials.gov/show/NCT04796896
NCT04470427 A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04470427
NCT05148949 Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients https://ClinicalTrials.gov/show/NCT05148949
NCT05097053 A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19 https://ClinicalTrials.gov/show/NCT05097053
NCT05135585 Evaluation of the Post-vaccination Immune Response to COVID-19 in the New Caledonian Population https://ClinicalTrials.gov/show/NCT05135585
NCT05087173 Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT05087173
NCT05067894 Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine https://ClinicalTrials.gov/show/NCT05067894
NCT05057923 The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores https://ClinicalTrials.gov/show/NCT05057923
NCT05057169 Randomized Trial of COVID-19 Booster Vaccinations (Cobovax Study) https://ClinicalTrials.gov/show/NCT05057169
NCT04955626 To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of a Booster Dose of BNT162b2 Against COVID-19 in Participants ≥12 Years of Age. https://ClinicalTrials.gov/show/NCT04955626
NCT04951310 COVID-19 Vaccinations With a Sweepstakes https://ClinicalTrials.gov/show/NCT04951310
NCT04816643 A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Young Adults https://ClinicalTrials.gov/show/NCT04816643
NCT04758962 A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04758962
NCT04537208 Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older https://ClinicalTrials.gov/show/NCT04537208
NCT04523246 Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents https://ClinicalTrials.gov/show/NCT04523246
NCT04368728 Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals https://ClinicalTrials.gov/show/NCT04368728
NCT04498247 A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) https://ClinicalTrials.gov/show/NCT04498247
NCT04999111 A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2 https://ClinicalTrials.gov/show/NCT04999111
NCT04569786 Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) https://ClinicalTrials.gov/show/NCT04569786
NCT04526990 Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above https://ClinicalTrials.gov/show/NCT04526990
NCT04527081 Study of COVID-19 DNA Vaccine (AG0302-COVID19) https://ClinicalTrials.gov/show/NCT04527081
NCT04510207 A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above https://ClinicalTrials.gov/show/NCT04510207
NCT04497298 Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04497298
NCT04495933 A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04495933
NCT04480957 Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT04480957
NCT04475302 BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots https://ClinicalTrials.gov/show/NCT04475302
NCT04473690 KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04473690
NCT04471519 Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04471519
NCT04470609 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years https://ClinicalTrials.gov/show/NCT04470609
NCT04466085 Clinical Study of Recombinant Novel Coronavirus Vaccine https://ClinicalTrials.gov/show/NCT04466085
NCT04463472 Study of COVID-19 DNA Vaccine (AG0301-COVID19) https://ClinicalTrials.gov/show/NCT04463472
NCT04461379 Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04461379
NCT04456595 Clinical Trial of Efficacy and Safety of Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals https://ClinicalTrials.gov/show/NCT04456595
NCT04453852 Monovalent Recombinant COVID19 Vaccine https://ClinicalTrials.gov/show/NCT04453852
NCT04450004 Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. https://ClinicalTrials.gov/show/NCT04450004
NCT04447781 Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 https://ClinicalTrials.gov/show/NCT04447781
NCT04445194 Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine https://ClinicalTrials.gov/show/NCT04445194
NCT04444674 COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection https://ClinicalTrials.gov/show/NCT04444674
NCT04437875 An Open Study of the Safety, Tolerability and Immunogenicity of “Gam-COVID-Vac Lyo” Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04437875
NCT04436471 An Open Study of the Safety, Tolerability and Immunogenicity of the Drug “Gam-COVID-Vac” Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04436471
NCT04417335 Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination https://ClinicalTrials.gov/show/NCT04417335
NCT04414267 Bacillus Calmette-guérin Vaccination to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04414267
NCT04412538 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 https://ClinicalTrials.gov/show/NCT04412538
NCT04405908 SCB-2019 as COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04405908
NCT04384549 Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers https://ClinicalTrials.gov/show/NCT04384549
NCT04383574 Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) https://ClinicalTrials.gov/show/NCT04383574
NCT04380532 Tableted COVID-19 Therapeutic Vaccine https://ClinicalTrials.gov/show/NCT04380532
NCT04373291 Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04373291
NCT04372589 Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) https://ClinicalTrials.gov/show/NCT04372589
NCT04369794 COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement https://ClinicalTrials.gov/show/NCT04369794
NCT04352608 Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04352608
NCT04348370 BCG Vaccine for Health Care Workers as Defense Against COVID 19 https://ClinicalTrials.gov/show/NCT04348370
NCT04341389 A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) https://ClinicalTrials.gov/show/NCT04341389
NCT04328441 Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine https://ClinicalTrials.gov/show/NCT04328441
NCT04313127 Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults https://ClinicalTrials.gov/show/NCT04313127
NCT04299724 Safety and Immunity of Covid-19 aAPC Vaccine https://ClinicalTrials.gov/show/NCT04299724
NCT04276896 Immunity and Safety of Covid-19 Synthetic Minigene Vaccine https://ClinicalTrials.gov/show/NCT04276896
NCT04951323 Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo) https://ClinicalTrials.gov/show/NCT04951323
NCT05079152 Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 https://ClinicalTrials.gov/show/NCT05079152
NCT04930965 Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate https://ClinicalTrials.gov/show/NCT04930965
NCT05047445 A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection https://ClinicalTrials.gov/show/NCT05047445
NCT04750343 Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19) https://ClinicalTrials.gov/show/NCT04750343
NCT04742738 Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19) https://ClinicalTrials.gov/show/NCT04742738
NCT04715438 Vaccination Against COVID-19 in Cancer https://ClinicalTrials.gov/show/NCT04715438
NCT04641858 BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04641858
NCT04838795 Sisonke (Together): OPEN LABEL TRIAL COVID-19 https://ClinicalTrials.gov/show/NCT04838795
NCT04522089 A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine https://ClinicalTrials.gov/show/NCT04522089
NCT04942405 Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine https://ClinicalTrials.gov/show/NCT04942405
NCT04852861 COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine https://ClinicalTrials.gov/show/NCT04852861
NCT05085145 Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV https://ClinicalTrials.gov/show/NCT05085145
NCT05028257 Allergy and COVID-19 Vaccines https://ClinicalTrials.gov/show/NCT05028257
NCT04952376 Equitable Access to COVID-19 Vaccines https://ClinicalTrials.gov/show/NCT04952376
NCT04790851 Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4 https://ClinicalTrials.gov/show/NCT04790851
NCT05089045 Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity https://ClinicalTrials.gov/show/NCT05089045
NCT05077267 ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects https://ClinicalTrials.gov/show/NCT05077267
NCT05075083 Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD https://ClinicalTrials.gov/show/NCT05075083
NCT05075070 Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People With HIV Infected https://ClinicalTrials.gov/show/NCT05075070
NCT05075057 Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD https://ClinicalTrials.gov/show/NCT05075057
NCT05075044 Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected https://ClinicalTrials.gov/show/NCT05075044
NCT05007951 Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19) https://ClinicalTrials.gov/show/NCT05007951
NCT05091411 Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells) https://ClinicalTrials.gov/show/NCT05091411
NCT05069129 Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above https://ClinicalTrials.gov/show/NCT05069129
NCT05054621 Immunogenicity of COVID-19 Vaccine on Heterologous Schedule https://ClinicalTrials.gov/show/NCT05054621
NCT05037201 Text Message Nudges for COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT05037201
NCT05096026 Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination Among Elderly Patients https://ClinicalTrials.gov/show/NCT05096026
NCT04960228 Exploring Changes in COVID-19 Vaccination Intentions by Prompting Altruistic Motives Using a Video Intervention https://ClinicalTrials.gov/show/NCT04960228
NCT04839042 A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04839042
NCT04956224 Immunogenicity of VLA2101 Compared to VLA2001. https://ClinicalTrials.gov/show/NCT04956224
NCT04756271 Safety and Immunogenicity of Oxford AstraZeneca Vaccine Against COVID-19 Infection https://ClinicalTrials.gov/show/NCT04756271
NCT04773067 A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers https://ClinicalTrials.gov/show/NCT04773067
NCT04864561 Study To Compare The Immunogenicity Against COVID-19, Of VLA2001 Vaccine To AZD1222 Vaccine https://ClinicalTrials.gov/show/NCT04864561
NCT05099497 Supporting Audit and Feedback to Encourage Vaccine Uptake https://ClinicalTrials.gov/show/NCT05099497
NCT04992208 Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents https://ClinicalTrials.gov/show/NCT04992208
NCT04911790 Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04911790
NCT04671017 Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects https://ClinicalTrials.gov/show/NCT04671017
NCT04505774 Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE https://ClinicalTrials.gov/show/NCT04505774
NCT04927065 A Study to Evaluate the Immunogenicity and Safety of mRNA-1273.211 Vaccine for COVID-19 Variants https://ClinicalTrials.gov/show/NCT04927065
NCT04642638 Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure https://ClinicalTrials.gov/show/NCT04642638
NCT05048849 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study https://ClinicalTrials.gov/show/NCT05048849
NCT05107375 Clinical Study of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell) Combined With Influenza Vaccine https://ClinicalTrials.gov/show/NCT05107375
NCT05038618 A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study https://ClinicalTrials.gov/show/NCT05038618
NCT04977024 SARS-CoV-2 Vaccine (COH04S1) Versus Emergency Use Authorization SARS-COV-2 Vaccine for the Treatment of COVID-19 in Patients With Blood Cancer https://ClinicalTrials.gov/show/NCT04977024
NCT04695652 A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult https://ClinicalTrials.gov/show/NCT04695652
NCT04822025 A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults https://ClinicalTrials.gov/show/NCT04822025
NCT04951388 A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents https://ClinicalTrials.gov/show/NCT04951388
NCT04953078 A Study to Evaluate Safety, Tolerability, and Reactogenicity of an RBD-Fc-based Vaccine to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04953078
NCT04569383 Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04569383
NCT04460703 COVID-19 Vaccine Messaging, Part 1 https://ClinicalTrials.gov/show/NCT04460703
NCT05113849 Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19) https://ClinicalTrials.gov/show/NCT05113849
NCT04523571 Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects https://ClinicalTrials.gov/show/NCT04523571
NCT05046548 This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 https://ClinicalTrials.gov/show/NCT05046548
NCT05037097 A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults https://ClinicalTrials.gov/show/NCT05037097
NCT04816019 A Study of Intranasal ChAdOx1 nCOV-19 https://ClinicalTrials.gov/show/NCT04816019
NCT04969601 Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings https://ClinicalTrials.gov/show/NCT04969601
NCT05113862 Evaluation of Safety and Immunogenicity of a T-Cell Priming Peptide Vaccine Against Coronavirus COVID-19 https://ClinicalTrials.gov/show/NCT05113862
NCT04870593 What Works to Get the Elderly Vaccinated Against COVID-19? Experimental Evidence From India https://ClinicalTrials.gov/show/NCT04870593
NCT05125874 Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization https://ClinicalTrials.gov/show/NCT05125874
NCT05047718 Factors Influencing the COVID-19 Vaccine Immune Response According to Age and Presence or Not of a Past History of COVID-19 https://ClinicalTrials.gov/show/NCT05047718
NCT04869358 Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab https://ClinicalTrials.gov/show/NCT04869358
NCT04798027 Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older https://ClinicalTrials.gov/show/NCT04798027
NCT04847102 A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above https://ClinicalTrials.gov/show/NCT04847102
NCT04800133 Covid-19 Vaccination in Adolescents and Children https://ClinicalTrials.gov/show/NCT04800133
NCT05128721 Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT05128721
NCT05128643 Clinical Study on the Immune Program of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell) https://ClinicalTrials.gov/show/NCT05128643
NCT04839146 Safety and Tolerability of COVID-19 Vaccine (ABNCoV2) https://ClinicalTrials.gov/show/NCT04839146
NCT05109598 Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus(COVID-19) Vaccine (CHO Cell) https://ClinicalTrials.gov/show/NCT05109598
NCT05107557 Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell) https://ClinicalTrials.gov/show/NCT05107557
NCT05028361 Simultaneous mRNA COVID-19 and IIV4 Vaccination Study https://ClinicalTrials.gov/show/NCT05028361
NCT05133609 COVID-19 VACCINE SAFETY AND EFFECTIVENESS https://ClinicalTrials.gov/show/NCT05133609
NCT05037266 Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen https://ClinicalTrials.gov/show/NCT05037266
NCT04445428 OPV as Potential Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04445428
NCT05069649 Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2 https://ClinicalTrials.gov/show/NCT05069649
NCT04867174 COVID-19 Vaccination Take-Up https://ClinicalTrials.gov/show/NCT04867174
NCT04904549 Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older https://ClinicalTrials.gov/show/NCT04904549
NCT04979949 Booster Vaccination Against COVID-19 https://ClinicalTrials.gov/show/NCT04979949
NCT04568031 Study of AZD1222 for the Prevention of COVID-19 in Japan https://ClinicalTrials.gov/show/NCT04568031
NCT04405076 Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older https://ClinicalTrials.gov/show/NCT04405076
NCT04334980 Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04334980
NCT05069454 Study on COVID-19 Vaccine Effectiveness Among Health Workers in Azerbaijan https://ClinicalTrials.gov/show/NCT05069454
NCT05060939 SARS-CoV-2 Infection in COVID-19 Vaccinated Patients https://ClinicalTrials.gov/show/NCT05060939
NCT05060991 Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients https://ClinicalTrials.gov/show/NCT05060991
NCT05059106 EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19 https://ClinicalTrials.gov/show/NCT05059106
NCT05043259 Heterologous Prime-boost Immunization With an Aerosolised Adenovirus Type-5 Vector-based COVID-19 Vaccine (Ad5-nCoV) After Priming With an Inactivated SARS-CoV-2 Vaccine https://ClinicalTrials.gov/show/NCT05043259
NCT05037188 Clinical Study of the Safety and Immunogenicity of a Recombinant Viral Vector AAV5 (Adeno-Associated Virus Type 5 )-RBD (Receptor Binding Domain)-S Vaccine for the Prevention of Coronavirus Infection (COVID-19) https://ClinicalTrials.gov/show/NCT05037188
NCT05033860 The Influence of Education During Waiting Time of Vaccination on the Knowledge Towards COVID-19 Among Chinese Residents https://ClinicalTrials.gov/show/NCT05033860
NCT05033158 The Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population. https://ClinicalTrials.gov/show/NCT05033158
NCT05027672 Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines. https://ClinicalTrials.gov/show/NCT05027672
NCT05028374 COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT05028374
NCT05021016 Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above https://ClinicalTrials.gov/show/NCT05021016
NCT05018078 Safety and Immunogenicity of COVID-19 Vaccination in Patients With Cancer https://ClinicalTrials.gov/show/NCT05018078
NCT05017805 COVID-19 Vaccines in Patients With Chronic Liver Disease https://ClinicalTrials.gov/show/NCT05017805
NCT05017792 Evaluation of Clinical and Antibody Response to Covid-19 Vaccination Strategy in TBRI, Egypt https://ClinicalTrials.gov/show/NCT05017792
NCT05012800 Safety and Immunogenicity of COVID-19 Vaccine Administered in Older Adults https://ClinicalTrials.gov/show/NCT05012800
NCT05007509 Safety and Immunogenicity Study of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers (COVID-19) https://ClinicalTrials.gov/show/NCT05007509
NCT05007496 Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19 https://ClinicalTrials.gov/show/NCT05007496
NCT05005156 Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in Adults 18 Years of Age and Older. https://ClinicalTrials.gov/show/NCT05005156
NCT04996238 Local and General Immune Response After Coronavirus Disease (COVID-19) Vaccination in Volunteers https://ClinicalTrials.gov/show/NCT04996238
NCT04993586 Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose) https://ClinicalTrials.gov/show/NCT04993586
NCT04993209 Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil https://ClinicalTrials.gov/show/NCT04993209
NCT04992182 Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster https://ClinicalTrials.gov/show/NCT04992182
NCT04990544 Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) https://ClinicalTrials.gov/show/NCT04990544
NCT04988048 Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina https://ClinicalTrials.gov/show/NCT04988048
NCT04983537 Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population https://ClinicalTrials.gov/show/NCT04983537
NCT04982068 Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) https://ClinicalTrials.gov/show/NCT04982068
NCT04977479 The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose https://ClinicalTrials.gov/show/NCT04977479
NCT04969276 Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04969276
NCT04969263 COVID-19 Protection After Transplant Pilot Study https://ClinicalTrials.gov/show/NCT04969263
NCT04967807 Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study) https://ClinicalTrials.gov/show/NCT04967807
NCT04964154 Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans’ Perceptions/Beliefs About COVID-19 Testing and Vaccination Study https://ClinicalTrials.gov/show/NCT04964154
NCT04962893 Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine https://ClinicalTrials.gov/show/NCT04962893
NCT04962906 Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes https://ClinicalTrials.gov/show/NCT04962906
NCT04962308 Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04962308
NCT04961502 Humoral and Cellular Responses to Vaccination Against Coronavirus Disease 2019 (COVID-19) in the Very Elderly Living in Geriatric Institutions https://ClinicalTrials.gov/show/NCT04961502
NCT04961359 Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2(COVID-19) Phase I Clinical Trial (3~17 Years Old) https://ClinicalTrials.gov/show/NCT04961359
NCT04954092 Study of Gam-COVID-Vac in Adolescents https://ClinicalTrials.gov/show/NCT04954092
NCT04953325 Immunogenicity and Safety of an Inactivated COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04953325
NCT04952766 Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults https://ClinicalTrials.gov/show/NCT04952766
NCT04952727 Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults https://ClinicalTrials.gov/show/NCT04952727
NCT04939519 SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers https://ClinicalTrials.gov/show/NCT04939519
NCT04939402 SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector https://ClinicalTrials.gov/show/NCT04939402
NCT04935528 Mechanisms of Anti COVID-19 Humoral and Cellular Immune Response After Vaccination in a Sample of Patients and Salaried Staff From a French Anti-cancer Center https://ClinicalTrials.gov/show/NCT04935528
NCT04932824 Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19. https://ClinicalTrials.gov/show/NCT04932824
NCT04930003 Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04930003
NCT04928456 Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps https://ClinicalTrials.gov/show/NCT04928456
NCT04922788 Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04922788
NCT04918940 Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma https://ClinicalTrials.gov/show/NCT04918940
NCT04918797 COVAXIN in a Pediatric Cohort https://ClinicalTrials.gov/show/NCT04918797
NCT04915989 Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals https://ClinicalTrials.gov/show/NCT04915989
NCT04916886 A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups. https://ClinicalTrials.gov/show/NCT04916886
NCT04915820 Iron and COVID-19 Vaccine Response https://ClinicalTrials.gov/show/NCT04915820
NCT04907331 Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2 https://ClinicalTrials.gov/show/NCT04907331
NCT04900467 Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine https://ClinicalTrials.gov/show/NCT04900467
NCT04896788 Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff https://ClinicalTrials.gov/show/NCT04896788
NCT04894227 Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04894227
NCT04892459 Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector) https://ClinicalTrials.gov/show/NCT04892459
NCT04885907 Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients https://ClinicalTrials.gov/show/NCT04885907
NCT04885764 Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University https://ClinicalTrials.gov/show/NCT04885764
NCT04885361 To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults https://ClinicalTrials.gov/show/NCT04885361
NCT04884685 Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents https://ClinicalTrials.gov/show/NCT04884685
NCT04881227 The Impact of a Chatbot on COVID-19 Vaccine Perceptions and Intentions in ESPERES Cohort (ESPERES-COVID-19-CHATBOT) https://ClinicalTrials.gov/show/NCT04881227
NCT04880174 SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT04880174
NCT04873128 Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS Approach https://ClinicalTrials.gov/show/NCT04873128
NCT04871737 Study of a Live rNDV Based Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04871737
NCT04869592 A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19 https://ClinicalTrials.gov/show/NCT04869592
NCT04866069 Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04866069
NCT04863638 A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated https://ClinicalTrials.gov/show/NCT04863638
NCT04863131 Safety and Immunogenicity of EXG-5003 https://ClinicalTrials.gov/show/NCT04863131
NCT04860739 Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose https://ClinicalTrials.gov/show/NCT04860739
NCT04860258 A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities for COVID-19 https://ClinicalTrials.gov/show/NCT04860258
NCT04844346 Plant Stanol Esters and COVID-19 Vaccination Response https://ClinicalTrials.gov/show/NCT04844346
NCT04844489 Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People https://ClinicalTrials.gov/show/NCT04844489
NCT04842708 Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis https://ClinicalTrials.gov/show/NCT04842708
NCT04840992 Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation https://ClinicalTrials.gov/show/NCT04840992
NCT04839315 COVID-19 Vaccination in Rheumatic Disease Patients https://ClinicalTrials.gov/show/NCT04839315
NCT04838080 Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo https://ClinicalTrials.gov/show/NCT04838080
NCT04834726 COVID-19 Vaccine Text Outreach https://ClinicalTrials.gov/show/NCT04834726
NCT04833101 Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine https://ClinicalTrials.gov/show/NCT04833101
NCT04830800 A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC https://ClinicalTrials.gov/show/NCT04830800
NCT04824638 BNT162b2 Vaccination With Two Doses in COVID-19 Negative Adult Volunteers and With a Single Dose in COVID-19 Positive Adult Volunteers https://ClinicalTrials.gov/show/NCT04824638
NCT04824391 Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19 https://ClinicalTrials.gov/show/NCT04824391
NCT04818281 Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04818281
NCT04813770 The Impact of Theory-based Messaging on Covid-19 Vaccination Intentions https://ClinicalTrials.gov/show/NCT04813770
NCT04813562 Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells) https://ClinicalTrials.gov/show/NCT04813562
NCT04811664 A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04811664
NCT04805931 VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans https://ClinicalTrials.gov/show/NCT04805931
NCT04806113 COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases https://ClinicalTrials.gov/show/NCT04806113
NCT04801888 Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine https://ClinicalTrials.gov/show/NCT04801888
NCT04801524 Text-based Reminders to Promote COVID-19 Vaccinations https://ClinicalTrials.gov/show/NCT04801524
NCT04800965 Text-based Interventions to Promote COVID-19 Vaccinations https://ClinicalTrials.gov/show/NCT04800965
NCT04798677 Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine https://ClinicalTrials.gov/show/NCT04798677
NCT04798001 Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults https://ClinicalTrials.gov/show/NCT04798001
NCT04794946 Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT04794946
NCT04791423 Study of GRAd-COV2 for the Prevention of COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04791423
NCT04789356 Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity https://ClinicalTrials.gov/show/NCT04789356
NCT04784767 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04784767
NCT04783311 Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04783311
NCT04780035 Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04780035
NCT04780659 COVID-19 Vaccination of Immunodeficient Persons (COVAXID) https://ClinicalTrials.gov/show/NCT04780659
NCT04779827 Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks https://ClinicalTrials.gov/show/NCT04779827
NCT04775069 Antibody Response to COVID-19 Vaccines in Liver Disease Patients https://ClinicalTrials.gov/show/NCT04775069
NCT04773665 Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a https://ClinicalTrials.gov/show/NCT04773665
NCT04771559 Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients https://ClinicalTrials.gov/show/NCT04771559
NCT04765839 Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations https://ClinicalTrials.gov/show/NCT04765839
NCT04765436 PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64 https://ClinicalTrials.gov/show/NCT04765436
NCT04760743 Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19) https://ClinicalTrials.gov/show/NCT04760743
NCT04760132 National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) https://ClinicalTrials.gov/show/NCT04760132
NCT04758273 A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) https://ClinicalTrials.gov/show/NCT04758273
NCT04756830 A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04756830
NCT04756323 A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) https://ClinicalTrials.gov/show/NCT04756323
NCT04751682 Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19 https://ClinicalTrials.gov/show/NCT04751682
NCT04747821 An Effectiveness Study of the Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine https://ClinicalTrials.gov/show/NCT04747821
NCT04732468 COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA https://ClinicalTrials.gov/show/NCT04732468
NCT04732819 Improving COVID-19 Vaccine Uptake in Nursing Homes https://ClinicalTrials.gov/show/NCT04732819
NCT04728594 Emails Promoting COVID-19 Vaccination Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04728594
NCT04713553 A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants https://ClinicalTrials.gov/show/NCT04713553
NCT04713488 An Open Study on the Safety, Tolerability, and Immunogenicity of “Sputnik Light” Vaccine https://ClinicalTrials.gov/show/NCT04713488
NCT04710303 COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults https://ClinicalTrials.gov/show/NCT04710303
NCT04691908 Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04691908
NCT04691947 Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC https://ClinicalTrials.gov/show/NCT04691947
NCT04685603 Dendritic Cell Vaccine to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04685603
NCT04679909 Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study) https://ClinicalTrials.gov/show/NCT04679909
NCT04674189 A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19 https://ClinicalTrials.gov/show/NCT04674189
NCT04672291 Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults https://ClinicalTrials.gov/show/NCT04672291
NCT04668339 A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults https://ClinicalTrials.gov/show/NCT04668339
NCT04666012 Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04666012
NCT04659941 Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers https://ClinicalTrials.gov/show/NCT04659941
NCT04659239 The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 https://ClinicalTrials.gov/show/NCT04659239
NCT04655625 Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19) https://ClinicalTrials.gov/show/NCT04655625
NCT04652102 A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults for COVID-19 https://ClinicalTrials.gov/show/NCT04652102
NCT04651790 Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04651790
NCT04648800 Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland https://ClinicalTrials.gov/show/NCT04648800
NCT04649021 Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population https://ClinicalTrials.gov/show/NCT04649021
NCT04641481 An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers https://ClinicalTrials.gov/show/NCT04641481
NCT04640233 Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection https://ClinicalTrials.gov/show/NCT04640233
NCT04640402 A Phase â…¡ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) https://ClinicalTrials.gov/show/NCT04640402
NCT04639375 Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04639375
NCT04636697 Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults https://ClinicalTrials.gov/show/NCT04636697
NCT04636333 Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell) https://ClinicalTrials.gov/show/NCT04636333
NCT04627675 CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) https://ClinicalTrials.gov/show/NCT04627675
NCT04619628 Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04619628
NCT04617483 Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults https://ClinicalTrials.gov/show/NCT04617483
NCT04612972 Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru https://ClinicalTrials.gov/show/NCT04612972
NCT04608305 Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine https://ClinicalTrials.gov/show/NCT04608305
NCT04604743 Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama https://ClinicalTrials.gov/show/NCT04604743
NCT04591717 COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers https://ClinicalTrials.gov/show/NCT04591717
NCT04591184 A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults https://ClinicalTrials.gov/show/NCT04591184
NCT04587219 The Study of “Gam-COVID-Vac” Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older https://ClinicalTrials.gov/show/NCT04587219
NCT04582344 Clinical Trial For SARS-CoV-2 Vaccine (COVID-19) https://ClinicalTrials.gov/show/NCT04582344
NCT04568811 The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04568811
NCT04566770 A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) https://ClinicalTrials.gov/show/NCT04566770
NCT04564716 Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus https://ClinicalTrials.gov/show/NCT04564716
NCT04563702 Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04563702
NCT04552366 A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults https://ClinicalTrials.gov/show/NCT04552366
NCT04551547 Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04551547
NCT04550351 Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old) https://ClinicalTrials.gov/show/NCT04550351
NCT04545749 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04545749
NCT04542330 Using BCG to Protect Senior Citizens During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04542330
NCT04542395 COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents https://ClinicalTrials.gov/show/NCT04542395
NCT04540419 Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19 https://ClinicalTrials.gov/show/NCT04540419
NCT04540185 A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 https://ClinicalTrials.gov/show/NCT04540185
NCT04537663 Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults https://ClinicalTrials.gov/show/NCT04537663
NCT04536051 A Study of a Candidate COVID-19 Vaccine (COV003) https://ClinicalTrials.gov/show/NCT04536051
NCT04533399 A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults https://ClinicalTrials.gov/show/NCT04533399
NCT04530396 Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04530396
NCT04530656 Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell) https://ClinicalTrials.gov/show/NCT04530656
NCT04530357 Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04530357
NCT04528641 GRAd-COV2 Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04528641
NCT04527575 Study of the Safety, Reactogenicity and Immunogenicity of “EpiVacCorona” Vaccine for the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04527575
NCT05107479 Effectiveness of Interactive Voice Response for COVID-19 Vaccination Training in the Democratic Republic of the Congo https://ClinicalTrials.gov/show/NCT05107479
NCT04516746 Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04516746
NCT05142319 Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC] https://ClinicalTrials.gov/show/NCT05142319
NCT05142514 Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2) https://ClinicalTrials.gov/show/NCT05142514
NCT05142488 Study of Immunogenicity Equivalence of a Homologous Third Dose of Covid-19 (Recombinante) Vaccine https://ClinicalTrials.gov/show/NCT05142488

Phase

phase Study_Count
Early Phase 1 4
Not Applicable 69
Phase 1 78
Phase 1/Phase 2 68
Phase 2 62
Phase 2/Phase 3 22
Phase 3 75
Phase 4 58

Country

country Study_Count
Argentina 10
Australia 12
Austria 2
Azerbaijan 2
Bahrain 1
Belarus 1
Belgium 14
Botswana 1
Brazil 23
Canada 19
Cape Verde 1
Chile 5
China 75
Colombia 3
Denmark 3
Dominican Republic 1
Ecuador 1
Egypt 5
Finland 1
France 18
Germany 16
Ghana 1
Greece 1
Guinea-Bissau 2
Honduras 3
Hong Kong 6
India 9
Indonesia 9
Iran, Islamic Republic of 3
Israel 3
Italy 5
Japan 9
Jordan 1
Kazakhstan 3
Kenya 5
Korea, Republic of 13
Malawi 1
Malaysia 3
Mexico 13
Mongolia 1
Mozambique 1
Nepal 1
Netherlands 11
New Caledonia 1
New Zealand 4
Nigeria 1
Norway 1
Pakistan 3
Panama 2
Peru 4
Philippines 5
Poland 4
Puerto Rico 3
Russian Federation 16
Singapore 4
South Africa 14
Spain 12
Sri Lanka 1
Swaziland 1
Sweden 1
Switzerland 3
Taiwan 13
Thailand 3
Turkey 15
Uganda 2
Ukraine 1
United Arab Emirates 5
United Kingdom 18
United States 103
Uzbekistan 1
Vietnam 6
Zambia 1
Zimbabwe 1

Site Count

Site_count Study_Count
1 246
2 36
3 20
4 17
5 16
6 10
7 5
8 9
9 2
10 7
11 3
12 7
13 1
14 3
15 2
16 1
17 1
18 5
20 2
21 2
22 1
23 4
25 3
26 2
28 1
29 2
31 3
33 1
34 1
35 2
36 1
39 1
40 1
41 1
53 1
54 1
55 1
60 1
62 1
66 1
74 1
84 2
87 1
91 1
94 1
100 1
102 1
145 1
156 1
166 1

Arms

number_of_arms Study_Count
1 62
2 143
3 67
4 52
5 16
6 23
7 9
8 14
9 11
10 7
12 8
14 2
15 5
16 2
17 1
18 2
19 1
20 2
21 1
22 2
29 1
32 1
4

Enrollment

Measure Vaccine
Min 4.0
1st Qu 120.0
Median 400.0
Mean 101898.2
3rd Qu 1532.5
Max 40000000.0

Model

intervention_model Study_Count
Crossover Assignment 6
Factorial Assignment 3
Parallel Assignment 295
Sequential Assignment 58
Single Group Assignment 74

Group Types

group_type Group_Count
Experimental 1259
Placebo Comparator 253
Active Comparator 197
Other 48
No Intervention 28
4
Sham Comparator 3

Update Count

Count of Versions Count of Studies
1 73
2 103
3 62
4 69
5 39
6 20
7 18
8 11
9 4
10 6
11 3
12 4
13 3
14 4
15 1
16 2
18 1
19 4
20 1
21 1
22 3
25 1
35 1
36 1
38 1

Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 1484 363 4.088154
Contacts/Locations 833 308 2.704546
Recruitment Status 445 297 1.498317
None (earliest Version on record) 436 436 1.000000
Study Design 309 193 1.601036
Outcome Measures 257 155 1.658065
Eligibility 236 137 1.722628
Study Description 229 140 1.635714
Arms 209 127 1.645669
Interventions 209 127 1.645669
Study Identification 207 149 1.389262
Oversight 94 89 1.056180
Sponsor/Collaborators 54 45 1.200000
Conditions 53 44 1.204546
References 30 19 1.578947
Document Section 26 20 1.300000
IPDSharing 11 11 1.000000
Results 6 6 1.000000
Results Submission Events 4 4 1.000000

Observational Studies

Studies by Country

Country Study_Count
France 452
United States 339
Turkey 178
Italy 167
United Kingdom 143
Egypt 121
China 71
Germany 71
Spain 67
Canada 56
Belgium 44
Switzerland 41
Denmark 25
Russian Federation 25
Austria 24
Mexico 24
India 23
Israel 22
Brazil 21
Norway 21
Poland 21
Netherlands 20
Sweden 20
Argentina 19
Greece 18
Hong Kong 18
Pakistan 18
Czechia 16
Saudi Arabia 13
Chile 11
Malaysia 11
Singapore 9
Jordan 8
Korea, Republic of 8
Colombia 6
Japan 6
6
Portugal 6
Taiwan 6
United Arab Emirates 6
Hungary 5
Indonesia 5
Qatar 5
Slovenia 5
Australia 4
Croatia 4
Iran, Islamic Republic of 4
Kazakhstan 4
Romania 4
United States|Puerto Rico 4
Ecuador 3
Finland 3
Ireland 3
Lithuania 3
Monaco 3
Peru 3
Thailand 3
Tunisia 3
Bangladesh 2
Congo, The Democratic Republic of the 2
Dominican Republic 2
France|French Guiana 2
Iraq 2
Luxembourg 2
Morocco 2
Mozambique 2
Nepal 2
Serbia 2
United States|Canada 2
Albania 1
Albania|Bosnia and Herzegovina|Croatia|Montenegro|Serbia 1
Albania|Brazil|Bulgaria|Chile|Cyprus|France|Greece|Israel|Malta|Portugal|Spain|Turkey|United Kingdom 1
Algeria 1
Argentina|Belgium|Brazil|Chile|Colombia|Costa Rica|Croatia|Denmark|France|Germany|Greece|Hungary|India|Italy|Japan|Mexico|Peru|Poland|Portugal|Romania|Russian Federation|Serbia|South Africa|Spain|Switzerland|Turkey|Ukraine 1
Argentina|Bosnia and Herzegovina|Ghana|India|Iran, Islamic Republic of|Sudan 1
Argentina|Brazil|Cameroon|India|Malaysia|Nigeria|South Africa|Thailand|Uganda|Zimbabwe 1
Argentina|Chile|Colombia|Ecuador|Spain 1
Australia|Canada|China|France|Gambia|Germany|Israel|Italy|Malaysia|Poland|Portugal|Romania|Singapore|Switzerland 1
Austria|Belgium|Canada|Finland|France|Germany|Greece|Iran, Islamic Republic of|Ireland|Italy|Norway|Poland|Portugal|Spain|Switzerland|United Kingdom 1
Austria|Belgium|Czechia|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Lithuania|Netherlands|Poland|Portugal|Russian Federation|Spain|Sweden|Switzerland|United Kingdom 1
Austria|Belgium|Czechia|Germany|Greece|Italy|Netherlands|United Kingdom 1
Austria|France|Germany|Sweden 1
Austria|France|Italy 1
Austria|Germany 1
Bahrain 1
Belarus 1
Belarus|Russian Federation 1
Belgium|Denmark|France|Georgia|Germany|Ireland|Italy|Netherlands|Poland|Romania|Sweden 1
Belgium|France|Italy 1
Belgium|Greece|Italy 1
Belgium|Italy|United Kingdom 1
Bolivia 1
Brazil|Chile|Uruguay 1
Brazil|Denmark|Germany|Ireland|Italy|Mexico|Spain|Turkey 1
Brazil|Mexico|Spain 1
Burkina Faso 1
Burkina Faso|Guinea 1
Burkina Faso|Guinea|Mali|Senegal|Sierra Leone 1
Chile|Colombia|Ecuador|Spain 1
China|Pakistan 1
Congo, The Democratic Republic of the|Guinea|Indonesia|Liberia|Mali|Mexico|Mongolia 1
Congo, The Democratic Republic of the|India|Senegal 1
Congo, The Democratic Republic of the|South Sudan 1
Croatia|Finland|France|Greece|Italy 1
Czechia|Germany|Slovakia 1
Denmark|France|Germany|Norway 1
Ethiopia 1
Finland|France|Germany|Italy|Sweden|United Kingdom 1
France|Guadeloupe|Martinique 1
France|Israel|Netherlands|Spain|United Kingdom 1
France|Martinique 1
France|Martinique|Mayotte|Réunion 1
France|United Kingdom 1
Gabon 1
Georgia 1
Germany|Portugal|Spain|United Kingdom 1
Germany|Romania 1
Greece|Italy|Singapore 1
Italy|Romania|United Kingdom 1
Italy|San Marino 1
Kenya 1
Kuwait 1
Martinique 1
Philippines 1
Puerto Rico 1
Slovakia 1
South Africa 1
Ukraine 1
United States|Albania|Australia|Czechia|France|Germany|Hong Kong|Israel|Italy|Lebanon|Norway|Poland|Spain|Sweden|Taiwan 1
United States|Argentina|Armenia|Australia|Bolivia|Chile|Costa Rica|Czechia|Germany|Guatemala|Italy|Lebanon|Mexico|Netherlands|Nigeria|Puerto Rico|Saudi Arabia|Spain|Tunisia|Turkey|Venezuela 1
United States|Argentina|Botswana|Brazil|Malawi|Mexico|Peru|South Africa|Tanzania|Zambia|Zimbabwe 1
United States|Argentina|Denmark|United Kingdom 1
United States|Bolivia|Canada|Chile|India|United Kingdom 1
United States|Brazil|Denmark|Japan|Philippines 1
United States|Brazil|India|Italy|United Kingdom 1
United States|Canada|Croatia|Czechia|Estonia|Ethiopia|Germany|Ghana|Mexico|Poland|Portugal|Russian Federation|Serbia|Slovenia 1
United States|Canada|Puerto Rico 1
United States|Croatia|France|Germany|Italy|Poland|Spain|United Kingdom 1
United States|Egypt|Germany|Peru|Singapore 1
United States|Egypt|Iran, Islamic Republic of 1
United States|France|Germany|Spain|Switzerland 1
United States|India 1
United States|India|Spain|United Kingdom 1
United States|Kenya|United Kingdom 1
United States|Malawi|Peru|South Africa|Zambia|Zimbabwe 1
United States|Spain 1
United States|United Kingdom 1
Zimbabwe 1

Sites per Study

Site_count Study_Count
1 1918
2 143
3 65
4 43
5 26
6 20
7 17
8 12
9 10
10 10
11 8
12 12
13 4
14 10
15 7
17 4
18 3
19 2
20 4
22 4
23 2
26 1
27 3
31 2
32 1
33 1
34 1
37 1
41 1
44 2
45 1
51 1
52 1
53 1
68 2
77 1
81 1
97 1
98 1
128 1
191 1
941 1

Number of Updates

Count of Versions Count of Studies
1 731
2 729
3 442
4 219
5 106
6 44
7 19
8 7
9 4
10 5
11 5
12 3
13 1
14 1
16 2
19 1
21 2
22 2
23 1
29 2
33 1
42 1
43 1
44 2
47 2
110 1
119 1
145 1
154 1
176 1
187 1
194 1
210 1
214 1
217 1
220 1
222 1
230 1
242 1
252 1
273 1
309 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 7204 1619 4.449660
None (earliest Version on record) 2350 2350 1.000000
Contacts/Locations 1827 1060 1.723585
Recruitment Status 1284 1003 1.280159
Study Design 805 700 1.150000
Study Description 635 481 1.320166
Outcome Measures 628 533 1.178236
Study Identification 527 464 1.135776
Eligibility 392 317 1.236593
Oversight 281 273 1.029304
Groups 244 205 1.190244
Interventions 244 205 1.190244
Sponsor/Collaborators 215 194 1.108247
Conditions 189 176 1.073864
References 97 88 1.102273
IPDSharing 29 28 1.035714
Document Section 24 20 1.200000
Results Submission Events 16 16 1.000000
Results 11 11 1.000000
Baseline Characteristics 2 1 2.000000

Enrollment Metrics

Measure Observational
Min 3.00
1st Qu 100.00
Median 285.50
Mean 58324.53
3rd Qu 1000.00
Max 50000000.00

Observation Model

observational_model Study_Count
Cohort 1475
Case-Control 258
Case-Only 257
Other 250
Ecologic or Community 77
Case-Crossover 24
Family-Based 8
1

Time Perspective

time_perspective Study_Count
Prospective 1325
Retrospective 589
Cross-Sectional 301
Other 134
1

Has Results

nct_id brief_title link
NCT04474496 Impact of COVID-19 on Marshallese Communities in the U.S. https://ClinicalTrials.gov/show/NCT04474496
NCT04431908 Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects https://ClinicalTrials.gov/show/NCT04431908
NCT04425850 USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 https://ClinicalTrials.gov/show/NCT04425850
NCT04425863 Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19 https://ClinicalTrials.gov/show/NCT04425863
NCT04385238 Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04385238
NCT04347408 Seroprevalence of SARS-Cov-2 Antibodies in Children https://ClinicalTrials.gov/show/NCT04347408
NCT05043142 Epidemiological Study of the COVID-2019 in Participating Organizations. https://ClinicalTrials.gov/show/NCT05043142
NCT04912700 The Impact of Vaccination on Severity of Illness in COVID-19 https://ClinicalTrials.gov/show/NCT04912700
NCT04709068 Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization https://ClinicalTrials.gov/show/NCT04709068
NCT04542226 Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04542226

Registries

Studies by Country

Country Study_Count
United States 46
France 40
Spain 31
Turkey 29
Italy 22
Egypt 20
Germany 14
Argentina 10
Switzerland 10
Belgium 8
Sweden 8
Brazil 7
China 7
Canada 6
Denmark 6
Mexico 6
Netherlands 6
Pakistan 6
Poland 6
United Kingdom 6
Israel 4
Russian Federation 4
Chile 3
Colombia 3
Norway 3
Austria 2
Bangladesh 2
France|Martinique 2
Greece 2
India 2
Kuwait 2
Qatar 2
South Africa 2
Tunisia 2
Australia 1
Belgium|Congo|France|Italy|Netherlands|Spain 1
Belgium|France 1
Brazil|India 1
Brazil|Mexico|Spain 1
Cape Verde 1
China|Hong Kong|Spain 1
China|India|Indonesia|Japan|Malaysia|Pakistan|Singapore 1
Congo, The Democratic Republic of the 1
Czechia|France|Germany|Italy|Lithuania 1
Hungary 1
Iceland 1
Iran, Islamic Republic of 1
Ireland 1
Italy|Spain 1
Kazakhstan 1
Korea, Republic of 1
Lebanon 1
1
Netherlands|Ukraine 1
Nigeria|South Africa 1
Saudi Arabia 1
Singapore 1
Ukraine 1
United States|Brazil|Colombia|Egypt|France|Mexico|Spain 1
United States|Canada|Israel|Japan|Serbia|Spain|United Kingdom 1
United States|India|Sweden 1
United States|Poland 1
United States|United Kingdom 1
Uruguay 1

Sites per Study

Site_count Study_Count
1 282
2 26
3 6
4 6
5 3
6 3
7 3
8 2
9 1
10 1
11 3
13 2
14 2
15 2
17 2
18 1
22 1
27 2
31 1
36 1
39 1
47 1
50 1
53 1
63 1
75 1
76 1
109 1
148 1

Number of Updates

Count of Versions Count of Studies
1 107
2 112
3 72
4 30
5 16
6 10
7 6
8 2
9 1
11 2
14 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 545 252 2.162698
None (earliest Version on record) 359 359 1.000000
Contacts/Locations 246 153 1.607843
Recruitment Status 176 144 1.222222
Study Design 133 108 1.231481
Outcome Measures 98 81 1.209877
Study Description 98 83 1.180723
Study Identification 74 67 1.104478
Eligibility 56 50 1.120000
Sponsor/Collaborators 39 39 1.000000
Groups 35 33 1.060606
Interventions 35 33 1.060606
Oversight 33 33 1.000000
Conditions 22 22 1.000000
References 17 14 1.214286
Document Section 8 6 1.333333
IPDSharing 8 8 1.000000
Results Submission Events 6 6 1.000000
Results 2 2 1.000000

Enrollment Metrics

Measure Registries
Min 1.0
1st Qu 100.0
Median 395.0
Mean 40624.1
3rd Qu 1218.5
Max 12000000.0

Registry Model

observational_model Study_Count
Cohort 241
Case-Control 44
Other 35
Case-Only 32
Ecologic or Community 6
Case-Crossover 1

Time Perspective

time_perspective Study_Count
Prospective 259
Other 52
Cross-Sectional 48

Follow-up

target_duration Study_Count
1 Year 42
12 Months 37
6 Months 35
1 Month 32
1 Day 24
2 Months 18
2 Years 17
3 Months 17
30 Days 12
4 Weeks 12
18 Months 10
28 Days 7
14 Days 6
24 Months 6
5 Years 6
9 Months 6
1 Week 4
2 Weeks 4
90 Days 4
10 Days 3
10 Months 3
3 Weeks 3
3 Years 3
36 Months 3
4 Months 3
4 Years 3
5 Months 3
6 Weeks 3
60 Days 3
7 Days 3
12 Weeks 2
2 Days 2
20 Days 2
20 Years 2
21 Days 2
21 Months 2
5 Days 2
7 Months 2
10 Years 1
100 Years 1
12 Years 1
14 Weeks 1
16 Months 1
16 Weeks 1
20 Months 1
3 Days 1
8 Months 1
8 Weeks 1
9 Weeks 1

Has Results

nct_id brief_title link
NCT04898166 Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19). https://ClinicalTrials.gov/show/NCT04898166
NCT04323592 Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome https://ClinicalTrials.gov/show/NCT04323592

Overview of trials

Interventional Trials

nct_id brief_title link
NCT04382053 Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04382053
NCT04331899 Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04331899
NCT04347954 PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19) https://ClinicalTrials.gov/show/NCT04347954
NCT04349098 Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04349098
NCT04353037 PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine https://ClinicalTrials.gov/show/NCT04353037
NCT04355767 Convalescent Plasma in Outpatients With COVID-19 https://ClinicalTrials.gov/show/NCT04355767
NCT04358068 Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 https://ClinicalTrials.gov/show/NCT04358068
NCT04317040 CD24Fc (MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) https://ClinicalTrials.gov/show/NCT04317040
NCT04435184 Crizanlizumab for Treating COVID-19 Vasculopathy https://ClinicalTrials.gov/show/NCT04435184
NCT04388826 COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 https://ClinicalTrials.gov/show/NCT04388826
NCT04484207 Addressing COVID-19 Mental Health Problems Among US Veterans https://ClinicalTrials.gov/show/NCT04484207
NCT04401293 Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients https://ClinicalTrials.gov/show/NCT04401293
NCT04492475 Adaptive COVID-19 Treatment Trial 3 (ACTT-3) https://ClinicalTrials.gov/show/NCT04492475
NCT04497948 Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04497948
NCT04501952 Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734â„¢) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting https://ClinicalTrials.gov/show/NCT04501952
NCT04504032 A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) https://ClinicalTrials.gov/show/NCT04504032
NCT04507867 Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III https://ClinicalTrials.gov/show/NCT04507867
NCT04411628 A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 https://ClinicalTrials.gov/show/NCT04411628
NCT04418947 Project Resurgence Communication Trial https://ClinicalTrials.gov/show/NCT04418947
NCT04420273 Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access https://ClinicalTrials.gov/show/NCT04420273
NCT04523831 Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection https://ClinicalTrials.gov/show/NCT04523831
NCT04701658 A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04701658
NCT04706416 N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19) https://ClinicalTrials.gov/show/NCT04706416
NCT04502056 Covid-19 Messaging to Underserved Communities - 2nd Experiment https://ClinicalTrials.gov/show/NCT04502056
NCT04491994 Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression https://ClinicalTrials.gov/show/NCT04491994
NCT04491240 Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia. https://ClinicalTrials.gov/show/NCT04491240
NCT04463004 Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation https://ClinicalTrials.gov/show/NCT04463004
NCT04475588 Efficacy and Safety of Itolizumab in COVID-19 Complications https://ClinicalTrials.gov/show/NCT04475588
NCT04452435 Safety and Efficacy of C21 in Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04452435
NCT04435808 Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19 https://ClinicalTrials.gov/show/NCT04435808
NCT04402970 Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) https://ClinicalTrials.gov/show/NCT04402970
NCT04410159 Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients https://ClinicalTrials.gov/show/NCT04410159
NCT04392141 Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04392141
NCT04422561 Prophylactic Ivermectin in COVID-19 Contacts https://ClinicalTrials.gov/show/NCT04422561
NCT04421404 Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04421404
NCT04411667 Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04411667
NCT04409886 Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04409886
NCT04407507 Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms https://ClinicalTrials.gov/show/NCT04407507
NCT04392219 COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04392219
NCT04390022 Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial https://ClinicalTrials.gov/show/NCT04390022
NCT04401202 Nigella Sativa in COVID-19 https://ClinicalTrials.gov/show/NCT04401202
NCT04382066 Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04382066
NCT04380688 Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. https://ClinicalTrials.gov/show/NCT04380688
NCT04401579 Adaptive COVID-19 Treatment Trial 2 (ACTT-2) https://ClinicalTrials.gov/show/NCT04401579
NCT04399980 Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation https://ClinicalTrials.gov/show/NCT04399980
NCT04372186 A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04372186
NCT04371419 COVID-19 Health Messaging to Underserved Communities https://ClinicalTrials.gov/show/NCT04371419
NCT04370834 Tocilizumab for Patients With Cancer and COVID-19 Disease https://ClinicalTrials.gov/show/NCT04370834
NCT04363736 A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04363736
NCT04358081 Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04358081
NCT04356937 Efficacy of Tocilizumab on Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04356937
NCT04365699 Cardiovascular Effects of COVID-19 https://ClinicalTrials.gov/show/NCT04365699
NCT04340557 Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04340557
NCT04365153 Canakinumab in Covid-19 Cardiac Injury (The Three C Study) https://ClinicalTrials.gov/show/NCT04365153
NCT04362137 Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm https://ClinicalTrials.gov/show/NCT04362137
NCT04346199 Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. https://ClinicalTrials.gov/show/NCT04346199
NCT04354870 COVID-19 PrEP HCW HCQ Study https://ClinicalTrials.gov/show/NCT04354870
NCT04338009 Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04338009
NCT04334876 Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers https://ClinicalTrials.gov/show/NCT04334876
NCT04333225 Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers https://ClinicalTrials.gov/show/NCT04333225
NCT04332991 Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease https://ClinicalTrials.gov/show/NCT04332991
NCT04345653 Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers https://ClinicalTrials.gov/show/NCT04345653
NCT04343261 Convalescent Plasma in the Treatment of COVID 19 https://ClinicalTrials.gov/show/NCT04343261
NCT04343092 Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management https://ClinicalTrials.gov/show/NCT04343092
NCT04342663 A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04342663
NCT04342897 A Study of LY3127804 in Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04342897
NCT04329923 The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) https://ClinicalTrials.gov/show/NCT04329923
NCT04328467 Pre-exposure Prophylaxis for SARS-Coronavirus-2 https://ClinicalTrials.gov/show/NCT04328467
NCT04327388 Sarilumab COVID-19 https://ClinicalTrials.gov/show/NCT04327388
NCT04332081 Hyperbaric Oxygen for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04332081
NCT04332107 Azithromycin for COVID-19 Treatment in Outpatients Nationwide https://ClinicalTrials.gov/show/NCT04332107
NCT04322396 Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04322396
NCT04322682 Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) https://ClinicalTrials.gov/show/NCT04322682
NCT04338074 TXA and Corona Virus 2019 (COVID19) in Outpatients https://ClinicalTrials.gov/show/NCT04338074
NCT04335136 Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04335136
NCT04320615 A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04320615
NCT04335552 Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04335552
NCT04315298 Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04315298
NCT04308668 Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 https://ClinicalTrials.gov/show/NCT04308668
NCT04280705 Adaptive COVID-19 Treatment Trial (ACTT) https://ClinicalTrials.gov/show/NCT04280705
NCT04292899 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04292899
NCT04292730 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment https://ClinicalTrials.gov/show/NCT04292730
NCT04558125 Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism https://ClinicalTrials.gov/show/NCT04558125
NCT05175625 Immunogenicity and Safety of a Booster Dose of the SpikoGen COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05175625
NCT04381988 A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy https://ClinicalTrials.gov/show/NCT04381988
NCT05175807 A Telemedicine Brief Mindfulness Intervention in Post-COVID-19 https://ClinicalTrials.gov/show/NCT05175807
NCT05148091 The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults https://ClinicalTrials.gov/show/NCT05148091
NCT05158855 Oral Neutralizing Antibody Booster for Post-vaccinated People With COVID19 Vaccine https://ClinicalTrials.gov/show/NCT05158855
NCT05142553 Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against the Virus That Cause COVID-19, Know as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2) in Healthy Adults Volunteers Fully Vaccinated https://ClinicalTrials.gov/show/NCT05142553
NCT05064254 Treatment of Anxiety in Pregnancy Study https://ClinicalTrials.gov/show/NCT05064254
NCT04952402 SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine https://ClinicalTrials.gov/show/NCT04952402
NCT04944368 Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen) https://ClinicalTrials.gov/show/NCT04944368
NCT04937088 Outpatient Liquid Aspirin (OLA) https://ClinicalTrials.gov/show/NCT04937088
NCT04930874 Cerebral Autoregulation and COVID-19 https://ClinicalTrials.gov/show/NCT04930874
NCT04901689 Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation https://ClinicalTrials.gov/show/NCT04901689
NCT04901676 Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04901676
NCT05005559 Phase III Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen) https://ClinicalTrials.gov/show/NCT05005559
NCT04954287 Phase 1 Study of Intranasal PIV5-vectored COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults https://ClinicalTrials.gov/show/NCT04954287
NCT04919031 Inspiratory Muscle Trainer and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Persistent Symptoms https://ClinicalTrials.gov/show/NCT04919031
NCT04803227 Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19 https://ClinicalTrials.gov/show/NCT04803227
NCT04860518 Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With CoronavirUS https://ClinicalTrials.gov/show/NCT04860518
NCT04858542 Evaluating the Impact of Vocal Health Education on Mask-wearing Workers During COVID-19 https://ClinicalTrials.gov/show/NCT04858542
NCT04761822 COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations https://ClinicalTrials.gov/show/NCT04761822
NCT04602507 Ivermectin in Adults With Severe COVID-19. https://ClinicalTrials.gov/show/NCT04602507
NCT04469491 Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study https://ClinicalTrials.gov/show/NCT04469491
NCT04449588 Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS https://ClinicalTrials.gov/show/NCT04449588
NCT04353271 Trial of Hydroxychloroquine In Covid-19 Kinetics https://ClinicalTrials.gov/show/NCT04353271
NCT04279197 Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu https://ClinicalTrials.gov/show/NCT04279197
NCT05178290 Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers https://ClinicalTrials.gov/show/NCT05178290
NCT05178186 Impact of the COVID-19 Pandemic on Surgery for Thyroid Cancer https://ClinicalTrials.gov/show/NCT05178186
NCT05178160 Positive End Espiratory Pressure Trial in Coronavirus Disease 19 Treated With Continuous Positive Airway Pressure https://ClinicalTrials.gov/show/NCT05178160
NCT04993534 RESPOND: Improving the Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns Resulting From the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04993534
NCT04895449 Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19 https://ClinicalTrials.gov/show/NCT04895449
NCT04805125 Immunocompromised Swiss Cohorts Based Trial Platform https://ClinicalTrials.gov/show/NCT04805125
NCT04706403 Views on COVID-19 and Vaccination https://ClinicalTrials.gov/show/NCT04706403
NCT04542031 COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL https://ClinicalTrials.gov/show/NCT04542031
NCT04508023 A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04508023
NCT04415151 Tofacitinib for Treatment of Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04415151
NCT05181709 A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study. https://ClinicalTrials.gov/show/NCT05181709
NCT05180513 Mellowing Mind: Comparing Two Technology Based Mindfulness Interventions for Stress Impacted by COVID-19 in Underserved Communities https://ClinicalTrials.gov/show/NCT05180513
NCT05156723 The Objectives of This Study Are Study the Immunogenicity, Safety and Tolerability of the Coronavirus Vaccine in Healthy Adult Volunteer Aged 18 to 60 Years. https://ClinicalTrials.gov/show/NCT05156723
NCT04973449 Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04973449
NCT04907877 Bifido- and Lactobacilli in Symptomatic Adult COVID-19 Outpatients https://ClinicalTrials.gov/show/NCT04907877
NCT04673149 GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04673149
NCT04661839 A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults https://ClinicalTrials.gov/show/NCT04661839
NCT04661813 Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV https://ClinicalTrials.gov/show/NCT04661813
NCT04523181 Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients https://ClinicalTrials.gov/show/NCT04523181
NCT05185804 Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05185804
NCT05185687 Public Support for COVID-19 Test Allocation https://ClinicalTrials.gov/show/NCT05185687
NCT05185284 Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05185284
NCT05162365 A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05162365
NCT05160766 Assessing Immune Response of Different COVID-19 Vaccines in Older Adults https://ClinicalTrials.gov/show/NCT05160766
NCT05157230 Evaluation of Deltoid Exercises on Injection Site Pain After (BNT162b2) COVID - 19 Vaccination https://ClinicalTrials.gov/show/NCT05157230
NCT05148962 Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers https://ClinicalTrials.gov/show/NCT05148962
NCT05126563 Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome https://ClinicalTrials.gov/show/NCT05126563
NCT05012943 The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01) https://ClinicalTrials.gov/show/NCT05012943
NCT04952389 Acupuncture Therapy for COVID-Related Olfactory Loss https://ClinicalTrials.gov/show/NCT04952389
NCT04896866 Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP) https://ClinicalTrials.gov/show/NCT04896866
NCT04896606 SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease https://ClinicalTrials.gov/show/NCT04896606
NCT04797858 COVID-19 Self-Testing Through Rapid Network Distribution https://ClinicalTrials.gov/show/NCT04797858
NCT04771611 COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications https://ClinicalTrials.gov/show/NCT04771611
NCT04742842 The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04742842
NCT04724681 Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04724681
NCT04686773 Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention https://ClinicalTrials.gov/show/NCT04686773
NCT04655586 Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19 https://ClinicalTrials.gov/show/NCT04655586
NCT04537299 COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes https://ClinicalTrials.gov/show/NCT04537299
NCT04529499 Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04529499
NCT04502472 Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma https://ClinicalTrials.gov/show/NCT04502472
NCT04431453 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734â„¢) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04431453
NCT04412785 Cyclosporine in Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04412785
NCT04405739 The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID) https://ClinicalTrials.gov/show/NCT04405739
NCT04385108 Predictive Immune Biomarkers for COVID-19 Pathogenesis https://ClinicalTrials.gov/show/NCT04385108
NCT04377711 A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04377711
NCT04356690 Etoposide in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04356690
NCT04355364 Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE) https://ClinicalTrials.gov/show/NCT04355364
NCT04336410 Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04336410
NCT05187793 Randomized Study of Efficacy of Different Treatment Regimens of Olokizumab https://ClinicalTrials.gov/show/NCT05187793
NCT05009732 A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects https://ClinicalTrials.gov/show/NCT05009732
NCT04939428 Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013) https://ClinicalTrials.gov/show/NCT04939428
NCT04715243 Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS Patients https://ClinicalTrials.gov/show/NCT04715243
NCT04560881 Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19) https://ClinicalTrials.gov/show/NCT04560881
NCT05191394 IMPACT OF THERAPEUTIC PLASMA EXCHANGE ON ACQUIRED VACCINAL ANTI-SARS-CoV-2 ANTIBODIES. https://ClinicalTrials.gov/show/NCT05191394
NCT05050474 Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) https://ClinicalTrials.gov/show/NCT05050474
NCT04894435 Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity https://ClinicalTrials.gov/show/NCT04894435
NCT04668950 Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2) https://ClinicalTrials.gov/show/NCT04668950
NCT04494646 BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04494646
NCT04420182 COVID-19 Virtual Care at Home https://ClinicalTrials.gov/show/NCT04420182
NCT05172102 Quality of Life and Lung Function on Post Covid-19 Patient https://ClinicalTrials.gov/show/NCT05172102
NCT05011526 A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults https://ClinicalTrials.gov/show/NCT05011526
NCT04847050 A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy, Including Boost… https://ClinicalTrials.gov/show/NCT04847050
NCT04745351 Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04745351
NCT04535674 Asunercept in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04535674
NCT04504734 Bucillamine in Treatment of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04504734
NCT04497415 The COVID-19 and Healthcare Workers: An Active Intervention https://ClinicalTrials.gov/show/NCT04497415
NCT04493242 Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS https://ClinicalTrials.gov/show/NCT04493242
NCT04458298 A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04458298
NCT04990531 Low-field Magnetic Resonance Imaging of Pediatric COVID-19 https://ClinicalTrials.gov/show/NCT04990531
NCT04647604 Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids - https://ClinicalTrials.gov/show/NCT04647604
NCT04593940 Immune Modulators for Treating COVID-19 https://ClinicalTrials.gov/show/NCT04593940
NCT04389333 Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04389333
NCT05175742 PTX-COVID19-B, an mRNA Humoral Vaccine, Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Demonstrate the Safety, Tolerability, and Immunogenicity of PTX-COVID19-B in Comparison to the Pfizer-BioNTech COVID-19 Vaccine. https://ClinicalTrials.gov/show/NCT05175742
NCT04649151 A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04649151
NCT04639466 A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04639466
NCT04547257 Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19 https://ClinicalTrials.gov/show/NCT04547257
NCT04364763 A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) https://ClinicalTrials.gov/show/NCT04364763
NCT04338828 Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED https://ClinicalTrials.gov/show/NCT04338828
NCT05184127 Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT05184127
NCT05184114 Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance https://ClinicalTrials.gov/show/NCT05184114
NCT05182554 COVID-19 Messaging for Vaccination https://ClinicalTrials.gov/show/NCT05182554
NCT05182515 Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies https://ClinicalTrials.gov/show/NCT05182515
NCT05163496 Frontline Clinician Psilocybin Study https://ClinicalTrials.gov/show/NCT05163496
NCT05085613 Does Framing and Humor Improve the Effectiveness of Messages About COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05085613
NCT05065879 Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes https://ClinicalTrials.gov/show/NCT05065879
NCT04951336 RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT04951336
NCT04939532 SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers https://ClinicalTrials.gov/show/NCT04939532
NCT04893512 First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects https://ClinicalTrials.gov/show/NCT04893512
NCT04780698 DCI COVID-19 Surveillance Project https://ClinicalTrials.gov/show/NCT04780698
NCT04754594 Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older https://ClinicalTrials.gov/show/NCT04754594
NCT04611802 A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years) at Risk for SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04611802
NCT04602312 How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample) https://ClinicalTrials.gov/show/NCT04602312
NCT04602286 How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample) https://ClinicalTrials.gov/show/NCT04602286
NCT04591015 Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19 https://ClinicalTrials.gov/show/NCT04591015
NCT04583956 ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04583956
NCT04581200 Lift Mobile Mindfulness for COVID-19 Distress Symptoms https://ClinicalTrials.gov/show/NCT04581200
NCT04542421 Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04542421
NCT04541979 Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04541979
NCT04536350 Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS https://ClinicalTrials.gov/show/NCT04536350
NCT04518410 ACTIV-2: A Study for Outpatients With COVID-19 https://ClinicalTrials.gov/show/NCT04518410
NCT04482673 Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04482673
NCT04449276 A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults https://ClinicalTrials.gov/show/NCT04449276
NCT04389450 Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04389450
NCT04386616 A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04386616
NCT04960202 EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04960202
NCT04460183 A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04460183
NCT04416048 Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19 https://ClinicalTrials.gov/show/NCT04416048
NCT04410562 Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum https://ClinicalTrials.gov/show/NCT04410562
NCT05096845 Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III https://ClinicalTrials.gov/show/NCT05096845
NCT05096832 Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study https://ClinicalTrials.gov/show/NCT05096832
NCT05057182 Third Dose of mRNA Vaccination to Boost COVID-19 Immunity (mBoost Study) https://ClinicalTrials.gov/show/NCT05057182
NCT05033847 Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above https://ClinicalTrials.gov/show/NCT05033847
NCT04700137 Mental Health Among Patients, Providers, and Staff During the COVID-19 Era https://ClinicalTrials.gov/show/NCT04700137
NCT04537949 A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04537949
NCT04517123 Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The “PRONE” Study https://ClinicalTrials.gov/show/NCT04517123
NCT04508075 Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine https://ClinicalTrials.gov/show/NCT04508075
NCT04380701 A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults https://ClinicalTrials.gov/show/NCT04380701
NCT04445220 A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy https://ClinicalTrials.gov/show/NCT04445220
NCT04347239 Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04347239
NCT05197478 THE EFFECT OF LIFESTYLE ON THE PROGRESS OF COVID 19 https://ClinicalTrials.gov/show/NCT05197478
NCT05197582 The Effect of Telemonitoring on Anxiety and Quality of Life in Patients in COVID 19 Quarantine https://ClinicalTrials.gov/show/NCT05197582
NCT05197452 Increasing COVID-19 Testing in Chicago’s African American Testing Desserts https://ClinicalTrials.gov/show/NCT05197452
NCT05197114 Assessing the Feasibility and Acceptability of a Virtual Food Skills Program for Children With Type 1 Diabetes During COVID-19 https://ClinicalTrials.gov/show/NCT05197114
NCT05195242 The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19 https://ClinicalTrials.gov/show/NCT05195242
NCT05196581 Efficacy of Breathox Device Inhalation Therapy in the Treatment of Acute Symptoms Associated With COVID-19 and in the Prevention of the Use of Health Resources https://ClinicalTrials.gov/show/NCT05196581
NCT05195749 A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 (’005) for Moderate to Severe COVID-19 Disease Along With Standard of Care https://ClinicalTrials.gov/show/NCT05195749
NCT05195229 Quantifying Viral Load in Respiratory Particles That Are Generated by Children and Adults With COVID-19 Infection https://ClinicalTrials.gov/show/NCT05195229
NCT05132855 The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05132855
NCT05124210 Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT05124210
NCT05091307 A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults https://ClinicalTrials.gov/show/NCT05091307
NCT05074420 A Study of Baricitinib (LY3009104) in Children With COVID-19 (COV-BARRIER-PEDS) https://ClinicalTrials.gov/show/NCT05074420
NCT05035186 Efficacy of Clarithromycin and Flouroquinolones Based Regimens in H.Pylori Eradication in Covid-19 Era https://ClinicalTrials.gov/show/NCT05035186
NCT05032950 Drug-Drug Interaction Study to Estimate the Effect of PF-07321332/Ritonavir and Ritonavir on Midazolam in Healthy Participants https://ClinicalTrials.gov/show/NCT05032950
NCT04941183 Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients https://ClinicalTrials.gov/show/NCT04941183
NCT05007080 A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive https://ClinicalTrials.gov/show/NCT05007080
NCT04967430 TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04967430
NCT04954469 B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency https://ClinicalTrials.gov/show/NCT04954469
NCT04878055 Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia. https://ClinicalTrials.gov/show/NCT04878055
NCT04908722 A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults https://ClinicalTrials.gov/show/NCT04908722
NCT04843761 ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 https://ClinicalTrials.gov/show/NCT04843761
NCT04792567 Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC) https://ClinicalTrials.gov/show/NCT04792567
NCT04765384 A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19) https://ClinicalTrials.gov/show/NCT04765384
NCT04546841 Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults https://ClinicalTrials.gov/show/NCT04546841
NCT04623671 Intravenous Infusion of CAP-1002 in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04623671
NCT04572399 UVA Light Device to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04572399
NCT04535453 A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents https://ClinicalTrials.gov/show/NCT04535453
NCT04530409 Timing of Corticosteroids in COVID-19 https://ClinicalTrials.gov/show/NCT04530409
NCT04646590 A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04646590
NCT04614948 A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04614948
NCT04583592 Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT) https://ClinicalTrials.gov/show/NCT04583592
NCT04401410 Anti-SARS Cov-2 T Cell Infusions for COVID 19 https://ClinicalTrials.gov/show/NCT04401410
NCT04495816 COVID-19 Anosmia Study https://ClinicalTrials.gov/show/NCT04495816
NCT04424212 ICBT for Mental Health Problems Related to the Coronavirus Pandemic https://ClinicalTrials.gov/show/NCT04424212
NCT04476953 COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation https://ClinicalTrials.gov/show/NCT04476953
NCT04436276 A Study of Ad26.COV2.S in Adults (COVID-19) https://ClinicalTrials.gov/show/NCT04436276
NCT04361396 Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04361396
NCT04354259 Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 https://ClinicalTrials.gov/show/NCT04354259
NCT04377620 Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) https://ClinicalTrials.gov/show/NCT04377620
NCT04303507 Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting https://ClinicalTrials.gov/show/NCT04303507
NCT04283461 Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04283461
NCT05178225 Spa Rehabilitation, Antioxidant and Bioenergetic Supportive Treatment of Patients With Post-Covid-19 Syndrome https://ClinicalTrials.gov/show/NCT05178225
NCT05198336 Immunogenicity of an Inactivated COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05198336
NCT05198102 ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization https://ClinicalTrials.gov/show/NCT05198102
NCT05184205 Photodynamic Therapy for COVID-19 Prevention https://ClinicalTrials.gov/show/NCT05184205
NCT05175768 Study to Evaluate the Effect of Nicotinamide Mononucleotide (NMN) As an Adjuvant to Standard of Care (SOC) On Fatigue Associated With COVID-19 Infection https://ClinicalTrials.gov/show/NCT05175768
NCT05167279 A Study of JS026 and JS026 Together With JS016 for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT05167279
NCT05163613 Use of Low-frequency Magnetic Fields in the Hybrid Treatment of COVID-19 Patients https://ClinicalTrials.gov/show/NCT05163613
NCT04858789 The Effectiveness of a CA-CBI on Psychological Distress of University Students During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04858789
NCT04878211 A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab https://ClinicalTrials.gov/show/NCT04878211
NCT04872686 Virucidal Effect of PVP-I on COVID-19 and as Well as Safety of Its Application on Nasopharynx & Oropharynx https://ClinicalTrials.gov/show/NCT04872686
NCT04579549 Repeat Testing for SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04579549
NCT04864548 COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection Study https://ClinicalTrials.gov/show/NCT04864548
NCT04588428 Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04588428
NCT04703205 Study in COvid-19 Patients With iveRmectin (CORVETTE-01) https://ClinicalTrials.gov/show/NCT04703205
NCT04615949 Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors https://ClinicalTrials.gov/show/NCT04615949
NCT04460690 Rapid, Onsite COVID-19 Detection https://ClinicalTrials.gov/show/NCT04460690
NCT04512079 FREEDOM COVID-19 Anticoagulation Strategy https://ClinicalTrials.gov/show/NCT04512079
NCT04381936 Randomised Evaluation of COVID-19 Therapy https://ClinicalTrials.gov/show/NCT04381936
NCT04374019 Novel Agents for Treatment of High-risk COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04374019
NCT04357730 Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04357730
NCT05184192 Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction https://ClinicalTrials.gov/show/NCT05184192
NCT05201625 Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients https://ClinicalTrials.gov/show/NCT05201625
NCT05200754 Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients https://ClinicalTrials.gov/show/NCT05200754
NCT05137236 A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters https://ClinicalTrials.gov/show/NCT05137236
NCT05069623 A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT05069623
NCT04501978 ACTIV-3: Therapeutics for Inpatients With COVID-19 https://ClinicalTrials.gov/show/NCT04501978
NCT04813796 A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04813796
NCT04685213 Electrical Stimulation for Critically Ill Covid-19 Patients https://ClinicalTrials.gov/show/NCT04685213
NCT04537806 A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19 https://ClinicalTrials.gov/show/NCT04537806
NCT04894266 An Open-Label Study of Apabetalone in Covid Infection https://ClinicalTrials.gov/show/NCT04894266
NCT04889274 Investigation of the Effects of Dietary Nitrate and Sex on COVID-19 Vaccine Induced Vascular Dysfunction in Healthy Men and Women (DiNOVasc-COVID-19) https://ClinicalTrials.gov/show/NCT04889274
NCT04842747 VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study https://ClinicalTrials.gov/show/NCT04842747
NCT04826367 Relaxation Training by Tele-Rehabilitation in Patients With Breast Cancer https://ClinicalTrials.gov/show/NCT04826367
NCT04790786 UPMC OPTIMISE-C19 Trial, a COVID-19 Study https://ClinicalTrials.gov/show/NCT04790786
NCT04400838 Investigating a Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04400838
NCT04324606 A Study of a Candidate COVID-19 Vaccine (COV001) https://ClinicalTrials.gov/show/NCT04324606
NCT04324463 Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial https://ClinicalTrials.gov/show/NCT04324463
NCT04344444 Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease https://ClinicalTrials.gov/show/NCT04344444
NCT05205655 Detection Dogs as a Help in the Detection of COVID-19 https://ClinicalTrials.gov/show/NCT05205655
NCT05205642 Exercise Fatigue Parameters and Endothelial Function in Pediatric Patients With a History of COVID-19 Infection or MIS-C https://ClinicalTrials.gov/show/NCT05205642
NCT05204511 Exercise and Post-COVID/ Long-COVID: Effects of Different Training Modalities on Various Parameters in People Affected by the Sequelae of COVID-19 https://ClinicalTrials.gov/show/NCT05204511
NCT05175833 Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19 https://ClinicalTrials.gov/show/NCT05175833
NCT05205759 Non-inferiority Trial on Monoclonal Antibodies in COVID-19 https://ClinicalTrials.gov/show/NCT05205759
NCT05205746 Phase II Immunogenicity Study of AVX/COVID-12 (Patria) Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence https://ClinicalTrials.gov/show/NCT05205746
NCT05205460 Telehealth Exercise Training in Post-COVID Patients https://ClinicalTrials.gov/show/NCT05205460
NCT05205434 Efficacy of Synchronous and Asynchronous Telerehabilitation in COVID-19 Discharges https://ClinicalTrials.gov/show/NCT05205434
NCT05205096 Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac https://ClinicalTrials.gov/show/NCT05205096
NCT05205083 Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV https://ClinicalTrials.gov/show/NCT05205083
NCT05204589 Heterologous Boost Immunization With an Aerosolised Ad5-nCoV After Two-dose Priming With an Inactivated SARS-CoV-2 Vaccine https://ClinicalTrials.gov/show/NCT05204589
NCT05198466 Electrical Stimulation for Critically Ill Post-Covid-19 Patients https://ClinicalTrials.gov/show/NCT05198466
NCT05172050 Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients. https://ClinicalTrials.gov/show/NCT05172050
NCT05168813 Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern https://ClinicalTrials.gov/show/NCT05168813
NCT05055427 Efficacy Evaluation of Shen Cao Gan Jiang Tang on Mild and Moderate COVID-19 Patients https://ClinicalTrials.gov/show/NCT05055427
NCT05043311 The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine. https://ClinicalTrials.gov/show/NCT05043311
NCT05043285 The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine. https://ClinicalTrials.gov/show/NCT05043285
NCT05049226 Third Dose Vaccination With AstraZeneca or Pfizer COVID-19 Vaccine Among Adults Received Sinovac COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05049226
NCT05047692 Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers https://ClinicalTrials.gov/show/NCT05047692
NCT04988035 ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04988035
NCT04924660 Novel Experimental COVID-19 Therapies Affecting Host Response https://ClinicalTrials.gov/show/NCT04924660
NCT04980573 Essential Oils and Post COVID-19 Fatigue https://ClinicalTrials.gov/show/NCT04980573
NCT04787211 A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 https://ClinicalTrials.gov/show/NCT04787211
NCT04859517 Evaluation of ADG20 for the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04859517
NCT04805671 Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04805671
NCT04729595 Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04729595
NCT04754113 Effect of Prone Position onV/Q Matching in Non-intubated Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04754113
NCT04751630 Effects of COVID-19 Hospitalization on Physical Performance https://ClinicalTrials.gov/show/NCT04751630
NCT04771598 Breathing Exercise After COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04771598
NCT04640194 A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19 https://ClinicalTrials.gov/show/NCT04640194
NCT04672564 Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04672564
NCT04650087 COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis https://ClinicalTrials.gov/show/NCT04650087
NCT04425720 Use of Remote Monitoring for COVID-19 Patient https://ClinicalTrials.gov/show/NCT04425720
NCT04606069 Treat COVID-19 Patients With Regadenoson https://ClinicalTrials.gov/show/NCT04606069
NCT04570384 Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness https://ClinicalTrials.gov/show/NCT04570384
NCT04409509 Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04409509
NCT04549376 Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo https://ClinicalTrials.gov/show/NCT04549376
NCT04401150 Lessening Organ Dysfunction With VITamin C - COVID-19 https://ClinicalTrials.gov/show/NCT04401150
NCT04417257 Study of LAU-7b for the Treatment of COVID-19 Disease in Adults https://ClinicalTrials.gov/show/NCT04417257
NCT04377659 Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04377659
NCT04380519 Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04380519
NCT04362813 Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia https://ClinicalTrials.gov/show/NCT04362813
NCT04379336 BCG Vaccination for Healthcare Workers in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04379336
NCT04349371 Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID https://ClinicalTrials.gov/show/NCT04349371
NCT05209477 Effects of Body Position and Recruiting Maneuver on Lung Aeration Assessed Through Ultrasound in Patients Intubated for Acute Respiratory Failure Related to Novel Coronavirus 19 Disease https://ClinicalTrials.gov/show/NCT05209477
NCT05142306 A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes as a Single Dose Regimen to SARS-CoV-2 Uninfected Adults https://ClinicalTrials.gov/show/NCT05142306
NCT05077969 Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2) https://ClinicalTrials.gov/show/NCT05077969
NCT05087381 Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community https://ClinicalTrials.gov/show/NCT05087381
NCT05022329 COVID-19 Vaccine Boosters in Patients With CKD https://ClinicalTrials.gov/show/NCT05022329
NCT04519437 Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19 https://ClinicalTrials.gov/show/NCT04519437
NCT04941001 Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS) https://ClinicalTrials.gov/show/NCT04941001
NCT04613297 HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment https://ClinicalTrials.gov/show/NCT04613297
NCT04883138 Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04883138
NCT04784559 Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection https://ClinicalTrials.gov/show/NCT04784559
NCT04540120 Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome https://ClinicalTrials.gov/show/NCT04540120
NCT04510194 COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04510194
NCT04327206 BCG Vaccination to Protect Healthcare Workers Against COVID-19 https://ClinicalTrials.gov/show/NCT04327206
NCT04405102 COVID-19 Ozanimod Intervention Study https://ClinicalTrials.gov/show/NCT04405102
NCT04400799 Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04400799
NCT04365985 Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 https://ClinicalTrials.gov/show/NCT04365985
NCT05213000 Health Factors and Immune Response to Coronavirus Disease 2019 (COVID-19) Vaccine https://ClinicalTrials.gov/show/NCT05213000
NCT05212948 A Phase 3 Study of S-268019 for the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT05212948
NCT05214196 The Efficacy of Oral Antiseptics Against SARS-CoV-2 https://ClinicalTrials.gov/show/NCT05214196
NCT05212675 Short Daily Versus Conventional Hemodialysis for COVID-19 Patients https://ClinicalTrials.gov/show/NCT05212675
NCT05212532 A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms https://ClinicalTrials.gov/show/NCT05212532
NCT05210101 A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals https://ClinicalTrials.gov/show/NCT05210101
NCT05210179 Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19 https://ClinicalTrials.gov/show/NCT05210179
NCT05158140 Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911) https://ClinicalTrials.gov/show/NCT05158140
NCT05132907 Safety And Immunogenicity Of HDT-301 Targeting A SARS-CoV-2 Variant Spike Protein https://ClinicalTrials.gov/show/NCT05132907
NCT05150847 Prone Positioning in COVID-19 Patients https://ClinicalTrials.gov/show/NCT05150847
NCT05130671 Nutritional Supplementation of Flavonoids Quercetin and Curcumin for Early Mild Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT05130671
NCT05135546 Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial https://ClinicalTrials.gov/show/NCT05135546
NCT05087524 BinaxNOW for Evaluating Children for Infection With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT05087524
NCT05102643 A Study to Evaluate Safety & Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19 https://ClinicalTrials.gov/show/NCT05102643
NCT05041907 Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV) https://ClinicalTrials.gov/show/NCT05041907
NCT05065619 Safety Immunogenicity Study of MT-2766 in Japanese Adults(COVID-19) https://ClinicalTrials.gov/show/NCT05065619
NCT05033223 Psycho-traumatic Consequences of the COVID-19 Health Crisis Among Professionals in Emergency Services https://ClinicalTrials.gov/show/NCT05033223
NCT04966013 Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04966013
NCT04889209 Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines https://ClinicalTrials.gov/show/NCT04889209
NCT04935489 Accelerated Intermittent Theta Burst Stimulation for Depressed Patients During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04935489
NCT04924881 Chinese Medicine for Patients With LCOVID-19 Symptoms https://ClinicalTrials.gov/show/NCT04924881
NCT04854941 Efficacy of Probiotics in the Treatment of Hospitalised Patients With Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04854941
NCT04776317 Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults https://ClinicalTrials.gov/show/NCT04776317
NCT04785144 Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults https://ClinicalTrials.gov/show/NCT04785144
NCT04762680 Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older https://ClinicalTrials.gov/show/NCT04762680
NCT04765449 Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04765449
NCT04708158 Novaferon for COVID-19 Treatment Trial (NCTT-005) https://ClinicalTrials.gov/show/NCT04708158
NCT04630054 Face Masks to Reduce COVID-19 in Bangladesh https://ClinicalTrials.gov/show/NCT04630054
NCT04640038 Contrast Enhanced Ultrasound in COVID-19 https://ClinicalTrials.gov/show/NCT04640038
NCT04659746 MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay https://ClinicalTrials.gov/show/NCT04659746
NCT04647656 Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome https://ClinicalTrials.gov/show/NCT04647656
NCT04565379 Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients https://ClinicalTrials.gov/show/NCT04565379
NCT04397614 Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients https://ClinicalTrials.gov/show/NCT04397614
NCT04534673 Pegylated Interferon Lambda for Treatment of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04534673
NCT04532294 Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants https://ClinicalTrials.gov/show/NCT04532294
NCT04479332 The Change of Critical Patient Managements and Subsequent Influences Under Epidemic of Coronavirus Disease 19 (COVID-19) https://ClinicalTrials.gov/show/NCT04479332
NCT04382755 Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure https://ClinicalTrials.gov/show/NCT04382755
NCT04379154 Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04379154
NCT04360980 The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection https://ClinicalTrials.gov/show/NCT04360980
NCT05075304 A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients https://ClinicalTrials.gov/show/NCT05075304
NCT04333732 CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION https://ClinicalTrials.gov/show/NCT04333732
NCT05075499 Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab https://ClinicalTrials.gov/show/NCT05075499
NCT04667247 Mushroom-based Product for COVID-19 https://ClinicalTrials.gov/show/NCT04667247
NCT04962022 Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants https://ClinicalTrials.gov/show/NCT04962022
NCT05004805 COVID-19 Methylene Blue Antiviral Treatment https://ClinicalTrials.gov/show/NCT05004805
NCT05074368 Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT05074368
NCT05074979 Telerehabilitation in COVID-19 Survivors https://ClinicalTrials.gov/show/NCT05074979
NCT04427501 A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness https://ClinicalTrials.gov/show/NCT04427501
NCT04521296 Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo https://ClinicalTrials.gov/show/NCT04521296
NCT04542408 Hamburg Edoxaban for Anticoagulation in COVID-19 Study https://ClinicalTrials.gov/show/NCT04542408
NCT04431466 A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19 https://ClinicalTrials.gov/show/NCT04431466
NCT04628039 Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs https://ClinicalTrials.gov/show/NCT04628039
NCT05143372 Influence of Vibroacoustic Therapy Modes on the Course of Coronavirus Infection https://ClinicalTrials.gov/show/NCT05143372
NCT04980326 A Scalable Psychological Intervention to Reduce Psychological Distress Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04980326
NCT04707664 Sargramostim Use in COVID-19 to Recover Patient Health https://ClinicalTrials.gov/show/NCT04707664
NCT04649736 Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04649736
NCT05118737 Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia. https://ClinicalTrials.gov/show/NCT05118737
NCT04830033 ENO Breathe vs Usual Care in COVID-19 Recovery https://ClinicalTrials.gov/show/NCT04830033
NCT04821674 Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects https://ClinicalTrials.gov/show/NCT04821674
NCT04600895 The Prevent Severe COVID-19 (PRESECO) Study https://ClinicalTrials.gov/show/NCT04600895
NCT04551898 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04551898
NCT04524507 Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04524507
NCT04957082 Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake https://ClinicalTrials.gov/show/NCT04957082
NCT04384497 Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study https://ClinicalTrials.gov/show/NCT04384497
NCT04382924 Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease https://ClinicalTrials.gov/show/NCT04382924
NCT04425538 A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19). https://ClinicalTrials.gov/show/NCT04425538
NCT04335032 EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2) https://ClinicalTrials.gov/show/NCT04335032
NCT04852978 COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT04852978
NCT04961541 Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine https://ClinicalTrials.gov/show/NCT04961541
NCT04635943 Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 https://ClinicalTrials.gov/show/NCT04635943
NCT04368988 Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant https://ClinicalTrials.gov/show/NCT04368988
NCT04583995 A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom https://ClinicalTrials.gov/show/NCT04583995
NCT04355728 Use of UC-MSCs for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04355728
NCT04344535 Convalescent Plasma vs. Standard Plasma for COVID-19 https://ClinicalTrials.gov/show/NCT04344535
NCT05114655 Aromatherapy for Stress and Burnout Among Healthcare Providers https://ClinicalTrials.gov/show/NCT05114655
NCT05077176 Phase 3 Booster Vaccination Against COVID-19 https://ClinicalTrials.gov/show/NCT05077176
NCT04894721 Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC) https://ClinicalTrials.gov/show/NCT04894721
NCT05007275 A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT05007275
NCT04343989 A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection https://ClinicalTrials.gov/show/NCT04343989
NCT04581863 COVID-19 Watch + COVID-19 Pulse https://ClinicalTrials.gov/show/NCT04581863
NCT04515147 A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 https://ClinicalTrials.gov/show/NCT04515147
NCT05148936 Communities Fighting COVID-19! https://ClinicalTrials.gov/show/NCT05148936
NCT04392232 A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection https://ClinicalTrials.gov/show/NCT04392232
NCT05148845 Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study. https://ClinicalTrials.gov/show/NCT05148845
NCT04992260 Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents https://ClinicalTrials.gov/show/NCT04992260
NCT05057221 Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT05057221
NCT05047640 COVID-19 3rd Dose Vaccine in Transplant Patients https://ClinicalTrials.gov/show/NCT05047640
NCT04936997 Immune Response to the COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04936997
NCT04668209 Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04668209
NCT04830761 Behavior Change in Context to Contain the Spread of COVID-19 https://ClinicalTrials.gov/show/NCT04830761
NCT04818801 Safety, Reactogenicity and Immunogenicity Study of ReCOV https://ClinicalTrials.gov/show/NCT04818801
NCT04625972 Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04625972
NCT04920942 Ivermectin Treatment Efficacy in Covid-19 High Risk Patients https://ClinicalTrials.gov/show/NCT04920942
NCT04913129 The Burden of COVID-19 Survivorship https://ClinicalTrials.gov/show/NCT04913129
NCT04469634 Are SARS-CoV-2 Specific Antibodies a Correlate for Protection? https://ClinicalTrials.gov/show/NCT04469634
NCT04582201 An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing. https://ClinicalTrials.gov/show/NCT04582201
NCT05151614 Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection https://ClinicalTrials.gov/show/NCT05151614
NCT05150860 Communities Fighting COVID Return to School https://ClinicalTrials.gov/show/NCT05150860
NCT05069610 Evaluating Safety, Tolerability, and Potential Efficacy of Intranasal AD17002 in Adults With Mild COVID-19 https://ClinicalTrials.gov/show/NCT05069610
NCT04715997 Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04715997
NCT04750759 Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat https://ClinicalTrials.gov/show/NCT04750759
NCT04609423 Cod Liver Oil for Covid-19 Prevention Study https://ClinicalTrials.gov/show/NCT04609423
NCT04445389 Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04445389
NCT04584684 Mouth Rinses for Inactivation of COVID-19 https://ClinicalTrials.gov/show/NCT04584684
NCT04516512 Assessment of SARS-CoV-2 Seroprevalence in Detention https://ClinicalTrials.gov/show/NCT04516512
NCT04527198 Brainstem Dysfunction in COVID-19 Critically Ill Patients: a Prospective Observational Study https://ClinicalTrials.gov/show/NCT04527198
NCT04526821 Lactoferrin for Prevention of COVID-19 in Health Care Workers https://ClinicalTrials.gov/show/NCT04526821
NCT04365257 Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) https://ClinicalTrials.gov/show/NCT04365257
NCT05152849 Efficacy, Safety, Tolerability of AXA1125 in Fatigue Predominant PASC https://ClinicalTrials.gov/show/NCT05152849
NCT05092698 The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19 https://ClinicalTrials.gov/show/NCT05092698
NCT05124171 Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination https://ClinicalTrials.gov/show/NCT05124171
NCT04803409 UNITE Study (UCSD-SW) for COVID-19 https://ClinicalTrials.gov/show/NCT04803409
NCT04616846 Thromboembolic Risk Screening in Patients With Cancer and COVID-19 https://ClinicalTrials.gov/show/NCT04616846
NCT04638634 Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT04638634
NCT05047770 A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine https://ClinicalTrials.gov/show/NCT05047770
NCT04446429 Anti-Androgen Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04446429
NCT04331366 Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19 https://ClinicalTrials.gov/show/NCT04331366
NCT04372017 Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection https://ClinicalTrials.gov/show/NCT04372017
NCT04960215 Coenzyme Q10 as Treatment for Long Term COVID-19 https://ClinicalTrials.gov/show/NCT04960215
NCT04876274 Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04876274
NCT04721457 The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load https://ClinicalTrials.gov/show/NCT04721457
NCT04749173 To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers. https://ClinicalTrials.gov/show/NCT04749173
NCT04524598 A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19 https://ClinicalTrials.gov/show/NCT04524598
NCT04501796 A Trial of NT-I7 in COVID-19 (SPESELPIS) https://ClinicalTrials.gov/show/NCT04501796
NCT04366856 PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study) https://ClinicalTrials.gov/show/NCT04366856
NCT04326075 Early CPAP in COVID-19 Patients With Respiratory Failure. https://ClinicalTrials.gov/show/NCT04326075
NCT04441996 Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity https://ClinicalTrials.gov/show/NCT04441996
NCT05157178 Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses. https://ClinicalTrials.gov/show/NCT05157178
NCT05157139 Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral Disease https://ClinicalTrials.gov/show/NCT05157139
NCT05112913 Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 Years https://ClinicalTrials.gov/show/NCT05112913
NCT05137418 Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years https://ClinicalTrials.gov/show/NCT05137418
NCT04904744 Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT04904744
NCT04530539 The Effect of Melatonin and Vitamin C on COVID-19 https://ClinicalTrials.gov/show/NCT04530539
NCT04394169 Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection. https://ClinicalTrials.gov/show/NCT04394169
NCT04460014 Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT https://ClinicalTrials.gov/show/NCT04460014
NCT04456153 Atovaquone for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04456153
NCT04379518 Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients https://ClinicalTrials.gov/show/NCT04379518
NCT04351243 A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) https://ClinicalTrials.gov/show/NCT04351243
NCT04321174 COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir https://ClinicalTrials.gov/show/NCT04321174
NCT05158842 Treatment of COVID-19 Positive/Negative Bangladeshi Adults With Severe Respiratory Complaints by a Locally Made bCPAP: Feasibility Study https://ClinicalTrials.gov/show/NCT05158842
NCT05076253 Efficacy of Ivermectin in COVID-19 https://ClinicalTrials.gov/show/NCT05076253
NCT05115071 Online Childbirth Preparation Education in Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT05115071
NCT04739020 Respiratory Aerosols in Patients With COVID-19 and Healthy Controls https://ClinicalTrials.gov/show/NCT04739020
NCT04644172 Improving Thinking in Everyday Life After Covid-19 https://ClinicalTrials.gov/show/NCT04644172
NCT05030974 RECOVAC Third Vaccination Study https://ClinicalTrials.gov/show/NCT05030974
NCT04682197 Cereset Research In Healthcare Workers During COVID-19 https://ClinicalTrials.gov/show/NCT04682197
NCT04377672 Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04377672
NCT04519216 Breastfeeding Education in the Time of COVID-19 https://ClinicalTrials.gov/show/NCT04519216
NCT04345861 Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) https://ClinicalTrials.gov/show/NCT04345861
NCT05022472 Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California https://ClinicalTrials.gov/show/NCT05022472
NCT05043324 Prevention and Treatment of Patient Before, During, and After Covid-19 Infection https://ClinicalTrials.gov/show/NCT05043324
NCT04967742 A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04967742
NCT05000216 COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders https://ClinicalTrials.gov/show/NCT05000216
NCT04880642 A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects https://ClinicalTrials.gov/show/NCT04880642
NCT04690387 Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection https://ClinicalTrials.gov/show/NCT04690387
NCT04545008 Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19 https://ClinicalTrials.gov/show/NCT04545008
NCT04499677 FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals https://ClinicalTrials.gov/show/NCT04499677
NCT04378920 A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes https://ClinicalTrials.gov/show/NCT04378920
NCT04390178 Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04390178
NCT04439071 A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19) https://ClinicalTrials.gov/show/NCT04439071
NCT04328961 Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) https://ClinicalTrials.gov/show/NCT04328961
NCT04911777 Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandirâ„¢ UPPTA for Patients With Early COVID-19 https://ClinicalTrials.gov/show/NCT04911777
NCT05135624 SP16 as a Therapeutic for COVID-19 Induced ARDS https://ClinicalTrials.gov/show/NCT05135624
NCT05067933 A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05067933
NCT04244591 Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04244591
NCT04402944 Pulmozyme to Improve COVID-19 ARDS Outcomes https://ClinicalTrials.gov/show/NCT04402944
NCT04526912 Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04526912
NCT04376593 PET/CT Imaging in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04376593
NCT05164120 Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05164120
NCT05163743 Diet and COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT05163743
NCT05163730 Clinical Evaluation of the Panbioâ„¢ COVID-19/ Flu A&B Rapid Panel https://ClinicalTrials.gov/show/NCT05163730
NCT05140005 GlowTest COVID-19 Antigen Home Test Kit QRI Use Study https://ClinicalTrials.gov/show/NCT05140005
NCT05074446 Stereotype Threat Effect On the Performance of the Non-Intensivist Physicians Assigned in Covid-19 Intensive Care Unit https://ClinicalTrials.gov/show/NCT05074446
NCT04969250 Vaccination for Recovered Inpatients With COVID-19 (VATICO) https://ClinicalTrials.gov/show/NCT04969250
NCT04959760 BinaxNow COVID-19 IgG Rapid Test Device and Antibody Self Test https://ClinicalTrials.gov/show/NCT04959760
NCT04816669 A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04816669
NCT04858425 Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection https://ClinicalTrials.gov/show/NCT04858425
NCT04813497 Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members https://ClinicalTrials.gov/show/NCT04813497
NCT04662060 COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol https://ClinicalTrials.gov/show/NCT04662060
NCT04760730 Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04760730
NCT04762186 Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19 https://ClinicalTrials.gov/show/NCT04762186
NCT04681092 Anti-COVID19 AKS-452 Fusion Protein Vaccine - ACT Study https://ClinicalTrials.gov/show/NCT04681092
NCT04662086 COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol https://ClinicalTrials.gov/show/NCT04662086
NCT04662073 COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol https://ClinicalTrials.gov/show/NCT04662073
NCT04588480 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults https://ClinicalTrials.gov/show/NCT04588480
NCT04568122 Rapid Turnaround, Home-based Saliva Testing for COVID-19 https://ClinicalTrials.gov/show/NCT04568122
NCT04466800 Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19) https://ClinicalTrials.gov/show/NCT04466800
NCT05166005 Severity of COVID-19 and Vitamin D Supplementation https://ClinicalTrials.gov/show/NCT05166005
NCT05165966 Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT05165966
NCT04373707 Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 https://ClinicalTrials.gov/show/NCT04373707
NCT04372628 Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 https://ClinicalTrials.gov/show/NCT04372628
NCT04952857 Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04952857
NCT04904471 A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells) https://ClinicalTrials.gov/show/NCT04904471
NCT04899232 Antithrombin III in Infectious Disease Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04899232
NCT04788459 Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT04788459
NCT04860297 A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants https://ClinicalTrials.gov/show/NCT04860297
NCT04821934 Tele-rehabilitation Program After Hospitalization for COVID-19 https://ClinicalTrials.gov/show/NCT04821934
NCT04482595 BIO 300 Oral Suspension in Discharged COVID-19 Patients https://ClinicalTrials.gov/show/NCT04482595
NCT04796896 A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age https://ClinicalTrials.gov/show/NCT04796896
NCT04644328 The Doctors for Coronavirus Prevention Project Thanksgiving / Christmas Messaging Campaign https://ClinicalTrials.gov/show/NCT04644328
NCT04470427 A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04470427
NCT05167357 Multicentric Evaluation of the Impact on Hypoxia Sensitivity of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05167357
NCT05166915 Respiratory COVID-19: A Randomized, Sham-Controlled Study https://ClinicalTrials.gov/show/NCT05166915
NCT05167227 Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center? https://ClinicalTrials.gov/show/NCT05167227
NCT05148949 Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients https://ClinicalTrials.gov/show/NCT05148949
NCT05148832 Administration of Systemic Corticosteroids and the Recovery of Gustatory Functions in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05148832
NCT05143567 Hemostasis and Inflammation in COVID19 Patients With Venous and Arterial Thrombotic Complications https://ClinicalTrials.gov/show/NCT05143567
NCT05097053 A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19 https://ClinicalTrials.gov/show/NCT05097053
NCT05135585 Evaluation of the Post-vaccination Immune Response to COVID-19 in the New Caledonian Population https://ClinicalTrials.gov/show/NCT05135585
NCT05087173 Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT05087173
NCT05063825 Understanding Reactions to Emotional Material in the Media During COVID-19 - Study 2 https://ClinicalTrials.gov/show/NCT05063825
NCT05067894 Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine https://ClinicalTrials.gov/show/NCT05067894
NCT04956887 Cognitive Training in Survivors of Covid-19: A Randomized Trial https://ClinicalTrials.gov/show/NCT04956887
NCT04992273 COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age https://ClinicalTrials.gov/show/NCT04992273
NCT04987957 Effect Of Musıc Therapy On Anxıety Levels In COVID-19 Pandemıc https://ClinicalTrials.gov/show/NCT04987957
NCT05057923 The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores https://ClinicalTrials.gov/show/NCT05057923
NCT05057169 Randomized Trial of COVID-19 Booster Vaccinations (Cobovax Study) https://ClinicalTrials.gov/show/NCT05057169
NCT05036941 A Trial of Two Mask Systems in Preventing SARS CoV-2 in Healthcare Workers (HCW) https://ClinicalTrials.gov/show/NCT05036941
NCT04955626 To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of a Booster Dose of BNT162b2 Against COVID-19 in Participants ≥12 Years of Age. https://ClinicalTrials.gov/show/NCT04955626
NCT04951310 COVID-19 Vaccinations With a Sweepstakes https://ClinicalTrials.gov/show/NCT04951310
NCT04935476 Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19 https://ClinicalTrials.gov/show/NCT04935476
NCT04871854 Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints https://ClinicalTrials.gov/show/NCT04871854
NCT04920890 Radiofrequency Intervention in Post COVID-19 Patients https://ClinicalTrials.gov/show/NCT04920890
NCT04894305 A Study of Ad26.COV2.S in Healthy Adults (COVID-19) https://ClinicalTrials.gov/show/NCT04894305
NCT04828161 A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19 https://ClinicalTrials.gov/show/NCT04828161
NCT04858451 COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04858451
NCT04841759 The Effects of a Multi-factorial Rehabilitation Program for Healthcare Workers Suffering From Post-COVID-19 Fatigue Syndrome https://ClinicalTrials.gov/show/NCT04841759
NCT04885530 ACTIV-6: COVID-19 Study of Repurposed Medications https://ClinicalTrials.gov/show/NCT04885530
NCT04826588 Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY) https://ClinicalTrials.gov/show/NCT04826588
NCT04780321 JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects https://ClinicalTrials.gov/show/NCT04780321
NCT04816643 A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Young Adults https://ClinicalTrials.gov/show/NCT04816643
NCT04795557 Efficacy of Adaptogens in Patients With Long COVID-19 https://ClinicalTrials.gov/show/NCT04795557
NCT04758962 A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04758962
NCT04537208 Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older https://ClinicalTrials.gov/show/NCT04537208
NCT04708327 Single-Blind Study of STAT-205 in Mild COVID-19 https://ClinicalTrials.gov/show/NCT04708327
NCT04673292 Community Collaboration to Combat COVID-19 (C-FORWARD) https://ClinicalTrials.gov/show/NCT04673292
NCT04652518 LYT-100 in Post-acute COVID-19 Respiratory Disease https://ClinicalTrials.gov/show/NCT04652518
NCT04632706 Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19 https://ClinicalTrials.gov/show/NCT04632706
NCT04631367 mHealth Intervention for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Uganda https://ClinicalTrials.gov/show/NCT04631367
NCT04685655 RescuE pLAsma eXchange in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04685655
NCT04646044 A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04646044
NCT04565665 Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04565665
NCT04559035 Nasal Irrigation to Reduce COVID-19 Morbidity https://ClinicalTrials.gov/show/NCT04559035
NCT04523246 Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents https://ClinicalTrials.gov/show/NCT04523246
NCT04535791 Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers https://ClinicalTrials.gov/show/NCT04535791
NCT04368728 Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals https://ClinicalTrials.gov/show/NCT04368728
NCT04505722 A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants https://ClinicalTrials.gov/show/NCT04505722
NCT04513990 Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04513990
NCT04498247 A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) https://ClinicalTrials.gov/show/NCT04498247
NCT04412018 An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 https://ClinicalTrials.gov/show/NCT04412018
NCT04359797 COVID-19 Patient Positioning Pragmatic Trial https://ClinicalTrials.gov/show/NCT04359797
NCT05172037 Phase III Study of Novaferon in Non-hospitalized Adult Patients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT05172037
NCT05171829 An Educational Self-tracking Tool for Identification of SARS-CoV-2 Risk Transmission https://ClinicalTrials.gov/show/NCT05171829
NCT04690400 Telehealth Stretching Exercise Program for Women With Fibromyalgia During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04690400
NCT05123755 AV-001 for Hospitalized Patients With COVID-19 Disease https://ClinicalTrials.gov/show/NCT05123755
NCT05077332 LEAP-CT for Treatment of COVID-19 Patients (Master Protocol) https://ClinicalTrials.gov/show/NCT05077332
NCT04941703 “CHANGE COVID-19 Severity” https://ClinicalTrials.gov/show/NCT04941703
NCT04999111 A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2 https://ClinicalTrials.gov/show/NCT04999111
NCT04682873 A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19, Caused by the SARS-CoV-2 Virus https://ClinicalTrials.gov/show/NCT04682873
NCT04607928 Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19 https://ClinicalTrials.gov/show/NCT04607928
NCT04420741 Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure https://ClinicalTrials.gov/show/NCT04420741
NCT04407286 Vitamin D Testing and Treatment for COVID 19 https://ClinicalTrials.gov/show/NCT04407286
NCT04569786 Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) https://ClinicalTrials.gov/show/NCT04569786
NCT04569266 Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU https://ClinicalTrials.gov/show/NCT04569266
NCT04475185 Safety and Effectiveness Assessment of the MakAir Artificial Ventilator https://ClinicalTrials.gov/show/NCT04475185
NCT04333472 Piclidenoson for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04333472
NCT04526990 Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above https://ClinicalTrials.gov/show/NCT04526990
NCT04527133 An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04527133
NCT04526145 OUR Stress/ Emotion Management for Black/African American Women With Hypertension https://ClinicalTrials.gov/show/NCT04526145
NCT04527081 Study of COVID-19 DNA Vaccine (AG0302-COVID19) https://ClinicalTrials.gov/show/NCT04527081
NCT04526054 Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients https://ClinicalTrials.gov/show/NCT04526054
NCT04525820 High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study https://ClinicalTrials.gov/show/NCT04525820
NCT04525742 COVID-19 Pandemic and Parents of Disabled Children https://ClinicalTrials.gov/show/NCT04525742
NCT04525417 Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers https://ClinicalTrials.gov/show/NCT04525417
NCT04525378 MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04525378
NCT04522986 An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04522986
NCT04524663 Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients https://ClinicalTrials.gov/show/NCT04524663
NCT04523090 Catalysing the Containment of COVID-19 https://ClinicalTrials.gov/show/NCT04523090
NCT04522830 A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04522830
NCT04522492 Impact of COVID-19 on Mental Health of Patients With Skin Picking https://ClinicalTrials.gov/show/NCT04522492
NCT04522466 Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients https://ClinicalTrials.gov/show/NCT04522466
NCT04522128 Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life? https://ClinicalTrials.gov/show/NCT04522128
NCT04521322 Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease https://ClinicalTrials.gov/show/NCT04521322
NCT04521309 SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04521309
NCT04519411 Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure https://ClinicalTrials.gov/show/NCT04519411
NCT04519320 Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae https://ClinicalTrials.gov/show/NCT04519320
NCT04519385 Toclizumam Versus Dexamethasone in Severe Covid-19 Cases https://ClinicalTrials.gov/show/NCT04519385
NCT04518969 Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19 https://ClinicalTrials.gov/show/NCT04518969
NCT04518514 Telemedical Risk Assessment and Preoperative Evaluation (TAPE) https://ClinicalTrials.gov/show/NCT04518514
NCT04517396 FEnofibRate as a Metabolic INtervention for COVID-19 https://ClinicalTrials.gov/show/NCT04517396
NCT04517422 Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19 https://ClinicalTrials.gov/show/NCT04517422
NCT04517006 Prosocial Behavior Can Safeguard Mental Health and Foster Emotional Well-being During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04517006
NCT04516837 Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19) https://ClinicalTrials.gov/show/NCT04516837
NCT04516954 Convalescent Plasma for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04516954
NCT04516941 CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19 https://ClinicalTrials.gov/show/NCT04516941
NCT04516915 IMU-838 and Oseltamivir in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04516915
NCT04516811 Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04516811
NCT04517162 Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04517162
NCT04516759 AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04516759
NCT04514900 Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program https://ClinicalTrials.gov/show/NCT04514900
NCT04514705 Characteristics in Post Covid-19 Patients https://ClinicalTrials.gov/show/NCT04514705
NCT04513470 Allocetra-OTS in COVID-19 https://ClinicalTrials.gov/show/NCT04513470
NCT04514627 Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04514627
NCT04513158 Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04513158
NCT04513184 Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04513184
NCT04512027 Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support. https://ClinicalTrials.gov/show/NCT04512027
NCT04511650 A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04511650
NCT04510662 Telmisartan in Respiratory Failure Due to COVID-19 https://ClinicalTrials.gov/show/NCT04510662
NCT04511949 COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease https://ClinicalTrials.gov/show/NCT04511949
NCT04511923 Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury https://ClinicalTrials.gov/show/NCT04511923
NCT04511819 Losmapimod Safety and Efficacy in COVID-19 https://ClinicalTrials.gov/show/NCT04511819
NCT04510493 Canakinumab in Patients With COVID-19 and Type 2 Diabetes https://ClinicalTrials.gov/show/NCT04510493
NCT04509973 Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia https://ClinicalTrials.gov/show/NCT04509973
NCT04510207 A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above https://ClinicalTrials.gov/show/NCT04510207
NCT04508439 Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04508439
NCT04508868 Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19 https://ClinicalTrials.gov/show/NCT04508868
NCT04506268 COVID-19 SAFE Enrollment https://ClinicalTrials.gov/show/NCT04506268
NCT04505592 Tenecteplase in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04505592
NCT04505761 The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19 https://ClinicalTrials.gov/show/NCT04505761
NCT04504877 Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19 https://ClinicalTrials.gov/show/NCT04504877
NCT04502667 Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19 https://ClinicalTrials.gov/show/NCT04502667
NCT04502433 Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19) https://ClinicalTrials.gov/show/NCT04502433
NCT04502342 Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04502342
NCT04501965 Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients https://ClinicalTrials.gov/show/NCT04501965
NCT04501783 Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04501783
NCT04500132 To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia https://ClinicalTrials.gov/show/NCT04500132
NCT04500418 Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04500418
NCT04499391 COVID-19 Project ECHO in Nursing Homes https://ClinicalTrials.gov/show/NCT04499391
NCT04499313 Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04499313
NCT04501458 Western Kenya Integrated COVID-19 Response https://ClinicalTrials.gov/show/NCT04501458
NCT04501445 Psychological Symptoms and Families of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04501445
NCT04500366 GERAS Frailty Rehabilitation at Home During COVID-19 https://ClinicalTrials.gov/show/NCT04500366
NCT04500067 Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment https://ClinicalTrials.gov/show/NCT04500067
NCT04498442 A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls https://ClinicalTrials.gov/show/NCT04498442
NCT04498936 Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04498936
NCT04497987 A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff https://ClinicalTrials.gov/show/NCT04497987
NCT04497623 Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons. https://ClinicalTrials.gov/show/NCT04497623
NCT04497298 Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04497298
NCT04497272 Assesment of the Metabolomic Signature in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04497272
NCT04497454 Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04497454
NCT04497649 Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients https://ClinicalTrials.gov/show/NCT04497649
NCT04497389 Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04497389
NCT04496245 Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85 https://ClinicalTrials.gov/show/NCT04496245
NCT04495543 Mitigating Suicide Risk With Single Session ‘Brief Skills for Safer Living’ https://ClinicalTrials.gov/show/NCT04495543
NCT04495842 The Effect of Aromatherapy on COVID-19-induced Anxiety https://ClinicalTrials.gov/show/NCT04495842
NCT04495933 A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04495933
NCT04495101 Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04495101
NCT04495803 Augmented CBGT for Perinatal Anxiety During a Global Pandemic (COVID-19) https://ClinicalTrials.gov/show/NCT04495803
NCT04494984 A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19. https://ClinicalTrials.gov/show/NCT04494984
NCT04494724 Clazakizumab vs. Placebo - COVID-19 Infection https://ClinicalTrials.gov/show/NCT04494724
NCT04494399 IFN Beta-1b and Ribavirin for Covid-19 https://ClinicalTrials.gov/show/NCT04494399
NCT04494204 Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients https://ClinicalTrials.gov/show/NCT04494204
NCT04494867 Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04494867
NCT04494386 Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04494386
NCT04493359 Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04493359
NCT04492514 Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation https://ClinicalTrials.gov/show/NCT04492514
NCT04492410 COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID) https://ClinicalTrials.gov/show/NCT04492410
NCT04492254 Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04492254
NCT04492358 Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center https://ClinicalTrials.gov/show/NCT04492358
NCT04492501 Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan https://ClinicalTrials.gov/show/NCT04492501
NCT04492228 Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome https://ClinicalTrials.gov/show/NCT04492228
NCT04492527 Student-delivered Telehealth Program for COVID-19 Education and Health Promotion https://ClinicalTrials.gov/show/NCT04492527
NCT04490824 Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals https://ClinicalTrials.gov/show/NCT04490824
NCT04490473 Turkish of the SARS-CoV-2 Anxiety Scale https://ClinicalTrials.gov/show/NCT04490473
NCT04490850 COVID-19 Seroprevalence Study in French Guiana https://ClinicalTrials.gov/show/NCT04490850
NCT04490278 CoV-PICS: A Virtual Post-ICU Clinic https://ClinicalTrials.gov/show/NCT04490278
NCT04490200 Effectiveness of a Novel Respirator With Chitosan Nanoparticles https://ClinicalTrials.gov/show/NCT04490200
NCT04489628 Tele-health Enabled Clinical Trial for COVID-19 https://ClinicalTrials.gov/show/NCT04489628
NCT04489446 Sildenafil in COVID-19 https://ClinicalTrials.gov/show/NCT04489446
NCT04488796 STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers https://ClinicalTrials.gov/show/NCT04488796
NCT04487990 CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04487990
NCT04488484 Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2. https://ClinicalTrials.gov/show/NCT04488484
NCT04488081 I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients https://ClinicalTrials.gov/show/NCT04488081
NCT04487964 Complementary Intervention for COVID-19 https://ClinicalTrials.gov/show/NCT04487964
NCT04487691 Nebulized PL for Post-COVID-19 Syndrome https://ClinicalTrials.gov/show/NCT04487691
NCT04487886 Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04487886
NCT04487210 A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19 https://ClinicalTrials.gov/show/NCT04487210
NCT04487639 Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ? https://ClinicalTrials.gov/show/NCT04487639
NCT04487444 Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection https://ClinicalTrials.gov/show/NCT04487444
NCT04487171 Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic https://ClinicalTrials.gov/show/NCT04487171
NCT04487574 A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04487574
NCT04486508 Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04486508
NCT04486313 Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04486313
NCT04486482 A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function https://ClinicalTrials.gov/show/NCT04486482
NCT04486001 Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19 https://ClinicalTrials.gov/show/NCT04486001
NCT04485169 Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm; https://ClinicalTrials.gov/show/NCT04485169
NCT04485130 DISulfiram for COvid-19 (DISCO) Trial https://ClinicalTrials.gov/show/NCT04485130
NCT04484493 Corticosteroid Nasal Spray in COVID-19 Anosmia https://ClinicalTrials.gov/show/NCT04484493
NCT04483830 Suloexide in the Treatment of Early Stages of COVID-19 https://ClinicalTrials.gov/show/NCT04483830
NCT04483960 Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial https://ClinicalTrials.gov/show/NCT04483960
NCT04483375 Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects https://ClinicalTrials.gov/show/NCT04483375
NCT04483752 Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images https://ClinicalTrials.gov/show/NCT04483752
NCT04482621 Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial https://ClinicalTrials.gov/show/NCT04482621
NCT04483635 PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams https://ClinicalTrials.gov/show/NCT04483635
NCT04483271 The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm https://ClinicalTrials.gov/show/NCT04483271
NCT04482647 Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04482647
NCT04482634 Tele-rehabilitation Versus Home Exercise Program in COVID-19 https://ClinicalTrials.gov/show/NCT04482634
NCT04482387 DigiVis: Self-testing Vision App for Telephone Consultations https://ClinicalTrials.gov/show/NCT04482387
NCT04481685 A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04481685
NCT04481633 Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04481633
NCT04480957 Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT04480957
NCT04480593 The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19. https://ClinicalTrials.gov/show/NCT04480593
NCT04480138 Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19) https://ClinicalTrials.gov/show/NCT04480138
NCT04480112 Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults https://ClinicalTrials.gov/show/NCT04480112
NCT04477668 Helmet Non-Invasive Ventilation for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04477668
NCT04479540 Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease https://ClinicalTrials.gov/show/NCT04479540
NCT04479163 Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2 https://ClinicalTrials.gov/show/NCT04479163
NCT04479202 The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04479202
NCT04477993 Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 https://ClinicalTrials.gov/show/NCT04477993
NCT04477954 Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia https://ClinicalTrials.gov/show/NCT04477954
NCT04478019 SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding https://ClinicalTrials.gov/show/NCT04478019
NCT04478539 Extracorporeal Blood Purification as a Treatment Modality for COVID-19 https://ClinicalTrials.gov/show/NCT04478539
NCT04476992 Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement https://ClinicalTrials.gov/show/NCT04476992
NCT04477083 Development and Validation of “Ready-to-Use” Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04477083
NCT04476888 Convalescent Plasma Treatment in COVID-19 https://ClinicalTrials.gov/show/NCT04476888
NCT04477655 Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04477655
NCT04476979 Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04476979
NCT04476667 Online Delivery of Psychotherapy, Tailored to Patients’ Suffering From Mental Health Problems Due to COVID-19 https://ClinicalTrials.gov/show/NCT04476667
NCT04476680 Influence of Military Preventive Policy for reCruit Training on COVID-19 Seroconversion https://ClinicalTrials.gov/show/NCT04476680
NCT04476745 The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People https://ClinicalTrials.gov/show/NCT04476745
NCT04475913 Digital vs Analog Impression in Cases of All-on-4 - Prosthesis https://ClinicalTrials.gov/show/NCT04475913
NCT04475991 Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults https://ClinicalTrials.gov/show/NCT04475991
NCT04475562 Can the Electronic Nose Smell COVID-19? https://ClinicalTrials.gov/show/NCT04475562
NCT04475575 Can the Electronic Nose Smell COVID-19 Antibodies? https://ClinicalTrials.gov/show/NCT04475575
NCT04475107 The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients https://ClinicalTrials.gov/show/NCT04475107
NCT04475302 BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots https://ClinicalTrials.gov/show/NCT04475302
NCT04475601 Enzalutamide Treatment in COVID-19 https://ClinicalTrials.gov/show/NCT04475601
NCT04475120 Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients https://ClinicalTrials.gov/show/NCT04475120
NCT04474483 Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04474483
NCT04474340 COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients https://ClinicalTrials.gov/show/NCT04474340
NCT04473690 KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04473690
NCT04473898 Telerehabilitation After Coronavirus https://ClinicalTrials.gov/show/NCT04473898
NCT04473274 GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study https://ClinicalTrials.gov/show/NCT04473274
NCT04473248 Spartan COVID-19 System: Evaluation of Clinical Sample Collection https://ClinicalTrials.gov/show/NCT04473248
NCT04473261 Efficacy of Iodine Complex Against COVID-19 Patients https://ClinicalTrials.gov/show/NCT04473261
NCT04473053 DEFINE - Evaluating Therapies for COVID-19 https://ClinicalTrials.gov/show/NCT04473053
NCT04473170 Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 https://ClinicalTrials.gov/show/NCT04473170
NCT04472585 Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04472585
NCT04472559 Acupressure for COVID-19 Related Quality of Life and Stress https://ClinicalTrials.gov/show/NCT04472559
NCT04472611 Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial https://ClinicalTrials.gov/show/NCT04472611
NCT04471636 Telemedicine in Outpatient Covid-19 Patients https://ClinicalTrials.gov/show/NCT04471636
NCT04470869 Impact on the OLAF Intervention to Prevent Post Traumatic Disorders During the Confinement. https://ClinicalTrials.gov/show/NCT04470869
NCT04471519 Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04471519
NCT04470999 Changes in Cellular Immune Profile During COVID-19 Infection https://ClinicalTrials.gov/show/NCT04470999
NCT04470531 Role of Co-trimoxazole in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04470531
NCT04470739 Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities? https://ClinicalTrials.gov/show/NCT04470739
NCT04470544 Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04470544
NCT04470609 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years https://ClinicalTrials.gov/show/NCT04470609
NCT04470258 Elmo Respiratory Support Project - COVID-19 https://ClinicalTrials.gov/show/NCT04470258
NCT04469621 A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04469621
NCT04468971 REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia https://ClinicalTrials.gov/show/NCT04468971
NCT04469114 Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04469114
NCT04468646 To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04468646
NCT04467840 Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04467840
NCT04468139 The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04468139
NCT04467918 CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms https://ClinicalTrials.gov/show/NCT04467918
NCT04468009 Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma https://ClinicalTrials.gov/show/NCT04468009
NCT04466605 Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown https://ClinicalTrials.gov/show/NCT04466605
NCT04466683 Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia https://ClinicalTrials.gov/show/NCT04466683
NCT04466670 Hemostasis in COVID-19: an Adaptive Clinical Trial https://ClinicalTrials.gov/show/NCT04466670
NCT04466540 Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04466540
NCT04466280 Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04466280
NCT04466241 Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial https://ClinicalTrials.gov/show/NCT04466241
NCT04466085 Clinical Study of Recombinant Novel Coronavirus Vaccine https://ClinicalTrials.gov/show/NCT04466085
NCT04465695 Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19 https://ClinicalTrials.gov/show/NCT04465695
NCT04466098 Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) https://ClinicalTrials.gov/show/NCT04466098
NCT04465604 Hypertonic Saline for COVID-19 Symptoms https://ClinicalTrials.gov/show/NCT04465604
NCT04465513 Investigation of the Efficacy of CARDIO Softgels PLUS Best-standard-of-care in the Recovery of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04465513
NCT04464486 Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic https://ClinicalTrials.gov/show/NCT04464486
NCT04464395 Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04464395
NCT04463849 Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients https://ClinicalTrials.gov/show/NCT04463849
NCT04463602 Desidustat in the Management of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04463602
NCT04463420 Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04463420
NCT04463472 Study of COVID-19 DNA Vaccine (AG0301-COVID19) https://ClinicalTrials.gov/show/NCT04463472
NCT04463433 Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China https://ClinicalTrials.gov/show/NCT04463433
NCT04463264 Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04463264
NCT04462757 SCIL-1Ra in COVID-19 Feasibility & PK/PD https://ClinicalTrials.gov/show/NCT04462757
NCT04462627 Reduction of COVID 19 Transmission to Health Care Professionals https://ClinicalTrials.gov/show/NCT04462627
NCT04461925 Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs https://ClinicalTrials.gov/show/NCT04461925
NCT04461379 Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04461379
NCT04461340 Efficacy and Safety of Sirolimus in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04461340
NCT04460651 PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial https://ClinicalTrials.gov/show/NCT04460651
NCT04460534 Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab) https://ClinicalTrials.gov/show/NCT04460534
NCT04460443 Sofosbuvir in Treatment of COVID 19 https://ClinicalTrials.gov/show/NCT04460443
NCT04460027 W-SUDs for COVID-19 https://ClinicalTrials.gov/show/NCT04460027
NCT04459325 Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04459325
NCT04459520 Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance https://ClinicalTrials.gov/show/NCT04459520
NCT04459455 Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04459455
NCT04459962 Covid-19 Breath Test https://ClinicalTrials.gov/show/NCT04459962
NCT04459676 Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04459676
NCT04456595 Clinical Trial of Efficacy and Safety of Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals https://ClinicalTrials.gov/show/NCT04456595
NCT04458519 Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection https://ClinicalTrials.gov/show/NCT04458519
NCT04458246 Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04458246
NCT04457726 Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04457726
NCT04457609 Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04457609
NCT04458948 Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients https://ClinicalTrials.gov/show/NCT04458948
NCT04457388 Tele-Yoga Therapy for Chronic Pain https://ClinicalTrials.gov/show/NCT04457388
NCT04457349 Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19 https://ClinicalTrials.gov/show/NCT04457349
NCT04456361 Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04456361
NCT04456452 Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation https://ClinicalTrials.gov/show/NCT04456452
NCT04456413 Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection https://ClinicalTrials.gov/show/NCT04456413
NCT04456062 Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04456062
NCT04455308 COVID-19 and Chilblains https://ClinicalTrials.gov/show/NCT04455308
NCT04455360 Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial https://ClinicalTrials.gov/show/NCT04455360
NCT04454606 The New Silicone N99 Half-Piece Respirator https://ClinicalTrials.gov/show/NCT04454606
NCT04453852 Monovalent Recombinant COVID19 Vaccine https://ClinicalTrials.gov/show/NCT04453852
NCT04453774 At Home Monitoring for Patients With Covid19 https://ClinicalTrials.gov/show/NCT04453774
NCT04453657 Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid COVID-19 https://ClinicalTrials.gov/show/NCT04453657
NCT04453514 Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic https://ClinicalTrials.gov/show/NCT04453514
NCT04453475 Feasibility and Benefits of Digital Services During the COVID19 Pandemic https://ClinicalTrials.gov/show/NCT04453475
NCT04453384 Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia https://ClinicalTrials.gov/show/NCT04453384
NCT04452773 Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers https://ClinicalTrials.gov/show/NCT04452773
NCT04452669 VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04452669
NCT04452565 NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04452565
NCT04452318 COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay https://ClinicalTrials.gov/show/NCT04452318
NCT04451889 Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04451889
NCT04451291 Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure https://ClinicalTrials.gov/show/NCT04451291
NCT04451174 Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04451174
NCT04448756 Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE) https://ClinicalTrials.gov/show/NCT04448756
NCT04450004 Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. https://ClinicalTrials.gov/show/NCT04450004
NCT04449718 Vitamin D Supplementation in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04449718
NCT04449380 Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04449380
NCT04448769 Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) https://ClinicalTrials.gov/show/NCT04448769
NCT04447781 Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 https://ClinicalTrials.gov/show/NCT04447781
NCT04448119 Control of COVID-19 Outbreaks in Long Term Care https://ClinicalTrials.gov/show/NCT04448119
NCT04447469 Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation https://ClinicalTrials.gov/show/NCT04447469
NCT04447534 Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04447534
NCT04447404 DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury https://ClinicalTrials.gov/show/NCT04447404
NCT04447235 Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04447235
NCT04446377 A Study of LAM-002A for the Prevention of Progression of COVID-19 https://ClinicalTrials.gov/show/NCT04446377
NCT04445597 ANalyzing Olfactory Dysfunction Mechanisms In COVID-19 https://ClinicalTrials.gov/show/NCT04445597
NCT04446104 A Preventive Treatment for Migrant Workers at High-risk of COVID-19 https://ClinicalTrials.gov/show/NCT04446104
NCT04445935 Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial https://ClinicalTrials.gov/show/NCT04445935
NCT04445467 An Adaptive Clinical Trial of Antivirals for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04445467
NCT04445376 Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery. https://ClinicalTrials.gov/show/NCT04445376
NCT04445272 Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04445272
NCT04445311 Ivermectin in Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04445311
NCT04445285 Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure https://ClinicalTrials.gov/show/NCT04445285
NCT04445324 Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19 https://ClinicalTrials.gov/show/NCT04445324
NCT04445454 Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection https://ClinicalTrials.gov/show/NCT04445454
NCT04445194 Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine https://ClinicalTrials.gov/show/NCT04445194
NCT04445246 Inhaled Iloprost for Suspected COVID-19 Respiratory Failure https://ClinicalTrials.gov/show/NCT04445246
NCT04444596 Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04444596
NCT04444674 COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection https://ClinicalTrials.gov/show/NCT04444674
NCT04444271 Mesenchymal Stem Cell Infusion for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04444271
NCT04443881 Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS) https://ClinicalTrials.gov/show/NCT04443881
NCT04443673 Glycine Supplement for Severe COVID-19 https://ClinicalTrials.gov/show/NCT04443673
NCT04442958 Effectiveness of Convalescent Immune Plasma Therapy https://ClinicalTrials.gov/show/NCT04442958
NCT04442178 InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ) https://ClinicalTrials.gov/show/NCT04442178
NCT04442152 Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants https://ClinicalTrials.gov/show/NCT04442152
NCT04442230 NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04442230
NCT04442048 Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure https://ClinicalTrials.gov/show/NCT04442048
NCT04441684 Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19) https://ClinicalTrials.gov/show/NCT04441684
NCT04442191 Convalescent Plasma as a Possible Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04442191
NCT04441632 Effect of Positive Attitudes on Behavior and Wellness https://ClinicalTrials.gov/show/NCT04441632
NCT04441918 Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects https://ClinicalTrials.gov/show/NCT04441918
NCT04439825 Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction https://ClinicalTrials.gov/show/NCT04439825
NCT04441424 Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04441424
NCT04441385 Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19). https://ClinicalTrials.gov/show/NCT04441385
NCT04438980 Glucocorticoids in COVID-19 (CORTIVID) https://ClinicalTrials.gov/show/NCT04438980
NCT04439006 Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04439006
NCT04438850 COVidIVERmectin: Ivermectin for Treatment of Covid-19 https://ClinicalTrials.gov/show/NCT04438850
NCT04438694 Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection https://ClinicalTrials.gov/show/NCT04438694
NCT04439045 Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity https://ClinicalTrials.gov/show/NCT04439045
NCT04437823 Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04437823
NCT04438070 COVID Screening Strategies in Homeless Shelters https://ClinicalTrials.gov/show/NCT04438070
NCT04438057 Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04438057
NCT04437875 An Open Study of the Safety, Tolerability and Immunogenicity of “Gam-COVID-Vac Lyo” Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04437875
NCT04437719 Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04437719
NCT04436471 An Open Study of the Safety, Tolerability and Immunogenicity of the Drug “Gam-COVID-Vac” Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04436471
NCT04435795 Inhaled Ciclesonide for Outpatients With COVID19 https://ClinicalTrials.gov/show/NCT04435795
NCT04435717 Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01) https://ClinicalTrials.gov/show/NCT04435717
NCT04435587 Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection https://ClinicalTrials.gov/show/NCT04435587
NCT04435275 Virtual Assistant for COVID-19 PPE https://ClinicalTrials.gov/show/NCT04435275
NCT04435522 Maraviroc in Patients With Moderate and Severe COVID-19 https://ClinicalTrials.gov/show/NCT04435522
NCT04435353 Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19 https://ClinicalTrials.gov/show/NCT04435353
NCT04434248 An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04434248
NCT04433910 A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04433910
NCT04434131 Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04434131
NCT04433949 Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04433949
NCT04433546 Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). https://ClinicalTrials.gov/show/NCT04433546
NCT04431856 CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment https://ClinicalTrials.gov/show/NCT04431856
NCT04432805 Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04432805
NCT04432324 Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04432324
NCT04432298 Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease https://ClinicalTrials.gov/show/NCT04432298
NCT04432051 The Use of Lung Ultrasonography in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04432051
NCT04432987 Dornase Alpha for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04432987
NCT04432103 Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma https://ClinicalTrials.gov/show/NCT04432103
NCT04431297 Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04431297
NCT04431180 Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial# https://ClinicalTrials.gov/show/NCT04431180
NCT04430608 Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients https://ClinicalTrials.gov/show/NCT04430608
NCT04429724 Health Professional Exposure Assessment to Covid-19 https://ClinicalTrials.gov/show/NCT04429724
NCT04429867 Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease https://ClinicalTrials.gov/show/NCT04429867
NCT04429594 Study of the Incidence of SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04429594
NCT04429711 Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04429711
NCT04429529 Safety of TY027, a Treatment for COVID-19, in Humans https://ClinicalTrials.gov/show/NCT04429529
NCT04429828 COVID-19 Psychological Wellbeing for Healthcare Students https://ClinicalTrials.gov/show/NCT04429828
NCT04429555 Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS https://ClinicalTrials.gov/show/NCT04429555
NCT04429334 Efficacy and Safety Study of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support and Features of Systemic Inflammation. https://ClinicalTrials.gov/show/NCT04429334
NCT04428099 Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression https://ClinicalTrials.gov/show/NCT04428099
NCT04428021 Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure https://ClinicalTrials.gov/show/NCT04428021
NCT04428008 Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients https://ClinicalTrials.gov/show/NCT04428008
NCT04427566 Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise https://ClinicalTrials.gov/show/NCT04427566
NCT04427254 Study of the Sars-Cov2 Neuroinvasiveness - COVID19 https://ClinicalTrials.gov/show/NCT04427254
NCT04427137 Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04427137
NCT04427098 Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients https://ClinicalTrials.gov/show/NCT04427098
NCT04426305 Community Health Workers Against COVID19 https://ClinicalTrials.gov/show/NCT04426305
NCT04426318 COVID-19 and the Healthy Minds Program for Educators https://ClinicalTrials.gov/show/NCT04426318
NCT04426201 InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ) https://ClinicalTrials.gov/show/NCT04426201
NCT04426006 Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04426006
NCT04425707 Ivermectin In Treatment of COVID 19 Patients https://ClinicalTrials.gov/show/NCT04425707
NCT04425616 SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer https://ClinicalTrials.gov/show/NCT04425616
NCT04425629 Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04425629
NCT04425252 Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04425252
NCT04425005 Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric https://ClinicalTrials.gov/show/NCT04425005
NCT04424953 To Compare Videolaryngoscope Against Direct Laryngoscope for Intubation When Powered Air Purifying Respirator is Worn https://ClinicalTrials.gov/show/NCT04424953
NCT04425317 Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04425317
NCT04424901 Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04424901
NCT04424797 Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol https://ClinicalTrials.gov/show/NCT04424797
NCT04423991 Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning https://ClinicalTrials.gov/show/NCT04423991
NCT04424082 External Dead Space in Ventilated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04424082
NCT04422509 Lanadelumab for Treatment of COVID-19 Disease https://ClinicalTrials.gov/show/NCT04422509
NCT04423289 Telematic Monitoring Through a Mobile Application of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04423289
NCT04422353 Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04422353
NCT04421664 Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada) https://ClinicalTrials.gov/show/NCT04421664
NCT04421612 COVID-19 - No Health Without Mental Health https://ClinicalTrials.gov/show/NCT04421612
NCT04421625 Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04421625
NCT04421508 A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04421508
NCT04421391 QuadraMune(TM) for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04421391
NCT04420247 Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 https://ClinicalTrials.gov/show/NCT04420247
NCT04420676 Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection https://ClinicalTrials.gov/show/NCT04420676
NCT04420390 Low Dose Radiotherapy for COVID-19 Pneumonitis https://ClinicalTrials.gov/show/NCT04420390
NCT04420260 Primary Prevention of Infection by COVID-19 in Workers https://ClinicalTrials.gov/show/NCT04420260
NCT04420299 Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19 https://ClinicalTrials.gov/show/NCT04420299
NCT04420806 Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women https://ClinicalTrials.gov/show/NCT04420806
NCT04421027 A Study of Baricitinib (LY3009104) in Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04421027
NCT04420338 SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study https://ClinicalTrials.gov/show/NCT04420338
NCT04419610 RAS and Coagulopathy in COVID19 https://ClinicalTrials.gov/show/NCT04419610
NCT04419623 A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer https://ClinicalTrials.gov/show/NCT04419623
NCT04419025 Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease https://ClinicalTrials.gov/show/NCT04419025
NCT04418505 Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04418505
NCT04418206 Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19 https://ClinicalTrials.gov/show/NCT04418206
NCT04417335 Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination https://ClinicalTrials.gov/show/NCT04417335
NCT04416919 Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment https://ClinicalTrials.gov/show/NCT04416919
NCT04417270 Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge https://ClinicalTrials.gov/show/NCT04417270
NCT04416334 PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS https://ClinicalTrials.gov/show/NCT04416334
NCT04416399 STerOids in COVID-19 Study https://ClinicalTrials.gov/show/NCT04416399
NCT04416308 COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB) https://ClinicalTrials.gov/show/NCT04416308
NCT04416139 Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 https://ClinicalTrials.gov/show/NCT04416139
NCT04416113 Photodynamic Therapy for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04416113
NCT04416360 Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04416360
NCT04415060 SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival https://ClinicalTrials.gov/show/NCT04415060
NCT04414293 Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis https://ClinicalTrials.gov/show/NCT04414293
NCT04414618 A Study of Opaganib in Coronavirus Disease 2019 Pneumonia https://ClinicalTrials.gov/show/NCT04414618
NCT04414371 Tools for Wellbeing COVID-19 National Study of Undergraduate Students https://ClinicalTrials.gov/show/NCT04414371
NCT04414267 Bacillus Calmette-guérin Vaccination to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04414267
NCT04414124 A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 https://ClinicalTrials.gov/show/NCT04414124
NCT04413968 COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants https://ClinicalTrials.gov/show/NCT04413968
NCT04413864 Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19 https://ClinicalTrials.gov/show/NCT04413864
NCT04412772 Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS https://ClinicalTrials.gov/show/NCT04412772
NCT04412538 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 https://ClinicalTrials.gov/show/NCT04412538
NCT04413006 Self-compassion for Chronic Pain Virtual Group Treatment Program https://ClinicalTrials.gov/show/NCT04413006
NCT04412668 Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19 https://ClinicalTrials.gov/show/NCT04412668
NCT04412291 A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study https://ClinicalTrials.gov/show/NCT04412291
NCT04412343 The Seniors COvid-19 Pandemic and Exercise Study https://ClinicalTrials.gov/show/NCT04412343
NCT04412356 Timing of Tracheotomy in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04412356
NCT04412330 Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 https://ClinicalTrials.gov/show/NCT04412330
NCT04412239 To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04412239
NCT04412057 Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury https://ClinicalTrials.gov/show/NCT04412057
NCT04411680 Study of Sargramostim in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04411680
NCT04411433 Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04411433
NCT04411446 Cholecalciferol to Improve the Outcomes of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04411446
NCT04410692 Can the Prediction Market Improve Predictions of COVID-19? https://ClinicalTrials.gov/show/NCT04410692
NCT04410510 P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04410510
NCT04410458 Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial) https://ClinicalTrials.gov/show/NCT04410458
NCT04410536 Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency https://ClinicalTrials.gov/show/NCT04410536
NCT04410354 Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19 https://ClinicalTrials.gov/show/NCT04410354
NCT04410328 Aggrenox To Treat Acute Covid-19 https://ClinicalTrials.gov/show/NCT04410328
NCT04409925 DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1) https://ClinicalTrials.gov/show/NCT04409925
NCT04410016 Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study https://ClinicalTrials.gov/show/NCT04410016
NCT04409821 Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care https://ClinicalTrials.gov/show/NCT04409821
NCT04409522 Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients https://ClinicalTrials.gov/show/NCT04409522
NCT04409873 Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) https://ClinicalTrials.gov/show/NCT04409873
NCT04409496 Chat-based Support for Preventing Smoking Relapse https://ClinicalTrials.gov/show/NCT04409496
NCT04409262 A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04409262
NCT04408456 Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04408456
NCT04409327 Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes https://ClinicalTrials.gov/show/NCT04409327
NCT04408287 Improving Activity Engagement Among Persons With SCI During COVID-19 https://ClinicalTrials.gov/show/NCT04408287
NCT04408027 Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions https://ClinicalTrials.gov/show/NCT04408027
NCT04408209 Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04408209
NCT04408157 A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04408157
NCT04408066 COVID-19: A POC Test Under Research & Evaluation https://ClinicalTrials.gov/show/NCT04408066
NCT04408131 Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study https://ClinicalTrials.gov/show/NCT04408131
NCT04408040 Use of Convalescent Plasma for COVID-19 https://ClinicalTrials.gov/show/NCT04408040
NCT04407689 InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort https://ClinicalTrials.gov/show/NCT04407689
NCT04407182 Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 https://ClinicalTrials.gov/show/NCT04407182
NCT04407208 Convalescent Plasma Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04407208
NCT04407390 Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly https://ClinicalTrials.gov/show/NCT04407390
NCT04407130 Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. https://ClinicalTrials.gov/show/NCT04407130
NCT04406181 Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04406181
NCT04406389 Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial) https://ClinicalTrials.gov/show/NCT04406389
NCT04406246 Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide https://ClinicalTrials.gov/show/NCT04406246
NCT04406493 Monitoring COVID-19 Patients’ Lung Fluid Using Impedance Technique https://ClinicalTrials.gov/show/NCT04406493
NCT04405999 Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease https://ClinicalTrials.gov/show/NCT04405999
NCT04405908 SCB-2019 as COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04405908
NCT04405570 A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19 https://ClinicalTrials.gov/show/NCT04405570
NCT04405843 Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial) https://ClinicalTrials.gov/show/NCT04405843
NCT04405986 Exploring Brain Damages After COVID-19 Infection https://ClinicalTrials.gov/show/NCT04405986
NCT04405544 Determination of Acute Encephalopathy Predictors in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04405544
NCT04405310 Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial https://ClinicalTrials.gov/show/NCT04405310
NCT04404361 PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer https://ClinicalTrials.gov/show/NCT04404361
NCT04404218 The Açaí Berry COVID-19 Anti-Inflammation Trial https://ClinicalTrials.gov/show/NCT04404218
NCT04404426 CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04404426
NCT04403685 Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers https://ClinicalTrials.gov/show/NCT04403685
NCT04403477 Convalescent Plasma Therapy in Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04403477
NCT04403555 Ivermectin as a Novel Therapy in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04403555
NCT04402866 TD-0903 for ALI Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04402866
NCT04403646 Tannin Specific Natural Extract for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04403646
NCT04403100 Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: “The Hope Coalition - 1” https://ClinicalTrials.gov/show/NCT04403100
NCT04402983 The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients https://ClinicalTrials.gov/show/NCT04402983
NCT04403269 NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE https://ClinicalTrials.gov/show/NCT04403269
NCT04402957 LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04402957
NCT04402879 CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals https://ClinicalTrials.gov/show/NCT04402879
NCT04402060 A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 https://ClinicalTrials.gov/show/NCT04402060
NCT04402840 Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) https://ClinicalTrials.gov/show/NCT04402840
NCT04402203 Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh https://ClinicalTrials.gov/show/NCT04402203
NCT04402918 Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy https://ClinicalTrials.gov/show/NCT04402918
NCT04401475 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04401475
NCT04401423 TXA127 for the Treatment of Severe COVID-19 https://ClinicalTrials.gov/show/NCT04401423
NCT04401046 COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder https://ClinicalTrials.gov/show/NCT04401046
NCT04400890 Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19 https://ClinicalTrials.gov/show/NCT04400890
NCT04399746 Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 https://ClinicalTrials.gov/show/NCT04399746
NCT04400929 Using GM-CSF as a Host Directed Therapeutic Against COVID-19 https://ClinicalTrials.gov/show/NCT04400929
NCT04400279 The COVID-19 Pandemic and Exercise Study https://ClinicalTrials.gov/show/NCT04400279
NCT04399317 Flow Controlled Ventilation in ARDS Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04399317
NCT04400032 Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04400032
NCT04399252 Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19 https://ClinicalTrials.gov/show/NCT04399252
NCT04399681 The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 https://ClinicalTrials.gov/show/NCT04399681
NCT04399109 Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER) https://ClinicalTrials.gov/show/NCT04399109
NCT04399005 The Efficacy Comparing Daily and After-each-case Room Disinfection. https://ClinicalTrials.gov/show/NCT04399005
NCT04398004 Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early https://ClinicalTrials.gov/show/NCT04398004
NCT04397757 COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. https://ClinicalTrials.gov/show/NCT04397757
NCT04397666 RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04397666
NCT04398277 A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04398277
NCT04397705 Remote Monitoring of Cancer Patients With Suspected Covid-19 https://ClinicalTrials.gov/show/NCT04397705
NCT04397523 Efficacy and Safety of COVID-19 Convalescent Plasma https://ClinicalTrials.gov/show/NCT04397523
NCT04397510 Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury https://ClinicalTrials.gov/show/NCT04397510
NCT04397692 Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) https://ClinicalTrials.gov/show/NCT04397692
NCT04397796 Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04397796
NCT04397718 Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04397718
NCT04395807 Helmet CPAP Versus HFNC in COVID-19 https://ClinicalTrials.gov/show/NCT04395807
NCT04395911 Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections https://ClinicalTrials.gov/show/NCT04395911
NCT04395768 International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 https://ClinicalTrials.gov/show/NCT04395768
NCT04395430 A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19 https://ClinicalTrials.gov/show/NCT04395430
NCT04395144 COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss https://ClinicalTrials.gov/show/NCT04395144
NCT04395105 Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04395105
NCT04394455 Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms https://ClinicalTrials.gov/show/NCT04394455
NCT04394793 Low Dose Radiation Therapy for Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04394793
NCT04394182 Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 https://ClinicalTrials.gov/show/NCT04394182
NCT04394442 Hydroxychloroquine in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04394442
NCT04394416 Trial of Imatinib for Hospitalized Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04394416
NCT04394403 Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress https://ClinicalTrials.gov/show/NCT04394403
NCT04394208 Silymarin in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04394208
NCT04393961 At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study https://ClinicalTrials.gov/show/NCT04393961
NCT04394377 Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial https://ClinicalTrials.gov/show/NCT04394377
NCT04393818 Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19 https://ClinicalTrials.gov/show/NCT04393818
NCT04393792 SINUS WASH Pilot Study in Adults Testing Positive for COVID-19 https://ClinicalTrials.gov/show/NCT04393792
NCT04394013 A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period https://ClinicalTrials.gov/show/NCT04394013
NCT04394039 Post-Pandemic Perception of Public Space in Singapore https://ClinicalTrials.gov/show/NCT04394039
NCT04393948 Lung Irradiation for COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04393948
NCT04393727 Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04393727
NCT04393636 Digital Cardiac Counseling Trial: DCC Trial https://ClinicalTrials.gov/show/NCT04393636
NCT04393415 Using PRP and Cord Blood in Treatment of Covid -19 https://ClinicalTrials.gov/show/NCT04393415
NCT04393246 mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms https://ClinicalTrials.gov/show/NCT04393246
NCT04393077 Emotional Freedom Technique (EFT) Effect on Nurses https://ClinicalTrials.gov/show/NCT04393077
NCT04393038 ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04393038
NCT04392973 FAvipiravir and HydroxyChloroquine Combination Therapy https://ClinicalTrials.gov/show/NCT04392973
NCT04392778 Clinical Use of Stem Cells for the Treatment of Covid-19 https://ClinicalTrials.gov/show/NCT04392778
NCT04392713 Efficacy of Ivermectin in COVID-19 https://ClinicalTrials.gov/show/NCT04392713
NCT04392414 Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04392414
NCT04392531 Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19 https://ClinicalTrials.gov/show/NCT04392531
NCT04392453 Upper Limb Robotic Rehabilitation During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04392453
NCT04391829 Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males https://ClinicalTrials.gov/show/NCT04391829
NCT04390503 Convalescent Plasma for Early Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04390503
NCT04391309 COVID-19 and Anti-CD14 Treatment Trial https://ClinicalTrials.gov/show/NCT04391309
NCT04390477 Study to Evaluate the Effect of a Probiotic in COVID-19 https://ClinicalTrials.gov/show/NCT04390477
NCT04390516 Respiratory Decompensation and Model for the Triage of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04390516
NCT04391712 Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease https://ClinicalTrials.gov/show/NCT04391712
NCT04391140 Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS https://ClinicalTrials.gov/show/NCT04391140
NCT04391127 Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04391127
NCT04391179 Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 https://ClinicalTrials.gov/show/NCT04391179
NCT04390464 mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R) https://ClinicalTrials.gov/show/NCT04390464
NCT04390412 Low Dose Radiotherapy in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04390412
NCT04390139 Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 https://ClinicalTrials.gov/show/NCT04390139
NCT04390594 Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal https://ClinicalTrials.gov/show/NCT04390594
NCT04389944 Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04389944
NCT04390152 Safety and Efficacy of Intravenous Wharton’s Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19 https://ClinicalTrials.gov/show/NCT04390152
NCT04390191 Early CPAP in COVID-19 Confirmed or Suspected Patients https://ClinicalTrials.gov/show/NCT04390191
NCT04389840 Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure https://ClinicalTrials.gov/show/NCT04389840
NCT04389710 Convalescent Plasma for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04389710
NCT04389372 Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse https://ClinicalTrials.gov/show/NCT04389372
NCT04389385 COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo) https://ClinicalTrials.gov/show/NCT04389385
NCT04388683 Inhaled Nitric Oxide for Preventing Progression in COVID-19 https://ClinicalTrials.gov/show/NCT04388683
NCT04388410 Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04388410
NCT04388514 Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure https://ClinicalTrials.gov/show/NCT04388514
NCT04388527 COVID-19 Convalescent Plasma for Mechanically Ventilated Population https://ClinicalTrials.gov/show/NCT04388527
NCT04387409 Study to Assess VPM1002 in Reducing Healthcare Professionals’ Absenteeism in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04387409
NCT04387292 Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic https://ClinicalTrials.gov/show/NCT04387292
NCT04386798 Stress and Anxiety Levels of Mothers Lying in the Baby Newborn Intensive Care Unit https://ClinicalTrials.gov/show/NCT04386798
NCT04386668 Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic https://ClinicalTrials.gov/show/NCT04386668
NCT04386694 Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04386694
NCT04386850 Oral 25-hydroxyvitamin D3 and COVID-19 https://ClinicalTrials.gov/show/NCT04386850
NCT04386291 Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19 https://ClinicalTrials.gov/show/NCT04386291
NCT04386239 Study on the Use of Sarilumab in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04386239
NCT04385940 Vitamin D and COVID-19 Management https://ClinicalTrials.gov/show/NCT04385940
NCT04385810 Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19 https://ClinicalTrials.gov/show/NCT04385810
NCT04385901 Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth https://ClinicalTrials.gov/show/NCT04385901
NCT04385849 Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04385849
NCT04385836 Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) https://ClinicalTrials.gov/show/NCT04385836
NCT04385199 Convalescent Plasma for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04385199
NCT04385095 Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04385095
NCT04384588 COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) https://ClinicalTrials.gov/show/NCT04384588
NCT04385043 Hyperimmune Plasma in Patients With COVID-19 Severe Infection https://ClinicalTrials.gov/show/NCT04385043
NCT04385017 Role of Inflammasomes in COVID-19 Disease https://ClinicalTrials.gov/show/NCT04385017
NCT04384445 Zofin (Organicell Flow) for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04384445
NCT04384549 Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers https://ClinicalTrials.gov/show/NCT04384549
NCT04384380 Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04384380
NCT04384731 Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19 https://ClinicalTrials.gov/show/NCT04384731
NCT04384458 Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis https://ClinicalTrials.gov/show/NCT04384458
NCT04383613 Prone Positioning for Patients on General Medical Wards With COVID19 https://ClinicalTrials.gov/show/NCT04383613
NCT04383535 Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia https://ClinicalTrials.gov/show/NCT04383535
NCT04383574 Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) https://ClinicalTrials.gov/show/NCT04383574
NCT04382846 Novel Regimens in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04382846
NCT04382651 Study of Efficacy and Safety of MAS825 in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04382651
NCT04382768 Inhaled Ibuprofen to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04382768
NCT04383002 High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients) https://ClinicalTrials.gov/show/NCT04383002
NCT04382560 Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04382560
NCT04382729 Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia https://ClinicalTrials.gov/show/NCT04382729
NCT04382547 Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells https://ClinicalTrials.gov/show/NCT04382547
NCT04382586 Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants https://ClinicalTrials.gov/show/NCT04382586
NCT04382391 Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04382391
NCT04382092 Co-infection Management in COVID-19 Critically Ill https://ClinicalTrials.gov/show/NCT04382092
NCT04382131 Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19) https://ClinicalTrials.gov/show/NCT04382131
NCT04382378 Effects of NMES in Critically Ill Patients https://ClinicalTrials.gov/show/NCT04382378
NCT04381884 Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04381884
NCT04381962 A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2) https://ClinicalTrials.gov/show/NCT04381962
NCT04382040 A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04382040
NCT04381364 Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) https://ClinicalTrials.gov/show/NCT04381364
NCT04381377 Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19 https://ClinicalTrials.gov/show/NCT04381377
NCT04381000 Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic. https://ClinicalTrials.gov/show/NCT04381000
NCT04380961 A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19 https://ClinicalTrials.gov/show/NCT04380961
NCT04381052 Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection https://ClinicalTrials.gov/show/NCT04381052
NCT04380935 Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04380935
NCT04380909 ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation https://ClinicalTrials.gov/show/NCT04380909
NCT04380532 Tableted COVID-19 Therapeutic Vaccine https://ClinicalTrials.gov/show/NCT04380532
NCT04381858 Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04381858
NCT04380818 Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19 https://ClinicalTrials.gov/show/NCT04380818
NCT04380402 Atorvastatin as Adjunctive Therapy in COVID-19 https://ClinicalTrials.gov/show/NCT04380402
NCT04380376 Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia https://ClinicalTrials.gov/show/NCT04380376
NCT04379531 LDCT in COVID-19 Pneumonia: a Prospective Moscow Study https://ClinicalTrials.gov/show/NCT04379531
NCT04379271 A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator’s Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19) https://ClinicalTrials.gov/show/NCT04379271
NCT04379375 Nudges to Improve Health Behaviors That Limit COVID-19 Spread https://ClinicalTrials.gov/show/NCT04379375
NCT04379453 Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses https://ClinicalTrials.gov/show/NCT04379453
NCT04379661 SUNLIGHT Study: Online Support Groups for MS to Address COVID-19 https://ClinicalTrials.gov/show/NCT04379661
NCT04379076 InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort https://ClinicalTrials.gov/show/NCT04379076
NCT04379037 Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients https://ClinicalTrials.gov/show/NCT04379037
NCT04378803 Mindfulness Training for Seniors https://ClinicalTrials.gov/show/NCT04378803
NCT04378712 Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04378712
NCT04378738 Social Media and Covid19 Pandemic https://ClinicalTrials.gov/show/NCT04378738
NCT04377789 Effect of Quercetin on Prophylaxis and Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04377789
NCT04377750 The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation https://ClinicalTrials.gov/show/NCT04377750
NCT04377308 Fluoxetine to Reduce Intubation and Death After COVID19 Infection https://ClinicalTrials.gov/show/NCT04377308
NCT04376840 Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19 https://ClinicalTrials.gov/show/NCT04376840
NCT04377165 Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities https://ClinicalTrials.gov/show/NCT04377165
NCT04377477 COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19) https://ClinicalTrials.gov/show/NCT04377477
NCT04376476 Host-pathogen Interactions During SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04376476
NCT04376814 Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 https://ClinicalTrials.gov/show/NCT04376814
NCT04376788 Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04376788
NCT04376684 Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease https://ClinicalTrials.gov/show/NCT04376684
NCT04376034 Convalescent Plasma Collection and Treatment in Pediatrics and Adults https://ClinicalTrials.gov/show/NCT04376034
NCT04375774 Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE) https://ClinicalTrials.gov/show/NCT04375774
NCT04375397 Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury https://ClinicalTrials.gov/show/NCT04375397
NCT04375098 Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04375098
NCT04374942 Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus? https://ClinicalTrials.gov/show/NCT04374942
NCT04375124 Treatment of Angiotensin Peptide (1-7) for COVID-19 https://ClinicalTrials.gov/show/NCT04375124
NCT04374591 The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04374591
NCT04374786 Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04374786
NCT04374526 Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. https://ClinicalTrials.gov/show/NCT04374526
NCT04374487 Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications https://ClinicalTrials.gov/show/NCT04374487
NCT04374461 A Study of N-acetylcysteine in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04374461
NCT04375202 Colchicine in COVID-19: a Pilot Study https://ClinicalTrials.gov/show/NCT04375202
NCT04374539 Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT04374539
NCT04374565 Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia https://ClinicalTrials.gov/show/NCT04374565
NCT04374032 Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04374032
NCT04373824 Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study https://ClinicalTrials.gov/show/NCT04373824
NCT04373382 Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04373382
NCT04373291 Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04373291
NCT04373161 Home Pulse Oximeter Use in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04373161
NCT04373135 Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19 https://ClinicalTrials.gov/show/NCT04373135
NCT04373096 Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers https://ClinicalTrials.gov/show/NCT04373096
NCT04372979 Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04372979
NCT04373200 Human Ab Response & immunoMONItoring of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04373200
NCT04372680 WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound https://ClinicalTrials.gov/show/NCT04372680
NCT04373044 Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19 https://ClinicalTrials.gov/show/NCT04373044
NCT04372693 Unplanned Shifting to Online Distance Learning: Nursing Students’ Perception and Achievement https://ClinicalTrials.gov/show/NCT04372693
NCT04372602 Duvelisib to Combat COVID-19 https://ClinicalTrials.gov/show/NCT04372602
NCT04372589 Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) https://ClinicalTrials.gov/show/NCT04372589
NCT04372004 Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19) https://ClinicalTrials.gov/show/NCT04372004
NCT04371965 Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04371965
NCT04371978 Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 https://ClinicalTrials.gov/show/NCT04371978
NCT04371393 MSCs in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04371393
NCT04371510 Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients https://ClinicalTrials.gov/show/NCT04371510
NCT04370782 Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting https://ClinicalTrials.gov/show/NCT04370782
NCT04370886 Recruit Blood Donors Via SMS During Epidemic of COVID-19 https://ClinicalTrials.gov/show/NCT04370886
NCT04371601 Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04371601
NCT04371367 Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE ) https://ClinicalTrials.gov/show/NCT04371367
NCT04371029 Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS https://ClinicalTrials.gov/show/NCT04371029
NCT04370236 INB03 for the Treatment of Pulmonary Complications From COVID-19 https://ClinicalTrials.gov/show/NCT04370236
NCT04370262 Multi-site Adaptive Trials for COVID-19 https://ClinicalTrials.gov/show/NCT04370262
NCT04369820 C5a Receptor Expression - COVID-19 (C5-COV) https://ClinicalTrials.gov/show/NCT04369820
NCT04369742 Treating COVID-19 With Hydroxychloroquine (TEACH) https://ClinicalTrials.gov/show/NCT04369742
NCT04370288 Clinical Application of Methylene Blue for Treatment of Covid-19 Patients https://ClinicalTrials.gov/show/NCT04370288
NCT04369794 COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement https://ClinicalTrials.gov/show/NCT04369794
NCT04369469 Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia https://ClinicalTrials.gov/show/NCT04369469
NCT04369456 Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients https://ClinicalTrials.gov/show/NCT04369456
NCT04369378 Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04369378
NCT04369365 A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic https://ClinicalTrials.gov/show/NCT04369365
NCT04368923 Management of Covid-19 Patients During Home Isolation https://ClinicalTrials.gov/show/NCT04368923
NCT04368845 Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study https://ClinicalTrials.gov/show/NCT04368845
NCT04368299 Telemedicine for Follow-up of Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT04368299
NCT04368377 Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04368377
NCT04368260 Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04368260
NCT04367662 Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19 https://ClinicalTrials.gov/show/NCT04367662
NCT04367831 Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04367831
NCT04367168 Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease https://ClinicalTrials.gov/show/NCT04367168
NCT04367077 MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) https://ClinicalTrials.gov/show/NCT04367077
NCT04366882 Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients https://ClinicalTrials.gov/show/NCT04366882
NCT04366297 Intravascular Access of COVID-19 Patient Under Personal Protective Equipment https://ClinicalTrials.gov/show/NCT04366297
NCT04366180 Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers https://ClinicalTrials.gov/show/NCT04366180
NCT04366245 Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04366245
NCT04366141 COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box https://ClinicalTrials.gov/show/NCT04366141
NCT04366089 Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora https://ClinicalTrials.gov/show/NCT04366089
NCT04366323 Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 https://ClinicalTrials.gov/show/NCT04366323
NCT04366063 Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04366063
NCT04365972 Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic https://ClinicalTrials.gov/show/NCT04365972
NCT04366050 Ramipril for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04366050
NCT04365439 Convalescent Plasma for COVID-19 https://ClinicalTrials.gov/show/NCT04365439
NCT04365127 Progesterone for the Treatment of COVID-19 in Hospitalized Men https://ClinicalTrials.gov/show/NCT04365127
NCT04365309 Protective Effect of Aspirin on COVID-19 Patients https://ClinicalTrials.gov/show/NCT04365309
NCT04364828 NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression https://ClinicalTrials.gov/show/NCT04364828
NCT04364802 COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients https://ClinicalTrials.gov/show/NCT04364802
NCT04364594 COVID-19 Search in Conjunctival Cells https://ClinicalTrials.gov/show/NCT04364594
NCT04364009 Anakinra for COVID-19 Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04364009
NCT04363593 Serology COVID-19 From the Cornwall Hospital Union https://ClinicalTrials.gov/show/NCT04363593
NCT04363853 Tocilizumab Treatment in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04363853
NCT04363502 Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection https://ClinicalTrials.gov/show/NCT04363502
NCT04363385 Collection of Biological Samples With Clinical Characterization of Covid-19 Patients https://ClinicalTrials.gov/show/NCT04363385
NCT04362358 Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic https://ClinicalTrials.gov/show/NCT04362358
NCT04362059 A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04362059
NCT04362189 Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04362189
NCT04361526 Pilot Study on Cytokine Filtration in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04361526
NCT04361214 Leflunomide in Mild COVID-19 Patients https://ClinicalTrials.gov/show/NCT04361214
NCT04360824 Covid-19 Associated Coagulopathy https://ClinicalTrials.gov/show/NCT04360824
NCT04360551 Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04360551
NCT04359875 A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment https://ClinicalTrials.gov/show/NCT04359875
NCT04359862 Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection https://ClinicalTrials.gov/show/NCT04359862
NCT04359537 Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 https://ClinicalTrials.gov/show/NCT04359537
NCT04359810 Plasma Therapy of COVID-19 in Severely Ill Patients https://ClinicalTrials.gov/show/NCT04359810
NCT04359264 Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT04359264
NCT04358939 Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19) https://ClinicalTrials.gov/show/NCT04358939
NCT04358614 Baricitinib Therapy in COVID-19 https://ClinicalTrials.gov/show/NCT04358614
NCT04358783 Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia https://ClinicalTrials.gov/show/NCT04358783
NCT04358926 Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19) https://ClinicalTrials.gov/show/NCT04358926
NCT04369066 COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur https://ClinicalTrials.gov/show/NCT04369066
NCT04368676 Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04368676
NCT04368000 Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04368000
NCT04368156 Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04368156
NCT04367636 The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19 https://ClinicalTrials.gov/show/NCT04367636
NCT04367545 Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04367545
NCT04366817 Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact https://ClinicalTrials.gov/show/NCT04366817
NCT04366960 Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04366960
NCT04366947 Intravascular Access in Suspected/Confirmed COVID-19 Patient https://ClinicalTrials.gov/show/NCT04366947
NCT04366908 Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome https://ClinicalTrials.gov/show/NCT04366908
NCT04366232 Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation https://ClinicalTrials.gov/show/NCT04366232
NCT04365738 Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04365738
NCT04365608 Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment https://ClinicalTrials.gov/show/NCT04365608
NCT04365101 Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04365101
NCT04364737 CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04364737
NCT04364893 Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 https://ClinicalTrials.gov/show/NCT04364893
NCT04363827 Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04363827
NCT04364022 Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland https://ClinicalTrials.gov/show/NCT04364022
NCT04363606 Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability https://ClinicalTrials.gov/show/NCT04363606
NCT04363749 COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities https://ClinicalTrials.gov/show/NCT04363749
NCT04363541 Local Thermotherapy for Patients With Mild-to-moderate COVID-19 https://ClinicalTrials.gov/show/NCT04363541
NCT04363528 Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU https://ClinicalTrials.gov/show/NCT04363528
NCT04363450 Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) https://ClinicalTrials.gov/show/NCT04363450
NCT04363437 COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04363437
NCT04363346 Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia https://ClinicalTrials.gov/show/NCT04363346
NCT04362111 Early Treatment of Cytokine Storm Syndrome in Covid-19 https://ClinicalTrials.gov/show/NCT04362111
NCT04362332 Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04362332
NCT04361942 Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV) https://ClinicalTrials.gov/show/NCT04361942
NCT04361916 Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino) https://ClinicalTrials.gov/show/NCT04361916
NCT04361838 The COVID-19 ICU PRAYER Study https://ClinicalTrials.gov/show/NCT04361838
NCT04361448 Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR https://ClinicalTrials.gov/show/NCT04361448
NCT04361253 Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy https://ClinicalTrials.gov/show/NCT04361253
NCT04361474 Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity https://ClinicalTrials.gov/show/NCT04361474
NCT04360837 PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04360837
NCT04359901 Sarilumab for Patients With Moderate COVID-19 Disease https://ClinicalTrials.gov/show/NCT04359901
NCT04359953 Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04359953
NCT04360811 Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04360811
NCT04359680 Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04359680
NCT04359095 Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia https://ClinicalTrials.gov/show/NCT04359095
NCT04359290 Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS https://ClinicalTrials.gov/show/NCT04359290
NCT04359251 Different PEEP Settings of COVID-19 Induced ARDS https://ClinicalTrials.gov/show/NCT04359251
NCT04358809 Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill https://ClinicalTrials.gov/show/NCT04358809
NCT04358406 Rhu-pGSN for Severe Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04358406
NCT04358549 Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04358549
NCT04357990 Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04357990
NCT04357782 Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation https://ClinicalTrials.gov/show/NCT04357782
NCT04357340 The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04357340
NCT04357444 Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19 https://ClinicalTrials.gov/show/NCT04357444
NCT04358003 Plasma Adsorption in Patients With Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04358003
NCT04357860 Clinical Trial of Sarilumab in Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04357860
NCT04357808 Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID) https://ClinicalTrials.gov/show/NCT04357808
NCT04357366 suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) https://ClinicalTrials.gov/show/NCT04357366
NCT04357106 COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma https://ClinicalTrials.gov/show/NCT04357106
NCT04357327 Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04357327
NCT04356482 CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19 https://ClinicalTrials.gov/show/NCT04356482
NCT04356833 Nebulised Rt-PA for ARDS Due to COVID-19 https://ClinicalTrials.gov/show/NCT04356833
NCT04356495 Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation https://ClinicalTrials.gov/show/NCT04356495
NCT04355637 Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia https://ClinicalTrials.gov/show/NCT04355637
NCT04355936 Telmisartan for Treatment of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04355936
NCT04355897 CoVID-19 Plasma in Treatment of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04355897
NCT04355962 Sevoflurane in COVID-19 ARDS (SevCov) https://ClinicalTrials.gov/show/NCT04355962
NCT04355234 Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns https://ClinicalTrials.gov/show/NCT04355234
NCT04355351 Study of Immune Response During SARS-CoV-2 Infection - (COVID-19) https://ClinicalTrials.gov/show/NCT04355351
NCT04355026 Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04355026
NCT04355143 Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) https://ClinicalTrials.gov/show/NCT04355143
NCT04355533 Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19 https://ClinicalTrials.gov/show/NCT04355533
NCT04355247 Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm https://ClinicalTrials.gov/show/NCT04355247
NCT04354155 COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial https://ClinicalTrials.gov/show/NCT04354155
NCT04354428 Treatment for COVID-19 in High-Risk Adult Outpatients https://ClinicalTrials.gov/show/NCT04354428
NCT04354610 Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection https://ClinicalTrials.gov/show/NCT04354610
NCT04353596 Stopping ACE-inhibitors in COVID-19 https://ClinicalTrials.gov/show/NCT04353596
NCT04353674 Modulation of Hyperinflammation in COVID-19 https://ClinicalTrials.gov/show/NCT04353674
NCT04353336 Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04353336
NCT04353518 Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04353518
NCT04353284 Camostat Mesylate in COVID-19 Outpatients https://ClinicalTrials.gov/show/NCT04353284
NCT04352959 COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses https://ClinicalTrials.gov/show/NCT04352959
NCT04352751 Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020 https://ClinicalTrials.gov/show/NCT04352751
NCT04352933 PROLIFIC ChemoprophylaxisTrial (COVID-19) https://ClinicalTrials.gov/show/NCT04352933
NCT04352348 Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being https://ClinicalTrials.gov/show/NCT04352348
NCT04352400 Efficacy of Nafamostat in Covid-19 Patients (RACONA Study) https://ClinicalTrials.gov/show/NCT04352400
NCT04352608 Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04352608
NCT04351763 Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms https://ClinicalTrials.gov/show/NCT04351763
NCT04351789 Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark https://ClinicalTrials.gov/show/NCT04351789
NCT04351906 Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04351906
NCT04351724 Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) https://ClinicalTrials.gov/show/NCT04351724
NCT04351542 Ayurveda for Flu Like Illness During Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04351542
NCT04351620 High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04351620
NCT04351347 The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04351347
NCT04351191 PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds https://ClinicalTrials.gov/show/NCT04351191
NCT04351581 Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19 https://ClinicalTrials.gov/show/NCT04351581
NCT04351152 Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04351152
NCT04350736 First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04350736
NCT04350593 Dapagliflozin in Respiratory Failure in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04350593
NCT04350320 Trial to Study the Benefit of Colchicine in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04350320
NCT04350684 Umifenovir in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04350684
NCT04350580 Polyvalent Immunoglobulin in COVID-19 Related ARds https://ClinicalTrials.gov/show/NCT04350580
NCT04350671 Interferon Beta 1a in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04350671
NCT04349618 Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia https://ClinicalTrials.gov/show/NCT04349618
NCT04349592 Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19 https://ClinicalTrials.gov/show/NCT04349592
NCT04350281 Double Therapy With IFN-beta 1b and Hydroxychloroquine https://ClinicalTrials.gov/show/NCT04350281
NCT04348305 Hydrocortisone for COVID-19 and Severe Hypoxia https://ClinicalTrials.gov/show/NCT04348305
NCT04349631 A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04349631
NCT04349410 The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol https://ClinicalTrials.gov/show/NCT04349410
NCT04349241 Efficacy and Safety of Favipiravir in Management of COVID-19 https://ClinicalTrials.gov/show/NCT04349241
NCT04348929 Birth Experience During COVID-19 Confinement https://ClinicalTrials.gov/show/NCT04348929
NCT04348695 Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19. https://ClinicalTrials.gov/show/NCT04348695
NCT04348435 A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04348435
NCT04348409 Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04348409
NCT04348383 Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19. https://ClinicalTrials.gov/show/NCT04348383
NCT04348370 BCG Vaccine for Health Care Workers as Defense Against COVID 19 https://ClinicalTrials.gov/show/NCT04348370
NCT04348513 Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04348513
NCT04347915 The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04347915
NCT04347980 Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 https://ClinicalTrials.gov/show/NCT04347980
NCT04347382 Honey & Nigella Sativa Trial Against COVID-19 https://ClinicalTrials.gov/show/NCT04347382
NCT04347031 A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 https://ClinicalTrials.gov/show/NCT04347031
NCT04346927 Telerehabilitation for Patients Diagnosed With Coronavirus https://ClinicalTrials.gov/show/NCT04346927
NCT04347174 A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients https://ClinicalTrials.gov/show/NCT04347174
NCT04346446 Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients https://ClinicalTrials.gov/show/NCT04346446
NCT04346797 CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort https://ClinicalTrials.gov/show/NCT04346797
NCT04346420 Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19 https://ClinicalTrials.gov/show/NCT04346420
NCT04346628 Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04346628
NCT04346667 Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds https://ClinicalTrials.gov/show/NCT04346667
NCT04346589 Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients https://ClinicalTrials.gov/show/NCT04346589
NCT04346355 Efficacy of Early Administration of Tocilizumab in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04346355
NCT04345549 Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04345549
NCT04345692 A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04345692
NCT04345601 Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease) https://ClinicalTrials.gov/show/NCT04345601
NCT04346017 Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome https://ClinicalTrials.gov/show/NCT04346017
NCT04346147 Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 https://ClinicalTrials.gov/show/NCT04346147
NCT04345848 Preventing COVID-19 Complications With Low- and High-dose Anticoagulation https://ClinicalTrials.gov/show/NCT04345848
NCT04345523 Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04345523
NCT04345419 Remdesivir Efficacy in Coronavirus Disease https://ClinicalTrials.gov/show/NCT04345419
NCT04345289 Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04345289
NCT04345679 Anti COVID-19 Convalescent Plasma Therapy https://ClinicalTrials.gov/show/NCT04345679
NCT04345614 A Study of Auxora in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04345614
NCT04344951 Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04344951
NCT04345276 Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04345276
NCT04344184 SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI) https://ClinicalTrials.gov/show/NCT04344184
NCT04344730 Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04344730
NCT04344561 Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation https://ClinicalTrials.gov/show/NCT04344561
NCT04344431 Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04344431
NCT04344457 Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04344457
NCT04344288 Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection https://ClinicalTrials.gov/show/NCT04344288
NCT04344600 Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04344600
NCT04344379 Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus https://ClinicalTrials.gov/show/NCT04344379
NCT04344106 Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study https://ClinicalTrials.gov/show/NCT04344106
NCT04344080 Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04344080
NCT04344041 COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) https://ClinicalTrials.gov/show/NCT04344041
NCT04344015 COVID-19 Plasma Collection https://ClinicalTrials.gov/show/NCT04344015
NCT04344210 Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus https://ClinicalTrials.gov/show/NCT04344210
NCT04343729 Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 https://ClinicalTrials.gov/show/NCT04343729
NCT04343794 Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19 https://ClinicalTrials.gov/show/NCT04343794
NCT04343976 Pegylated Interferon Lambda Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04343976
NCT04343755 Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04343755
NCT04343768 An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04343768
NCT04343963 Pyridostigmine in Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04343963
NCT04343651 Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04343651
NCT04343248 Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF) https://ClinicalTrials.gov/show/NCT04343248
NCT04343053 Pro-thrombotic Status in Patients With SARS-Cov-2 Infection https://ClinicalTrials.gov/show/NCT04343053
NCT04342728 Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation https://ClinicalTrials.gov/show/NCT04342728
NCT04342650 Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection https://ClinicalTrials.gov/show/NCT04342650
NCT04342169 University of Utah COVID-19 Hydrochloroquine Trial https://ClinicalTrials.gov/show/NCT04342169
NCT04342689 The Role of Resistant Starch in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04342689
NCT04342221 Hydroxychloroquine for COVID-19 https://ClinicalTrials.gov/show/NCT04342221
NCT04342182 Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) https://ClinicalTrials.gov/show/NCT04342182
NCT04341922 A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04341922
NCT04341584 CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection https://ClinicalTrials.gov/show/NCT04341584
NCT04341415 Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome https://ClinicalTrials.gov/show/NCT04341415
NCT04341675 Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04341675
NCT04341389 A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) https://ClinicalTrials.gov/show/NCT04341389
NCT04341441 Will Hydroxychloroquine Impede or Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04341441
NCT04341142 Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER https://ClinicalTrials.gov/show/NCT04341142
NCT04341493 Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04341493
NCT04341727 Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection https://ClinicalTrials.gov/show/NCT04341727
NCT04341207 Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients https://ClinicalTrials.gov/show/NCT04341207
NCT04340050 COVID-19 Convalescent Plasma https://ClinicalTrials.gov/show/NCT04340050
NCT04341038 Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury https://ClinicalTrials.gov/show/NCT04341038
NCT04340544 Hydroxychloroquine for the Treatment of Mild COVID-19 Disease https://ClinicalTrials.gov/show/NCT04340544
NCT04340349 Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals https://ClinicalTrials.gov/show/NCT04340349
NCT04339660 Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04339660
NCT04339816 Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial https://ClinicalTrials.gov/show/NCT04339816
NCT04339426 Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection https://ClinicalTrials.gov/show/NCT04339426
NCT04339712 Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction https://ClinicalTrials.gov/show/NCT04339712
NCT04338958 Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation https://ClinicalTrials.gov/show/NCT04338958
NCT04338698 Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT https://ClinicalTrials.gov/show/NCT04338698
NCT04338568 Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study https://ClinicalTrials.gov/show/NCT04338568
NCT04338841 HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04338841
NCT04337996 Dynamic Evaluation of COVID-19 Diagnostic Tests https://ClinicalTrials.gov/show/NCT04337996
NCT04337541 Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System https://ClinicalTrials.gov/show/NCT04337541
NCT04337918 Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection https://ClinicalTrials.gov/show/NCT04337918
NCT04336904 Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19 https://ClinicalTrials.gov/show/NCT04336904
NCT04337008 Renin Angiotensin System - CoronaVirus https://ClinicalTrials.gov/show/NCT04337008
NCT04336462 Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04336462
NCT04336254 Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04336254
NCT04336332 Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04336332
NCT04335851 Video-Based Exercises and Well-Being During Social Isolation https://ClinicalTrials.gov/show/NCT04335851
NCT04335786 Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease https://ClinicalTrials.gov/show/NCT04335786
NCT04335279 Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program https://ClinicalTrials.gov/show/NCT04335279
NCT04335305 Checkpoint Blockade in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04335305
NCT04335123 Study of Open Label Losartan in COVID-19 https://ClinicalTrials.gov/show/NCT04335123
NCT04335097 Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation https://ClinicalTrials.gov/show/NCT04335097
NCT04335071 Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04335071
NCT04334928 Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel https://ClinicalTrials.gov/show/NCT04334928
NCT04335201 Defibrotide in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04335201
NCT04334629 LIBERATE Trial in COVID-19 https://ClinicalTrials.gov/show/NCT04334629
NCT04334850 Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04334850
NCT04334512 A Study of Quintuple Therapy to Treat COVID-19 Infection https://ClinicalTrials.gov/show/NCT04334512
NCT04334265 Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019 https://ClinicalTrials.gov/show/NCT04334265
NCT04334434 Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19) https://ClinicalTrials.gov/show/NCT04334434
NCT04334460 Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects https://ClinicalTrials.gov/show/NCT04334460
NCT04334382 Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 https://ClinicalTrials.gov/show/NCT04334382
NCT04334044 Treatment of SARS Caused by COVID-19 With Ruxolitinib https://ClinicalTrials.gov/show/NCT04334044
NCT04333550 Application of Desferal to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04333550
NCT04333914 Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04333914
NCT04333589 Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive https://ClinicalTrials.gov/show/NCT04333589
NCT04333420 Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04333420
NCT04333654 Hydroxychloroquine in Outpatient Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04333654
NCT04333628 Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 https://ClinicalTrials.gov/show/NCT04333628
NCT04333355 Safety in Convalescent Plasma Transfusion to COVID-19 https://ClinicalTrials.gov/show/NCT04333355
NCT04332835 Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study https://ClinicalTrials.gov/show/NCT04332835
NCT04333368 Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS https://ClinicalTrials.gov/show/NCT04333368
NCT04333407 Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. https://ClinicalTrials.gov/show/NCT04333407
NCT04332380 Convalescent Plasma for Patients With COVID-19: A Pilot Study https://ClinicalTrials.gov/show/NCT04332380
NCT04332094 Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04332094
NCT04331795 Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis https://ClinicalTrials.gov/show/NCT04331795
NCT04331600 Chloroquine as Antiviral Treatment in Coronavirus Infection 2020 https://ClinicalTrials.gov/show/NCT04331600
NCT04331808 CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI) https://ClinicalTrials.gov/show/NCT04331808
NCT04331834 Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04331834
NCT04331470 Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04331470
NCT04331665 Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04331665
NCT04331054 Protective Role of Inhaled Steroids for Covid-19 Infection https://ClinicalTrials.gov/show/NCT04331054
NCT04330586 A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19 https://ClinicalTrials.gov/show/NCT04330586
NCT04330690 Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial https://ClinicalTrials.gov/show/NCT04330690
NCT04329611 ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease https://ClinicalTrials.gov/show/NCT04329611
NCT04329650 Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04329650
NCT04330638 Treatment of COVID-19 Patients With Anti-interleukin Drugs https://ClinicalTrials.gov/show/NCT04330638
NCT04329832 Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04329832
NCT04329533 Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04329533
NCT04328493 The Vietnam Chloroquine Treatment on COVID-19 https://ClinicalTrials.gov/show/NCT04328493
NCT04328129 Household Transmission Investigation Study for COVID-19 in Tropical Regions https://ClinicalTrials.gov/show/NCT04328129
NCT04328012 COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04328012
NCT04329195 ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04329195
NCT04328441 Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine https://ClinicalTrials.gov/show/NCT04328441
NCT04328285 Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers https://ClinicalTrials.gov/show/NCT04328285
NCT04328480 The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04328480
NCT04327401 COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III https://ClinicalTrials.gov/show/NCT04327401
NCT04327349 Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial https://ClinicalTrials.gov/show/NCT04327349
NCT04326920 Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) https://ClinicalTrials.gov/show/NCT04326920
NCT04326790 The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention https://ClinicalTrials.gov/show/NCT04326790
NCT04326426 ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection https://ClinicalTrials.gov/show/NCT04326426
NCT04326452 Treating COVID-19 With a Bidirectional Oxygenation Valve https://ClinicalTrials.gov/show/NCT04326452
NCT04326036 Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection https://ClinicalTrials.gov/show/NCT04326036
NCT04325893 Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease https://ClinicalTrials.gov/show/NCT04325893
NCT04325867 Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04325867
NCT04325906 Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS https://ClinicalTrials.gov/show/NCT04325906
NCT04324489 DAS181 for Severe COVID-19: Compassionate Use https://ClinicalTrials.gov/show/NCT04324489
NCT04324996 A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 https://ClinicalTrials.gov/show/NCT04324996
NCT04324021 Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. https://ClinicalTrials.gov/show/NCT04324021
NCT04325633 Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04325633
NCT04325061 Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04325061
NCT04324528 Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation https://ClinicalTrials.gov/show/NCT04324528
NCT04324190 DIgital Online SuPport for COVID-19 StrEss https://ClinicalTrials.gov/show/NCT04324190
NCT04324073 Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI https://ClinicalTrials.gov/show/NCT04324073
NCT04322565 Colchicine Counteracting Inflammation in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04322565
NCT04323800 Convalescent Plasma to Stem Coronavirus (CSSC-001) https://ClinicalTrials.gov/show/NCT04323800
NCT04323514 Use of Ascorbic Acid in Patients With COVID 19 https://ClinicalTrials.gov/show/NCT04323514
NCT04323345 Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus https://ClinicalTrials.gov/show/NCT04323345
NCT04323228 Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19 https://ClinicalTrials.gov/show/NCT04323228
NCT04323527 Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 https://ClinicalTrials.gov/show/NCT04323527
NCT04322344 Escin in Patients With Covid-19 Infection https://ClinicalTrials.gov/show/NCT04322344
NCT04322773 Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure https://ClinicalTrials.gov/show/NCT04322773
NCT04322123 Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) https://ClinicalTrials.gov/show/NCT04322123
NCT04321993 Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04321993
NCT04321928 Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary https://ClinicalTrials.gov/show/NCT04321928
NCT04321616 The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients https://ClinicalTrials.gov/show/NCT04321616
NCT04320238 Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff https://ClinicalTrials.gov/show/NCT04320238
NCT04321278 Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) https://ClinicalTrials.gov/show/NCT04321278
NCT04320953 Non-contact Endoscopy at Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04320953
NCT04320056 Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04320056
NCT04321421 Hyperimmune Plasma for Critical Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04321421
NCT04321096 The Impact of Camostat Mesilate on COVID-19 Infection https://ClinicalTrials.gov/show/NCT04321096
NCT04318431 Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children https://ClinicalTrials.gov/show/NCT04318431
NCT04319731 A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure https://ClinicalTrials.gov/show/NCT04319731
NCT04318444 Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04318444
NCT04319900 Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04319900
NCT04319445 Mindfulness During COVID-19 https://ClinicalTrials.gov/show/NCT04319445
NCT04318015 Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) https://ClinicalTrials.gov/show/NCT04318015
NCT04317092 Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) https://ClinicalTrials.gov/show/NCT04317092
NCT04316377 Norwegian Coronavirus Disease 2019 Study https://ClinicalTrials.gov/show/NCT04316377
NCT04315896 Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) https://ClinicalTrials.gov/show/NCT04315896
NCT04315480 Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis https://ClinicalTrials.gov/show/NCT04315480
NCT04312997 The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04312997
NCT04313127 Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults https://ClinicalTrials.gov/show/NCT04313127
NCT04313322 Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells https://ClinicalTrials.gov/show/NCT04313322
NCT04313023 The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04313023
NCT04312243 NO Prevention of COVID-19 for Healthcare Providers https://ClinicalTrials.gov/show/NCT04312243
NCT04307693 Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04307693
NCT04312009 Losartan for Patients With COVID-19 Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04312009
NCT04311177 Losartan for Patients With COVID-19 Not Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04311177
NCT04308317 Tetrandrine Tablets Used in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04308317
NCT04311697 Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure https://ClinicalTrials.gov/show/NCT04311697
NCT04310228 Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019 https://ClinicalTrials.gov/show/NCT04310228
NCT04306393 Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 https://ClinicalTrials.gov/show/NCT04306393
NCT04306055 Blood Donor Recruitment During Epidemic of COVID-19 https://ClinicalTrials.gov/show/NCT04306055
NCT04305457 Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04305457
NCT04303299 Fight COVID-19 Trial https://ClinicalTrials.gov/show/NCT04303299
NCT04304690 COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic https://ClinicalTrials.gov/show/NCT04304690
NCT04304313 A Pilot Study of Sildenafil in COVID-19 https://ClinicalTrials.gov/show/NCT04304313
NCT04305106 Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT https://ClinicalTrials.gov/show/NCT04305106
NCT04304053 Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention https://ClinicalTrials.gov/show/NCT04304053
NCT04299724 Safety and Immunity of Covid-19 aAPC Vaccine https://ClinicalTrials.gov/show/NCT04299724
NCT04296643 Medical Masks vs N95 Respirators for COVID-19 https://ClinicalTrials.gov/show/NCT04296643
NCT04291729 Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04291729
NCT04288102 Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04288102
NCT04282902 A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04282902
NCT04280224 NK Cells Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04280224
NCT04275414 Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04275414
NCT04276987 A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04276987
NCT04276896 Immunity and Safety of Covid-19 Synthetic Minigene Vaccine https://ClinicalTrials.gov/show/NCT04276896
NCT04276688 Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment https://ClinicalTrials.gov/show/NCT04276688
NCT04275245 Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04275245
NCT04273763 Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04273763
NCT04273321 Efficacy and Safety of Corticosteroids in COVID-19 https://ClinicalTrials.gov/show/NCT04273321
NCT04269525 Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia https://ClinicalTrials.gov/show/NCT04269525
NCT04264533 Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia https://ClinicalTrials.gov/show/NCT04264533
NCT04263402 The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia https://ClinicalTrials.gov/show/NCT04263402
NCT04261517 Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04261517
NCT04261270 A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04261270
NCT04260594 Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus https://ClinicalTrials.gov/show/NCT04260594
NCT04254874 A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04254874
NCT04257656 A Trial of Remdesivir in Adults With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04257656
NCT04255017 A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04255017
NCT04252118 Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04252118
NCT04252885 The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04252885
NCT04252274 Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04252274
NCT04251871 Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection https://ClinicalTrials.gov/show/NCT04251871
NCT04931888 Implementing and Evaluating a Social-Emotional Learning Program for Refugee Children During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04931888
NCT04978259 SOLIDARITY Finland Long COVID-19 https://ClinicalTrials.gov/show/NCT04978259
NCT04964570 Digital Mental Health Care for COVID-19 High-Risk Populations https://ClinicalTrials.gov/show/NCT04964570
NCT04951323 Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo) https://ClinicalTrials.gov/show/NCT04951323
NCT04638842 Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19 https://ClinicalTrials.gov/show/NCT04638842
NCT04346693 An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19 https://ClinicalTrials.gov/show/NCT04346693
NCT04471766 Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention https://ClinicalTrials.gov/show/NCT04471766
NCT04468893 Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19 https://ClinicalTrials.gov/show/NCT04468893
NCT04455815 A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive. https://ClinicalTrials.gov/show/NCT04455815
NCT05079152 Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 https://ClinicalTrials.gov/show/NCT05079152
NCT05077306 Receptive Music Therapy on Anxiety and Vital Parameters in Hospitalized Covid-19 Patients. https://ClinicalTrials.gov/show/NCT05077306
NCT05077943 The Effect of Home-based Exercise on Functional Capacity of Covid-19 Survivor With Cardiovascular Comorbidity https://ClinicalTrials.gov/show/NCT05077943
NCT05077930 Convalescent Plasma Therapy for Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05077930
NCT05077241 Efficacy of Home Inspiratory Muscle Training in Post-covid-19 Patients: a Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT05077241
NCT04930965 Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate https://ClinicalTrials.gov/show/NCT04930965
NCT05047445 A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection https://ClinicalTrials.gov/show/NCT05047445
NCT04890509 A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients https://ClinicalTrials.gov/show/NCT04890509
NCT04808284 Neuromodulation in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04808284
NCT04754698 COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS https://ClinicalTrials.gov/show/NCT04754698
NCT04734886 The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19 https://ClinicalTrials.gov/show/NCT04734886
NCT04750343 Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19) https://ClinicalTrials.gov/show/NCT04750343
NCT04742738 Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19) https://ClinicalTrials.gov/show/NCT04742738
NCT04715438 Vaccination Against COVID-19 in Cancer https://ClinicalTrials.gov/show/NCT04715438
NCT04641858 BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04641858
NCT04539275 COVID-19 (VA CURES-1) https://ClinicalTrials.gov/show/NCT04539275
NCT04551911 Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04551911
NCT04510454 Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19 https://ClinicalTrials.gov/show/NCT04510454
NCT04408183 GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04408183
NCT04425915 Efficacy of Convalescent Plasma Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04425915
NCT04350723 Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 COVID-19 (COVI-PRONE) https://ClinicalTrials.gov/show/NCT04350723
NCT05080920 Rosmalip® for Cancer Infections Prevention https://ClinicalTrials.gov/show/NCT05080920
NCT04838795 Sisonke (Together): OPEN LABEL TRIAL COVID-19 https://ClinicalTrials.gov/show/NCT04838795
NCT04345991 Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort https://ClinicalTrials.gov/show/NCT04345991
NCT04565249 Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 https://ClinicalTrials.gov/show/NCT04565249
NCT04522089 A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine https://ClinicalTrials.gov/show/NCT04522089
NCT04516564 A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects https://ClinicalTrials.gov/show/NCT04516564
NCT04357457 Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia https://ClinicalTrials.gov/show/NCT04357457
NCT05027815 Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS) https://ClinicalTrials.gov/show/NCT05027815
NCT05082727 Safety and Efficacy of KOVIR (TD0068) in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR) https://ClinicalTrials.gov/show/NCT05082727
NCT05042141 Safety and Efficacy of KOVIR in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR) https://ClinicalTrials.gov/show/NCT05042141
NCT05081362 Cardiovascular Assessment in Patient Recovered From COVID-19 and Recovery of Autonomic Nervous System in Association With the Severity of the Disease https://ClinicalTrials.gov/show/NCT05081362
NCT04918927 Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19 https://ClinicalTrials.gov/show/NCT04918927
NCT04942405 Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine https://ClinicalTrials.gov/show/NCT04942405
NCT04869228 A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients https://ClinicalTrials.gov/show/NCT04869228
NCT04852861 COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine https://ClinicalTrials.gov/show/NCT04852861
NCT04806074 FOODLIT-Trial: Digital Behaviour Change Intervention to Improve Food Literacy Amidst the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04806074
NCT04527614 Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection https://ClinicalTrials.gov/show/NCT04527614
NCT05085145 Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV https://ClinicalTrials.gov/show/NCT05085145
NCT05084898 Far-UVC Light Devices in Long-term Care Facilities to Reduce Infections https://ClinicalTrials.gov/show/NCT05084898
NCT05028257 Allergy and COVID-19 Vaccines https://ClinicalTrials.gov/show/NCT05028257
NCT05074771 At Home REhabilitation and Monitoring of People in poST-covid Condition Through ARc-inTellicare Platform (RESTART/RICOMINCIARE) https://ClinicalTrials.gov/show/NCT05074771
NCT04962204 Virtual Visitation in Intensive Care Unit Study https://ClinicalTrials.gov/show/NCT04962204
NCT04980534 Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip https://ClinicalTrials.gov/show/NCT04980534
NCT04952376 Equitable Access to COVID-19 Vaccines https://ClinicalTrials.gov/show/NCT04952376
NCT04790851 Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4 https://ClinicalTrials.gov/show/NCT04790851
NCT04927182 Impact of Moderate Exercise Training on Vitals and Peak VO2 in Different Age Categories of Adult in COVID-19. https://ClinicalTrials.gov/show/NCT04927182
NCT04931238 Efficacy and Safety of JS016 in Patients With SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04931238
NCT04726098 Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19 https://ClinicalTrials.gov/show/NCT04726098
NCT04701502 Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04701502
NCT04400305 “Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention” https://ClinicalTrials.gov/show/NCT04400305
NCT04595773 COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE) https://ClinicalTrials.gov/show/NCT04595773
NCT04470622 Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1) https://ClinicalTrials.gov/show/NCT04470622
NCT04528771 S-Nitrosylation Therapy of COVID-19 https://ClinicalTrials.gov/show/NCT04528771
NCT04394117 Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease https://ClinicalTrials.gov/show/NCT04394117
NCT04348864 COVID-19 Diagnostic Self-testing Using Virtual Point-of-care https://ClinicalTrials.gov/show/NCT04348864
NCT04335084 A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04335084
NCT05089045 Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity https://ClinicalTrials.gov/show/NCT05089045
NCT05077267 ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects https://ClinicalTrials.gov/show/NCT05077267
NCT05084911 The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3) https://ClinicalTrials.gov/show/NCT05084911
NCT05075083 Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD https://ClinicalTrials.gov/show/NCT05075083
NCT05075070 Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People With HIV Infected https://ClinicalTrials.gov/show/NCT05075070
NCT05075057 Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD https://ClinicalTrials.gov/show/NCT05075057
NCT05075044 Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected https://ClinicalTrials.gov/show/NCT05075044
NCT05007951 Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19) https://ClinicalTrials.gov/show/NCT05007951
NCT04932915 Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19 https://ClinicalTrials.gov/show/NCT04932915
NCT04484025 SPI-1005 Treatment in Moderate COVID-19 Patients https://ClinicalTrials.gov/show/NCT04484025
NCT04483973 SPI-1005 Treatment in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04483973
NCT05092607 Evaluation of the Detection Performance of the N Antigenemia of SARS-CoV-2 in the General Population for the Diagnosis and Screening of COVID-19 https://ClinicalTrials.gov/show/NCT05092607
NCT05092542 Multilevel Community-Based Mental Health Intervention to Address Structural Inequities and Adverse Disparate Consequences of COVID-19 Pandemic on Latinx Immigrant and African Refugees https://ClinicalTrials.gov/show/NCT05092542
NCT05091411 Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells) https://ClinicalTrials.gov/show/NCT05091411
NCT05069129 Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above https://ClinicalTrials.gov/show/NCT05069129
NCT05072210 Mobile Interventions for the Prevention and Detection of Distress https://ClinicalTrials.gov/show/NCT05072210
NCT04952350 Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT https://ClinicalTrials.gov/show/NCT04952350
NCT04716985 Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care https://ClinicalTrials.gov/show/NCT04716985
NCT04874766 The Effects of Wearing a Face Mask During Exercise in Youth Hockey Players During COVID-19 https://ClinicalTrials.gov/show/NCT04874766
NCT04710199 Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04710199
NCT04399889 hCT-MSCs for COVID19 ARDS https://ClinicalTrials.gov/show/NCT04399889
NCT05094726 Effect of PBM on Functional Capacity and Fatigability in Post Covid-19 Elderly https://ClinicalTrials.gov/show/NCT05094726
NCT05094674 Clinical Validation of Breath Analyser Tests for Diagnosis of COVID-19. https://ClinicalTrials.gov/show/NCT05094674
NCT05094661 Predictors of Non-invasive Respiratory Support Failure in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT05094661
NCT05079308 Clinical Trial on the Efficacy of Different Masks With and Without a Peripheral Sealing Device, Against Covid-19 https://ClinicalTrials.gov/show/NCT05079308
NCT05093530 Safety and Tolerability of Single and Multiple Doses of Neumifil https://ClinicalTrials.gov/show/NCT05093530
NCT05082935 COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) Phase II https://ClinicalTrials.gov/show/NCT05082935
NCT04880109 A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19. https://ClinicalTrials.gov/show/NCT04880109
NCT05054621 Immunogenicity of COVID-19 Vaccine on Heterologous Schedule https://ClinicalTrials.gov/show/NCT05054621
NCT05037201 Text Message Nudges for COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT05037201
NCT04859699 Reopening Schools Safely and Educating Youth (ROSSEY) COVID-19 Health Disparities Research Study https://ClinicalTrials.gov/show/NCT04859699
NCT04853836 Olfactory Disfunction and Co-ultraPEALut https://ClinicalTrials.gov/show/NCT04853836
NCT04704544 Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE) https://ClinicalTrials.gov/show/NCT04704544
NCT04631705 SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation https://ClinicalTrials.gov/show/NCT04631705
NCT04655638 HFNT vs. COT in COVID-19 https://ClinicalTrials.gov/show/NCT04655638
NCT04619680 The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 https://ClinicalTrials.gov/show/NCT04619680
NCT04657809 Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia https://ClinicalTrials.gov/show/NCT04657809
NCT04542850 Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04542850
NCT04444700 A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04444700
NCT04575610 IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC) https://ClinicalTrials.gov/show/NCT04575610
NCT04504240 Role of Famotidine in the Clinical Improvement of COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04504240
NCT04435379 Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04435379
NCT04469179 Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04469179
NCT04429854 Donated Antibodies Working Against nCoV https://ClinicalTrials.gov/show/NCT04429854
NCT04387760 Favipiravir vs Hydroxychloroquine vs Control in COVID -19 https://ClinicalTrials.gov/show/NCT04387760
NCT04362085 Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care https://ClinicalTrials.gov/show/NCT04362085
NCT04356534 Convalescent Plasma Trial in COVID -19 Patients https://ClinicalTrials.gov/show/NCT04356534
NCT05074745 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Buccal Screening Evaluation Using an RT-PCR Assay and a Rapid ELISA Test Among Symptomatic and Asymptomatic Patients https://ClinicalTrials.gov/show/NCT05074745
NCT05096026 Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination Among Elderly Patients https://ClinicalTrials.gov/show/NCT05096026
NCT04632381 Intravenous Zotatifin in Adults With Mild or Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04632381
NCT04960228 Exploring Changes in COVID-19 Vaccination Intentions by Prompting Altruistic Motives Using a Video Intervention https://ClinicalTrials.gov/show/NCT04960228
NCT04839042 A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04839042
NCT04514302 Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab’)2 Fragments (INOSARS) for Adult Patients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04514302
NCT04507256 AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04507256
NCT04492891 Cyclosporine For The Treatment Of COVID-19(+) https://ClinicalTrials.gov/show/NCT04492891
NCT04478071 Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04478071
NCT04415086 Treatment of Patients With COVID-19 With Convalescent Plasma https://ClinicalTrials.gov/show/NCT04415086
NCT04410549 Pulmonary Optical Coherence Tomography in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04410549
NCT04400058 Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression https://ClinicalTrials.gov/show/NCT04400058
NCT05062473 Utilizing Telemedicine for Hypertension Treatment Lifestyle Modification in Central Harlem https://ClinicalTrials.gov/show/NCT05062473
NCT05012267 Duration of Prone Position in the Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19). https://ClinicalTrials.gov/show/NCT05012267
NCT04956224 Immunogenicity of VLA2101 Compared to VLA2001. https://ClinicalTrials.gov/show/NCT04956224
NCT04414241 Hydroxychloroquine to Prevent SARS-CoV-2 Infection/COVID-19 https://ClinicalTrials.gov/show/NCT04414241
NCT04756271 Safety and Immunogenicity of Oxford AstraZeneca Vaccine Against COVID-19 Infection https://ClinicalTrials.gov/show/NCT04756271
NCT04773067 A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers https://ClinicalTrials.gov/show/NCT04773067
NCT04399356 Niclosamide for Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04399356
NCT04864561 Study To Compare The Immunogenicity Against COVID-19, Of VLA2001 Vaccine To AZD1222 Vaccine https://ClinicalTrials.gov/show/NCT04864561
NCT04497324 PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19 https://ClinicalTrials.gov/show/NCT04497324
NCT04347538 Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04347538
NCT05099497 Supporting Audit and Feedback to Encourage Vaccine Uptake https://ClinicalTrials.gov/show/NCT05099497
NCT05080244 WHO COVID-19 - Evaluation of the Efficacy of Probiotics to Reduce the Occurrence of Long COVID https://ClinicalTrials.gov/show/NCT05080244
NCT04992208 Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents https://ClinicalTrials.gov/show/NCT04992208
NCT04911790 Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04911790
NCT04621071 Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04621071
NCT04671017 Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects https://ClinicalTrials.gov/show/NCT04671017
NCT04573322 Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects https://ClinicalTrials.gov/show/NCT04573322
NCT05102565 A Dyadic Telehealth Program for Alzheimer’s Patients/Caregivers https://ClinicalTrials.gov/show/NCT05102565
NCT04505774 Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE https://ClinicalTrials.gov/show/NCT04505774
NCT04927065 A Study to Evaluate the Immunogenicity and Safety of mRNA-1273.211 Vaccine for COVID-19 Variants https://ClinicalTrials.gov/show/NCT04927065
NCT04896840 Tele-rehabilitation in Children With Cerebral Palsy in the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04896840
NCT04937556 Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19 (Coronavirus Disease). https://ClinicalTrials.gov/show/NCT04937556
NCT04870606 Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness https://ClinicalTrials.gov/show/NCT04870606
NCT04685681 The Get Outside Study https://ClinicalTrials.gov/show/NCT04685681
NCT04396106 Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting https://ClinicalTrials.gov/show/NCT04396106
NCT04500626 Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04500626
NCT04422613 Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04422613
NCT04351295 Efficacy of Faviprevir in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04351295
NCT04344587 Awake Prone Position for Early Hypoxemia in COVID-19 https://ClinicalTrials.gov/show/NCT04344587
NCT05052580 Test to Stay in School: COVID-19 Testing Following Exposure in School Communities https://ClinicalTrials.gov/show/NCT05052580
NCT04425031 Handling Oxygenation Targets in COVID-19 https://ClinicalTrials.gov/show/NCT04425031
NCT04642638 Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure https://ClinicalTrials.gov/show/NCT04642638
NCT04930861 Study of Codivir in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04930861
NCT04667780 Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04667780
NCT04482686 Trial of Combination Therapy to Treat COVID-19 Infection https://ClinicalTrials.gov/show/NCT04482686
NCT04341116 Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04341116
NCT04459286 The Nitazoxanide Plus Atazanavir for COVID-19 Study https://ClinicalTrials.gov/show/NCT04459286
NCT04459247 Short Term, High Dose Vitamin D Supplementation for COVID-19 https://ClinicalTrials.gov/show/NCT04459247
NCT05104827 Integrative Medicine Impact on Frontline COVID-19 Personnel Wellbeing https://ClinicalTrials.gov/show/NCT05104827
NCT05104749 Homeopathic Treatment of Post-acute COVID-19 Syndrome https://ClinicalTrials.gov/show/NCT05104749
NCT05104372 Hypertonic Saline Nasal Irrigation and Gargling (HSNIG) for Suspected COVID-19 in Pakistan https://ClinicalTrials.gov/show/NCT05104372
NCT04847141 A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients https://ClinicalTrials.gov/show/NCT04847141
NCT04700462 COVID-19 Preventive Behavior in African Americans https://ClinicalTrials.gov/show/NCT04700462
NCT04642950 A Phase II/III Study of Sargramostim https://ClinicalTrials.gov/show/NCT04642950
NCT04546737 Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04546737
NCT04528667 Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19 https://ClinicalTrials.gov/show/NCT04528667
NCT04440007 Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04440007
NCT05048849 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study https://ClinicalTrials.gov/show/NCT05048849
NCT05083000 Reducing Hypoxia in Patients With Coronavirus Disease (COVID-19) Using Topotecan With Standard of Care https://ClinicalTrials.gov/show/NCT05083000
NCT05107375 Clinical Study of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell) Combined With Influenza Vaccine https://ClinicalTrials.gov/show/NCT05107375
NCT05038618 A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study https://ClinicalTrials.gov/show/NCT05038618
NCT04977024 SARS-CoV-2 Vaccine (COH04S1) Versus Emergency Use Authorization SARS-COV-2 Vaccine for the Treatment of COVID-19 in Patients With Blood Cancer https://ClinicalTrials.gov/show/NCT04977024
NCT04695652 A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult https://ClinicalTrials.gov/show/NCT04695652
NCT04822025 A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults https://ClinicalTrials.gov/show/NCT04822025
NCT04821999 Diode Laser 940 nm in Management of Loss of Taste Sensation https://ClinicalTrials.gov/show/NCT04821999
NCT04951388 A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents https://ClinicalTrials.gov/show/NCT04951388
NCT04732949 Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 https://ClinicalTrials.gov/show/NCT04732949
NCT04575597 Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) https://ClinicalTrials.gov/show/NCT04575597
NCT04611425 REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19: REHSCU Study https://ClinicalTrials.gov/show/NCT04611425
NCT04426292 SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04426292
NCT04498377 Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04498377
NCT04362176 Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults https://ClinicalTrials.gov/show/NCT04362176
NCT05102084 The Effect Of Music On Compliance Of Patients Ä°n COVÄ°D-19 Intensive Care Unit With CPAP Device https://ClinicalTrials.gov/show/NCT05102084
NCT05024474 Effects of Inspiratory Muscle Training After Covid-19 (ReCOV) https://ClinicalTrials.gov/show/NCT05024474
NCT04953078 A Study to Evaluate Safety, Tolerability, and Reactogenicity of an RBD-Fc-based Vaccine to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04953078
NCT04849598 Automatic Oxygen Titration in Patients After SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04849598
NCT04958902 RESTORE in Patients Who Had COVID-19 and Close Others https://ClinicalTrials.gov/show/NCT04958902
NCT04909905 Glutamine Supplementation and Short-term Mortality in Covid-19 https://ClinicalTrials.gov/show/NCT04909905
NCT04799392 NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons https://ClinicalTrials.gov/show/NCT04799392
NCT04569383 Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04569383
NCT04625738 Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04625738
NCT04488575 Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04488575
NCT04472494 Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise https://ClinicalTrials.gov/show/NCT04472494
NCT04468087 Antiviral Agents Against COVID-19 Infection https://ClinicalTrials.gov/show/NCT04468087
NCT04464408 Favipiravir Therapy in Adults With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04464408
NCT04460703 COVID-19 Vaccine Messaging, Part 1 https://ClinicalTrials.gov/show/NCT04460703
NCT04460677 ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19 https://ClinicalTrials.gov/show/NCT04460677
NCT04348656 CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) https://ClinicalTrials.gov/show/NCT04348656
NCT05110560 Effects of the Programme Developed for Sedentary Elderly in the COVID-19 Pandemic: Mobile Interventional Study https://ClinicalTrials.gov/show/NCT05110560
NCT05104346 Presentation and Outcomes of Acute Appendicitis During COVID Pandemic https://ClinicalTrials.gov/show/NCT05104346
NCT04910230 Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04910230
NCT04709835 Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04709835
NCT04689542 Surgical Face Mask Effects in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04689542
NCT04842734 Comparison of the Effect of Online Physical Exercise and Computerized Cognitive Stimulation in Patients With Alzheimer’s Disease During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04842734
NCT04790240 Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID) https://ClinicalTrials.gov/show/NCT04790240
NCT04615936 Nasal Photodisinfection COVID-19 Proof of Concept Study https://ClinicalTrials.gov/show/NCT04615936
NCT04531254 Back to School COVID-19 Simulation Study https://ClinicalTrials.gov/show/NCT04531254
NCT05115435 The Effect of Neuro Linguistic Programming on COVID-19 Fear in Kidney Transplant https://ClinicalTrials.gov/show/NCT05115435
NCT04327505 Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04327505
NCT04409743 Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04409743
NCT04392323 Incidence of COVID-19 Test Conversion in Post-surgical Patients https://ClinicalTrials.gov/show/NCT04392323
NCT04353206 Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure https://ClinicalTrials.gov/show/NCT04353206
NCT05115162 The Effects of the Hybrid Telerehabilitation Exercise in Inactive Students https://ClinicalTrials.gov/show/NCT05115162
NCT05113849 Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19) https://ClinicalTrials.gov/show/NCT05113849
NCT05113823 In Situ Simulation Training in Transferring Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT05113823
NCT05112887 Osteopathic Manipulative Therapy Effects on Prolonged Post-COVID Olfactory Dysfunction https://ClinicalTrials.gov/show/NCT05112887
NCT05109624 Is Prolonged Period of Prone Position Effective and Safe in Mechanically Ventilated Patients With SARS-COV-2? https://ClinicalTrials.gov/show/NCT05109624
NCT04953052 A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care. https://ClinicalTrials.gov/show/NCT04953052
NCT04818489 Colchicine and Post-COVID-19 Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT04818489
NCT04802408 SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial https://ClinicalTrials.gov/show/NCT04802408
NCT04841707 Total-Body Parametric 18F-FDG PET of COVID-19 https://ClinicalTrials.gov/show/NCT04841707
NCT04633772 Use of Angiotensin-(1-7) in COVID-19 https://ClinicalTrials.gov/show/NCT04633772
NCT04615429 Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19 https://ClinicalTrials.gov/show/NCT04615429
NCT04547140 Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04547140
NCT04414631 Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04414631
NCT04389671 The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04389671
NCT04822818 EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19 https://ClinicalTrials.gov/show/NCT04822818
NCT04359654 Nebulised Dornase Alfa for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04359654
NCT05089305 Ozone Plasma on Lung Function and Inflammatory Parameters in Pulmonary Sequelae Associated With Coronavirus 19 Infection https://ClinicalTrials.gov/show/NCT05089305
NCT05046561 Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial https://ClinicalTrials.gov/show/NCT05046561
NCT04482699 RAPA-501-Allo Therapy of COVID-19-ARDS https://ClinicalTrials.gov/show/NCT04482699
NCT04625725 Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult. https://ClinicalTrials.gov/show/NCT04625725
NCT04523571 Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects https://ClinicalTrials.gov/show/NCT04523571
NCT04540939 Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy https://ClinicalTrials.gov/show/NCT04540939
NCT04480424 Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04480424
NCT04375735 London’s Exogenous Surfactant Study for COVID19 https://ClinicalTrials.gov/show/NCT04375735
NCT05118373 Generic Behavioural Change Campaign for COVID-19 Prevention https://ClinicalTrials.gov/show/NCT05118373
NCT04363814 Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection https://ClinicalTrials.gov/show/NCT04363814
NCT04530604 Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) https://ClinicalTrials.gov/show/NCT04530604
NCT04472728 Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04472728
NCT05046548 This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 https://ClinicalTrials.gov/show/NCT05046548
NCT05037097 A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults https://ClinicalTrials.gov/show/NCT05037097
NCT05119634 The Effect of Whole Body Vibration Training in Individuals With Post COVID - 19 https://ClinicalTrials.gov/show/NCT05119634
NCT05056883 A Phase III Confirmatory Study of K-237 https://ClinicalTrials.gov/show/NCT05056883
NCT04884295 Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19 https://ClinicalTrials.gov/show/NCT04884295
NCT04816019 A Study of Intranasal ChAdOx1 nCOV-19 https://ClinicalTrials.gov/show/NCT04816019
NCT04969601 Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings https://ClinicalTrials.gov/show/NCT04969601
NCT04634409 A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness https://ClinicalTrials.gov/show/NCT04634409
NCT04954157 Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients https://ClinicalTrials.gov/show/NCT04954157
NCT04354831 A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04354831
NCT05122260 PREVENT-COVID-19: A Q-Griffithsin Intranasal Spray https://ClinicalTrials.gov/show/NCT05122260
NCT05122234 Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19 https://ClinicalTrials.gov/show/NCT05122234
NCT04910269 Outpatient Treatment With Anti-Coronavirus Immunoglobulin https://ClinicalTrials.gov/show/NCT04910269
NCT04905888 Hyperbaric Oxygen for Long COVID-19 Pulmonary Sequela https://ClinicalTrials.gov/show/NCT04905888
NCT04723446 Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva https://ClinicalTrials.gov/show/NCT04723446
NCT04828668 Study to Evaluate Benefits & Safety of Endourage Formula Câ„¢ Oral Drops in People With Post-Acute COVID-19 Syndrome. https://ClinicalTrials.gov/show/NCT04828668
NCT04723537 Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease https://ClinicalTrials.gov/show/NCT04723537
NCT04652596 Reducing Food Insecurity During COVID-19 https://ClinicalTrials.gov/show/NCT04652596
NCT04347681 Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 https://ClinicalTrials.gov/show/NCT04347681
NCT05124132 Resilience and Brain Health of Older Adults During the COVID-19 Pandemic (MEDEX-2) https://ClinicalTrials.gov/show/NCT05124132
NCT05037110 Physical Activity and Smell Trainings to Help Individuals With Coronavirus Disease (COVID-19) Recover From Persistent Smell and Taste Impairments - A Pilot Study https://ClinicalTrials.gov/show/NCT05037110
NCT05113862 Evaluation of Safety and Immunogenicity of a T-Cell Priming Peptide Vaccine Against Coronavirus COVID-19 https://ClinicalTrials.gov/show/NCT05113862
NCT05087329 Mindfulness Practice in Pregnancy as an Intervention to Decrease Prenatal Stress During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT05087329
NCT04921228 Biofeedback for CHAMPS https://ClinicalTrials.gov/show/NCT04921228
NCT04979858 Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask https://ClinicalTrials.gov/show/NCT04979858
NCT04870593 What Works to Get the Elderly Vaccinated Against COVID-19? Experimental Evidence From India https://ClinicalTrials.gov/show/NCT04870593
NCT04913675 Intramuscular VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04913675
NCT04828538 Vitamin D, Omega-3, and Combination Vitamins B, C and Zinc Supplementation for the Treatment and Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04828538
NCT04828434 Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study https://ClinicalTrials.gov/show/NCT04828434
NCT04793464 COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) https://ClinicalTrials.gov/show/NCT04793464
NCT05126628 The South Proxa-Rescue AndroCoV Trial Against COVID-19 https://ClinicalTrials.gov/show/NCT05126628
NCT04640168 Adaptive COVID-19 Treatment Trial 4 (ACTT-4) https://ClinicalTrials.gov/show/NCT04640168
NCT04384965 Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04384965
NCT05126602 Vitamin D Supplementation and Clinical Improvement in COVID-19 https://ClinicalTrials.gov/show/NCT05126602
NCT05125874 Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization https://ClinicalTrials.gov/show/NCT05125874
NCT05047718 Factors Influencing the COVID-19 Vaccine Immune Response According to Age and Presence or Not of a Past History of COVID-19 https://ClinicalTrials.gov/show/NCT05047718
NCT04949061 The Effectiveness of Culturally Adapted Cognitive Behavioral Intervention Among COVID-19 Survivors https://ClinicalTrials.gov/show/NCT04949061
NCT04869358 Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab https://ClinicalTrials.gov/show/NCT04869358
NCT04822701 A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04822701
NCT04798027 Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older https://ClinicalTrials.gov/show/NCT04798027
NCT04847102 A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above https://ClinicalTrials.gov/show/NCT04847102
NCT04800133 Covid-19 Vaccination in Adolescents and Children https://ClinicalTrials.gov/show/NCT04800133
NCT04705597 Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure https://ClinicalTrials.gov/show/NCT04705597
NCT04584567 OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 " https://ClinicalTrials.gov/show/NCT04584567
NCT04663945 Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 Survivors https://ClinicalTrials.gov/show/NCT04663945
NCT04405934 COG-UK Project Hospital-Onset COVID-19 Infections Study https://ClinicalTrials.gov/show/NCT04405934
NCT04373733 Early Intervention in COVID-19: Favipiravir Verses Standard Care https://ClinicalTrials.gov/show/NCT04373733
NCT04346615 Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen https://ClinicalTrials.gov/show/NCT04346615
NCT05128721 Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT05128721
NCT05128643 Clinical Study on the Immune Program of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell) https://ClinicalTrials.gov/show/NCT05128643
NCT05126511 Effects of Cranial Electrotherapy Stimulation on Anxiety of Patients After COVID-19 https://ClinicalTrials.gov/show/NCT05126511
NCT04539795 COVID-19 Study of Safety and Tolerability of Alvelestat https://ClinicalTrials.gov/show/NCT04539795
NCT04399967 COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via “Quit to Win” Contest 2020 https://ClinicalTrials.gov/show/NCT04399967
NCT04397562 A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04397562
NCT04839146 Safety and Tolerability of COVID-19 Vaccine (ABNCoV2) https://ClinicalTrials.gov/show/NCT04839146
NCT05109598 Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus(COVID-19) Vaccine (CHO Cell) https://ClinicalTrials.gov/show/NCT05109598
NCT04765371 Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, With CoViD-19 https://ClinicalTrials.gov/show/NCT04765371
NCT04742595 Viral Specific T Cell Therapy for COVID-19 Related Pneumonia https://ClinicalTrials.gov/show/NCT04742595
NCT04558450 Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN) https://ClinicalTrials.gov/show/NCT04558450
NCT04458363 Convalescent Plasma in Pediatric COVID-19 https://ClinicalTrials.gov/show/NCT04458363
NCT04442087 Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP https://ClinicalTrials.gov/show/NCT04442087
NCT05130541 Proning Early in Awake COVID-19 Hypoxic Respiratory Failure (PREACHR) Study https://ClinicalTrials.gov/show/NCT05130541
NCT04373460 Convalescent Plasma to Limit SARS-CoV-2 Associated Complications https://ClinicalTrials.gov/show/NCT04373460
NCT05130736 Rehabilitation Robot in Patients With Post-Coronavirus Disease (COVID-19) Fatigue Syndrome https://ClinicalTrials.gov/show/NCT05130736
NCT05107557 Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell) https://ClinicalTrials.gov/show/NCT05107557
NCT05043376 Study to Investigate the Treatment Benefits of Probiotic Streptococcus Salivarius K12 for Mild-to-moderate COVID-19 https://ClinicalTrials.gov/show/NCT05043376
NCT05028361 Simultaneous mRNA COVID-19 and IIV4 Vaccination Study https://ClinicalTrials.gov/show/NCT05028361
NCT04873401 Leveraging Social Networks to Increase COVID-19 Testing Uptake https://ClinicalTrials.gov/show/NCT04873401
NCT04590547 GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04590547
NCT04847362 The Effect of Tele-Health Education Provided in the Postpartum Period in the Covid 19 Pandemic https://ClinicalTrials.gov/show/NCT04847362
NCT04830774 Natural History of COVID-19-Related Atrial Fibrillation https://ClinicalTrials.gov/show/NCT04830774
NCT04590586 Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04590586
NCT04377100 Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses https://ClinicalTrials.gov/show/NCT04377100
NCT04353128 Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. https://ClinicalTrials.gov/show/NCT04353128
NCT05019456 Exercise and COVID-19 Viral T-cell Immunity https://ClinicalTrials.gov/show/NCT05019456
NCT05133622 Physical Fitness in Young Healthy Adults After COVID-19 Infection https://ClinicalTrials.gov/show/NCT05133622
NCT05133609 COVID-19 VACCINE SAFETY AND EFFECTIVENESS https://ClinicalTrials.gov/show/NCT05133609
NCT05074433 A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults https://ClinicalTrials.gov/show/NCT05074433
NCT05132933 Gas Exchange Derangement Physiopathology in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05132933
NCT05132972 Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT05132972
NCT05119348 Transmission of Coronavirus Disease 2019 (COVID19) in Crowded Environments https://ClinicalTrials.gov/show/NCT05119348
NCT05037266 Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen https://ClinicalTrials.gov/show/NCT05037266
NCT04818320 Favipiravir in High-risk COVID-19 Patients https://ClinicalTrials.gov/show/NCT04818320
NCT04589117 Expressive Writing for COVID-19 Resilience for Parents https://ClinicalTrials.gov/show/NCT04589117
NCT04509947 A Study of Ad26.COV2.S in Adults (COVID-19) https://ClinicalTrials.gov/show/NCT04509947
NCT04445428 OPV as Potential Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04445428
NCT04374084 Moxibustion Plus Cupping in Convalescent Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04374084
NCT05081388 COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease https://ClinicalTrials.gov/show/NCT05081388
NCT05135598 Partners For Life: Off-line Health Promotion Program for Ultra-orthodox Jewish Women During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT05135598
NCT04315948 Trial of Treatments for COVID-19 in Hospitalized Adults https://ClinicalTrials.gov/show/NCT04315948
NCT05074888 Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia. https://ClinicalTrials.gov/show/NCT05074888
NCT05069649 Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2 https://ClinicalTrials.gov/show/NCT05069649
NCT05054075 Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19 https://ClinicalTrials.gov/show/NCT05054075
NCT04928430 Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19 https://ClinicalTrials.gov/show/NCT04928430
NCT04867174 COVID-19 Vaccination Take-Up https://ClinicalTrials.gov/show/NCT04867174
NCT04904549 Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older https://ClinicalTrials.gov/show/NCT04904549
NCT04903327 Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress https://ClinicalTrials.gov/show/NCT04903327
NCT04776044 Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04776044
NCT04622332 A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04622332
NCT04720612 COVID-19 Immunologic Antiviral Therapy With Omalizumab https://ClinicalTrials.gov/show/NCT04720612
NCT04644705 Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat https://ClinicalTrials.gov/show/NCT04644705
NCT04636034 The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection https://ClinicalTrials.gov/show/NCT04636034
NCT04979949 Booster Vaccination Against COVID-19 https://ClinicalTrials.gov/show/NCT04979949
NCT04387955 Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID) https://ClinicalTrials.gov/show/NCT04387955
NCT04387253 Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID https://ClinicalTrials.gov/show/NCT04387253
NCT04359329 Estrogen Patch for COVID-19 Symptoms https://ClinicalTrials.gov/show/NCT04359329
NCT05082714 Tocilizumab Versus Baricitinib in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT05082714
NCT05047783 Masitinib in Patients With Symptomatic Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT05047783
NCT04905836 Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress https://ClinicalTrials.gov/show/NCT04905836
NCT04803812 Supporting the Wellness of Ontario Physicians During COVID-19 https://ClinicalTrials.gov/show/NCT04803812
NCT04568564 Telerehabilitation in Lung Surgery Patients https://ClinicalTrials.gov/show/NCT04568564
NCT04844138 Evaluating Overcoming Anxiety in Pregnancy and Postpartum as an Online Self-Directed Program https://ClinicalTrials.gov/show/NCT04844138
NCT04629703 Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects https://ClinicalTrials.gov/show/NCT04629703
NCT04602000 To Evaluate the Safety and Efficacy of CT-P59 in Patients With Mild to Moderate Syptoms of Severe Acute Respiratory Syndrome COVID-19 https://ClinicalTrials.gov/show/NCT04602000
NCT04568031 Study of AZD1222 for the Prevention of COVID-19 in Japan https://ClinicalTrials.gov/show/NCT04568031
NCT04409834 Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial https://ClinicalTrials.gov/show/NCT04409834
NCT04405076 Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older https://ClinicalTrials.gov/show/NCT04405076
NCT04498273 COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 https://ClinicalTrials.gov/show/NCT04498273
NCT04347226 Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04347226
NCT04334980 Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04334980
NCT05069103 ImplementatioN of Remote Surgical wOund Assessment During the coviD-19 pandEmic https://ClinicalTrials.gov/show/NCT05069103
NCT05069454 Study on COVID-19 Vaccine Effectiveness Among Health Workers in Azerbaijan https://ClinicalTrials.gov/show/NCT05069454
NCT05062681 RCT on the Efficacy of Dexamethasone Versus Methyl Prednisolone in Covid-19 Infected Patients With High Oxygen Flow https://ClinicalTrials.gov/show/NCT05062681
NCT05060939 SARS-CoV-2 Infection in COVID-19 Vaccinated Patients https://ClinicalTrials.gov/show/NCT05060939
NCT05060991 Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients https://ClinicalTrials.gov/show/NCT05060991
NCT05060510 The School SPIT Study - COVID-19 Testing in Secondary Schools https://ClinicalTrials.gov/show/NCT05060510
NCT05059106 EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19 https://ClinicalTrials.gov/show/NCT05059106
NCT05058742 Non-invasive Nervus Vagus Stimulation in Patients With COVID-19 and ARDS https://ClinicalTrials.gov/show/NCT05058742
NCT05054322 FLuticasone in cOvid Treatment (FLOT) https://ClinicalTrials.gov/show/NCT05054322
NCT05055492 The School SPIT Study - Elementary Schools in High COVID-19 Incidence Regions https://ClinicalTrials.gov/show/NCT05055492
NCT05055505 The School SPIT Study - Elementary Schools in Low COVID-19 Incidence Regions https://ClinicalTrials.gov/show/NCT05055505
NCT05054114 Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19 https://ClinicalTrials.gov/show/NCT05054114
NCT05047952 Vortioxetine for Post-Covid-19 Syndrome https://ClinicalTrials.gov/show/NCT05047952
NCT05050201 Implementation of Digital CBT for Insomnia in First Episode Psychosis https://ClinicalTrials.gov/show/NCT05050201
NCT05049213 Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05049213
NCT05045989 Process Evaluation of a Residence-Based SARS-CoV-2 Testing Participation Pilot https://ClinicalTrials.gov/show/NCT05045989
NCT05043259 Heterologous Prime-boost Immunization With an Aerosolised Adenovirus Type-5 Vector-based COVID-19 Vaccine (Ad5-nCoV) After Priming With an Inactivated SARS-CoV-2 Vaccine https://ClinicalTrials.gov/show/NCT05043259
NCT05043220 Covid-19 Predictors: Safety of Gynecological Oncology Patients Undergoing Chemotherapy https://ClinicalTrials.gov/show/NCT05043220
NCT05038488 Phase 2a MIB-626 vs. Placebo COVID-19 https://ClinicalTrials.gov/show/NCT05038488
NCT05040737 PMMA vs Polysulfone in SARS-CoV-2 Infection Hemodialysis Patients https://ClinicalTrials.gov/show/NCT05040737
NCT05040724 Evaluation of the Impact of the Administration of Single Dose of Ivermectin in the Early Phase of COVID-19 https://ClinicalTrials.gov/show/NCT05040724
NCT05038514 The Effect of Music Therapy in COVID-19 Patients Given Prone Position https://ClinicalTrials.gov/show/NCT05038514
NCT05037188 Clinical Study of the Safety and Immunogenicity of a Recombinant Viral Vector AAV5 (Adeno-Associated Virus Type 5 )-RBD (Receptor Binding Domain)-S Vaccine for the Prevention of Coronavirus Infection (COVID-19) https://ClinicalTrials.gov/show/NCT05037188
NCT05037240 Quercetin in the Prevention of Covid-19 Infection https://ClinicalTrials.gov/show/NCT05037240
NCT05037448 Exploring Telehealth to Deliver Me & My Wishes During Coronavirus-19 https://ClinicalTrials.gov/show/NCT05037448
NCT05037253 COVID-19 Morbidity in Healthcare Workers and Vitamin D Supplementation https://ClinicalTrials.gov/show/NCT05037253
NCT05035550 Effects of Open-label Placebos on COVID-related Psychological Health https://ClinicalTrials.gov/show/NCT05035550
NCT05035524 A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT05035524
NCT05035628 Cardiopulmonary Rehabilitation in Long COVID-19 Patients With Persistent Breathlessness and Fatigue https://ClinicalTrials.gov/show/NCT05035628
NCT05035563 Impact of a Communication Strategy in the Prevention of Depressive Symptoms in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT05035563
NCT05035576 A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19 https://ClinicalTrials.gov/show/NCT05035576
NCT04922905 Nervous System Symptoms Associated With COVID 19 https://ClinicalTrials.gov/show/NCT04922905
NCT05033860 The Influence of Education During Waiting Time of Vaccination on the Knowledge Towards COVID-19 Among Chinese Residents https://ClinicalTrials.gov/show/NCT05033860
NCT05033158 The Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population. https://ClinicalTrials.gov/show/NCT05033158
NCT05032885 Early Physiotherapy in Covid Patients https://ClinicalTrials.gov/show/NCT05032885
NCT05027672 Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines. https://ClinicalTrials.gov/show/NCT05027672
NCT05028374 COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT05028374
NCT05028244 Evaluation of Serial Ultrasound Screening in ICU COVID-19 Patients https://ClinicalTrials.gov/show/NCT05028244
NCT05024006 Public Health Emergency: SOLIDARITY TRIAL Philippines https://ClinicalTrials.gov/show/NCT05024006
NCT05024461 Comparison of Detection of SARS-CoV2 (COVID-19) Between Nasopharyngeal Swab Specimens and Those Obtained by Salivary Sputum https://ClinicalTrials.gov/show/NCT05024461
NCT05024500 Clinical and Functional Outcomes of Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05024500
NCT05022303 AT1001 for the Treatment of COVID-19 Related MIS-C https://ClinicalTrials.gov/show/NCT05022303
NCT05021588 Steroid and Anticoagulant Therapy in covid19 https://ClinicalTrials.gov/show/NCT05021588
NCT05021016 Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above https://ClinicalTrials.gov/show/NCT05021016
NCT05019287 Menstrual Blood Stem Cells in Severe Covid-19 https://ClinicalTrials.gov/show/NCT05019287
NCT05019326 Andrographis Paniculata vs Boesenbergia Rotunda vs Control in Asymptomatic COVID-19 https://ClinicalTrials.gov/show/NCT05019326
NCT05018065 Sexual Functions and Covid-19 https://ClinicalTrials.gov/show/NCT05018065
NCT05018078 Safety and Immunogenicity of COVID-19 Vaccination in Patients With Cancer https://ClinicalTrials.gov/show/NCT05018078
NCT05017805 COVID-19 Vaccines in Patients With Chronic Liver Disease https://ClinicalTrials.gov/show/NCT05017805
NCT05017792 Evaluation of Clinical and Antibody Response to Covid-19 Vaccination Strategy in TBRI, Egypt https://ClinicalTrials.gov/show/NCT05017792
NCT05014373 Philippine Trial to Determine Efficacy and Safety of Favipiravir for COVID-19 https://ClinicalTrials.gov/show/NCT05014373
NCT05012800 Safety and Immunogenicity of COVID-19 Vaccine Administered in Older Adults https://ClinicalTrials.gov/show/NCT05012800
NCT05012826 Osteopathy and Physiotherapy Compared to Physiotherapy Alone on Fatigue and Functional Status in Long COVID https://ClinicalTrials.gov/show/NCT05012826
NCT05012319 Phase 3 Clinical Study Evaluating Nitric Oxide Nasal Spray (NONS) Efficacy To Treat and Prevent the Exacerbation of Infection in Individuals With Documented Asymptomatic or Mild COVID-19 https://ClinicalTrials.gov/show/NCT05012319
NCT05011344 Evolution of Protective Immunization Against COVID-19 Among Hospital Workers in Health Care Facilities https://ClinicalTrials.gov/show/NCT05011344
NCT05011513 Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). https://ClinicalTrials.gov/show/NCT05011513
NCT05010876 Evaluation of the Effects of Bradykinin Antagonists on Pulmonary Manifestations of COVID-19 Infections (AntagoBrad-Cov Study). https://ClinicalTrials.gov/show/NCT05010876
NCT05009563 COvid iMaging With POSitron Emission Tomography https://ClinicalTrials.gov/show/NCT05009563
NCT05008393 Efficacy of PJS-539 for Adult Patients With COVID-19. https://ClinicalTrials.gov/show/NCT05008393
NCT05009186 Changing of Prostate Specific Antigen Value in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT05009186
NCT05008380 Efficacy of the Early Prone-positioning in Hospitalized Patients With Mild Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT05008380
NCT05007457 The Effectiveness of Respiratory Tele-rehabilitation After COVID-19 Pneumonia Related: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT05007457
NCT05007678 Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease https://ClinicalTrials.gov/show/NCT05007678
NCT05007600 Online Interactive Courses on Loneliness and Quality of Life of Older Adults https://ClinicalTrials.gov/show/NCT05007600
NCT05007236 Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection. https://ClinicalTrials.gov/show/NCT05007236
NCT05007509 Safety and Immunogenicity Study of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers (COVID-19) https://ClinicalTrials.gov/show/NCT05007509
NCT05007496 Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19 https://ClinicalTrials.gov/show/NCT05007496
NCT05005156 Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in Adults 18 Years of Age and Older. https://ClinicalTrials.gov/show/NCT05005156
NCT05004753 A Study to Evaluate the Safety and Efficacy of Artemisinin- a Herbal Supplement on COVID-19 Subjects https://ClinicalTrials.gov/show/NCT05004753
NCT05002517 Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab https://ClinicalTrials.gov/show/NCT05002517
NCT05001542 Digital Interventions for Detection and Reduction of Moral Distress https://ClinicalTrials.gov/show/NCT05001542
NCT05002348 Laser Acupuncture Improves Constipation in Patients Hospitalized for Stroke During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT05002348
NCT05000008 Aerobic Versus Anaerobic Exercise on Immune Functions and Disease Severity in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05000008
NCT05000307 Co-Sér: Serological Analysis and Viral Neutralization in People With a Documented COVID-19 Infection https://ClinicalTrials.gov/show/NCT05000307
NCT05000255 Coping With Covid-19: Loneliness, Self-Efficacy, Social Support, Depression & Anxiety in Patients in Medical Rehab. https://ClinicalTrials.gov/show/NCT05000255
NCT04998253 Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2 https://ClinicalTrials.gov/show/NCT04998253
NCT04998708 Relaxation Exercise in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04998708
NCT04997551 Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized With Covid-19 https://ClinicalTrials.gov/show/NCT04997551
NCT04996238 Local and General Immune Response After Coronavirus Disease (COVID-19) Vaccination in Volunteers https://ClinicalTrials.gov/show/NCT04996238
NCT04993586 Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose) https://ClinicalTrials.gov/show/NCT04993586
NCT04993547 Cluster-RCT Collective Nasopharyngeal COVID-19 Testing Amongst Pupils https://ClinicalTrials.gov/show/NCT04993547
NCT04993209 Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil https://ClinicalTrials.gov/show/NCT04993209
NCT04992182 Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster https://ClinicalTrials.gov/show/NCT04992182
NCT04992390 A Brief GAmeplay Intervention for NHS ICU Staff Affected by COVID-19 Trauma (GAINS Study) https://ClinicalTrials.gov/show/NCT04992390
NCT04992000 Self-Care of Hypertension Among Older Adults During COVID-19 https://ClinicalTrials.gov/show/NCT04992000
NCT04990830 Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia https://ClinicalTrials.gov/show/NCT04990830
NCT04990544 Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) https://ClinicalTrials.gov/show/NCT04990544
NCT04988217 Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19) https://ClinicalTrials.gov/show/NCT04988217
NCT04988048 Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina https://ClinicalTrials.gov/show/NCT04988048
NCT04988282 Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT04988282
NCT04987554 Glycophosphopeptical AM3 A Potential Adjuvant in the Treatment of SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04987554
NCT04982887 Tele-Rehabilitation in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04982887
NCT04983394 The Effect of Virtual Reality Exercises on Patients With Post-SARS-CoV-2 Syndrome https://ClinicalTrials.gov/show/NCT04983394
NCT04983537 Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population https://ClinicalTrials.gov/show/NCT04983537
NCT04982757 Accelerated TMS for Depression and OCD https://ClinicalTrials.gov/show/NCT04982757
NCT04982068 Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) https://ClinicalTrials.gov/show/NCT04982068
NCT04981743 The Efficacy of Nigella Sativa Versus VitaminD3 as Supplement Therapy in Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04981743
NCT04981379 Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment https://ClinicalTrials.gov/show/NCT04981379
NCT04982042 Post COVID-19 Pulmonary Rehabilitation Program https://ClinicalTrials.gov/show/NCT04982042
NCT04981314 Echinacea Drug for Covid-19 https://ClinicalTrials.gov/show/NCT04981314
NCT04980508 Effects of COVID-19 on Cavernous Smooth Muscle https://ClinicalTrials.gov/show/NCT04980508
NCT04979923 Efficacy of Nebulized Lidocaine, Salbutamol, and Beclomethasone Plus Salbutamol in the Covid-19 Patients With ARDS on Non-invasive Ventilation; Randomized Control Trial https://ClinicalTrials.gov/show/NCT04979923
NCT04978207 A Faithful Response to COVID-19 Project https://ClinicalTrials.gov/show/NCT04978207
NCT04979221 Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04979221
NCT04978025 Colloidal Silver, Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04978025
NCT04977921 Lab Skills Nursing Education Into Effective Clinical Practice During COVID-19: Elsevier Clinical Skill Platform https://ClinicalTrials.gov/show/NCT04977921
NCT04977479 The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose https://ClinicalTrials.gov/show/NCT04977479
NCT04978051 Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04978051
NCT04973462 Evaluation of The Efficacy of Triazavirin Versus Oseltamivir in Egyptian Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04973462
NCT04974203 Saliva-based COVID-19 DNA Aptamer Test https://ClinicalTrials.gov/show/NCT04974203
NCT04973488 Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04973488
NCT04970719 Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus https://ClinicalTrials.gov/show/NCT04970719
NCT04972864 Effects of Respiratory Muscle Training in Patients With Post COVID-19 https://ClinicalTrials.gov/show/NCT04972864
NCT04970563 Detection of Asymptomatic SARS-Cov2 Infected Patients by Detection Dogs: “Proof of Concept” Study (CoviDetectionDog)-Covid-19 https://ClinicalTrials.gov/show/NCT04970563
NCT04969991 Study of Varespladib in Patients Hospitalized With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04969991
NCT04969172 A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04969172
NCT04969276 Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04969276
NCT04969263 COVID-19 Protection After Transplant Pilot Study https://ClinicalTrials.gov/show/NCT04969263
NCT04967794 Effectiveness of Teleorientation in Oral Hygiene During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04967794
NCT04967729 COVID-19 and Lung Ultrasound Utility https://ClinicalTrials.gov/show/NCT04967729
NCT04967755 Jing-Si-Herbal-Tea Accelerates SARS-Cov-2 Load Reduction Among COVID-19 Patients https://ClinicalTrials.gov/show/NCT04967755
NCT04967807 Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study) https://ClinicalTrials.gov/show/NCT04967807
NCT04966910 Stay Connected: Testing an Intervention to Combat COVID-19 Related Social Isolation Among Seattle-area Older Adults https://ClinicalTrials.gov/show/NCT04966910
NCT04964154 Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans’ Perceptions/Beliefs About COVID-19 Testing and Vaccination Study https://ClinicalTrials.gov/show/NCT04964154
NCT04964414 Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19 https://ClinicalTrials.gov/show/NCT04964414
NCT04964583 Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04964583
NCT04962893 Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine https://ClinicalTrials.gov/show/NCT04962893
NCT04962906 Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes https://ClinicalTrials.gov/show/NCT04962906
NCT04962308 Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04962308
NCT04961333 Internet-based Multidisciplinary Rehabilitation for Longterm COVID-19 Syndrome https://ClinicalTrials.gov/show/NCT04961333
NCT04961502 Humoral and Cellular Responses to Vaccination Against Coronavirus Disease 2019 (COVID-19) in the Very Elderly Living in Geriatric Institutions https://ClinicalTrials.gov/show/NCT04961502
NCT04961359 Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2(COVID-19) Phase I Clinical Trial (3~17 Years Old) https://ClinicalTrials.gov/show/NCT04961359
NCT04959786 MANS-NRIZ Trial for COVID-19 Treatment : Extension Study https://ClinicalTrials.gov/show/NCT04959786
NCT04957017 Effect of Hand-Washing Training in Covid-19 https://ClinicalTrials.gov/show/NCT04957017
NCT04958863 Impact of Facemasks on Running During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04958863
NCT04957940 Lipid Emulsion Infusion and COVID-19 Patients https://ClinicalTrials.gov/show/NCT04957940
NCT04954092 Study of Gam-COVID-Vac in Adolescents https://ClinicalTrials.gov/show/NCT04954092
NCT04953325 Immunogenicity and Safety of an Inactivated COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04953325
NCT04954118 A Different Use of The Aerosol Box in COVID-19 Patients; Internal Jugular Vein Cannulation https://ClinicalTrials.gov/show/NCT04954118
NCT04954014 Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04954014
NCT04954040 Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19 https://ClinicalTrials.gov/show/NCT04954040
NCT04952805 Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19. https://ClinicalTrials.gov/show/NCT04952805
NCT04952766 Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults https://ClinicalTrials.gov/show/NCT04952766
NCT04953234 Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Best Standard of Care for the Treatment of Hospitalized COVID-19 Patients and Continued Treatment Following Discharge https://ClinicalTrials.gov/show/NCT04953234
NCT04952519 Efficacy of Amantadine Treatment in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04952519
NCT04952727 Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults https://ClinicalTrials.gov/show/NCT04952727
NCT04894617 Amantadine for COVID-19 https://ClinicalTrials.gov/show/NCT04894617
NCT04950803 A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 Patients https://ClinicalTrials.gov/show/NCT04950803
NCT04951362 Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia https://ClinicalTrials.gov/show/NCT04951362
NCT04951349 Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19. https://ClinicalTrials.gov/show/NCT04951349
NCT04950725 Covid-19 Virtual Recovery Study https://ClinicalTrials.gov/show/NCT04950725
NCT04948203 Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis https://ClinicalTrials.gov/show/NCT04948203
NCT04947488 Evaluation of the Effects of Treatment With Bioarginin C in Adult Subjects Belonging to the Post-Covid Day Hospital https://ClinicalTrials.gov/show/NCT04947488
NCT04945811 Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta https://ClinicalTrials.gov/show/NCT04945811
NCT04945356 Telerehabilitation During Pandemic Containment Measures of COVID19 https://ClinicalTrials.gov/show/NCT04945356
NCT04945564 Covid-19 Patients Management During Home Isolation https://ClinicalTrials.gov/show/NCT04945564
NCT04944121 Phase 2 Study of RSLV-132 in Subjects With Long COVID https://ClinicalTrials.gov/show/NCT04944121
NCT04942990 The Effectiveness of Calistenic Exercise Training in Adolescents https://ClinicalTrials.gov/show/NCT04942990
NCT04942392 Digital Dance for People With Parkinson’s Disease During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04942392
NCT04941105 Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19 https://ClinicalTrials.gov/show/NCT04941105
NCT04939519 SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers https://ClinicalTrials.gov/show/NCT04939519
NCT04940182 A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04940182
NCT04939714 Caregiving During Crisis https://ClinicalTrials.gov/show/NCT04939714
NCT04939402 SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector https://ClinicalTrials.gov/show/NCT04939402
NCT04939415 Chinese Herbal Formula for COVID-19 https://ClinicalTrials.gov/show/NCT04939415
NCT04936893 Effects of Mindfulness Practice on Healthcare Workers https://ClinicalTrials.gov/show/NCT04936893
NCT04935437 Implementing a Rehabilitation Program in Patients Recovering From Covid-19 Infection https://ClinicalTrials.gov/show/NCT04935437
NCT04935502 Home Based Exercises With and Without Posture and Ergonomics Training Among Students During COVID-19 https://ClinicalTrials.gov/show/NCT04935502
NCT04936503 Support for the Resumption of Training of High-level Athletes Post-epidemic COVID-19 https://ClinicalTrials.gov/show/NCT04936503
NCT04935528 Mechanisms of Anti COVID-19 Humoral and Cellular Immune Response After Vaccination in a Sample of Patients and Salaried Staff From a French Anti-cancer Center https://ClinicalTrials.gov/show/NCT04935528
NCT04935515 C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients. https://ClinicalTrials.gov/show/NCT04935515
NCT04933864 COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy https://ClinicalTrials.gov/show/NCT04933864
NCT04933799 IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation. https://ClinicalTrials.gov/show/NCT04933799
NCT04933929 Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During Hospitalization https://ClinicalTrials.gov/show/NCT04933929
NCT04932850 Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease. https://ClinicalTrials.gov/show/NCT04932850
NCT04932824 Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19. https://ClinicalTrials.gov/show/NCT04932824
NCT04932369 The Effect of Emotion Regulation Training on Anxiety, in College Students in Egypt https://ClinicalTrials.gov/show/NCT04932369
NCT04930003 Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04930003
NCT04929691 The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04929691
NCT04927845 StriveWeekly Trial Post-pandemic https://ClinicalTrials.gov/show/NCT04927845
NCT04928456 Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps https://ClinicalTrials.gov/show/NCT04928456
NCT04926428 In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection https://ClinicalTrials.gov/show/NCT04926428
NCT04927169 InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort) https://ClinicalTrials.gov/show/NCT04927169
NCT04926779 Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test https://ClinicalTrials.gov/show/NCT04926779
NCT04922827 Infliximab in the Treatment of Patients With Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04922827
NCT04923061 The Effect of Acupressure on the Sleep Quality and Fatigue https://ClinicalTrials.gov/show/NCT04923061
NCT04922957 A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS) https://ClinicalTrials.gov/show/NCT04922957
NCT04922788 Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04922788
NCT04922918 Ligilactobacillus Salivarius MP101 for Elderly in a Nursing Home https://ClinicalTrials.gov/show/NCT04922918
NCT04920916 Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04920916
NCT04920838 Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04920838
NCT04920773 Community-based Post-exposure Prophylaxis for COVID-19 https://ClinicalTrials.gov/show/NCT04920773
NCT04918914 Critical Care Results of SARS-CoV-2 ARDS by Dapsone and Standard COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04918914
NCT04918940 Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma https://ClinicalTrials.gov/show/NCT04918940
NCT04918797 COVAXIN in a Pediatric Cohort https://ClinicalTrials.gov/show/NCT04918797
NCT04915989 Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals https://ClinicalTrials.gov/show/NCT04915989
NCT04916886 A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups. https://ClinicalTrials.gov/show/NCT04916886
NCT04916821 Investigation of Clinical Effectiveness of Propolis Extracts as Food Supplements in Patients With SARS-CoV-2(COVID-19) https://ClinicalTrials.gov/show/NCT04916821
NCT04916574 Clinical Trial of BioBlock COVID-19 Nasal Spray Containing Anti-SARS-CoV-2 Antibodies Derived From Bovine Colostrum https://ClinicalTrials.gov/show/NCT04916574
NCT04915820 Iron and COVID-19 Vaccine Response https://ClinicalTrials.gov/show/NCT04915820
NCT04914767 Nigella 5 in the Treatment of SARS COV2 (COVID-19) https://ClinicalTrials.gov/show/NCT04914767
NCT04914377 To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants https://ClinicalTrials.gov/show/NCT04914377
NCT04913740 Nursing Study of Skin Lesions Related to Health Care Protection in Novel Nursing Study of Skin Lesions Related to Health Care Protection in Novel Coronavirus Epidemic https://ClinicalTrials.gov/show/NCT04913740
NCT04912895 Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04912895
NCT04913779 Safety and Effectiveness of an Immunobiological Drug in CoViD-19 https://ClinicalTrials.gov/show/NCT04913779
NCT04912011 Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19. https://ClinicalTrials.gov/show/NCT04912011
NCT04910932 Effects of Breathing Exercises on Fear of COVID-19, Anxiety, Sleep and Quality of Life During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04910932
NCT04910516 Emotional Freedom Technique (EFT) Effect on Nurses https://ClinicalTrials.gov/show/NCT04910516
NCT04910542 Epidemiologic Intelligence Network (EpI-Net) to Promote COVID-19 Testing https://ClinicalTrials.gov/show/NCT04910542
NCT04910191 Collecting Respiratory Sound Samples From Corona Patients to Extend the Diagnostic Capability of VOQX Electronic Stethoscope to Diagnose COVID-19 Patients https://ClinicalTrials.gov/show/NCT04910191
NCT04909996 Study on the Performance and Safety of Sentinox in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04909996
NCT04909918 Impact of Steroids on Inflammatory Response in Covid-19 https://ClinicalTrials.gov/show/NCT04909918
NCT04904783 Low-Dose Radiation Therapy to Lungs in Moderate COVID-19 Pneumonitis: A Case-Control Pilot Study https://ClinicalTrials.gov/show/NCT04904783
NCT04907331 Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2 https://ClinicalTrials.gov/show/NCT04907331
NCT04904510 Evaluation of the INDICAIDâ„¢ COVID-19 Rapid Antigen Test https://ClinicalTrials.gov/show/NCT04904510
NCT04904497 Early Occupational Therapy in Mechanical Ventilated Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04904497
NCT04902911 Point of Care Evaluation of Novir 2019-nCoV Immunoglobulin G/ Immunoglobulin M (IgG/IgM) Antibody Test (Collodial Gold) https://ClinicalTrials.gov/show/NCT04902911
NCT04902976 Evaluation of SARS-COV-2 Viral Load of Covid-19 Patients After Rinsing With Oral Antimicrobial Mouthwashes https://ClinicalTrials.gov/show/NCT04902976
NCT04903184 Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers https://ClinicalTrials.gov/show/NCT04903184
NCT04902183 Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19 https://ClinicalTrials.gov/show/NCT04902183
NCT04901624 Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities https://ClinicalTrials.gov/show/NCT04901624
NCT04900155 Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19 https://ClinicalTrials.gov/show/NCT04900155
NCT04900337 Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04900337
NCT04900454 Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19 https://ClinicalTrials.gov/show/NCT04900454
NCT04900961 CISCO-21 Prevent and Treat Long COVID-19. https://ClinicalTrials.gov/show/NCT04900961
NCT04900428 Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPSâ„¢) in Outpatient Adults With COVID-19 (UK) https://ClinicalTrials.gov/show/NCT04900428
NCT04900467 Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine https://ClinicalTrials.gov/show/NCT04900467
NCT04900415 Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction https://ClinicalTrials.gov/show/NCT04900415
NCT04900129 Inhalation of Vapor With Medication (Diclofenac Sodium, Menthol, Methyl Salicylate and N-Acetyl Cysteine) Reduces Oxygen Need and Hospital Stay in COVID-19 Patients - A Case Control Study https://ClinicalTrials.gov/show/NCT04900129
NCT04899245 ReSET Aim 1b: Restarting Safe Education and Testing for Children With Medical Complexity - COVID-19 Testing in School With Children and Staff https://ClinicalTrials.gov/show/NCT04899245
NCT04898205 Cardiopulmonary Rehabilitation in COVID-19 Longhaulers https://ClinicalTrials.gov/show/NCT04898205
NCT04898088 A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients https://ClinicalTrials.gov/show/NCT04898088
NCT04898062 CRP-Apheresis for Attenuation of Pulmonary, MYocardial and/or Kidney Injury in COvid-19 https://ClinicalTrials.gov/show/NCT04898062
NCT04896710 COVID-19 Rapid Testing for Self-Administration Among an Asymptomatic Sample https://ClinicalTrials.gov/show/NCT04896710
NCT04896853 Treatment of Respiratory Complications Associated With COVID-19 Infection Using ProTrans® https://ClinicalTrials.gov/show/NCT04896853
NCT04896788 Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff https://ClinicalTrials.gov/show/NCT04896788
NCT04895085 ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance https://ClinicalTrials.gov/show/NCT04895085
NCT04895267 Low-field Thoracic Magnetic Stimulation Increases Peripheral Oxygen Saturation Levels in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04895267
NCT04894409 Evaluation of Silver Nanoparticles for the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04894409
NCT04894227 Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04894227
NCT04892979 3R Rehabilitation Management of COVID-19 Survivors https://ClinicalTrials.gov/show/NCT04892979
NCT04890483 tDCS in Post-Acute COVID-19 Patients With SARDs https://ClinicalTrials.gov/show/NCT04890483
NCT04892459 Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector) https://ClinicalTrials.gov/show/NCT04892459
NCT04891172 Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04891172
NCT04891302 The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04891302
NCT04890665 Online Multi-component Psychological Intervention for Healthcare Workers During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04890665
NCT04890626 Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04890626
NCT04888949 A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04888949
NCT04889040 Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04889040
NCT04887129 Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD) https://ClinicalTrials.gov/show/NCT04887129
NCT04887350 SSIPP vs. PST vs. WLC https://ClinicalTrials.gov/show/NCT04887350
NCT04885907 Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients https://ClinicalTrials.gov/show/NCT04885907
NCT04885764 Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University https://ClinicalTrials.gov/show/NCT04885764
NCT04885491 A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Covid-19 Patients With aPH https://ClinicalTrials.gov/show/NCT04885491
NCT04885517 Breathing Effort in Covid-19 Pneumonia: Effects of Positive Pressure, Inspired Oxygen Fraction and Decubitus https://ClinicalTrials.gov/show/NCT04885517
NCT04885361 To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults https://ClinicalTrials.gov/show/NCT04885361
NCT04884529 Virtual Chair Yoga for Older Adults and Caregivers: Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT04884529
NCT04884776 Modulation of Gut Microbiota to Enhance Health and Immunity https://ClinicalTrials.gov/show/NCT04884776
NCT04884685 Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents https://ClinicalTrials.gov/show/NCT04884685
NCT04883528 Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04883528
NCT04883203 The Effect of Vitamin D Supplementation on COVID-19 Recovery https://ClinicalTrials.gov/show/NCT04883203
NCT04881227 The Impact of a Chatbot on COVID-19 Vaccine Perceptions and Intentions in ESPERES Cohort (ESPERES-COVID-19-CHATBOT) https://ClinicalTrials.gov/show/NCT04881227
NCT04881214 COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program https://ClinicalTrials.gov/show/NCT04881214
NCT04880694 A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019(COVID-19)Pneumonia https://ClinicalTrials.gov/show/NCT04880694
NCT04880122 Dried Blood Spots for SARS-CoV-2 Serology (COVID-19). https://ClinicalTrials.gov/show/NCT04880122
NCT04880174 SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT04880174
NCT04878809 Rapid Screening Circuit of COVID 19 in Schools, Pilot Study https://ClinicalTrials.gov/show/NCT04878809
NCT04880161 A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID) https://ClinicalTrials.gov/show/NCT04880161
NCT04880135 Supervised Versus Home Based Exercises Neck and Low Back Pain Among Students Due to Quarantine During COVID-19 https://ClinicalTrials.gov/show/NCT04880135
NCT04878328 Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO https://ClinicalTrials.gov/show/NCT04878328
NCT04877769 Bronchopulmonary PK of AT-527 (R07496998) https://ClinicalTrials.gov/show/NCT04877769
NCT04878042 COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray https://ClinicalTrials.gov/show/NCT04878042
NCT04876417 tDCS for Post COVID-19 Fatigue https://ClinicalTrials.gov/show/NCT04876417
NCT04876560 Implementation of a CDSS in Oncology Patients During COVID-19 https://ClinicalTrials.gov/show/NCT04876560
NCT04873128 Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS Approach https://ClinicalTrials.gov/show/NCT04873128
NCT04873414 Convalescent Plasma as Adjunct Therapy for COVID-19 https://ClinicalTrials.gov/show/NCT04873414
NCT04871958 Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward https://ClinicalTrials.gov/show/NCT04871958
NCT04872712 Comparing Press and Filiform Needle Acupuncture Effectiveness for Improving Insomnia in COVID-19 Healthcare Workers https://ClinicalTrials.gov/show/NCT04872712
NCT04872075 Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event https://ClinicalTrials.gov/show/NCT04872075
NCT04871828 The Efficacy of Leukotriene Inhibitor in Adult Patients With Moderate SARS-COV-2 Symptoms (COVID19) https://ClinicalTrials.gov/show/NCT04871828
NCT04871815 Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers. https://ClinicalTrials.gov/show/NCT04871815
NCT04871633 Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore https://ClinicalTrials.gov/show/NCT04871633
NCT04871737 Study of a Live rNDV Based Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04871737
NCT04871646 Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314 https://ClinicalTrials.gov/show/NCT04871646
NCT04870723 #SafeHandsSafeHearts: An eHealth Intervention for COVID-19 Prevention and Support https://ClinicalTrials.gov/show/NCT04870723
NCT04870385 An Islamic Psychospiritual-Acceptance and Commitment-based Prevention Program for At-risk Young Adults in the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04870385
NCT04870333 PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V https://ClinicalTrials.gov/show/NCT04870333
NCT04869592 A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19 https://ClinicalTrials.gov/show/NCT04869592
NCT04870164 Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19) https://ClinicalTrials.gov/show/NCT04870164
NCT04869397 Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells https://ClinicalTrials.gov/show/NCT04869397
NCT04868890 A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19 https://ClinicalTrials.gov/show/NCT04868890
NCT04869072 Convalescent Plasma Therapy - Zurich Protocol https://ClinicalTrials.gov/show/NCT04869072
NCT04868903 Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04868903
NCT04866303 Protecting Our Community: COVID-19 Testing https://ClinicalTrials.gov/show/NCT04866303
NCT04867265 Mouth-to-mouth Ventilation Efficiency Through Breathable Self-sterilizing Respirator During BLS in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04867265
NCT04866069 Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04866069
NCT04867226 Effectiveness of Colchicine Among Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04867226
NCT04865237 SARS-CoV-2 Human Challenge Characterisation Study https://ClinicalTrials.gov/show/NCT04865237
NCT04865107 Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04865107
NCT04865029 Estradiol and Progesterone in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04865029
NCT04864899 Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR) https://ClinicalTrials.gov/show/NCT04864899
NCT04864015 COVID-19 Aerosol in EGD Using a Droplet Reduction Mouthpiece https://ClinicalTrials.gov/show/NCT04864015
NCT04863638 A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated https://ClinicalTrials.gov/show/NCT04863638
NCT04863131 Safety and Immunogenicity of EXG-5003 https://ClinicalTrials.gov/show/NCT04863131
NCT04860895 Detection of SARS-CoV-2 in Nasopharyngeal Swabs by Using Multi-Spectral Screening System https://ClinicalTrials.gov/show/NCT04860895
NCT04860739 Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose https://ClinicalTrials.gov/show/NCT04860739
NCT04861298 Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early COVID-19 Symptoms at Home https://ClinicalTrials.gov/show/NCT04861298
NCT04860271 Manual Acupuncture Using Acupuncture Needle vs Press Needle for COVID-19 Healthcare Anxiety https://ClinicalTrials.gov/show/NCT04860271
NCT04860258 A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities for COVID-19 https://ClinicalTrials.gov/show/NCT04860258
NCT04860284 Hydroxychloroquine for Treatment of Non-Severe COVID-19 https://ClinicalTrials.gov/show/NCT04860284
NCT04860219 Lactoferrin Use in (SARS-CoV-2) Management https://ClinicalTrials.gov/show/NCT04860219
NCT04859023 Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19). https://ClinicalTrials.gov/show/NCT04859023
NCT04856111 Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia https://ClinicalTrials.gov/show/NCT04856111
NCT04859244 First-in-Human Study of Orally Administered GS-441524 for COVID-19 https://ClinicalTrials.gov/show/NCT04859244
NCT04858412 Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19 https://ClinicalTrials.gov/show/NCT04858412
NCT04858633 Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04858633
NCT04857060 Palliative Care Educator https://ClinicalTrials.gov/show/NCT04857060
NCT04854798 UNITE Study (UMN-SW) for COVID-19 https://ClinicalTrials.gov/show/NCT04854798
NCT04854759 The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms https://ClinicalTrials.gov/show/NCT04854759
NCT04854928 Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection. https://ClinicalTrials.gov/show/NCT04854928
NCT04854382 Tailored Information About the Coronavirus in Chronic Kidney Disease Patients https://ClinicalTrials.gov/show/NCT04854382
NCT04854772 Mind Body Intervention for COVID-19 Long Haul Syndrome https://ClinicalTrials.gov/show/NCT04854772
NCT04853979 Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure https://ClinicalTrials.gov/show/NCT04853979
NCT04853901 Remdesivir Efficacy In Management Of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04853901
NCT04853927 Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit https://ClinicalTrials.gov/show/NCT04853927
NCT04853966 The Effects of Physical Activity Counseling on Physical Activity and Quality of Life in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04853966
NCT04853199 Quercetin In The Treatment Of SARS-COV 2 https://ClinicalTrials.gov/show/NCT04853199
NCT04853134 Proxalutamide Treatment for COVID-19 Female Outpatients https://ClinicalTrials.gov/show/NCT04853134
NCT04851821 The Effectiveness of Phytotherapy in SARS-COV2(COVID-19) https://ClinicalTrials.gov/show/NCT04851821
NCT04849793 The Effect of Acupressure on the Anxiety Level https://ClinicalTrials.gov/show/NCT04849793
NCT04852770 Efficacy of TBCT, MBHP and PPT for PTSD During the Covid-19 Pandemics https://ClinicalTrials.gov/show/NCT04852770
NCT04849637 Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04849637
NCT04847583 A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04847583
NCT04847661 Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04847661
NCT04847791 Lactoferrin in Covid-19 Hospitalized Patients https://ClinicalTrials.gov/show/NCT04847791
NCT04847544 A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19. https://ClinicalTrials.gov/show/NCT04847544
NCT04847518 Assessment of Efficacy of KAN-JANG® in Mild COVID-19 https://ClinicalTrials.gov/show/NCT04847518
NCT04847479 COVID-19 Close Contact Self-Testing Study https://ClinicalTrials.gov/show/NCT04847479
NCT04847349 Live Microbials to Boost Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Immunity Clinical Trial https://ClinicalTrials.gov/show/NCT04847349
NCT04845880 SARS Cov_2 Incidence of Healthy Health Workers https://ClinicalTrials.gov/show/NCT04845880
NCT04846790 The Effect of a Combined Nature-based and Virtual Mindfulness Intervention on Perceived Stress in Healthcare Workers https://ClinicalTrials.gov/show/NCT04846790
NCT04846010 Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04846010
NCT04845971 Efficacy and Safety of Oral Immunotherapy With GcMAF in Hospitalized Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04845971
NCT04844554 Protocol of Assistance to Patients With Covid-19 Submitted to Treatment With HD-tDCS https://ClinicalTrials.gov/show/NCT04844554
NCT04844580 A Clinical Study Evaluating Inhaled Aviptadil on COVID-19 https://ClinicalTrials.gov/show/NCT04844580
NCT04844710 The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms https://ClinicalTrials.gov/show/NCT04844710
NCT04844567 Virtual Reality Intervention to Alleviate Breathlessness (COVID-19) https://ClinicalTrials.gov/show/NCT04844567
NCT04844346 Plant Stanol Esters and COVID-19 Vaccination Response https://ClinicalTrials.gov/show/NCT04844346
NCT04844489 Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People https://ClinicalTrials.gov/show/NCT04844489
NCT04843930 Improving Cognitive Health in COVID-19 Survivors https://ClinicalTrials.gov/show/NCT04843930
NCT04842435 Clinical Study in the Treatment of Patients With Moderate Course of COVID-19 https://ClinicalTrials.gov/show/NCT04842435
NCT04842708 Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis https://ClinicalTrials.gov/show/NCT04842708
NCT04842448 Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome https://ClinicalTrials.gov/show/NCT04842448
NCT04842331 PREvent Viral Exposure aNd Transmission Study: a SARS-CoV-2 PEP Study (PREVENT) https://ClinicalTrials.gov/show/NCT04842331
NCT04842292 Nebulized Heparin for COVID19-associated Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04842292
NCT04841681 Video-based Psychotherapy for COVID-19 Patients in Isolation Ward in Jakarta https://ClinicalTrials.gov/show/NCT04841681
NCT04841746 Efficacy of FES Cycling After a Severe Form of COVID-19 https://ClinicalTrials.gov/show/NCT04841746
NCT04840992 Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation https://ClinicalTrials.gov/show/NCT04840992
NCT04840459 Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting https://ClinicalTrials.gov/show/NCT04840459
NCT04839965 Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen https://ClinicalTrials.gov/show/NCT04839965
NCT04839315 COVID-19 Vaccination in Rheumatic Disease Patients https://ClinicalTrials.gov/show/NCT04839315
NCT04838080 Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo https://ClinicalTrials.gov/show/NCT04838080
NCT04838821 Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04838821
NCT04836780 DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04836780
NCT04836260 Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04836260
NCT04836052 Omega-3 Oil Use in COVID-19 Patients in Qatar https://ClinicalTrials.gov/show/NCT04836052
NCT04836351 Rehabilitation for Patients With Persistent Symptoms Post COVID-19 https://ClinicalTrials.gov/show/NCT04836351
NCT04834856 Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04834856
NCT04834908 Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection https://ClinicalTrials.gov/show/NCT04834908
NCT04834726 COVID-19 Vaccine Text Outreach https://ClinicalTrials.gov/show/NCT04834726
NCT04834739 Comparison of Functional Capacities of Healthcare Workers With and Without Covid-19 https://ClinicalTrials.gov/show/NCT04834739
NCT04834115 Efficacy of Ivermectin in Outpatients With Non-severe COVID-19 https://ClinicalTrials.gov/show/NCT04834115
NCT04833101 Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine https://ClinicalTrials.gov/show/NCT04833101
NCT04832919 A Nurse-Community Health Worker-Family Partnership Model: Addressing Uptake of COVID-19 Testing and Control Measures https://ClinicalTrials.gov/show/NCT04832919
NCT04830800 A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC https://ClinicalTrials.gov/show/NCT04830800
NCT04830943 Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia https://ClinicalTrials.gov/show/NCT04830943
NCT04830020 Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes https://ClinicalTrials.gov/show/NCT04830020
NCT04826822 Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04826822
NCT04828135 Dual MRI for Cardiopulmonary COVID-19 Long Haulers https://ClinicalTrials.gov/show/NCT04828135
NCT04824638 BNT162b2 Vaccination With Two Doses in COVID-19 Negative Adult Volunteers and With a Single Dose in COVID-19 Positive Adult Volunteers https://ClinicalTrials.gov/show/NCT04824638
NCT04824391 Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19 https://ClinicalTrials.gov/show/NCT04824391
NCT04824443 Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19 https://ClinicalTrials.gov/show/NCT04824443
NCT04824365 Sodium Pyruvate Nasal Spray Treatment of COVID-19 and Influenza Infections https://ClinicalTrials.gov/show/NCT04824365
NCT04821973 Respiratory Tele Monitoring COVID 19 (TMR COVID-19) https://ClinicalTrials.gov/show/NCT04821973
NCT04822285 Effect Psychological Triaging Intervention on Students’ Psychological Distress and Resilience Capacity https://ClinicalTrials.gov/show/NCT04822285
NCT04820803 Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04820803
NCT04821037 Nurse Health Pilot: Feasibility and Acceptability of a Virtual ACT-intervention in Nurses During COVID-19 https://ClinicalTrials.gov/show/NCT04821037
NCT04818970 Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04818970
NCT04818216 Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection https://ClinicalTrials.gov/show/NCT04818216
NCT04818281 Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04818281
NCT04817332 STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19 https://ClinicalTrials.gov/show/NCT04817332
NCT04817371 Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection. https://ClinicalTrials.gov/show/NCT04817371
NCT04816656 An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04816656
NCT04816682 Silymarin in COVID-19 Patients Admitted to Hospital With Elevated Liver Enzymes https://ClinicalTrials.gov/show/NCT04816682
NCT04816084 SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes https://ClinicalTrials.gov/show/NCT04816084
NCT04816942 Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt https://ClinicalTrials.gov/show/NCT04816942
NCT04815096 Imaging Immune Activation in COVID-19 https://ClinicalTrials.gov/show/NCT04815096
NCT04815057 The Effects of Wellness Training Given to Fifth Grade Students During the Covid-19 Epidemic Period https://ClinicalTrials.gov/show/NCT04815057
NCT04813770 The Impact of Theory-based Messaging on Covid-19 Vaccination Intentions https://ClinicalTrials.gov/show/NCT04813770
NCT04813575 COVID-19 Pathophysiology of Long Term Implications https://ClinicalTrials.gov/show/NCT04813575
NCT04813718 Post COVID-19 Syndrome and the Gut-lung Axis https://ClinicalTrials.gov/show/NCT04813718
NCT04813471 Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH https://ClinicalTrials.gov/show/NCT04813471
NCT04813562 Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells) https://ClinicalTrials.gov/show/NCT04813562
NCT04811664 A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04811664
NCT04811339 Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol) https://ClinicalTrials.gov/show/NCT04811339
NCT04811859 The Effect of Inspiratory Muscle Training in Post COVID-19 Patients https://ClinicalTrials.gov/show/NCT04811859
NCT04810949 Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml https://ClinicalTrials.gov/show/NCT04810949
NCT04810689 Pilot Trial of XFBD, a TCM, in Persons With COVID-19 https://ClinicalTrials.gov/show/NCT04810689
NCT04810637 A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04810637
NCT04810728 Efficacy of Psidii Guava’s Extract For COVID-19 https://ClinicalTrials.gov/show/NCT04810728
NCT04809974 Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID) https://ClinicalTrials.gov/show/NCT04809974
NCT04810065 SingStrong: Strong Lungs Through Song - Long COVID-19 Study https://ClinicalTrials.gov/show/NCT04810065
NCT04809389 A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19 https://ClinicalTrials.gov/show/NCT04809389
NCT04809272 ePLH Pilot Study: Online Support Parent Groups - ParentChat https://ClinicalTrials.gov/show/NCT04809272
NCT04808921 Performance Evaluation of SARS-COV-2 (Covid-19) Antigen Rapid Test https://ClinicalTrials.gov/show/NCT04808921
NCT04808882 ANTIcoagulation in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04808882
NCT04805931 VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans https://ClinicalTrials.gov/show/NCT04805931
NCT04805892 Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test. https://ClinicalTrials.gov/show/NCT04805892
NCT04806113 COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases https://ClinicalTrials.gov/show/NCT04806113
NCT04805684 Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04805684
NCT04805203 Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma https://ClinicalTrials.gov/show/NCT04805203
NCT04805086 The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19 https://ClinicalTrials.gov/show/NCT04805086
NCT04803370 Efficacy of Reinforcing Standard Therapy in COVID-19 Patients With Repeated Transfusion of Convalescent Plasma https://ClinicalTrials.gov/show/NCT04803370
NCT04801836 Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection https://ClinicalTrials.gov/show/NCT04801836
NCT04802187 Implementation of COVID-19 Testing Strategies in Community Health Centers https://ClinicalTrials.gov/show/NCT04802187
NCT04802382 Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04802382
NCT04801888 Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine https://ClinicalTrials.gov/show/NCT04801888
NCT04801940 HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID) https://ClinicalTrials.gov/show/NCT04801940
NCT04802018 Clinical Decision Support System Based on Non-invasive Tele-monitoring of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04802018
NCT04801524 Text-based Reminders to Promote COVID-19 Vaccinations https://ClinicalTrials.gov/show/NCT04801524
NCT04800939 The Effect of Acupressure on the Sleep Quality and Daytime Sleepiness https://ClinicalTrials.gov/show/NCT04800939
NCT04800965 Text-based Interventions to Promote COVID-19 Vaccinations https://ClinicalTrials.gov/show/NCT04800965
NCT04800120 Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress https://ClinicalTrials.gov/show/NCT04800120
NCT04800224 Brazilian Green Propolis Extract (EPP-AF) as an Adjunct Treatment for Hospitalized COVID-19 Patients (BeeCovid2) https://ClinicalTrials.gov/show/NCT04800224
NCT04799743 The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients https://ClinicalTrials.gov/show/NCT04799743
NCT04799561 Teleprehabilitation for Surgical Cancer Patients https://ClinicalTrials.gov/show/NCT04799561
NCT04798599 Information and Communication Technologies (ICTS) in Dentistry for SUS https://ClinicalTrials.gov/show/NCT04798599
NCT04798677 Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine https://ClinicalTrials.gov/show/NCT04798677
NCT04798001 Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults https://ClinicalTrials.gov/show/NCT04798001
NCT04797871 Resistance Training and Clinical Status in Patients With Post Discharge Symptoms After Covid-19 https://ClinicalTrials.gov/show/NCT04797871
NCT04798053 Impact of COVID-19 Pandemic and Social Distancing on Mental Health of Chronic Inflammatory Rheumatism Affected Patients https://ClinicalTrials.gov/show/NCT04798053
NCT04797936 BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19 https://ClinicalTrials.gov/show/NCT04797936
NCT04796402 A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19 https://ClinicalTrials.gov/show/NCT04796402
NCT04796064 Low Versus High-Intensity Aerobic Training in Community-dwelling Older Men With Post-COVID 19 (SARS-CoV-2) Sarcopenia https://ClinicalTrials.gov/show/NCT04796064
NCT04794946 Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT04794946
NCT04794036 Efficacy of an Asynchronous Telerehabilitation Programme in Post-COVID-19 Patient https://ClinicalTrials.gov/show/NCT04794036
NCT04793984 Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04793984
NCT04794803 Reparixin in COVID-19 Pneumonia - Efficacy and Safety https://ClinicalTrials.gov/show/NCT04794803
NCT04794374 Effects of Telerehabilitation After Discharge in COVID-19 Survivors https://ClinicalTrials.gov/show/NCT04794374
NCT04794400 The Application of a Mask in Patients With Severe Covid-19 Already Treated With High-flow Nasal Cannula. https://ClinicalTrials.gov/show/NCT04794400
NCT04794088 Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04794088
NCT04793243 Vitamin D3 Levels in COVID-19 Outpatients From Western Mexico https://ClinicalTrials.gov/show/NCT04793243
NCT04791241 A Check-list Including Lung Ultrasound for ED Patients With ARF https://ClinicalTrials.gov/show/NCT04791241
NCT04792021 Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04792021
NCT04791423 Study of GRAd-COV2 for the Prevention of COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04791423
NCT04789603 Effects of Using Mask During the 6-minute Walking Test in Times of COVID-19 https://ClinicalTrials.gov/show/NCT04789603
NCT04789525 Physical Training and Diet for Childhood Obesity https://ClinicalTrials.gov/show/NCT04789525
NCT04789499 Smell in Covid-19 and Efficacy of Nasal Theophylline https://ClinicalTrials.gov/show/NCT04789499
NCT04789356 Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity https://ClinicalTrials.gov/show/NCT04789356
NCT04788355 Prevention of Complications (SARS-CoV-2): Clinical Study https://ClinicalTrials.gov/show/NCT04788355
NCT04788407 Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts https://ClinicalTrials.gov/show/NCT04788407
NCT04785898 Diagnostic Performance of the ID Nowâ„¢ COVID-19 Screening Test Versus Simplexaâ„¢ COVID-19 Direct Assay https://ClinicalTrials.gov/show/NCT04785898
NCT04786483 The Effect of Laughter Therapy on Students in the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04786483
NCT04786080 Supporting Parents & Kids Through Lockdown Experiences (SPARKLE). https://ClinicalTrials.gov/show/NCT04786080
NCT04784767 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04784767
NCT04784754 Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04784754
NCT04784481 Ivermectin Reproposing for Mild Stage COVID-19 Outpatients https://ClinicalTrials.gov/show/NCT04784481
NCT04784897 A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04784897
NCT04783311 Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04783311
NCT04783025 A Blended Gaming COVID-19 Training System (BGCTS) With WHO Guidelines for Staff in Residential Care Homes https://ClinicalTrials.gov/show/NCT04783025
NCT04782700 P-Co-Li (Pulmonary Covid-19 Study) https://ClinicalTrials.gov/show/NCT04782700
NCT04782336 Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test https://ClinicalTrials.gov/show/NCT04782336
NCT04780035 Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04780035
NCT04780672 Clinical Study in the Treatment of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04780672
NCT04780581 Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients https://ClinicalTrials.gov/show/NCT04780581
NCT04780659 COVID-19 Vaccination of Immunodeficient Persons (COVAXID) https://ClinicalTrials.gov/show/NCT04780659
NCT04780685 A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19 https://ClinicalTrials.gov/show/NCT04780685
NCT04780425 Structured Diabetes Self-Management Education and Care Outcomes in Adults liVIng With Type 2 Diabetes in Accra, Ghana https://ClinicalTrials.gov/show/NCT04780425
NCT04780152 TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04780152
NCT04779827 Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks https://ClinicalTrials.gov/show/NCT04779827
NCT04780061 Dietary Supplements for COVID-19 https://ClinicalTrials.gov/show/NCT04780061
NCT04779450 Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors https://ClinicalTrials.gov/show/NCT04779450
NCT04779879 Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04779879
NCT04779047 Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04779047
NCT04778059 Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19 https://ClinicalTrials.gov/show/NCT04778059
NCT04776941 Expressive Writing for the Management of Stress in Cancer Survivors https://ClinicalTrials.gov/show/NCT04776941
NCT04775069 Antibody Response to COVID-19 Vaccines in Liver Disease Patients https://ClinicalTrials.gov/show/NCT04775069
NCT04773665 Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a https://ClinicalTrials.gov/show/NCT04773665
NCT04772859 Evaluation of an Online Lifestyle Intervention in Mexican School Children During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04772859
NCT04771559 Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients https://ClinicalTrials.gov/show/NCT04771559
NCT04771351 Study to Evaluate a Single Dose of STI-2020 (COVI-AMGâ„¢) in Hospitalized Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04771351
NCT04770740 Randomized Controlled Clinical Trial to Investigate Effects of Vitamin K2 in COVID-19 https://ClinicalTrials.gov/show/NCT04770740
NCT04771585 Quantification of Exhaled Particles to Identify Airborne Transmission Risks of COVID-19 https://ClinicalTrials.gov/show/NCT04771585
NCT04771013 Safety and Efficacy of Thymic Peptides in the Treatment of Hospitalized COVID-19 Patients in Honduras https://ClinicalTrials.gov/show/NCT04771013
NCT04771000 A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19 https://ClinicalTrials.gov/show/NCT04771000
NCT04769297 Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04769297
NCT04769999 Computer Assisted Lessening of Intrusive Memories in the Emergency Department https://ClinicalTrials.gov/show/NCT04769999
NCT04765839 Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations https://ClinicalTrials.gov/show/NCT04765839
NCT04767477 Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors https://ClinicalTrials.gov/show/NCT04767477
NCT04766931 The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04766931
NCT04767087 Honey and Nigella Sativa in COVID-19 Prophylaxis https://ClinicalTrials.gov/show/NCT04767087
NCT04767958 The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing https://ClinicalTrials.gov/show/NCT04767958
NCT04765475 Protecting Native Families From COVID-19 https://ClinicalTrials.gov/show/NCT04765475
NCT04762173 Self-Help for Stress Related to COVID-19 https://ClinicalTrials.gov/show/NCT04762173
NCT04763681 Couple HOPES (Helping Overcome PTSD and Enhance Satisfaction) https://ClinicalTrials.gov/show/NCT04763681
NCT04762628 Trial Efficacy of Saisei Pharma Dietary Supplements MAF Capsules, 148 mg and M Capsules, 148 mg in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04762628
NCT04765436 PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64 https://ClinicalTrials.gov/show/NCT04765436
NCT04764981 Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19) https://ClinicalTrials.gov/show/NCT04764981
NCT04760418 Trauma and Trauma-Focused Therapy in the University of Kentucky SMART Clinic https://ClinicalTrials.gov/show/NCT04760418
NCT04761874 Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04761874
NCT04760821 Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19 https://ClinicalTrials.gov/show/NCT04760821
NCT04760743 Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19) https://ClinicalTrials.gov/show/NCT04760743
NCT04760132 National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) https://ClinicalTrials.gov/show/NCT04760132
NCT04758299 Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits https://ClinicalTrials.gov/show/NCT04758299
NCT04757818 Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%. https://ClinicalTrials.gov/show/NCT04757818
NCT04757857 COVID-19 Antithrombotic Rivaroxaban Evaluation https://ClinicalTrials.gov/show/NCT04757857
NCT04758286 Anesthetic & Surgical Protocol for Emergency Surgeries During the Era of COVID-19 https://ClinicalTrials.gov/show/NCT04758286
NCT04758273 A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) https://ClinicalTrials.gov/show/NCT04758273
NCT04757298 COVID-19 Treatment Cascade Optimization Study https://ClinicalTrials.gov/show/NCT04757298
NCT04756466 Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly https://ClinicalTrials.gov/show/NCT04756466
NCT04756830 A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04756830
NCT04756323 A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) https://ClinicalTrials.gov/show/NCT04756323
NCT04756856 Muscle-targeted Nutritional Therapy for the Recovery From COVID-19 https://ClinicalTrials.gov/show/NCT04756856
NCT04753645 BRAC Institute of Governance and Development-Hygiene Behavioural Change and Coalition https://ClinicalTrials.gov/show/NCT04753645
NCT04755972 Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2 https://ClinicalTrials.gov/show/NCT04755972
NCT04756128 Impact of Colchicine and Low-dose Naltrexone on COVID-19 https://ClinicalTrials.gov/show/NCT04756128
NCT04756141 CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)) https://ClinicalTrials.gov/show/NCT04756141
NCT04753476 Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia https://ClinicalTrials.gov/show/NCT04753476
NCT04753619 Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management https://ClinicalTrials.gov/show/NCT04753619
NCT04751617 Pulmonary Rehabilitation of Patients With a History of COVID-19 https://ClinicalTrials.gov/show/NCT04751617
NCT04751474 The Effect of Motivational Messages on Optimism, Hopelessness and Life Satisfaction https://ClinicalTrials.gov/show/NCT04751474
NCT04751682 Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19 https://ClinicalTrials.gov/show/NCT04751682
NCT04751643 Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections https://ClinicalTrials.gov/show/NCT04751643
NCT04751604 Improvement of the Nutritional Status Regarding Nicotinamide (Vitamin B3) and the Disease Course of COVID-19 https://ClinicalTrials.gov/show/NCT04751604
NCT04750720 Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04750720
NCT04750265 Robotic Assisted Early Mobilization in Ventilated ICU Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04750265
NCT04750278 A Phase 2/3, Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of FP-025 in Patients With Severe to Critical COVID 19 With Associated Acute Respiratory Distress Syndrome (ARDS) https://ClinicalTrials.gov/show/NCT04750278
NCT04750317 Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04750317
NCT04749121 Ultraviolet Germicidal Irradiation on the New Silicone Half-Piece Elastometric Respirators https://ClinicalTrials.gov/show/NCT04749121
NCT04748783 Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19 https://ClinicalTrials.gov/show/NCT04748783
NCT04748757 Annexin A5 in Patients With Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04748757
NCT04748536 Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04748536
NCT04748120 Operative vs Non-Operative Management of Acute Appendicitis and Acute Cholecystitis in COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04748120
NCT04747574 Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04747574
NCT04747756 Creating a Virtual Village for People Aging With HIV During COVID-19 https://ClinicalTrials.gov/show/NCT04747756
NCT04747821 An Effectiveness Study of the Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine https://ClinicalTrials.gov/show/NCT04747821
NCT04747158 COVID-19 Convalescent Plasma Therapy https://ClinicalTrials.gov/show/NCT04747158
NCT04747132 Effectiveness of a Telegeriatric Intervention in Older Adults During the Covid-19 Contingency https://ClinicalTrials.gov/show/NCT04747132
NCT04747249 Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19 https://ClinicalTrials.gov/show/NCT04747249
NCT04746339 Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19 https://ClinicalTrials.gov/show/NCT04746339
NCT04746183 AGILE (Early Phase Platform Trial for COVID-19) https://ClinicalTrials.gov/show/NCT04746183
NCT04746430 COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study https://ClinicalTrials.gov/show/NCT04746430
NCT04746365 Ivermectin Role in Covid-19 Clinical Trial https://ClinicalTrials.gov/show/NCT04746365
NCT04745442 Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04745442
NCT04743349 Steam Inhalations in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04743349
NCT04743401 Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04743401
NCT04743232 COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment https://ClinicalTrials.gov/show/NCT04743232
NCT04743011 Enriched Heparin Anti COVID-19 Trial https://ClinicalTrials.gov/show/NCT04743011
NCT04742725 A Study to Evaluate the Efficacy and Safety of Prothioneâ„¢ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04742725
NCT04739410 Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients https://ClinicalTrials.gov/show/NCT04739410
NCT04739462 SMS Maama Project COVID-19 https://ClinicalTrials.gov/show/NCT04739462
NCT04738045 Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04738045
NCT04734717 Coordination and Locomotor Problems in Patients With Covid-19 Virus https://ClinicalTrials.gov/show/NCT04734717
NCT04734873 CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients https://ClinicalTrials.gov/show/NCT04734873
NCT04734860 Study to Evaluate a Single Dose of STI-2020 (COVI-AMGâ„¢) in Adults With Mild COVID-19 Symptoms https://ClinicalTrials.gov/show/NCT04734860
NCT04733833 A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04733833
NCT04734912 Evaluation of Transnasal Endoscopy During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04734912
NCT04734561 Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease https://ClinicalTrials.gov/show/NCT04734561
NCT04734171 Social Activity, Loneliness and Stigma During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04734171
NCT04733625 The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection https://ClinicalTrials.gov/show/NCT04733625
NCT04732468 COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA https://ClinicalTrials.gov/show/NCT04732468
NCT04732819 Improving COVID-19 Vaccine Uptake in Nursing Homes https://ClinicalTrials.gov/show/NCT04732819
NCT04730856 Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID) https://ClinicalTrials.gov/show/NCT04730856
NCT04730401 Convalescent Plasma in the Treatment of Covid-19 https://ClinicalTrials.gov/show/NCT04730401
NCT04731116 Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection https://ClinicalTrials.gov/show/NCT04731116
NCT04730661 Efficacy of the Sit to Stand Test in the Decision to Hospitalize a Patient Consulting the Emergency Dept for COVID 19 https://ClinicalTrials.gov/show/NCT04730661
NCT04730427 Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04730427
NCT04730323 TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience https://ClinicalTrials.gov/show/NCT04730323
NCT04730284 Evaluation of a Synbiotic Formula in Patient With COVID-19 https://ClinicalTrials.gov/show/NCT04730284
NCT04730206 The DAWN Camostat Trial for Ambulatory COVID-19 Patients https://ClinicalTrials.gov/show/NCT04730206
NCT04729491 EAT-DUTA AndroCoV Trial https://ClinicalTrials.gov/show/NCT04729491
NCT04728802 Proxalutamide Treatment for Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04728802
NCT04729140 An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization https://ClinicalTrials.gov/show/NCT04729140
NCT04728594 Emails Promoting COVID-19 Vaccination Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04728594
NCT04727424 Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms https://ClinicalTrials.gov/show/NCT04727424
NCT04726111 COVID-19 and Pregnancy: Placental and Immunological Impacts https://ClinicalTrials.gov/show/NCT04726111
NCT04726163 Tele-expertise in Patients With Diabetes Hospitalized for Covid-19 Infection https://ClinicalTrials.gov/show/NCT04726163
NCT04726371 Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings https://ClinicalTrials.gov/show/NCT04726371
NCT04723550 COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes https://ClinicalTrials.gov/show/NCT04723550
NCT04724616 CARTOON: CoronAviRus (COVID-19) educaTional prOgram fOr childreN https://ClinicalTrials.gov/show/NCT04724616
NCT04724538 Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19 https://ClinicalTrials.gov/show/NCT04724538
NCT04724720 Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04724720
NCT04724629 Survival TRial Using CytoKines in COVID-19 (STRUCK Trial) https://ClinicalTrials.gov/show/NCT04724629
NCT04723576 Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04723576
NCT04723563 Nebulized Heparin for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04723563
NCT04723524 Jinhua Qinggan Granules in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04723524
NCT04723459 Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff https://ClinicalTrials.gov/show/NCT04723459
NCT04723290 COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020 https://ClinicalTrials.gov/show/NCT04723290
NCT04718506 Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention https://ClinicalTrials.gov/show/NCT04718506
NCT04721236 Early Use of Hyperimmune Plasma in COVID-19 https://ClinicalTrials.gov/show/NCT04721236
NCT04720794 A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion https://ClinicalTrials.gov/show/NCT04720794
NCT04720235 A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit https://ClinicalTrials.gov/show/NCT04720235
NCT04723394 Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults https://ClinicalTrials.gov/show/NCT04723394
NCT04720404 Mindful Prevention of Psychopathology in Healthcare Workers During the COVID-19 Crisis (COVID-19 MindPreP) https://ClinicalTrials.gov/show/NCT04720404
NCT04720378 Safety and Tolerability Study of IV ST266 in COVID-19 Subjects https://ClinicalTrials.gov/show/NCT04720378
NCT04719234 Lung Ultrasonography in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04719234
NCT04719208 [COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse https://ClinicalTrials.gov/show/NCT04719208
NCT04718480 Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients https://ClinicalTrials.gov/show/NCT04718480
NCT04716556 TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04716556
NCT04718220 Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19 https://ClinicalTrials.gov/show/NCT04718220
NCT04716998 Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19 https://ClinicalTrials.gov/show/NCT04716998
NCT04716647 Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research https://ClinicalTrials.gov/show/NCT04716647
NCT04716569 Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19 https://ClinicalTrials.gov/show/NCT04716569
NCT04716179 Prospective Two-arm Study of Fertility in Men With COVID-19 https://ClinicalTrials.gov/show/NCT04716179
NCT04715763 INvestigating TELmisartin Study https://ClinicalTrials.gov/show/NCT04715763
NCT04715932 Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN) https://ClinicalTrials.gov/show/NCT04715932
NCT04715607 COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens https://ClinicalTrials.gov/show/NCT04715607
NCT04715360 Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy https://ClinicalTrials.gov/show/NCT04715360
NCT04716426 APTâ„¢ T3X on the COVID-19 Contamination Rate https://ClinicalTrials.gov/show/NCT04716426
NCT04715295 Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19 https://ClinicalTrials.gov/show/NCT04715295
NCT04713878 Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04713878
NCT04713553 A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants https://ClinicalTrials.gov/show/NCT04713553
NCT04713176 Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04713176
NCT04712344 Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO) https://ClinicalTrials.gov/show/NCT04712344
NCT04712045 Rational Use of Personal Protective Equipment During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04712045
NCT04713488 An Open Study on the Safety, Tolerability, and Immunogenicity of “Sputnik Light” Vaccine https://ClinicalTrials.gov/show/NCT04713488
NCT04713111 Stress and Recovery in Frontline COVID-19 Workers https://ClinicalTrials.gov/show/NCT04713111
NCT04712110 A Study of TAK-019 in Healthy Japanese Adults (COVID-19) https://ClinicalTrials.gov/show/NCT04712110
NCT04712357 Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19 https://ClinicalTrials.gov/show/NCT04712357
NCT04710381 IMUNOR® Preparation in the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04710381
NCT04710394 Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell https://ClinicalTrials.gov/show/NCT04710394
NCT04710303 COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults https://ClinicalTrials.gov/show/NCT04710303
NCT04710316 Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali https://ClinicalTrials.gov/show/NCT04710316
NCT04709172 Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia https://ClinicalTrials.gov/show/NCT04709172
NCT04707833 Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen https://ClinicalTrials.gov/show/NCT04707833
NCT04708340 Tolerability and Efficacy of RJX in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04708340
NCT04707703 Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis https://ClinicalTrials.gov/show/NCT04707703
NCT04707820 Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection https://ClinicalTrials.gov/show/NCT04707820
NCT04707742 Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04707742
NCT04707534 Dexamethasone for COVID-19 https://ClinicalTrials.gov/show/NCT04707534
NCT04705831 Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection https://ClinicalTrials.gov/show/NCT04705831
NCT04705753 Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients https://ClinicalTrials.gov/show/NCT04705753
NCT04706039 Rapid Diagnosis of COVID-19 by Chemical Analysis of Exhaled Air https://ClinicalTrials.gov/show/NCT04706039
NCT04703608 Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia https://ClinicalTrials.gov/show/NCT04703608
NCT04703907 Auricular Stimulation for Relief of Stress and Anxiety https://ClinicalTrials.gov/show/NCT04703907
NCT04704063 Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL) https://ClinicalTrials.gov/show/NCT04704063
NCT04703140 COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19 https://ClinicalTrials.gov/show/NCT04703140
NCT04703036 Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19 https://ClinicalTrials.gov/show/NCT04703036
NCT04703114 Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV) https://ClinicalTrials.gov/show/NCT04703114
NCT04701528 Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients https://ClinicalTrials.gov/show/NCT04701528
NCT04701606 The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04701606
NCT04701489 UNITE Study (UMN-GE) for COVID-19 https://ClinicalTrials.gov/show/NCT04701489
NCT04700163 RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04700163
NCT04701710 Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan https://ClinicalTrials.gov/show/NCT04701710
NCT04699916 EEG-based Sedation Protocol for Patients on Mechanical Ventilation Due to SARS-CoV-2 Pneumonia https://ClinicalTrials.gov/show/NCT04699916
NCT04699851 Optimization of the Management of COVID-19 Through Tailored Recommendations to the Citizens https://ClinicalTrials.gov/show/NCT04699851
NCT04699227 Can RIC Prevent Deterioration to Critical Care in Covid19 https://ClinicalTrials.gov/show/NCT04699227
NCT04698798 Skeletal Muscle Wasting in SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04698798
NCT04698993 Dräger COVID-19 Antigen Test Clinical Performance Study https://ClinicalTrials.gov/show/NCT04698993
NCT04695743 Group CST Using Zoom: A Proof of Concept Study https://ClinicalTrials.gov/show/NCT04695743
NCT04695197 Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso https://ClinicalTrials.gov/show/NCT04695197
NCT04695301 Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation https://ClinicalTrials.gov/show/NCT04695301
NCT04694612 Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal https://ClinicalTrials.gov/show/NCT04694612
NCT04694638 Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04694638
NCT04691908 Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04691908
NCT04691947 Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC https://ClinicalTrials.gov/show/NCT04691947
NCT04693026 Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients https://ClinicalTrials.gov/show/NCT04693026
NCT04690920 Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins https://ClinicalTrials.gov/show/NCT04690920
NCT04690413 NOWDx Test for the Detection of Antibodies to COVID-19 https://ClinicalTrials.gov/show/NCT04690413
NCT04687488 Aerosol and Droplet Dispersion During Gastrointestinal Motility Investigations https://ClinicalTrials.gov/show/NCT04687488
NCT04689399 Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test https://ClinicalTrials.gov/show/NCT04689399
NCT04686539 Synthetic CBD as a Therapy for COVID-19 https://ClinicalTrials.gov/show/NCT04686539
NCT04686760 Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04686760
NCT04685447 Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients https://ClinicalTrials.gov/show/NCT04685447
NCT04684446 Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04684446
NCT04685512 Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged Home https://ClinicalTrials.gov/show/NCT04685512
NCT04685603 Dendritic Cell Vaccine to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04685603
NCT04681859 Evaluation of a Low-cost CPAP Device on Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04681859
NCT04682574 Role of Mega Dose of Vitamin C in Critical COVID-19 Patients https://ClinicalTrials.gov/show/NCT04682574
NCT04682041 Evaluating the Impact of EnteraGam In People With COVID-19 https://ClinicalTrials.gov/show/NCT04682041
NCT04679909 Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study) https://ClinicalTrials.gov/show/NCT04679909
NCT04681053 Inhaled Ivermectin and COVID-19 https://ClinicalTrials.gov/show/NCT04681053
NCT04681430 Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals https://ClinicalTrials.gov/show/NCT04681430
NCT04681001 Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers https://ClinicalTrials.gov/show/NCT04681001
NCT04680949 suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19 https://ClinicalTrials.gov/show/NCT04680949
NCT04680858 Impact of Digital Communication Assist Tools in Endoscopic Team Communication During COVID-19 https://ClinicalTrials.gov/show/NCT04680858
NCT04679493 Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04679493
NCT04679350 Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04679350
NCT04679415 Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04679415
NCT04676867 Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04676867
NCT04678778 Virtual Reality Study - COVID-19 Protocol https://ClinicalTrials.gov/show/NCT04678778
NCT04678700 Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance https://ClinicalTrials.gov/show/NCT04678700
NCT04678739 Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT04678739
NCT04678687 COVID-19 and Tissue Damage in Vital Organs https://ClinicalTrials.gov/show/NCT04678687
NCT04677660 A Study of TAK-919 in Healthy Japanese Adults (COVID-19) https://ClinicalTrials.gov/show/NCT04677660
NCT04678830 COVID-19 Long-Haulers Study https://ClinicalTrials.gov/show/NCT04678830
NCT04676971 Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04676971
NCT04677270 Evaluation of Two Versions of a Digital Problem Solving Tool for the General Public Specific for the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04677270
NCT04674644 Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales https://ClinicalTrials.gov/show/NCT04674644
NCT04674566 Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04674566
NCT04674189 A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19 https://ClinicalTrials.gov/show/NCT04674189
NCT04673318 Physical Rehabilitation of COVID-19 Survivors by Heat Therapy https://ClinicalTrials.gov/show/NCT04673318
NCT04673214 Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment https://ClinicalTrials.gov/show/NCT04673214
NCT04672291 Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults https://ClinicalTrials.gov/show/NCT04672291
NCT04668339 A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults https://ClinicalTrials.gov/show/NCT04668339
NCT04668235 Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected) https://ClinicalTrials.gov/show/NCT04668235
NCT04669015 Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04669015
NCT04668625 Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures https://ClinicalTrials.gov/show/NCT04668625
NCT04668469 Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04668469
NCT04667286 Awake Pronation for Covid-19 Treatment https://ClinicalTrials.gov/show/NCT04667286
NCT04666493 Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19 https://ClinicalTrials.gov/show/NCT04666493
NCT04666233 Personal Protective Equipment for the Prevention of SARS-Cov-2 During Neonatal Resuscitation https://ClinicalTrials.gov/show/NCT04666233
NCT04666441 COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04666441
NCT04666558 Heal-Me Personalized Online Nutrition and Exercise Routines https://ClinicalTrials.gov/show/NCT04666558
NCT04666012 Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04666012
NCT04666116 Changes in Viral Load in COVID-19 After Probiotics https://ClinicalTrials.gov/show/NCT04666116
NCT04665193 An Approach to Screening for COVID-19 at Vancouver Airport https://ClinicalTrials.gov/show/NCT04665193
NCT04664010 Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04664010
NCT04663555 Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19 https://ClinicalTrials.gov/show/NCT04663555
NCT04663594 Online Culture for Mental Health in People Aged 16-24 https://ClinicalTrials.gov/show/NCT04663594
NCT04663737 Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04663737
NCT04662021 Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety https://ClinicalTrials.gov/show/NCT04662021
NCT04662684 Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial https://ClinicalTrials.gov/show/NCT04662684
NCT04662671 Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19 https://ClinicalTrials.gov/show/NCT04662671
NCT04661527 Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19 https://ClinicalTrials.gov/show/NCT04661527
NCT04661930 Fenofibrate for Patients With COVID-19 Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04661930
NCT04661540 A Study of Auxora in Patients With Critical COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04661540
NCT04661410 Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04661410
NCT04659941 Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers https://ClinicalTrials.gov/show/NCT04659941
NCT04659486 Adolescents With COVID-19/MIS-C at HCFMUSP https://ClinicalTrials.gov/show/NCT04659486
NCT04659707 Hyperpolarized 129Xe MRI of Survivors of COVID-19 https://ClinicalTrials.gov/show/NCT04659707
NCT04659109 Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19 https://ClinicalTrials.gov/show/NCT04659109
NCT04658979 Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study https://ClinicalTrials.gov/show/NCT04658979
NCT04659122 A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04659122
NCT04657471 Hospitalization or Outpatient ManagEment of Patients With SRAS-CoV-2 Infection - Revised HOME-CoV Score Study https://ClinicalTrials.gov/show/NCT04657471
NCT04659239 The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 https://ClinicalTrials.gov/show/NCT04659239
NCT04658433 The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People https://ClinicalTrials.gov/show/NCT04658433
NCT04657497 A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04657497
NCT04657484 Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease https://ClinicalTrials.gov/show/NCT04657484
NCT04656626 Brief Mindfulness Based Intervention to Improve Psychological Wellbeing https://ClinicalTrials.gov/show/NCT04656626
NCT04656691 At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04656691
NCT04655716 Urine Alkalinisation to Prevent AKI in COVID-19 https://ClinicalTrials.gov/show/NCT04655716
NCT04655625 Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19) https://ClinicalTrials.gov/show/NCT04655625
NCT04654481 Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04654481
NCT04653831 Treatment With Pirfenidone for COVID-19 Related Severe ARDS https://ClinicalTrials.gov/show/NCT04653831
NCT04652102 A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults for COVID-19 https://ClinicalTrials.gov/show/NCT04652102
NCT04652674 Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04652674
NCT04652648 Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts https://ClinicalTrials.gov/show/NCT04652648
NCT04652765 Camostat With Bicalutamide for COVID-19 https://ClinicalTrials.gov/show/NCT04652765
NCT04652115 Defibrotide for the Treatment of Severe COVID-19 https://ClinicalTrials.gov/show/NCT04652115
NCT04651790 Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04651790
NCT04649515 Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans https://ClinicalTrials.gov/show/NCT04649515
NCT04647305 Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission https://ClinicalTrials.gov/show/NCT04647305
NCT04648800 Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland https://ClinicalTrials.gov/show/NCT04648800
NCT04649021 Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population https://ClinicalTrials.gov/show/NCT04649021
NCT04649775 AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04649775
NCT04649424 COVID-19 Nasal Swab Trial https://ClinicalTrials.gov/show/NCT04649424
NCT04649086 Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04649086
NCT04647747 Silent Hypoxia and Awake Proning in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04647747
NCT04646603 MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04646603
NCT04647695 IFN-beta 1b and Remdesivir for COVID19 https://ClinicalTrials.gov/show/NCT04647695
NCT04646655 Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19 https://ClinicalTrials.gov/show/NCT04646655
NCT04646616 CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia. https://ClinicalTrials.gov/show/NCT04646616
NCT04646109 Ivermectin for Severe COVID-19 Management https://ClinicalTrials.gov/show/NCT04646109
NCT04645407 Effects of Fuzheng Huayu Tablets on COVID-19 https://ClinicalTrials.gov/show/NCT04645407
NCT04644185 The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04644185
NCT04644120 Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04644120
NCT04643964 Brief Video Interventions for Depression https://ClinicalTrials.gov/show/NCT04643964
NCT04644198 Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica https://ClinicalTrials.gov/show/NCT04644198
NCT04643678 Anakinra in the Management of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04643678
NCT04643691 Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS https://ClinicalTrials.gov/show/NCT04643691
NCT04643561 Using Travelan to Boost Immune Response in Vitro to COVID-19 https://ClinicalTrials.gov/show/NCT04643561
NCT04642326 Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis https://ClinicalTrials.gov/show/NCT04642326
NCT04642040 Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia https://ClinicalTrials.gov/show/NCT04642040
NCT04641481 An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers https://ClinicalTrials.gov/show/NCT04641481
NCT04641195 Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India https://ClinicalTrials.gov/show/NCT04641195
NCT04638673 NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis https://ClinicalTrials.gov/show/NCT04638673
NCT04639349 Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID https://ClinicalTrials.gov/show/NCT04639349
NCT04640233 Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection https://ClinicalTrials.gov/show/NCT04640233
NCT04640181 Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT) https://ClinicalTrials.gov/show/NCT04640181
NCT04640402 A Phase â…¡ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) https://ClinicalTrials.gov/show/NCT04640402
NCT04636671 Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT) https://ClinicalTrials.gov/show/NCT04636671
NCT04639375 Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04639375
NCT04637906 Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2) https://ClinicalTrials.gov/show/NCT04637906
NCT04637867 COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO) https://ClinicalTrials.gov/show/NCT04637867
NCT04637828 A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04637828
NCT04637477 Virtual Enhanced Lifestyle for Metabolic Syndrome (ELM) Proof-of-Concept Study https://ClinicalTrials.gov/show/NCT04637477
NCT04636086 Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04636086
NCT04636697 Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults https://ClinicalTrials.gov/show/NCT04636697
NCT04636320 Prevalence of Myocardial Scars on CMR After COVID-19 Infection https://ClinicalTrials.gov/show/NCT04636320
NCT04636333 Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell) https://ClinicalTrials.gov/show/NCT04636333
NCT04634903 Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04634903
NCT04635618 Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04635618
NCT04635241 Inhaled Heparin for Hospitalised COVID-19 Patients https://ClinicalTrials.gov/show/NCT04635241
NCT04635605 Methylene Blue Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04635605
NCT04634799 Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04634799
NCT04634422 Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure https://ClinicalTrials.gov/show/NCT04634422
NCT04634318 Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae (REHABCOVID) https://ClinicalTrials.gov/show/NCT04634318
NCT04632602 Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04632602
NCT04632719 The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04632719
NCT04632082 Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04632082
NCT04632368 Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04632368
NCT04632043 Early Versus Delayed Intubation of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04632043
NCT04631380 Prayer in Commbate to Corona Virus - Covid -19 https://ClinicalTrials.gov/show/NCT04631380
NCT04631536 Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC https://ClinicalTrials.gov/show/NCT04631536
NCT04631666 SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion https://ClinicalTrials.gov/show/NCT04631666
NCT04629989 Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19 https://ClinicalTrials.gov/show/NCT04629989
NCT04629105 Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER) https://ClinicalTrials.gov/show/NCT04629105
NCT04629157 The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19 https://ClinicalTrials.gov/show/NCT04629157
NCT04628143 A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04628143
NCT04627584 A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04627584
NCT04627519 Effectiveness and Safety of Rhea Health Tone® as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia https://ClinicalTrials.gov/show/NCT04627519
NCT04625985 Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. https://ClinicalTrials.gov/show/NCT04625985
NCT04627467 Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID) https://ClinicalTrials.gov/show/NCT04627467
NCT04627675 CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) https://ClinicalTrials.gov/show/NCT04627675
NCT04625114 The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden https://ClinicalTrials.gov/show/NCT04625114
NCT04622826 plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients https://ClinicalTrials.gov/show/NCT04622826
NCT04623021 A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04623021
NCT04623255 Randomised Study of Plasma Exchange in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04623255
NCT04622891 Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection https://ClinicalTrials.gov/show/NCT04622891
NCT04622865 Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19 https://ClinicalTrials.gov/show/NCT04622865
NCT04621461 Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting https://ClinicalTrials.gov/show/NCT04621461
NCT04621903 A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04621903
NCT04621149 An Outpatient Study Investigating Non-prescription Treatments for COVID-19 https://ClinicalTrials.gov/show/NCT04621149
NCT04621123 Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients https://ClinicalTrials.gov/show/NCT04621123
NCT04621058 Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19. https://ClinicalTrials.gov/show/NCT04621058
NCT04620798 Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students https://ClinicalTrials.gov/show/NCT04620798
NCT04619706 Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04619706
NCT04619719 Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia https://ClinicalTrials.gov/show/NCT04619719
NCT04619628 Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04619628
NCT04619290 Outpatient Treatment With CoVid-19 With Prexablu https://ClinicalTrials.gov/show/NCT04619290
NCT04618042 FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04618042
NCT04617483 Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults https://ClinicalTrials.gov/show/NCT04617483
NCT04615975 Ketogenic Diet as Protective Factor During COVID-19 https://ClinicalTrials.gov/show/NCT04615975
NCT04617262 Pilot Feasibility Study of Remote Problem Management Plus for Adults Affected by COVID-19 https://ClinicalTrials.gov/show/NCT04617262
NCT04616989 Mental Health in Communities Affected by COVID-19 in Uganda https://ClinicalTrials.gov/show/NCT04616989
NCT04615741 Finding Wellness in the Pandemic https://ClinicalTrials.gov/show/NCT04615741
NCT04614883 Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04614883
NCT04615416 Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04615416
NCT04614844 COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS) https://ClinicalTrials.gov/show/NCT04614844
NCT04615052 Home-based Exercise in COVID-19 Survivors https://ClinicalTrials.gov/show/NCT04615052
NCT04613739 Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19 https://ClinicalTrials.gov/show/NCT04613739
NCT04614025 Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04614025
NCT04614012 Hyperimmune Plasma for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04614012
NCT04613050 Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients https://ClinicalTrials.gov/show/NCT04613050
NCT04613310 PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04613310
NCT04613271 Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia https://ClinicalTrials.gov/show/NCT04613271
NCT04612972 Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru https://ClinicalTrials.gov/show/NCT04612972
NCT04611399 MIND-VR: Virtual Reality for COVID-19 Operators’ Psychological Support https://ClinicalTrials.gov/show/NCT04611399
NCT04611256 Mesenchymal Stem Cells in Patients Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04611256
NCT04610567 Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19) https://ClinicalTrials.gov/show/NCT04610567
NCT04610541 REMdesivir-HU Clinical Study and Severe Covid-19 Patients https://ClinicalTrials.gov/show/NCT04610541
NCT04605887 Angiotensin 1-7 as a Therapy in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04605887
NCT04610502 Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04610502
NCT04609969 Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test https://ClinicalTrials.gov/show/NCT04609969
NCT04610489 Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04610489
NCT04609865 Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT04609865
NCT04609722 Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04609722
NCT04609462 High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure. https://ClinicalTrials.gov/show/NCT04609462
NCT04609371 PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics https://ClinicalTrials.gov/show/NCT04609371
NCT04608305 Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine https://ClinicalTrials.gov/show/NCT04608305
NCT04608201 Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04608201
NCT04608097 Understanding Reactions to Emotional Material in the Media During COVID-19 https://ClinicalTrials.gov/show/NCT04608097
NCT04608266 CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients https://ClinicalTrials.gov/show/NCT04608266
NCT04606563 Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection? https://ClinicalTrials.gov/show/NCT04606563
NCT04607915 Technology-enabled Collaborative Care for Diabetes Management During COVID-19 https://ClinicalTrials.gov/show/NCT04607915
NCT04606784 Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress https://ClinicalTrials.gov/show/NCT04606784
NCT04605588 A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19 https://ClinicalTrials.gov/show/NCT04605588
NCT04604743 Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama https://ClinicalTrials.gov/show/NCT04604743
NCT04604704 Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome https://ClinicalTrials.gov/show/NCT04604704
NCT04604977 Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine https://ClinicalTrials.gov/show/NCT04604977
NCT04604184 ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19 https://ClinicalTrials.gov/show/NCT04604184
NCT04604145 Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCR https://ClinicalTrials.gov/show/NCT04604145
NCT04604327 Comparison of Two Different Doses of Bemiparin in COVID-19 https://ClinicalTrials.gov/show/NCT04604327
NCT04604223 Effect of Pioglitazone on T2DM Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04604223
NCT04603963 Inspiratory Muscle Training in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04603963
NCT04603729 Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease https://ClinicalTrials.gov/show/NCT04603729
NCT04603924 Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04603924
NCT04602832 Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19 https://ClinicalTrials.gov/show/NCT04602832
NCT04603794 Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19 https://ClinicalTrials.gov/show/NCT04603794
NCT04602949 Detection of COVID-19 Using Breath Analysis - Validation Study https://ClinicalTrials.gov/show/NCT04602949
NCT04602871 Early Detection of COVID-19 Using Breath Analysis - Feasibility Study https://ClinicalTrials.gov/show/NCT04602871
NCT04603781 CBD Oil for Reducing Emotional Impact of COVID-19 https://ClinicalTrials.gov/show/NCT04603781
NCT04602442 Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia https://ClinicalTrials.gov/show/NCT04602442
NCT04600440 Convalescent Plasma in the Treatment of Covid-19 https://ClinicalTrials.gov/show/NCT04600440
NCT04601077 The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American and Hispanic Origin https://ClinicalTrials.gov/show/NCT04601077
NCT04600999 Clinical Trial of Favipiravir Treatment of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04600999
NCT04600141 Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04600141
NCT04599959 COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR https://ClinicalTrials.gov/show/NCT04599959
NCT04598594 Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients https://ClinicalTrials.gov/show/NCT04598594
NCT04598581 Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19 https://ClinicalTrials.gov/show/NCT04598581
NCT04597047 Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test https://ClinicalTrials.gov/show/NCT04597047
NCT04597034 Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19 https://ClinicalTrials.gov/show/NCT04597034
NCT04596839 Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04596839
NCT04596085 Study to Evaluate Efficacy and Safety of “VIRACIDE” IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04596085
NCT04595136 Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient https://ClinicalTrials.gov/show/NCT04595136
NCT04595084 Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use https://ClinicalTrials.gov/show/NCT04595084
NCT04594668 Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency https://ClinicalTrials.gov/show/NCT04594668
NCT04595097 Inspiratory Muscle Training in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04595097
NCT04593641 This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04593641
NCT04594330 Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04594330
NCT04594343 Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04594343
NCT04593433 A 3-month Cycle of Virtual Guided Tours to Promote Health in Older Community Members in a Context of COVID-19 Induced Social Isolation: a Pilot Study https://ClinicalTrials.gov/show/NCT04593433
NCT04592549 Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04592549
NCT04593069 The COGCOV Study in ICU Patients https://ClinicalTrials.gov/show/NCT04593069
NCT04591717 COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers https://ClinicalTrials.gov/show/NCT04591717
NCT04592354 Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors https://ClinicalTrials.gov/show/NCT04592354
NCT04591158 COVID-19 and Lung Ultrasound Utility https://ClinicalTrials.gov/show/NCT04591158
NCT04591613 Late Clinical Events Associated With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04591613
NCT04591210 The COVID-RASi Trial (COVID-19) https://ClinicalTrials.gov/show/NCT04591210
NCT04591184 A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults https://ClinicalTrials.gov/show/NCT04591184
NCT04591600 Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients https://ClinicalTrials.gov/show/NCT04591600
NCT04590469 Improving Wellbeing and Health for Care Home Residents During COVID-19 https://ClinicalTrials.gov/show/NCT04590469
NCT04589936 Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care https://ClinicalTrials.gov/show/NCT04589936
NCT04589949 Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study) https://ClinicalTrials.gov/show/NCT04589949
NCT04590053 Allocetra-OTS in COVID-19, Phase II https://ClinicalTrials.gov/show/NCT04590053
NCT04589104 Expressive Writing for COVID-19 Resilience https://ClinicalTrials.gov/show/NCT04589104
NCT04590430 Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04590430
NCT04587414 eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19 https://ClinicalTrials.gov/show/NCT04587414
NCT04588415 Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04588415
NCT04588792 Furosemide as Supportive Therapy for COVID-19 Respiratory Failure https://ClinicalTrials.gov/show/NCT04588792
NCT04587921 Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19 https://ClinicalTrials.gov/show/NCT04587921
NCT04587219 The Study of “Gam-COVID-Vac” Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older https://ClinicalTrials.gov/show/NCT04587219
NCT04584710 A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults https://ClinicalTrials.gov/show/NCT04584710
NCT04586153 Study to Assess the Effect of Meplazumab on COVID-19 https://ClinicalTrials.gov/show/NCT04586153
NCT04579393 Fostamatinib for Hospitalized Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04579393
NCT04584580 D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04584580
NCT04584541 SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism https://ClinicalTrials.gov/show/NCT04584541
NCT04584593 Pilot Study to Detect SARS-CoV-2 Virus in Sperm https://ClinicalTrials.gov/show/NCT04584593
NCT04583189 Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department https://ClinicalTrials.gov/show/NCT04583189
NCT04582318 A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04582318
NCT04583410 Efficacy of Nicotine in Preventing COVID-19 Infection https://ClinicalTrials.gov/show/NCT04583410
NCT04583449 Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04583449
NCT04582344 Clinical Trial For SARS-CoV-2 Vaccine (COVID-19) https://ClinicalTrials.gov/show/NCT04582344
NCT04582214 Oscillation and Lung Expansion Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04582214
NCT04581915 PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 https://ClinicalTrials.gov/show/NCT04581915
NCT04581954 Inflammatory Signal Inhibitors for COVID-19 (MATIS) https://ClinicalTrials.gov/show/NCT04581954
NCT04581811 Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS) https://ClinicalTrials.gov/show/NCT04581811
NCT04581746 Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2) https://ClinicalTrials.gov/show/NCT04581746
NCT04581031 COntinuous Signs Monitoring In Covid-19 Patients https://ClinicalTrials.gov/show/NCT04581031
NCT04581291 The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial https://ClinicalTrials.gov/show/NCT04581291
NCT04581161 Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04581161
NCT04581018 An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04581018
NCT04579640 Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections https://ClinicalTrials.gov/show/NCT04579640
NCT04578158 Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04578158
NCT04578210 Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia https://ClinicalTrials.gov/show/NCT04578210
NCT04577534 COVID-19: Salvage TOcilizumab as a Rescue Measure https://ClinicalTrials.gov/show/NCT04577534
NCT04577235 Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores. https://ClinicalTrials.gov/show/NCT04577235
NCT04576728 Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04576728
NCT04576312 Safety of Ascending Doses of Niclosamide (UNI911 INHALATION) in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04576312
NCT04575584 Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001) https://ClinicalTrials.gov/show/NCT04575584
NCT04575038 CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19 https://ClinicalTrials.gov/show/NCT04575038
NCT04575064 An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY https://ClinicalTrials.gov/show/NCT04575064
NCT04570254 Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04570254
NCT04574219 Virtual Parental Presence on Induction https://ClinicalTrials.gov/show/NCT04574219
NCT04573153 Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04573153
NCT04573270 Mesenchymal Stem Cells for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04573270
NCT04572412 Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04572412
NCT04572360 Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04572360
NCT04570488 Predicting Favorable Outcomes in Hospitalized Covid-19 Patients https://ClinicalTrials.gov/show/NCT04570488
NCT04570397 Ravulizumab and COVID-19 https://ClinicalTrials.gov/show/NCT04570397
NCT04573764 Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04573764
NCT04573361 Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain https://ClinicalTrials.gov/show/NCT04573361
NCT04570202 Health cAre woRkers exposeD to COVID-19 https://ClinicalTrials.gov/show/NCT04570202
NCT04569877 GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04569877
NCT04569825 Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease https://ClinicalTrials.gov/show/NCT04569825
NCT04568811 The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04568811
NCT04569188 Convalescent Plasma in COVID-19 Elderly Patients https://ClinicalTrials.gov/show/NCT04569188
NCT04568525 Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs https://ClinicalTrials.gov/show/NCT04568525
NCT04568707 Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES) https://ClinicalTrials.gov/show/NCT04568707
NCT04568889 Minnesota COVID-19 Testing Project https://ClinicalTrials.gov/show/NCT04568889
NCT04569227 Prevention of COVID-19 Infection to Severe Pneumonia or ARDS https://ClinicalTrials.gov/show/NCT04569227
NCT04568863 Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19 https://ClinicalTrials.gov/show/NCT04568863
NCT04568876 Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04568876
NCT04567810 Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19) https://ClinicalTrials.gov/show/NCT04567810
NCT04567953 COVID-19 Tests With Saliva Specimens https://ClinicalTrials.gov/show/NCT04567953
NCT04568356 A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests https://ClinicalTrials.gov/show/NCT04568356
NCT04566770 A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) https://ClinicalTrials.gov/show/NCT04566770
NCT04567173 Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04567173
NCT04565509 Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04565509
NCT04564716 Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus https://ClinicalTrials.gov/show/NCT04564716
NCT04563676 Physiopathology and Sequelae of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04563676
NCT04563650 COVID-19 Serology and Immunosenescence https://ClinicalTrials.gov/show/NCT04563650
NCT04565197 Convalescent Plasma Therapy for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04565197
NCT04563702 Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04563702
NCT04563689 Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04563689
NCT04563208 Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19 https://ClinicalTrials.gov/show/NCT04563208
NCT04563065 Active Pregnancy Against COVID-19 https://ClinicalTrials.gov/show/NCT04563065
NCT04561219 Nitazoxanide Therapy for Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04561219
NCT04561154 Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV https://ClinicalTrials.gov/show/NCT04561154
NCT04560205 Tocilizumab in COVID-19 Lahore General Hospital https://ClinicalTrials.gov/show/NCT04560205
NCT04560257 High Flow Nasal Cannula HFNC In Covid-19 Patients https://ClinicalTrials.gov/show/NCT04560257
NCT04561063 COVID-19 Prophylaxis South Africa (COVER HCW) https://ClinicalTrials.gov/show/NCT04561063
NCT04560231 Remdesivir in COVID-19 Lahore General Hospital https://ClinicalTrials.gov/show/NCT04560231
NCT04559113 Methylprednisolone in COVID-19 Patients (Methyl19LGH) https://ClinicalTrials.gov/show/NCT04559113
NCT04559074 Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04559074
NCT04558021 A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19 https://ClinicalTrials.gov/show/NCT04558021
NCT04558372 Genosvid Diagnostic Test for Early Detection of COVID-19 https://ClinicalTrials.gov/show/NCT04558372
NCT04558476 Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04558476
NCT04558463 The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19 https://ClinicalTrials.gov/show/NCT04558463
NCT04558411 Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students https://ClinicalTrials.gov/show/NCT04558411
NCT04557046 Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test https://ClinicalTrials.gov/show/NCT04557046
NCT04557241 Brief Informational Intervention for COVID-19 Misinformation Prophylaxis https://ClinicalTrials.gov/show/NCT04557241
NCT04557605 Effects of a Face Mask on Oxygenation During Exercise https://ClinicalTrials.gov/show/NCT04557605
NCT04555213 A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04555213
NCT04555148 COVIDIG (COVID-19 Hyper-ImmunoGlobulin) https://ClinicalTrials.gov/show/NCT04555148
NCT04555096 A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 https://ClinicalTrials.gov/show/NCT04555096
NCT04554992 Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019) https://ClinicalTrials.gov/show/NCT04554992
NCT04555005 Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19 https://ClinicalTrials.gov/show/NCT04555005
NCT04554264 Complicated Grief in ICU in the Aftermath of COVID-19 https://ClinicalTrials.gov/show/NCT04554264
NCT04553705 Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19) https://ClinicalTrials.gov/show/NCT04553705
NCT04552951 Effect of Vitamin D on Morbidity and Mortality of the COVID-19 https://ClinicalTrials.gov/show/NCT04552951
NCT04552366 A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults https://ClinicalTrials.gov/show/NCT04552366
NCT04552483 Effects of Early Use of Nitazoxanide in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04552483
NCT04552379 The Containing Coronavirus Disease 19 (COVID-19) Trial https://ClinicalTrials.gov/show/NCT04552379
NCT04550325 Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 https://ClinicalTrials.gov/show/NCT04550325
NCT04536376 First Responder Resiliency Program During COVID-19 https://ClinicalTrials.gov/show/NCT04536376
NCT04551547 Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04551547
NCT04550351 Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old) https://ClinicalTrials.gov/show/NCT04550351
NCT04551768 Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19 https://ClinicalTrials.gov/show/NCT04551768
NCT04551781 Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT04551781
NCT04551339 Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 https://ClinicalTrials.gov/show/NCT04551339
NCT04549922 Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19 https://ClinicalTrials.gov/show/NCT04549922
NCT04549337 Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19 https://ClinicalTrials.gov/show/NCT04549337
NCT04548934 Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19-pandemic https://ClinicalTrials.gov/show/NCT04548934
NCT04547283 Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04547283
NCT04548531 Engaging Patients in Colon Cancer Screening Decisions During COVID-19 https://ClinicalTrials.gov/show/NCT04548531
NCT04548544 A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19 https://ClinicalTrials.gov/show/NCT04548544
NCT04547660 Convalescent Plasma for Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04547660
NCT04547634 Telerehabilitation in Oncology Patients https://ClinicalTrials.gov/show/NCT04547634
NCT04545060 VIR-7831 for the Early Treatment of COVID-19 in Outpatients https://ClinicalTrials.gov/show/NCT04545060
NCT04546581 Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) https://ClinicalTrials.gov/show/NCT04546581
NCT04545541 Nebulised Heparin in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04545541
NCT04547127 A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04547127
NCT04545749 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04545749
NCT04543760 Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19 https://ClinicalTrials.gov/show/NCT04543760
NCT04542447 To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04542447
NCT04542941 Assessment of Safety and Efficacy of CCP https://ClinicalTrials.gov/show/NCT04542941
NCT04542967 Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04542967
NCT04542343 COVID-19 Risk Reduction Among African American Parishioners https://ClinicalTrials.gov/show/NCT04542343
NCT04542330 Using BCG to Protect Senior Citizens During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04542330
NCT04542213 Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04542213
NCT04542694 Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04542694
NCT04542993 Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy https://ClinicalTrials.gov/show/NCT04542993
NCT04542876 Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection https://ClinicalTrials.gov/show/NCT04542876
NCT04542395 COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents https://ClinicalTrials.gov/show/NCT04542395
NCT04541680 Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT04541680
NCT04541485 To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines) https://ClinicalTrials.gov/show/NCT04541485
NCT04540419 Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19 https://ClinicalTrials.gov/show/NCT04540419
NCT04540185 A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 https://ClinicalTrials.gov/show/NCT04540185
NCT04540406 NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients https://ClinicalTrials.gov/show/NCT04540406
NCT04539626 Estrogen Therapy in Non-severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04539626
NCT04539262 Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation https://ClinicalTrials.gov/show/NCT04539262
NCT04539821 Virtual Pain Care Management (COVID-19) https://ClinicalTrials.gov/show/NCT04539821
NCT04537962 Salivary SARS-CoV-2 Load of Covid-19 Patients After Oral Antimicrobial Solutions and Dentifrices https://ClinicalTrials.gov/show/NCT04537962
NCT04537351 The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause https://ClinicalTrials.gov/show/NCT04537351
NCT04537663 Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults https://ClinicalTrials.gov/show/NCT04537663
NCT04537858 Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19 https://ClinicalTrials.gov/show/NCT04537858
NCT04536935 Mobile Mental Health Apps for Suicide Prevention https://ClinicalTrials.gov/show/NCT04536935
NCT04536441 Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order https://ClinicalTrials.gov/show/NCT04536441
NCT04536298 Vitamin D and COVID-19 Trial https://ClinicalTrials.gov/show/NCT04536298
NCT04536051 A Study of a Candidate COVID-19 Vaccine (COV003) https://ClinicalTrials.gov/show/NCT04536051
NCT04535778 COMPASS Study: an Online Cognitive-behavioural Therapy (CBT) Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04535778
NCT04535869 Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04535869
NCT04535856 Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04535856
NCT04535167 First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19. https://ClinicalTrials.gov/show/NCT04535167
NCT04535700 Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19 https://ClinicalTrials.gov/show/NCT04535700
NCT04535063 Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04535063
NCT04534790 Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04534790
NCT04534725 COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; https://ClinicalTrials.gov/show/NCT04534725
NCT04531618 Mother-infant Bonding During COVID-19 https://ClinicalTrials.gov/show/NCT04531618
NCT04533399 A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults https://ClinicalTrials.gov/show/NCT04533399
NCT04531774 RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19 https://ClinicalTrials.gov/show/NCT04531774
NCT04533347 Tafenoquine in Patients With Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04533347
NCT04532931 COVID-19 Treatment in South Africa https://ClinicalTrials.gov/show/NCT04532931
NCT04532372 Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy https://ClinicalTrials.gov/show/NCT04532372
NCT04530396 Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04530396
NCT04530578 Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19 https://ClinicalTrials.gov/show/NCT04530578
NCT04530435 PEP Flute-selfcare in COVID-19 https://ClinicalTrials.gov/show/NCT04530435
NCT04530448 Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization https://ClinicalTrials.gov/show/NCT04530448
NCT04530422 Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment https://ClinicalTrials.gov/show/NCT04530422
NCT04530617 Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients https://ClinicalTrials.gov/show/NCT04530617
NCT04530656 Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell) https://ClinicalTrials.gov/show/NCT04530656
NCT04530136 Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04530136
NCT04530370 Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients https://ClinicalTrials.gov/show/NCT04530370
NCT04530357 Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04530357
NCT04528641 GRAd-COV2 Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04528641
NCT04529525 Ivermectin to Prevent Hospitalizations in COVID-19 https://ClinicalTrials.gov/show/NCT04529525
NCT04528888 Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection https://ClinicalTrials.gov/show/NCT04528888
NCT04528368 Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support https://ClinicalTrials.gov/show/NCT04528368
NCT04528329 Anosmia and / or Ageusia and Early Corticosteroid Use https://ClinicalTrials.gov/show/NCT04528329
NCT04527562 Colchicine in Moderate Symptomatic COVID-19 Patients https://ClinicalTrials.gov/show/NCT04527562
NCT04527354 Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04527354
NCT04527471 Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04527471
NCT04527432 COVID-19 Health Professional Impact Study https://ClinicalTrials.gov/show/NCT04527432
NCT04527575 Study of the Safety, Reactogenicity and Immunogenicity of “EpiVacCorona” Vaccine for the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04527575
NCT05139979 Yogic Breathing and Guided Meditation for Long Covid Symptoms https://ClinicalTrials.gov/show/NCT05139979
NCT05121701 Covid-19 Pandemic and Use of Video Laryngoscopy https://ClinicalTrials.gov/show/NCT05121701
NCT05139433 Brief Internet-delivered Intervention for Children and Adolescents With Anxiety and Depression Symptoms https://ClinicalTrials.gov/show/NCT05139433
NCT05108584 Intubation in Coronavirus Disease 19 With Level 3 PPE https://ClinicalTrials.gov/show/NCT05108584
NCT05107479 Effectiveness of Interactive Voice Response for COVID-19 Vaccination Training in the Democratic Republic of the Congo https://ClinicalTrials.gov/show/NCT05107479
NCT04844658 Covid-19, Hospitalized, PatIents, Nasafytol https://ClinicalTrials.gov/show/NCT04844658
NCT05080179 Impact of Nudges on Downloads of COVID-19 Exposure Notification Smartphone Apps: A Randomized Trial https://ClinicalTrials.gov/show/NCT05080179
NCT04432272 ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS) https://ClinicalTrials.gov/show/NCT04432272
NCT05047601 A Post-Exposure Prophylaxis Study of PF-07321332/Ritonavir in Adult Household Contacts of an Individual With Symptomatic COVID-19 https://ClinicalTrials.gov/show/NCT05047601
NCT04583969 ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04583969
NCT04426695 Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04426695
NCT04412486 COVID-19 Convalescent Plasma (CCP) Transfusion https://ClinicalTrials.gov/show/NCT04412486
NCT04516746 Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04516746
NCT04360096 Inhaled ZYESAMIâ„¢ (Aviptadil Acetate) for the Treatment of Severe COVID-19 https://ClinicalTrials.gov/show/NCT04360096
NCT04389294 HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists https://ClinicalTrials.gov/show/NCT04389294
NCT04361344 Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection https://ClinicalTrials.gov/show/NCT04361344
NCT05142319 Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC] https://ClinicalTrials.gov/show/NCT05142319
NCT05142514 Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2) https://ClinicalTrials.gov/show/NCT05142514
NCT05142488 Study of Immunogenicity Equivalence of a Homologous Third Dose of Covid-19 (Recombinante) Vaccine https://ClinicalTrials.gov/show/NCT05142488
NCT05141058 T CELL THERAPY OPPOSING NOVEL COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS https://ClinicalTrials.gov/show/NCT05141058
NCT04912921 Effect of Palmitoylethanolamide on Proinflammatory Markers in Adults Recently Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04912921
NCT05017493 Treatment of Covid-19 With a Herbal Compound, Xagrotin https://ClinicalTrials.gov/show/NCT05017493
NCT05060978 Evaluation of the Effect of Two Online Interventions -Watch Your Weight During the Holidays Program and the Relative 5:2 Fasting- for the Prevention of Body Weight Gain at 8 Weeks in Mexican Adults in the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT05060978
NCT05040763 Abbott ID NOW COVID-19 https://ClinicalTrials.gov/show/NCT05040763
NCT04590365 Carrageenan Nasal Spray for COVID-19 Prophylaxis https://ClinicalTrials.gov/show/NCT04590365
NCT04678843 Adapting and Adopting Highly Specialized Pediatric Eating Disorder Treatment to Virtual Care: Implementation Research for the COVID-19 Context and Beyond https://ClinicalTrials.gov/show/NCT04678843
NCT04374149 Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS https://ClinicalTrials.gov/show/NCT04374149
NCT04479358 Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04479358
NCT04363463 Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress https://ClinicalTrials.gov/show/NCT04363463
NCT04348500 Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04348500
NCT04347941 Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE https://ClinicalTrials.gov/show/NCT04347941

Observational Studies

nct_id brief_title link
NCT04474496 Impact of COVID-19 on Marshallese Communities in the U.S. https://ClinicalTrials.gov/show/NCT04474496
NCT04431908 Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects https://ClinicalTrials.gov/show/NCT04431908
NCT04425850 USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 https://ClinicalTrials.gov/show/NCT04425850
NCT04425863 Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19 https://ClinicalTrials.gov/show/NCT04425863
NCT04385238 Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04385238
NCT05175963 Surveillance Among Healthcare Workers for SARS-Coronavirus-2 Infection https://ClinicalTrials.gov/show/NCT05175963
NCT05175859 Timing of Tracheostomy in COVID-19 - Impact on Mortality https://ClinicalTrials.gov/show/NCT05175859
NCT05156593 ‘Long COVID-19’ in Suffolk and North Essex: Defining the Disease and Optimising Outcomes https://ClinicalTrials.gov/show/NCT05156593
NCT05175339 Long-term Impact in Intensive Care Survivors of Coronavirus Disease-19 (AFTERCOR) https://ClinicalTrials.gov/show/NCT05175339
NCT05167305 The Second COVID-19 Wave: Collateral Impact on Patients of Liver Disease https://ClinicalTrials.gov/show/NCT05167305
NCT05144178 Insight Into the UAE Experience With Monoclonal Antibodies (Sotrovimab ) https://ClinicalTrials.gov/show/NCT05144178
NCT05078905 Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases https://ClinicalTrials.gov/show/NCT05078905
NCT05052307 A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in Brazil https://ClinicalTrials.gov/show/NCT05052307
NCT04924842 COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2) https://ClinicalTrials.gov/show/NCT04924842
NCT05017441 TOcilizumab and Covid-19 : Risk of Severe INfection https://ClinicalTrials.gov/show/NCT05017441
NCT04689724 Covid-19 Airway Management https://ClinicalTrials.gov/show/NCT04689724
NCT04752085 Prognosis and Course of COVID-19 Infection in Hospitalised Patients https://ClinicalTrials.gov/show/NCT04752085
NCT04653844 RT-PCR Database Analysis for COVID-19 Infections and Re-infection https://ClinicalTrials.gov/show/NCT04653844
NCT04414059 Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients https://ClinicalTrials.gov/show/NCT04414059
NCT04362865 Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection https://ClinicalTrials.gov/show/NCT04362865
NCT04361019 Physical Activity in University Students Around COVID-19 Confinement https://ClinicalTrials.gov/show/NCT04361019
NCT05178264 Transverse Myelitis Related to SARS-CoV-2 Vaccines https://ClinicalTrials.gov/show/NCT05178264
NCT05178251 Impact of SARS-Cov2 Pandemic on Severity of Perioperative Complications in Patients Undergoing Appendectomy https://ClinicalTrials.gov/show/NCT05178251
NCT05133648 Anesthesia Technique in COVID-19 Positive Hip Fracture Patients https://ClinicalTrials.gov/show/NCT05133648
NCT05075018 Musculoskeletal Problems and Endurance in Healthcare Professionals With and Without COVID-19 https://ClinicalTrials.gov/show/NCT05075018
NCT05181696 Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT05181696
NCT04716972 Evaluating the Impact of COVID-19 (Coronavirus) on Research in Care Homes https://ClinicalTrials.gov/show/NCT04716972
NCT04588363 COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C https://ClinicalTrials.gov/show/NCT04588363
NCT04525911 Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital https://ClinicalTrials.gov/show/NCT04525911
NCT05186597 Incidence of MIS-C Following SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT05186597
NCT05186571 Myopericarditis After mRNA COVID-19 Vaccination in Children 5-11 Years Old https://ClinicalTrials.gov/show/NCT05186571
NCT05185674 Sociodemographic, Clinical, Quality of Life and Health Care Conditions in COVID-19 Survivors. https://ClinicalTrials.gov/show/NCT05185674
NCT05162508 Impact of COVID-19 SARS-CoV-2 Variability in ICU Hospitalized Patients With Severe Disease https://ClinicalTrials.gov/show/NCT05162508
NCT05148793 N95 Reuse During COVID-19 https://ClinicalTrials.gov/show/NCT05148793
NCT05114967 Preoperative Anxiety During COVID-19 https://ClinicalTrials.gov/show/NCT05114967
NCT05069662 Impact of the COVID-19 Pandemic on Drug Use and Monitoring of Cancer Patients https://ClinicalTrials.gov/show/NCT05069662
NCT04957953 Pregnant Women Vaccinated Against Covid-19. https://ClinicalTrials.gov/show/NCT04957953
NCT04668170 Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management https://ClinicalTrials.gov/show/NCT04668170
NCT04623138 A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections https://ClinicalTrials.gov/show/NCT04623138
NCT04384419 Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic) https://ClinicalTrials.gov/show/NCT04384419
NCT04354584 Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04354584
NCT05188690 Polyneuropathy and COVID-19 https://ClinicalTrials.gov/show/NCT05188690
NCT05188651 Effect of FFP2 Masks on Peripheral Oxygen Saturation and Pulse Rate During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT05188651
NCT05188443 Radiological Imaging in Patients Tested for COVID-19 https://ClinicalTrials.gov/show/NCT05188443
NCT04422262 Analysis of Long Term Risk of Coronavirus Disease-19 Emergency https://ClinicalTrials.gov/show/NCT04422262
NCT05191433 Effects of Mechanical Ventilation on the Diaphragm in COVID-19 Intensive Care Patients. A Post-mortem Pathology Study https://ClinicalTrials.gov/show/NCT05191433
NCT05191407 Fear and Anxiety Level in Dental Patients During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT05191407
NCT04846907 Mental Health of Professionals Working in Pediatric Intensive Care Units During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04846907
NCT04748172 COVID-19 Vaccine and Ovarian Reserve https://ClinicalTrials.gov/show/NCT04748172
NCT04565067 Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans https://ClinicalTrials.gov/show/NCT04565067
NCT05171933 Stress Factors and Vaccine Attitudes Among Dental Students During COVID-19 https://ClinicalTrials.gov/show/NCT05171933
NCT05076266 COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation https://ClinicalTrials.gov/show/NCT05076266
NCT04916847 Comparative Analysis of Anti-COVID-19 (Severe Acute Respiratory Syndrome) Humoral and Memory T Cell Responses in Children With Various Degrees of Immunosuppression: https://ClinicalTrials.gov/show/NCT04916847
NCT04871165 Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals https://ClinicalTrials.gov/show/NCT04871165
NCT04830852 Pediatric COVID Outcomes Study (PECOS) https://ClinicalTrials.gov/show/NCT04830852
NCT04652505 Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study https://ClinicalTrials.gov/show/NCT04652505
NCT04581044 Impact of COVID-19 on Psoriasis Practice https://ClinicalTrials.gov/show/NCT04581044
NCT04573062 Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health https://ClinicalTrials.gov/show/NCT04573062
NCT04367740 ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 https://ClinicalTrials.gov/show/NCT04367740
NCT04320511 Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2 https://ClinicalTrials.gov/show/NCT04320511
NCT04838106 Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales https://ClinicalTrials.gov/show/NCT04838106
NCT04832841 IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation (TASMANIA) https://ClinicalTrials.gov/show/NCT04832841
NCT04503525 Nutritional Assessment of Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04503525
NCT04501432 Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19 https://ClinicalTrials.gov/show/NCT04501432
NCT04401449 Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons https://ClinicalTrials.gov/show/NCT04401449
NCT04379063 COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress https://ClinicalTrials.gov/show/NCT04379063
NCT05145751 SARS CoV-2 Infection and Inflammatory Biomarkers https://ClinicalTrials.gov/show/NCT05145751
NCT05143333 Cognitive Assessment in COVID-19 Positive Patients Using the DANA App https://ClinicalTrials.gov/show/NCT05143333
NCT05119530 POC Study to Evaluate the Performance of the AcuVid COVID-19 Rapid Antigen Saliva Test https://ClinicalTrials.gov/show/NCT05119530
NCT05057936 Antibody After COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT05057936
NCT04743947 Vaccination Against COVID-19 in Chronic Kidney Disease https://ClinicalTrials.gov/show/NCT04743947
NCT04692129 Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients https://ClinicalTrials.gov/show/NCT04692129
NCT04635787 Vital Sensor Monitors for CV19 Detection https://ClinicalTrials.gov/show/NCT04635787
NCT04370119 Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers https://ClinicalTrials.gov/show/NCT04370119
NCT04347408 Seroprevalence of SARS-Cov-2 Antibodies in Children https://ClinicalTrials.gov/show/NCT04347408
NCT05124509 Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant https://ClinicalTrials.gov/show/NCT05124509
NCT05096091 International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE) https://ClinicalTrials.gov/show/NCT05096091
NCT04636203 Burden of COVID-19 Infection in Populations With High or Low Risk of Infection https://ClinicalTrials.gov/show/NCT04636203
NCT04455451 Intensive Care Therapy of Covid-19 Disease in Germany https://ClinicalTrials.gov/show/NCT04455451
NCT04343898 Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04343898
NCT05031988 Determinants of Physical Activity and Mental Health During and After Covid-19 Lockdown https://ClinicalTrials.gov/show/NCT05031988
NCT04766788 Studying Students at Risk for COVID-19 https://ClinicalTrials.gov/show/NCT04766788
NCT04582266 PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US https://ClinicalTrials.gov/show/NCT04582266
NCT04466371 Perceptions of Undergraduate Students and Teaching Staff on Online Teaching https://ClinicalTrials.gov/show/NCT04466371
NCT05158790 Impact of Covid-19 on Training for ENT and Cervico-Facial Surgery Residents in France https://ClinicalTrials.gov/show/NCT05158790
NCT04369807 Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04369807
NCT05197699 Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)-Related Multiple Sclerosis (MS) Vaccination Study https://ClinicalTrials.gov/show/NCT05197699
NCT05197660 Routine Surgical Procedures During COVID-19 Pandemic: a French Nationwide Cohort Study https://ClinicalTrials.gov/show/NCT05197660
NCT05197634 The Impact of Covid-19 Pandemic On The Children With Autism Spectrum Disorder https://ClinicalTrials.gov/show/NCT05197634
NCT05197621 The Impact of COVID-19 on Maternal and Neonatal Outcomes https://ClinicalTrials.gov/show/NCT05197621
NCT05196477 Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT05196477
NCT05195736 Predicting COVID-19 Patients’ Clinical Outcomes Using ICU Mobility Scale and MRC Sumscore https://ClinicalTrials.gov/show/NCT05195736
NCT05195216 Psychosocial Factors and Quality of Life in the Effect of Fear of COVID-19 With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT05195216
NCT05195060 TURN-COVID Biobank: The Dutch Cohort Study for the Evaluation of the Use of Neutralizing Monoclonal Antibodies and Other Antiviral Agents Against SARS-CoV-2 https://ClinicalTrials.gov/show/NCT05195060
NCT05193526 COronaVirus Induced Acute Respiratory Disease Syndrome During PREGnancy https://ClinicalTrials.gov/show/NCT05193526
NCT05115097 AI Evaluation of COVID-19 Sounds (AI-EChOS) https://ClinicalTrials.gov/show/NCT05115097
NCT05172154 GlowTest COVID-19 Antigen Home Test Kit Usability Study https://ClinicalTrials.gov/show/NCT05172154
NCT05172076 COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor-2 https://ClinicalTrials.gov/show/NCT05172076
NCT05172024 Understanding the Long-term Impact of COVID-19 in Adults https://ClinicalTrials.gov/show/NCT05172024
NCT05074758 Characterization of the microVAScular Dysfunction in Covid-19 ARDS https://ClinicalTrials.gov/show/NCT05074758
NCT04885452 Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU (‘Autorisation Temporaire d’Utilisation’). A Prospectvie Cohort. https://ClinicalTrials.gov/show/NCT04885452
NCT04894760 Evaluation of a COVID-19 Rapid Diagnostic Test in ER Departments in Mexico: a Multi-center Study https://ClinicalTrials.gov/show/NCT04894760
NCT04786197 Detection of SARS-CoV-2 (COVID-19) by SERS Spectroscopy Combined With Artificial Intelligence https://ClinicalTrials.gov/show/NCT04786197
NCT04813731 COVID-19 And Lingering Symptoms In Primary Care Patients https://ClinicalTrials.gov/show/NCT04813731
NCT04686734 Long-term Effects of COVID-19 in Adolescents https://ClinicalTrials.gov/show/NCT04686734
NCT04624997 Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection https://ClinicalTrials.gov/show/NCT04624997
NCT04616950 Impact of the COVID-19 Epidemic on the Hospital Journey of Patients With Cancer of the Digestive System https://ClinicalTrials.gov/show/NCT04616950
NCT04505605 Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04505605
NCT04468412 Influence of COVID-19 on Vascular Endothelial Function https://ClinicalTrials.gov/show/NCT04468412
NCT04331886 An Observational Study of Patients With Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04331886
NCT05198453 Impact of Vaccination in Acute COVID-19 https://ClinicalTrials.gov/show/NCT05198453
NCT05198414 SER+ Against COVID-19 - Interventions to Strengthen the Resilience of HCWs in Ecuador https://ClinicalTrials.gov/show/NCT05198414
NCT05175820 COVID-19 and Working Conditions of Dentists https://ClinicalTrials.gov/show/NCT05175820
NCT05031468 Multisite Observational Maternal and Infant Study for COVID-19 https://ClinicalTrials.gov/show/NCT05031468
NCT05121428 Patients’ Attitudes Toward and Experiences With Buprenorphine Treatment https://ClinicalTrials.gov/show/NCT05121428
NCT05119400 COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes https://ClinicalTrials.gov/show/NCT05119400
NCT05084755 VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Subjects With Underlying Disease at High-risk for Worsening COVID-19 https://ClinicalTrials.gov/show/NCT05084755
NCT04742569 Wearable Diagnostic for Detection of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04742569
NCT04689711 Prognostic Models for COVID-19 Care https://ClinicalTrials.gov/show/NCT04689711
NCT04523051 Rehabilitation After Admission in Intensive Care Unit for COVID-19 https://ClinicalTrials.gov/show/NCT04523051
NCT04445493 EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic ( EPISODEPSCOVID ) https://ClinicalTrials.gov/show/NCT04445493
NCT05200819 Incidence and Predictors of Acute and Chronic Complications in Patients With Diabetes and Severe COVID-19 https://ClinicalTrials.gov/show/NCT05200819
NCT05200767 Physical Activity and the Course of COVID-19 https://ClinicalTrials.gov/show/NCT05200767
NCT05125913 Long Term Cardio-Vascular Risk Assessment in CKD and Kidney Transplanted Patients Following SARS-COV-2 https://ClinicalTrials.gov/show/NCT05125913
NCT04934215 Evaluation of Post-vaccination Anti-SARS-CoV-2 Serological Response in Health Care Workers With a History of COVID-19. https://ClinicalTrials.gov/show/NCT04934215
NCT04561102 Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population https://ClinicalTrials.gov/show/NCT04561102
NCT04561089 Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel https://ClinicalTrials.gov/show/NCT04561089
NCT04411147 A Longitudinal Study of COVID-19 Sequelae and Immunity https://ClinicalTrials.gov/show/NCT04411147
NCT05206240 Extracorporeal Shock Wave Therapy and Assessment Strategy Through a Novel Gait Analysis Tool for Post-stroke Spasticity https://ClinicalTrials.gov/show/NCT05206240
NCT05184166 Hospital Management and 1-year Outcome of Patients Aged 70 Years and Older With Severe COVID-19 https://ClinicalTrials.gov/show/NCT05184166
NCT05204537 The Role of Surgery in Patients With COVID-19 Related Thoracic Complications https://ClinicalTrials.gov/show/NCT05204537
NCT05197543 AAA Rupture Risk Assessment in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT05197543
NCT05175690 Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness https://ClinicalTrials.gov/show/NCT05175690
NCT05205707 Association of Circulating ACE2 Levels With COVID-19 https://ClinicalTrials.gov/show/NCT05205707
NCT05205694 Oral Health in Covid-19 Survivors https://ClinicalTrials.gov/show/NCT05205694
NCT05205681 The Role of Imaging in the Diagnosis of Acute Appendicitis During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT05205681
NCT05204602 Safety and Immunogenicity of SARS-CoV-2 Vaccine Booster in Patients With Liver Diseases https://ClinicalTrials.gov/show/NCT05204602
NCT05198388 Beta Endorphins,Interleukin 1 and Interleukin 38 in Covid Patients Associated With Neuropsychological Manifestations. https://ClinicalTrials.gov/show/NCT05198388
NCT05043168 Kidney Histopathology After COVID-19 and SARS-CoV-2 Vaccination https://ClinicalTrials.gov/show/NCT05043168
NCT04997915 Acute Kidney Injury in Coronavirus Disease-19 (COVID-19) Patients Admitted to the Intensive Care Unit (ICU) https://ClinicalTrials.gov/show/NCT04997915
NCT04903132 Cellular Senescence and COVID-19 Long-Hauler Syndrome https://ClinicalTrials.gov/show/NCT04903132
NCT04712175 Diagnostic Validation of Rapid Detection of the COVID-19 Causative Virus (SARS-CoV-2) in Saliva Samples by Mass Spectrometry https://ClinicalTrials.gov/show/NCT04712175
NCT04290780 COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus https://ClinicalTrials.gov/show/NCT04290780
NCT04334954 SARS-COV2 Pandemic Serosurvey and Blood Sampling https://ClinicalTrials.gov/show/NCT04334954
NCT05208983 SafeTy and Efficacy of Preventative CoVID Vaccines https://ClinicalTrials.gov/show/NCT05208983
NCT04913116 Generic Testing of Antigen Tests for COVID-19 in Denmark https://ClinicalTrials.gov/show/NCT04913116
NCT04713150 HEALthy Brain and Child Development Study - COVID-19 Supplement https://ClinicalTrials.gov/show/NCT04713150
NCT05212909 Anxiety Level Assessment of Anesthesia Providers During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT05212909
NCT05212961 COVID-19 and Rhino-orbital Mucormycosis https://ClinicalTrials.gov/show/NCT05212961
NCT05212883 You and Me Covid Free https://ClinicalTrials.gov/show/NCT05212883
NCT05212506 Correlation Analysis of Covid-19 IgG Antibody Level in Seminal Plasma and Semen Index https://ClinicalTrials.gov/show/NCT05212506
NCT05191368 Safety and Immunogenicity of Sars-cov-2 Vaccine in Patients With Rheumatic Diseases https://ClinicalTrials.gov/show/NCT05191368
NCT05175989 SARS-CoV-2 Antibody Response in Children Aged 5-11 Years Following Vaccination Against COVID-19 https://ClinicalTrials.gov/show/NCT05175989
NCT05054088 ImmuneSense COVID-19 Variant Study https://ClinicalTrials.gov/show/NCT05054088
NCT05020145 COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States https://ClinicalTrials.gov/show/NCT05020145
NCT04927442 Natural History Study of COVID-19 Using Digital Wearables https://ClinicalTrials.gov/show/NCT04927442
NCT04852289 A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans https://ClinicalTrials.gov/show/NCT04852289
NCT04794829 Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination https://ClinicalTrials.gov/show/NCT04794829
NCT04681079 Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04681079
NCT04703790 Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods https://ClinicalTrials.gov/show/NCT04703790
NCT04581148 SARS-CoV2 Antibodies in Pediatric Patients (COVID-19) https://ClinicalTrials.gov/show/NCT04581148
NCT04609085 SARS-COV2 Pandemic Serosurvey in a Rare Disease Population https://ClinicalTrials.gov/show/NCT04609085
NCT04417673 Living With Sickle Cell Disease in the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04417673
NCT04387656 NCI COVID-19 in Cancer Patients, NCCAPS Study https://ClinicalTrials.gov/show/NCT04387656
NCT04406545 Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19. https://ClinicalTrials.gov/show/NCT04406545
NCT04353401 WGS Analysis of COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04353401
NCT05074875 COVID-19 Respiratory Outcomes Registry https://ClinicalTrials.gov/show/NCT05074875
NCT04784546 Evaluation of Muscle Strength, Functional Independence, Myalgia, Fatigue and Dyspnea in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04784546
NCT05074043 COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital https://ClinicalTrials.gov/show/NCT05074043
NCT05074706 Evaluation of the Immune Response to Sars-Cov-2 Vaccines in Haematological Patients: Prospective Single Center Study https://ClinicalTrials.gov/show/NCT05074706
NCT04817397 The Lymphocyte/Neutrophil Ratio as a Prognostic Index for Short Term Outcome in the ICU Admitted COVID-19 Adult Patients https://ClinicalTrials.gov/show/NCT04817397
NCT04706533 Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19 https://ClinicalTrials.gov/show/NCT04706533
NCT04647682 Physical Activity Program Implementation in Hospitalized Positive Covid-19 Older Adults https://ClinicalTrials.gov/show/NCT04647682
NCT04779424 Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19) https://ClinicalTrials.gov/show/NCT04779424
NCT04483908 COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses https://ClinicalTrials.gov/show/NCT04483908
NCT04524520 COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery https://ClinicalTrials.gov/show/NCT04524520
NCT04479319 Decision Support System Algorithm for COVID-19 Diagnosis https://ClinicalTrials.gov/show/NCT04479319
NCT04818866 International Study of Inflammation in COVID-19 https://ClinicalTrials.gov/show/NCT04818866
NCT04333862 Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy https://ClinicalTrials.gov/show/NCT04333862
NCT05143320 Cognitive, Emotional and Behavioural Impairments in Patients After Sars-Cov2 Infection https://ClinicalTrials.gov/show/NCT05143320
NCT04384055 Predicting Outcomes for Covid-19 Using Sonography https://ClinicalTrials.gov/show/NCT04384055
NCT05125835 Periodontal Maintenance and the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT05125835
NCT04411576 Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare https://ClinicalTrials.gov/show/NCT04411576
NCT04651400 Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04651400
NCT04816630 Feasibility Study of Hematology Parameters in COVID-19 Disease https://ClinicalTrials.gov/show/NCT04816630
NCT05060445 Mental Health in Latin American Population During the Covid-19 Pandemic. A Cross-country Study. https://ClinicalTrials.gov/show/NCT05060445
NCT05148676 Residual Symptoms and the Quality of Life in Individuals Recovered From COVID-19 Infection: A Survey From Pakistan https://ClinicalTrials.gov/show/NCT05148676
NCT05126550 The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine https://ClinicalTrials.gov/show/NCT05126550
NCT04625296 Behaviour and Experience of Communities Healthcare Professionals Facing the SARS CoV-2 (COVID-19) Epidemic https://ClinicalTrials.gov/show/NCT04625296
NCT05152030 The Clinical Applicability of the ‘TIB’ Olfactory Test Device https://ClinicalTrials.gov/show/NCT05152030
NCT05150834 Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 Vaccines https://ClinicalTrials.gov/show/NCT05150834
NCT05150821 Impact of Covid-19 in the Emergency Department https://ClinicalTrials.gov/show/NCT05150821
NCT05150769 Preferences of Vaccination for COVID-19 Among University Students and Staff: A Discrete Choice Experiment https://ClinicalTrials.gov/show/NCT05150769
NCT05004740 Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1c https://ClinicalTrials.gov/show/NCT05004740
NCT05137431 High-flow Nasal Oxygenation and Non-invasive Ventilation Strategies for the Treatment of Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT05137431
NCT04701996 Transmission Dynamics of COVID-19 in a Rural Setting of the Democratic Republic of the Congo https://ClinicalTrials.gov/show/NCT04701996
NCT04431414 A Study of Immune Responses to the Virus That Causes COVID-19 https://ClinicalTrials.gov/show/NCT04431414
NCT05124548 Sleep Characteristics in Post-COVID-19 Patients https://ClinicalTrials.gov/show/NCT05124548
NCT04649840 Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04649840
NCT04561193 Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04561193
NCT04578509 Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva https://ClinicalTrials.gov/show/NCT04578509
NCT04491292 Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce https://ClinicalTrials.gov/show/NCT04491292
NCT04365361 The Psychological Impact of the COVID-19 on Students. https://ClinicalTrials.gov/show/NCT04365361
NCT04669925 COVID-19 Impact on the Lombardy Region’s Emergency System https://ClinicalTrials.gov/show/NCT04669925
NCT04323878 Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study. https://ClinicalTrials.gov/show/NCT04323878
NCT04320732 Risk Factors for Community- and Workplace Transmission of COVID-19 https://ClinicalTrials.gov/show/NCT04320732
NCT05157256 Monitoring of Anti-SARS-CoV-2 (COVID 19) and Encapsulated Vaccination in a Cohort of Patients With Thalassemic and Falcemic Syndromes https://ClinicalTrials.gov/show/NCT05157256
NCT05157152 Elevated Liver Enzymes as a Predictor of Acute Kidney Injury in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05157152
NCT04934020 Global Impact of the COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis, and Subarachnoid Hemorrhage https://ClinicalTrials.gov/show/NCT04934020
NCT04815109 Prospective Electroencephalography Evaluation of Sedation in COVID-19 https://ClinicalTrials.gov/show/NCT04815109
NCT04736004 Hearts of Athletes https://ClinicalTrials.gov/show/NCT04736004
NCT04492904 Singapore COVID-19 Chemosensory Tracking (SCCT) Study https://ClinicalTrials.gov/show/NCT04492904
NCT04245631 Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV https://ClinicalTrials.gov/show/NCT04245631
NCT05158816 Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05158816
NCT05156086 Safety and Effectiveness of COVID-19 Vaccine in Kidney Transplant Recipients https://ClinicalTrials.gov/show/NCT05156086
NCT05142540 Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster Vaccines https://ClinicalTrials.gov/show/NCT05142540
NCT05074719 Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study) https://ClinicalTrials.gov/show/NCT05074719
NCT05160649 Effect of Covid 19 Infection on Fetomaternal Outcome https://ClinicalTrials.gov/show/NCT05160649
NCT05013632 COVID-19 International Drug Pregnancy Registry https://ClinicalTrials.gov/show/NCT05013632
NCT04852276 Analysis of the Immune Response to COVID-19 Vaccination and Outcomes in Individuals With and Without Immune Deficiencies and Dysregulations https://ClinicalTrials.gov/show/NCT04852276
NCT04582903 Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence https://ClinicalTrials.gov/show/NCT04582903
NCT04665752 Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors https://ClinicalTrials.gov/show/NCT04665752
NCT04690816 Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases https://ClinicalTrials.gov/show/NCT04690816
NCT04684615 Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen https://ClinicalTrials.gov/show/NCT04684615
NCT04564274 COV2Base-A Rare Disease by COVID Study https://ClinicalTrials.gov/show/NCT04564274
NCT04505631 Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04505631
NCT04534400 Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04534400
NCT04490174 Serological Surveillance for COVID-19 in Central North Carolina https://ClinicalTrials.gov/show/NCT04490174
NCT04419870 Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic https://ClinicalTrials.gov/show/NCT04419870
NCT04401436 COVID-19 Associated Lymphopenia Pathogenesis Study in Blood https://ClinicalTrials.gov/show/NCT04401436
NCT04391816 COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study https://ClinicalTrials.gov/show/NCT04391816
NCT04383444 Surveillance of Individuals Following SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04383444
NCT04348240 Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions https://ClinicalTrials.gov/show/NCT04348240
NCT04339790 Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers https://ClinicalTrials.gov/show/NCT04339790
NCT04360278 Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04360278
NCT05162534 Independent Predictors on Clinical Outcomes in SARS-CoV2 Patients https://ClinicalTrials.gov/show/NCT05162534
NCT05162456 Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ Transplantation https://ClinicalTrials.gov/show/NCT05162456
NCT05139992 COVID-19 Vaccine Response in Sickle Cell Disease https://ClinicalTrials.gov/show/NCT05139992
NCT04606498 Blood Purification With Seraph 100 Microbind Affinity Blood Filter for Treatment of Severe COVID19 Observational Study https://ClinicalTrials.gov/show/NCT04606498
NCT04619693 Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04619693
NCT04393974 COVID-19 and Cancer Patients https://ClinicalTrials.gov/show/NCT04393974
NCT05123742 PREDICT: A PBRN Feasibility Study on COVID-19 Screening in Dental Practice https://ClinicalTrials.gov/show/NCT05123742
NCT05145803 Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant Setting https://ClinicalTrials.gov/show/NCT05145803
NCT05107245 Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of Patients With COVID-19. https://ClinicalTrials.gov/show/NCT05107245
NCT04958954 Post-Marketing Safety Study of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in the United States https://ClinicalTrials.gov/show/NCT04958954
NCT05164744 Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors https://ClinicalTrials.gov/show/NCT05164744
NCT04432350 Assessment of Mortality Rates in COVID-19 Infected Populations Treated With Repurposed Medications https://ClinicalTrials.gov/show/NCT04432350
NCT05165953 Relationship Between Bronchial Asthma and COVID-19 Infection in Adults: Clinical and Laboratory Assessment https://ClinicalTrials.gov/show/NCT05165953
NCT05165719 Validation of ‘Corona-T-test’ for Assessment of SARS-COV-2-specific T-cell Response After COVID-19 or Vaccination https://ClinicalTrials.gov/show/NCT05165719
NCT04387708 Care in Patients Hospitalized for Anorexia Nervosa at the Time of the Coronavirus-19 Epidemic (QUALICOVID) https://ClinicalTrials.gov/show/NCT04387708
NCT05088902 Validation of TERA Bio Station T101 of COVID-19 Tested Population. https://ClinicalTrials.gov/show/NCT05088902
NCT05008562 HOW SARS-CoV- 2 EFFECTS TO MUSCLE MASS CHANGE IN ICU? https://ClinicalTrials.gov/show/NCT05008562
NCT04590222 Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04590222
NCT04655612 Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases https://ClinicalTrials.gov/show/NCT04655612
NCT04342884 COVID-19 Community Research Partnership https://ClinicalTrials.gov/show/NCT04342884
NCT05148975 The Diagnosis of Superinfections in Mechanically Ventilated Covid-19 Patients https://ClinicalTrials.gov/show/NCT05148975
NCT05167240 ESH ABPM COVID-19 STUDY https://ClinicalTrials.gov/show/NCT05167240
NCT05130710 The Impact of COVID-19 Pandemic on Clinical Presentation and Staging of Gastric Cancer https://ClinicalTrials.gov/show/NCT05130710
NCT04900402 Activity Level and Quality of Life of Individuals With Physical Disabilities https://ClinicalTrials.gov/show/NCT04900402
NCT04863573 COVID-19 Antibody Responses In Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04863573
NCT04852822 Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma https://ClinicalTrials.gov/show/NCT04852822
NCT04667442 Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects https://ClinicalTrials.gov/show/NCT04667442
NCT04665258 Male Reproduction COVID Sequelae Study (MARCOS). https://ClinicalTrials.gov/show/NCT04665258
NCT04568551 COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor https://ClinicalTrials.gov/show/NCT04568551
NCT04545047 Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19 https://ClinicalTrials.gov/show/NCT04545047
NCT04649918 Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19 https://ClinicalTrials.gov/show/NCT04649918
NCT04566965 Serology to COVID-19 for Recording Exposures and Evaluating Needs https://ClinicalTrials.gov/show/NCT04566965
NCT04565080 Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson’s Disease (PD) https://ClinicalTrials.gov/show/NCT04565080
NCT04522076 Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia https://ClinicalTrials.gov/show/NCT04522076
NCT04474301 Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04474301
NCT04447495 Self-sampling for the Study of COVID-19 https://ClinicalTrials.gov/show/NCT04447495
NCT04403386 Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19 https://ClinicalTrials.gov/show/NCT04403386
NCT04378881 Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations https://ClinicalTrials.gov/show/NCT04378881
NCT04318366 COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor https://ClinicalTrials.gov/show/NCT04318366
NCT05172180 Correction of Metabolic Disorders and Its Effect on Respiratory Function of Lungs in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT05172180
NCT05171998 Characterisation of the Immune Response to SARS-CoV2 Infection in Type 1 Diabetes https://ClinicalTrials.gov/show/NCT05171998
NCT05171959 Platelet and Immune Response in Covid-19 Vaccine https://ClinicalTrials.gov/show/NCT05171959
NCT05171803 Investigating Immune Escape by SARS-CoV-2 Variants https://ClinicalTrials.gov/show/NCT05171803
NCT05145348 Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome. https://ClinicalTrials.gov/show/NCT05145348
NCT04823988 Emotional, Social, Cognitive and Behavioral Sequalae of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04823988
NCT04564287 An Observational Study of Neurologic Function After COVID-19 Infection https://ClinicalTrials.gov/show/NCT04564287
NCT04488510 Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia: https://ClinicalTrials.gov/show/NCT04488510
NCT04448717 COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children https://ClinicalTrials.gov/show/NCT04448717
NCT04525716 The Effect of Covid-19 on Patient Outcomes Among Operated Patients https://ClinicalTrials.gov/show/NCT04525716
NCT04524754 Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04524754
NCT04525404 MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients https://ClinicalTrials.gov/show/NCT04525404
NCT04523012 COVID-19 and HIV Patients https://ClinicalTrials.gov/show/NCT04523012
NCT04522037 Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04522037
NCT04521010 Staff Absenteeism and Delivery of Healthcare Services During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04521010
NCT04520191 Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 Study https://ClinicalTrials.gov/show/NCT04520191
NCT04519502 Maternal Morbidity and Mortality During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04519502
NCT04519398 Investigating the Involvement of ACE and Angiotensinogen Genes’ Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events https://ClinicalTrials.gov/show/NCT04519398
NCT04519034 Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04519034
NCT04518735 Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study) https://ClinicalTrials.gov/show/NCT04518735
NCT04517695 Blood Volume Assessment in COVID-19 ICU Patients - BVAC19 https://ClinicalTrials.gov/show/NCT04517695
NCT04517682 COVID-19 and SARS-CoV-2 Detection in Saliva https://ClinicalTrials.gov/show/NCT04517682
NCT04517097 Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic https://ClinicalTrials.gov/show/NCT04517097
NCT04516824 Experience of Orthopaedic and Spine Center Pakistan During COVID-19 https://ClinicalTrials.gov/show/NCT04516824
NCT04515225 COVID-19 Prevalence in HIV-infected Patients https://ClinicalTrials.gov/show/NCT04515225
NCT04515108 Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies https://ClinicalTrials.gov/show/NCT04515108
NCT04513964 Impact of COVID-19 on the Benefit of Cardiac Rehabilitation https://ClinicalTrials.gov/show/NCT04513964
NCT04510623 Host Response Mediators in Coronavirus (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04510623
NCT04511962 Feasibility, of Tele-rehabilitation Following COVID-19 https://ClinicalTrials.gov/show/NCT04511962
NCT04510441 Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms https://ClinicalTrials.gov/show/NCT04510441
NCT04510025 Capturing MultiORgan Effects of COVID-19 https://ClinicalTrials.gov/show/NCT04510025
NCT04510012 Characterizing the Immune Response and Neuronal Damage in COVID-19 https://ClinicalTrials.gov/show/NCT04510012
NCT04509752 Dysphagia Management During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04509752
NCT04509713 Canine COVID-19 Detection https://ClinicalTrials.gov/show/NCT04509713
NCT04508972 The VOICE-COVID-19 https://ClinicalTrials.gov/show/NCT04508972
NCT04507893 Comparison Between Positive and Negative COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04507893
NCT04507282 Eosinophil and Anticoagulation in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04507282
NCT04506632 Burden for STaff Working in the NHS https://ClinicalTrials.gov/show/NCT04506632
NCT04506229 Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function https://ClinicalTrials.gov/show/NCT04506229
NCT04501822 One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04501822
NCT04502108 Behavior During and After COVID-19 Crisis https://ClinicalTrials.gov/show/NCT04502108
NCT04501991 Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes https://ClinicalTrials.gov/show/NCT04501991
NCT04499300 Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age https://ClinicalTrials.gov/show/NCT04499300
NCT04500639 Over-the-counter Medications & COVID-19 https://ClinicalTrials.gov/show/NCT04500639
NCT04500652 Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04500652
NCT04499378 Tomographic Findings in COVID-19 and Influenza H1N1 https://ClinicalTrials.gov/show/NCT04499378
NCT04498299 Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness https://ClinicalTrials.gov/show/NCT04498299
NCT04498507 Psychosocial Outcomes in Families of COVID-19 ICU Patients https://ClinicalTrials.gov/show/NCT04498507
NCT04498286 COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients https://ClinicalTrials.gov/show/NCT04498286
NCT04498091 EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19 https://ClinicalTrials.gov/show/NCT04498091
NCT04498416 CoCo-20: a Longitudinal Follow-up Study of the French Paediatric Population During and After the Coronavirus Pandemic COVID-19 https://ClinicalTrials.gov/show/NCT04498416
NCT04497467 Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04497467
NCT04498065 MYocardial DOmmages Related to COVID-19 https://ClinicalTrials.gov/show/NCT04498065
NCT04497779 Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma https://ClinicalTrials.gov/show/NCT04497779
NCT04497311 Tomographic Findings in COVID-19 and Influenza https://ClinicalTrials.gov/show/NCT04497311
NCT04497441 Netizens’ Perception of COVID-19 Information & Information Sources. https://ClinicalTrials.gov/show/NCT04497441
NCT04497818 Correlation Fear of COVID-19 & Dental Treatment Anxiety https://ClinicalTrials.gov/show/NCT04497818
NCT04497246 Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19) https://ClinicalTrials.gov/show/NCT04497246
NCT04496141 Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19 https://ClinicalTrials.gov/show/NCT04496141
NCT04493307 The Evaluation of Hemostasis in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04493307
NCT04492267 Inflammatory Bowel Disease (IBD) and Covid-19 Infection https://ClinicalTrials.gov/show/NCT04492267
NCT04492371 COVID-19 Infection and Multiple Myeloma https://ClinicalTrials.gov/show/NCT04492371
NCT04491318 COVID-19 Quarantine on Musculoskeletal Status in Hemophilia https://ClinicalTrials.gov/show/NCT04491318
NCT04491201 National Survey of the Impact of COVID-19 Pandemics https://ClinicalTrials.gov/show/NCT04491201
NCT04490811 Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children https://ClinicalTrials.gov/show/NCT04490811
NCT04491071 Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity. https://ClinicalTrials.gov/show/NCT04491071
NCT04488471 Impact of Isolation in Patients With IBD During the COVID-19 Crisis https://ClinicalTrials.gov/show/NCT04488471
NCT04487769 Lung Ultrasound in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04487769
NCT04487977 Survey on COVID-19 Airway Management https://ClinicalTrials.gov/show/NCT04487977
NCT04487951 N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04487951
NCT04486729 Respiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04486729
NCT04487197 SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets) https://ClinicalTrials.gov/show/NCT04487197
NCT04486404 Needs, Perceptions and Acute Stress of Healtcare Workers Caring for COVID-19 Patients in South America https://ClinicalTrials.gov/show/NCT04486404
NCT04486417 Feasibility of a Telematics Pre-operative Assessment in a Bariatric Surgery During Covid-19 https://ClinicalTrials.gov/show/NCT04486417
NCT04486521 Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19 https://ClinicalTrials.gov/show/NCT04486521
NCT04485351 Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes https://ClinicalTrials.gov/show/NCT04485351
NCT04485364 Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04485364
NCT04484597 Predictors of COVID-19 Infection and Disease Progression https://ClinicalTrials.gov/show/NCT04484597
NCT04485338 Chest Radiography in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04485338
NCT04484545 Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04484545
NCT04483622 Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients https://ClinicalTrials.gov/show/NCT04483622
NCT04482023 Emotional Support and Stress Management in Patients Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04482023
NCT04481620 Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT https://ClinicalTrials.gov/show/NCT04481620
NCT04481516 Yoga in NHS Health Care Workers With COVID-19 Related Stress https://ClinicalTrials.gov/show/NCT04481516
NCT04481477 Results of Emotional Support Activities During Hospital Admission With a Diagnosis of COVID19 https://ClinicalTrials.gov/show/NCT04481477
NCT04480580 Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery https://ClinicalTrials.gov/show/NCT04480580
NCT04480398 Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients https://ClinicalTrials.gov/show/NCT04480398
NCT04479982 Microbial Infection and AMR in Hospitalized Patients With Covid 19 https://ClinicalTrials.gov/show/NCT04479982
NCT04480034 Obesity Surgery During 2020 Italian Pandemic https://ClinicalTrials.gov/show/NCT04480034
NCT04479293 Post COVID-19 Functional Status in Egypt https://ClinicalTrials.gov/show/NCT04479293
NCT04479280 Evaluation of Coagulopathy in Critically Ill COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04479280
NCT04476602 Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol https://ClinicalTrials.gov/show/NCT04476602
NCT04475471 WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey https://ClinicalTrials.gov/show/NCT04475471
NCT04475484 Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children https://ClinicalTrials.gov/show/NCT04475484
NCT04474288 The COVID-19 PUI Reality Check (CPRC) Study https://ClinicalTrials.gov/show/NCT04474288
NCT04475211 LILLE COVID RESEARCH NETWORK (Covid-19) https://ClinicalTrials.gov/show/NCT04475211
NCT04475068 Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection https://ClinicalTrials.gov/show/NCT04475068
NCT04474444 Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP) https://ClinicalTrials.gov/show/NCT04474444
NCT04474457 Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age https://ClinicalTrials.gov/show/NCT04474457
NCT04474067 COVID-19 - Cytokine Storm https://ClinicalTrials.gov/show/NCT04474067
NCT04474236 Lung Ultrasound for COVID-19 Initial Triage and Monitoring https://ClinicalTrials.gov/show/NCT04474236
NCT04473365 Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04473365
NCT04473183 Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota https://ClinicalTrials.gov/show/NCT04473183
NCT04473118 Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients https://ClinicalTrials.gov/show/NCT04473118
NCT04473131 Immune Profiling of COVID19-patients Admitted to ICU https://ClinicalTrials.gov/show/NCT04473131
NCT04471649 Hydroxy Chloroquine and Covid in RA Patients https://ClinicalTrials.gov/show/NCT04471649
NCT04472052 Frequency of Perforated Appendicitis in Times of COVID-19 https://ClinicalTrials.gov/show/NCT04472052
NCT04471701 Italian Web-based Cross-sectional Survey on COVID-19 https://ClinicalTrials.gov/show/NCT04471701
NCT04469660 Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in India https://ClinicalTrials.gov/show/NCT04469660
NCT04470323 Functional Exhaustion of T Cells in COVID19 Patients https://ClinicalTrials.gov/show/NCT04470323
NCT04469647 COVID 19 Seroprevalence Amongst Healthcare Workers in JHAH https://ClinicalTrials.gov/show/NCT04469647
NCT04470583 Evaluating Clinical Parameters of COVID-19 in Pregnancy https://ClinicalTrials.gov/show/NCT04470583
NCT04470648 COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey https://ClinicalTrials.gov/show/NCT04470648
NCT04468308 VRQOL in Cataract Patients During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04468308
NCT04469153 Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19 https://ClinicalTrials.gov/show/NCT04469153
NCT04468217 Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR https://ClinicalTrials.gov/show/NCT04468217
NCT04468256 The Heart Hive COVID-19 Study https://ClinicalTrials.gov/show/NCT04468256
NCT04468035 Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04468035
NCT04467931 ACEI or ARB and COVID-19 Severity and Mortality in US Veterans https://ClinicalTrials.gov/show/NCT04467931
NCT04466982 Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04466982
NCT04466644 COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics) https://ClinicalTrials.gov/show/NCT04466644
NCT04466839 Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients https://ClinicalTrials.gov/show/NCT04466839
NCT04465981 Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04465981
NCT04465656 Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04465656
NCT04465552 Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04465552
NCT04465058 Characteristics of Critically Ill COVID 19 Patients https://ClinicalTrials.gov/show/NCT04465058
NCT04463823 “NORPLASMA” Covid-19 Convalescent Plasma Treatment Monitoring Study https://ClinicalTrials.gov/show/NCT04463823
NCT04463628 Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic https://ClinicalTrials.gov/show/NCT04463628
NCT04463706 COVID19 Severity Prediction and Health Services Research Evaluation https://ClinicalTrials.gov/show/NCT04463706
NCT04463758 Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns https://ClinicalTrials.gov/show/NCT04463758
NCT04462367 Northeast COVID-19 and Pregnancy Study Group https://ClinicalTrials.gov/show/NCT04462367
NCT04460599 Neurological Features During COVID19 https://ClinicalTrials.gov/show/NCT04460599
NCT04460638 SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling https://ClinicalTrials.gov/show/NCT04460638
NCT04460664 Coagulation Changes Associated With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04460664
NCT04460274 Forecast Number of Covid-19 Cases Worldwide https://ClinicalTrials.gov/show/NCT04460274
NCT04460469 Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04460469
NCT04459312 National Covid-19 Surveillance Physicians https://ClinicalTrials.gov/show/NCT04459312
NCT04459390 Association of Comorbidities With COVID19 https://ClinicalTrials.gov/show/NCT04459390
NCT04459975 Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units https://ClinicalTrials.gov/show/NCT04459975
NCT04459533 Sparing in Neuromuscular Blockade in COVID 19 ICU https://ClinicalTrials.gov/show/NCT04459533
NCT04458337 SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19) https://ClinicalTrials.gov/show/NCT04458337
NCT04457570 Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer https://ClinicalTrials.gov/show/NCT04457570
NCT04459351 PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs https://ClinicalTrials.gov/show/NCT04459351
NCT04456010 COVID-19 in ART: Perception and Experience https://ClinicalTrials.gov/show/NCT04456010
NCT04456101 Study on the Recovery of Pulmonary Function, Chest CT, Hematologic, and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients https://ClinicalTrials.gov/show/NCT04456101
NCT04456075 Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19 https://ClinicalTrials.gov/show/NCT04456075
NCT04453670 Neuropathology in Adults Intensive Care Unit Patients With COVID 19 https://ClinicalTrials.gov/show/NCT04453670
NCT04453982 Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b https://ClinicalTrials.gov/show/NCT04453982
NCT04453969 Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a https://ClinicalTrials.gov/show/NCT04453969
NCT04453501 Anti Infective Agents Impact in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04453501
NCT04453566 Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes. https://ClinicalTrials.gov/show/NCT04453566
NCT04453527 The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04453527
NCT04453280 Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity) https://ClinicalTrials.gov/show/NCT04453280
NCT04452695 Acceptability of Telehealth Triage Using Robotic Systems in COVID-19 https://ClinicalTrials.gov/show/NCT04452695
NCT04452708 HFNC and NIV for COVID-19 Complicated by Respiratory Failure https://ClinicalTrials.gov/show/NCT04452708
NCT04452682 The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice https://ClinicalTrials.gov/show/NCT04452682
NCT04452604 Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19 https://ClinicalTrials.gov/show/NCT04452604
NCT04452487 Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments (COVID-19-LAT) https://ClinicalTrials.gov/show/NCT04452487
NCT04452630 Cardiovascular Consequences After COVID-19 https://ClinicalTrials.gov/show/NCT04452630
NCT04451694 Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19 https://ClinicalTrials.gov/show/NCT04451694
NCT04451577 Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection https://ClinicalTrials.gov/show/NCT04451577
NCT04451317 Physical Activity Following the Containment Period Imposed by the COVID-19 Pandemic in Patients https://ClinicalTrials.gov/show/NCT04451317
NCT04450017 Clinical Features of Severe Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04450017
NCT04449978 TARGet Kids! COVID-19 Study of Children and Families https://ClinicalTrials.gov/show/NCT04449978
NCT04449783 Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery https://ClinicalTrials.gov/show/NCT04449783
NCT04448405 Covid-19 Lockdown and Deviant Sexual Fantasies https://ClinicalTrials.gov/show/NCT04448405
NCT04448054 Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas https://ClinicalTrials.gov/show/NCT04448054
NCT04447222 Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors https://ClinicalTrials.gov/show/NCT04447222
NCT04447209 Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study https://ClinicalTrials.gov/show/NCT04447209
NCT04447144 Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome https://ClinicalTrials.gov/show/NCT04447144
NCT04447131 Effect of COVID-19 on Platelet Aggregation https://ClinicalTrials.gov/show/NCT04447131
NCT04446338 Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre https://ClinicalTrials.gov/show/NCT04446338
NCT04446169 COVID-19 (SARS-CoV-2) in Urine and Semen https://ClinicalTrials.gov/show/NCT04446169
NCT04445870 Oncology Care Pathway’s Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study https://ClinicalTrials.gov/show/NCT04445870
NCT04445259 Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury https://ClinicalTrials.gov/show/NCT04445259
NCT04445506 Short Term Corticosteroids in SARS-CoV2 Patients https://ClinicalTrials.gov/show/NCT04445506
NCT04444557 Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study https://ClinicalTrials.gov/show/NCT04444557
NCT04444609 PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort https://ClinicalTrials.gov/show/NCT04444609
NCT04444401 Registry on NEN Patients and COVID-19 https://ClinicalTrials.gov/show/NCT04444401
NCT04443712 Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19) https://ClinicalTrials.gov/show/NCT04443712
NCT04442789 Sequelae of Sars-CoV-2 Infections https://ClinicalTrials.gov/show/NCT04442789
NCT04443075 Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress https://ClinicalTrials.gov/show/NCT04443075
NCT04441476 Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis https://ClinicalTrials.gov/show/NCT04441476
NCT04441502 Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic https://ClinicalTrials.gov/show/NCT04441502
NCT04439084 COVID-19 in Patients With Chronic Liver Diseases https://ClinicalTrials.gov/show/NCT04439084
NCT04438941 Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic https://ClinicalTrials.gov/show/NCT04438941
NCT04438993 The COVID-19 Disease and CARdiac Events Study https://ClinicalTrials.gov/show/NCT04438993
NCT04438967 Brain Health in the Time of COVID-19 https://ClinicalTrials.gov/show/NCT04438967
NCT04438629 Evaluation of Immune Response in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04438629
NCT04438239 Rehabilitation Needs After COVID-19 Hospital Treatment https://ClinicalTrials.gov/show/NCT04438239
NCT04437940 Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test https://ClinicalTrials.gov/show/NCT04437940
NCT04437121 Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece https://ClinicalTrials.gov/show/NCT04437121
NCT04437342 Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia https://ClinicalTrials.gov/show/NCT04437342
NCT04435223 Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen https://ClinicalTrials.gov/show/NCT04435223
NCT04435327 Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04435327
NCT04435028 Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy https://ClinicalTrials.gov/show/NCT04435028
NCT04435106 Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04435106
NCT04434118 Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT04434118
NCT04434261 Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2 https://ClinicalTrials.gov/show/NCT04434261
NCT04434014 Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era https://ClinicalTrials.gov/show/NCT04434014
NCT04433754 The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection https://ClinicalTrials.gov/show/NCT04433754
NCT04433260 COVID19 and Physical and Emotional Wellbeing of HCP https://ClinicalTrials.gov/show/NCT04433260
NCT04433000 Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04433000
NCT04432948 Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management. https://ClinicalTrials.gov/show/NCT04432948
NCT04432779 Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children https://ClinicalTrials.gov/show/NCT04432779
NCT04431284 Impact of COVID-19 Lockdown on Obesity and Eating Behaviors https://ClinicalTrials.gov/show/NCT04431284
NCT04431310 Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04431310
NCT04430062 Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital https://ClinicalTrials.gov/show/NCT04430062
NCT04430049 Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients https://ClinicalTrials.gov/show/NCT04430049
NCT04429815 Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04429815
NCT04430322 Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study https://ClinicalTrials.gov/show/NCT04430322
NCT04429620 Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method https://ClinicalTrials.gov/show/NCT04429620
NCT04427735 Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI https://ClinicalTrials.gov/show/NCT04427735
NCT04427969 Early Prone Position on Coronavirus Disease 2019 Pneumonia https://ClinicalTrials.gov/show/NCT04427969
NCT04427332 Smell and Taste Disorders in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04427332
NCT04427176 Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19). https://ClinicalTrials.gov/show/NCT04427176
NCT04427267 Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients https://ClinicalTrials.gov/show/NCT04427267
NCT04427345 Predictive Factors COVID-19 Patients https://ClinicalTrials.gov/show/NCT04427345
NCT04426279 Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants https://ClinicalTrials.gov/show/NCT04426279
NCT04425889 COVID-19 Antibodies Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04425889
NCT04425044 AiM Covid Self Monitoring https://ClinicalTrials.gov/show/NCT04425044
NCT04424771 Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT04424771
NCT04425382 Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar https://ClinicalTrials.gov/show/NCT04425382
NCT04424992 The Natural History of Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04424992
NCT04424836 HFNC Treatment in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04424836
NCT04424004 MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study https://ClinicalTrials.gov/show/NCT04424004
NCT04424017 Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers https://ClinicalTrials.gov/show/NCT04424017
NCT04424849 Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04424849
NCT04424355 Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection. https://ClinicalTrials.gov/show/NCT04424355
NCT04422340 Senior-COVID-Rea Multicentric Survey https://ClinicalTrials.gov/show/NCT04422340
NCT04423640 Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04423640
NCT04422691 Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection https://ClinicalTrials.gov/show/NCT04422691
NCT04423770 COVID-19 Related Health and Infection Control Practices Among Dentists https://ClinicalTrials.gov/show/NCT04423770
NCT04423692 Knowledge About Covid-19 Infection in Pregnant Women https://ClinicalTrials.gov/show/NCT04423692
NCT04422535 Effects on the Qt Interval of COVID-19 Coronavirus Infection https://ClinicalTrials.gov/show/NCT04422535
NCT04422418 Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi https://ClinicalTrials.gov/show/NCT04422418
NCT04420468 Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children https://ClinicalTrials.gov/show/NCT04420468
NCT04420416 Mental Health and Academic Performance in COVID-19 https://ClinicalTrials.gov/show/NCT04420416
NCT04419545 Covid Radiographic Images Data-set for A.I https://ClinicalTrials.gov/show/NCT04419545
NCT04419571 Outcomes in Emergency Laparotomies During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04419571
NCT04418544 Vocal Feature Analysis Algorithm for COVID-19 Detection https://ClinicalTrials.gov/show/NCT04418544
NCT04418245 CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis https://ClinicalTrials.gov/show/NCT04418245
NCT04418284 Online Learning of Veterinary Anatomy During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04418284
NCT04417374 Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19 https://ClinicalTrials.gov/show/NCT04417374
NCT04416061 The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04416061
NCT04416438 COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias https://ClinicalTrials.gov/show/NCT04416438
NCT04416256 COVID-19 Pandemic and Worldwide Organ Procurement https://ClinicalTrials.gov/show/NCT04416256
NCT04416347 COVID19 Clinical Predictors and Outcome https://ClinicalTrials.gov/show/NCT04416347
NCT04416373 COVID-19 and Pregnancy Outcomes https://ClinicalTrials.gov/show/NCT04416373
NCT04416464 Quality of Life and Patient-centered Outcomes After ICU Admission for COVID-19 https://ClinicalTrials.gov/show/NCT04416464
NCT04416100 Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04416100
NCT04414657 USZ BioResource COVID https://ClinicalTrials.gov/show/NCT04414657
NCT04414319 Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly https://ClinicalTrials.gov/show/NCT04414319
NCT04413435 Clinical Characteristics of Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04413435
NCT04413045 Novel COVID-19, A National Analysis https://ClinicalTrials.gov/show/NCT04413045
NCT04413071 Cardiac COVID-19 Health Care Workers https://ClinicalTrials.gov/show/NCT04413071
NCT04412746 Covid-19 and Diabetes in West of Algeria https://ClinicalTrials.gov/show/NCT04412746
NCT04412655 Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry https://ClinicalTrials.gov/show/NCT04412655
NCT04412473 COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject’s Habits https://ClinicalTrials.gov/show/NCT04412473
NCT04412304 Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04412304
NCT04412265 Frailty in Elderly Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04412265
NCT04412369 Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury https://ClinicalTrials.gov/show/NCT04412369
NCT04412278 Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers https://ClinicalTrials.gov/show/NCT04412278
NCT04411459 Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04411459
NCT04411511 COVID-19, Obesity and Lifestyle in Children https://ClinicalTrials.gov/show/NCT04411511
NCT04410835 Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders https://ClinicalTrials.gov/show/NCT04410835
NCT04410718 Glycaemia and Cardiac Function in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04410718
NCT04409899 The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department https://ClinicalTrials.gov/show/NCT04409899
NCT04409847 COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX) https://ClinicalTrials.gov/show/NCT04409847
NCT04410107 Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19 https://ClinicalTrials.gov/show/NCT04410107
NCT04410263 Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches https://ClinicalTrials.gov/show/NCT04410263
NCT04410432 Immune Response and Risk of Serious Infection to SARS-Cov2 https://ClinicalTrials.gov/show/NCT04410432
NCT04409535 Effects of the COVID-19 Health Emergency on Biopsychosocial Health https://ClinicalTrials.gov/show/NCT04409535
NCT04409275 LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION https://ClinicalTrials.gov/show/NCT04409275
NCT04408365 Endothelial Function, Inflammation and Organ Dysfunction in COVID-19 https://ClinicalTrials.gov/show/NCT04408365
NCT04408378 Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients https://ClinicalTrials.gov/show/NCT04408378
NCT04408326 Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04408326
NCT04408222 Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure https://ClinicalTrials.gov/show/NCT04408222
NCT04408248 AKI Biomarkers in Coronavirus(COVID)-19 https://ClinicalTrials.gov/show/NCT04408248
NCT04407923 Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment https://ClinicalTrials.gov/show/NCT04407923
NCT04408001 Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff https://ClinicalTrials.gov/show/NCT04408001
NCT04408170 Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19) https://ClinicalTrials.gov/show/NCT04408170
NCT04407468 Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04407468
NCT04407273 Statin Therapy and COVID-19 Infection https://ClinicalTrials.gov/show/NCT04407273
NCT04407559 COVID-SErology in Rheumatoid Arthritis (COVID-19) https://ClinicalTrials.gov/show/NCT04407559
NCT04407585 Testing the Accuracy of a Digital Test to Diagnose Covid-19 https://ClinicalTrials.gov/show/NCT04407585
NCT04407429 Vienna Versus SARS-CoV-2 Virus Study https://ClinicalTrials.gov/show/NCT04407429
NCT04407663 Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near https://ClinicalTrials.gov/show/NCT04407663
NCT04407546 Role of Children in Transmission of COVID-19 to Immunocompromised Patients https://ClinicalTrials.gov/show/NCT04407546
NCT04407260 Use of Oxygen Hoods in Patients Failing on Conventional High-flow Oxygen Delivery Systems, Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic COVID-19 Patients. Prospective Cohort Study. https://ClinicalTrials.gov/show/NCT04407260
NCT04407195 COVID-19 and Mental Health https://ClinicalTrials.gov/show/NCT04407195
NCT04407494 Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19) https://ClinicalTrials.gov/show/NCT04407494
NCT04407169 Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease https://ClinicalTrials.gov/show/NCT04407169
NCT04406844 Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04406844
NCT04407299 COVID-19 Impact on Rheumatic Patients https://ClinicalTrials.gov/show/NCT04407299
NCT04406233 Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04406233
NCT04406324 COVID-19: Respiratory and Sleep Follow-up https://ClinicalTrials.gov/show/NCT04406324
NCT04406558 Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents https://ClinicalTrials.gov/show/NCT04406558
NCT04406571 Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer https://ClinicalTrials.gov/show/NCT04406571
NCT04405973 Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO https://ClinicalTrials.gov/show/NCT04405973
NCT04405869 Thromboembolic Events in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04405869
NCT04405726 Prognostic Factors of COVID19 https://ClinicalTrials.gov/show/NCT04405726
NCT04405466 A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers https://ClinicalTrials.gov/show/NCT04405466
NCT04404244 Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04404244
NCT04403880 Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19 https://ClinicalTrials.gov/show/NCT04403880
NCT04404062 Serological and PCR Testing for COVID-19 https://ClinicalTrials.gov/show/NCT04404062
NCT04404179 Setting up a COVID-19 Care Facility at a Prison in Pakistan https://ClinicalTrials.gov/show/NCT04404179
NCT04403607 Cardiac Imaging in SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04403607
NCT04403438 Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic https://ClinicalTrials.gov/show/NCT04403438
NCT04403009 The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04403009
NCT04402853 SARS Cov-2 in Conjunctival Secretion in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04402853
NCT04402814 IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing. https://ClinicalTrials.gov/show/NCT04402814
NCT04401098 Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak https://ClinicalTrials.gov/show/NCT04401098
NCT04401072 Attitude of Egyptian Population Toward COVID 19 in Ramadan https://ClinicalTrials.gov/show/NCT04401072
NCT04401254 Recovery of Patients From COVID-19 After Critical Illness https://ClinicalTrials.gov/show/NCT04401254
NCT04401228 Predictive Models for Intensive Care Admission and Death of COVID-19 https://ClinicalTrials.gov/show/NCT04401228
NCT04401085 COVID-19: Herd Immunity Study in the Czech Republic https://ClinicalTrials.gov/show/NCT04401085
NCT04401111 One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU) https://ClinicalTrials.gov/show/NCT04401111
NCT04399603 Mechanisms of Multi-organ Failure in COVID-19 https://ClinicalTrials.gov/show/NCT04399603
NCT04397939 Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04397939
NCT04397588 Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19 https://ClinicalTrials.gov/show/NCT04397588
NCT04397822 COVID-19 : Study of INFLAmmasome and PLAtelets Functions https://ClinicalTrials.gov/show/NCT04397822
NCT04397835 Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population https://ClinicalTrials.gov/show/NCT04397835
NCT04397172 Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19 https://ClinicalTrials.gov/show/NCT04397172
NCT04395482 Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury https://ClinicalTrials.gov/show/NCT04395482
NCT04396600 The Professional Peer Resilience Initiative https://ClinicalTrials.gov/show/NCT04396600
NCT04395755 Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed https://ClinicalTrials.gov/show/NCT04395755
NCT04395924 Maternal-foetal Transmission of SARS-Cov-2 https://ClinicalTrials.gov/show/NCT04395924
NCT04395859 Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents https://ClinicalTrials.gov/show/NCT04395859
NCT04395885 Sexual Function During COVID 19 Pandemic https://ClinicalTrials.gov/show/NCT04395885
NCT04396353 EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04396353
NCT04396197 Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care https://ClinicalTrials.gov/show/NCT04396197
NCT04395300 Sleep Quality in Healthcare Personnel During COVID-19 https://ClinicalTrials.gov/show/NCT04395300
NCT04394195 sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19? https://ClinicalTrials.gov/show/NCT04394195
NCT04394104 COVID-19 Wellness Survey https://ClinicalTrials.gov/show/NCT04394104
NCT04394429 Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04394429
NCT04393805 Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto https://ClinicalTrials.gov/show/NCT04393805
NCT04394078 Impact of COVID-19 Pandemic on Depression and Quality of Life https://ClinicalTrials.gov/show/NCT04394078
NCT04394026 Imaging Feature of SARS-CoV2 Infection https://ClinicalTrials.gov/show/NCT04394026
NCT04393402 Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19) https://ClinicalTrials.gov/show/NCT04393402
NCT04393233 Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation https://ClinicalTrials.gov/show/NCT04393233
NCT04393428 Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04393428
NCT04393155 COVID Cohort Study https://ClinicalTrials.gov/show/NCT04393155
NCT04393558 Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms https://ClinicalTrials.gov/show/NCT04393558
NCT04392401 COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study https://ClinicalTrials.gov/show/NCT04392401
NCT04392388 Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis https://ClinicalTrials.gov/show/NCT04392388
NCT04391881 Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population https://ClinicalTrials.gov/show/NCT04391881
NCT04391738 Association Between BMI and COVID-19 https://ClinicalTrials.gov/show/NCT04391738
NCT04392089 Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS https://ClinicalTrials.gov/show/NCT04392089
NCT04390269 Immunogenetics Predictors With COVID-19 https://ClinicalTrials.gov/show/NCT04390269
NCT04390074 COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality https://ClinicalTrials.gov/show/NCT04390074
NCT04389567 Famotidine Outpatient COVID-19 Treatment Study https://ClinicalTrials.gov/show/NCT04389567
NCT04390165 Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study https://ClinicalTrials.gov/show/NCT04390165
NCT04390126 COVID-19 Related Lockdown Effects On Chronic Diseases https://ClinicalTrials.gov/show/NCT04390126
NCT04389489 Postpartum Sexual Function in Pregnant Women With COVID-19 https://ClinicalTrials.gov/show/NCT04389489
NCT04389515 Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04389515
NCT04389320 Antimalarial and Covid 19 in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04389320
NCT04389463 Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04389463
NCT04388644 Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention https://ClinicalTrials.gov/show/NCT04388644
NCT04388670 Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04388670
NCT04388618 Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia https://ClinicalTrials.gov/show/NCT04388618
NCT04388657 COVID-19, bLOod Coagulation and Thrombosis https://ClinicalTrials.gov/show/NCT04388657
NCT04387838 Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff https://ClinicalTrials.gov/show/NCT04387838
NCT04387968 Epidemiological Study of the Covid-19 Presto Test - The “COVIDOR” Study https://ClinicalTrials.gov/show/NCT04387968
NCT04387799 Determinants of COVID-19 Pneumonia (MC-19) https://ClinicalTrials.gov/show/NCT04387799
NCT04387786 Dornase Alfa Administered to Patients With COVID-19 (DACOVID) https://ClinicalTrials.gov/show/NCT04387786
NCT04387214 COVID-19 Pandemic and Academic Performance of Veterinary Students https://ClinicalTrials.gov/show/NCT04387214
NCT04387279 The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT04387279
NCT04386369 Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04386369
NCT04386720 Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19. https://ClinicalTrials.gov/show/NCT04386720
NCT04386460 Covid-19 and Prevention of Malnutrition After Confinement by Dentists https://ClinicalTrials.gov/show/NCT04386460
NCT04386083 Neurologic Manifestations of COVID-19 https://ClinicalTrials.gov/show/NCT04386083
NCT04386564 Kidney Injury Severity and COVID-19 https://ClinicalTrials.gov/show/NCT04386564
NCT04386109 Neonatal Complications of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04386109
NCT04385147 Advanced Endoscopy During COVID-19 https://ClinicalTrials.gov/show/NCT04385147
NCT04385069 COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study https://ClinicalTrials.gov/show/NCT04385069
NCT04384887 “Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women” https://ClinicalTrials.gov/show/NCT04384887
NCT04385251 International SARS-CoV-2 (COVID-19) Infection Observational Study https://ClinicalTrials.gov/show/NCT04385251
NCT04385121 Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection https://ClinicalTrials.gov/show/NCT04385121
NCT04384926 Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis https://ClinicalTrials.gov/show/NCT04384926
NCT04385004 Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU https://ClinicalTrials.gov/show/NCT04385004
NCT04384471 Covid-19 Pandemic: Patients’ Experience in T1D https://ClinicalTrials.gov/show/NCT04384471
NCT04384250 Genetic Basis of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04384250
NCT04384042 Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study https://ClinicalTrials.gov/show/NCT04384042
NCT04383886 Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04383886
NCT04383730 Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19) https://ClinicalTrials.gov/show/NCT04383730
NCT04383678 Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04383678
NCT04383652 Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales https://ClinicalTrials.gov/show/NCT04383652
NCT04383483 CoV-ICU Score, Intensive Care Unit, SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04383483
NCT04383470 Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04383470
NCT04382794 Sitagliptin Treatment in Diabetic COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04382794
NCT04382781 Immunosupressive Treatment in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04382781
NCT04382196 Impact of COVID-19 on Mental Health of Health Care Workers https://ClinicalTrials.gov/show/NCT04382196
NCT04382417 Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden https://ClinicalTrials.gov/show/NCT04382417
NCT04382235 Non-invasive Ventilatory Support of Patients Affected by COVID-19 https://ClinicalTrials.gov/show/NCT04382235
NCT04382534 A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction https://ClinicalTrials.gov/show/NCT04382534
NCT04381819 Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19 https://ClinicalTrials.gov/show/NCT04381819
NCT04381286 Transpulmonary Driving Pressure in ARDS COVID19 Patients https://ClinicalTrials.gov/show/NCT04381286
NCT04381351 Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction https://ClinicalTrials.gov/show/NCT04381351
NCT04380870 Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19 https://ClinicalTrials.gov/show/NCT04380870
NCT04380987 Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis https://ClinicalTrials.gov/show/NCT04380987
NCT04380896 COVID-19 Staff Testing of Antibody Responses Study (Co-Stars) https://ClinicalTrials.gov/show/NCT04380896
NCT04378842 COVID-19 and ICU-acquired MDR Bacteria https://ClinicalTrials.gov/show/NCT04378842
NCT04379089 Neurologic Manifestations of COVID 19 in Children https://ClinicalTrials.gov/show/NCT04379089
NCT04379310 Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019) https://ClinicalTrials.gov/show/NCT04379310
NCT04378829 Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19 https://ClinicalTrials.gov/show/NCT04378829
NCT04378777 Immunophenotyping Assessment in a COVID-19 Cohort https://ClinicalTrials.gov/show/NCT04378777
NCT04378686 Serological Testing for COVID-19 (SARS-CoV-2) in ESKD https://ClinicalTrials.gov/show/NCT04378686
NCT04378595 Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin https://ClinicalTrials.gov/show/NCT04378595
NCT04378582 Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU https://ClinicalTrials.gov/show/NCT04378582
NCT04377815 Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste https://ClinicalTrials.gov/show/NCT04377815
NCT04377776 Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients https://ClinicalTrials.gov/show/NCT04377776
NCT04377490 Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy https://ClinicalTrials.gov/show/NCT04377490
NCT04377607 Haemoglobin Concentration on COVID-19 https://ClinicalTrials.gov/show/NCT04377607
NCT04377412 Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04377412
NCT04376853 CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch https://ClinicalTrials.gov/show/NCT04376853
NCT04376775 Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation https://ClinicalTrials.gov/show/NCT04376775
NCT04376879 Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19) https://ClinicalTrials.gov/show/NCT04376879
NCT04376944 Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation https://ClinicalTrials.gov/show/NCT04376944
NCT04377035 The Role of Ultrasound in COVID-19 https://ClinicalTrials.gov/show/NCT04377035
NCT04376658 Quality of Life and Long-term Outcomes After Hospitalization for COVID-19 https://ClinicalTrials.gov/show/NCT04376658
NCT04376996 Slovenian National COVID-19 Prevalence Study https://ClinicalTrials.gov/show/NCT04376996
NCT04376710 Surgical Telemedicine in the COVID-19 Pandemic Era https://ClinicalTrials.gov/show/NCT04376710
NCT04375501 A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04375501
NCT04375709 Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19); https://ClinicalTrials.gov/show/NCT04375709
NCT04375761 COVID-19: Human Epidemiology and Response to SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04375761
NCT04375670 COVID19-FOIE National Observatory https://ClinicalTrials.gov/show/NCT04375670
NCT04375748 Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases https://ClinicalTrials.gov/show/NCT04375748
NCT04375176 Monocytes and NK Cells Activity in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04375176
NCT04375137 Correlation Between Oxidative Stress Status and COVID-19 Severity https://ClinicalTrials.gov/show/NCT04375137
NCT04374838 Effect of COVID-19 Pandemic on Pediatric Cancer Care https://ClinicalTrials.gov/show/NCT04374838
NCT04374656 Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04374656
NCT04374422 COVID-19 Pandemic and Female Sexual Behavior https://ClinicalTrials.gov/show/NCT04374422
NCT04374058 Less Frequency Hemodialysis and COVID-19 https://ClinicalTrials.gov/show/NCT04374058
NCT04374071 Early Short Course Corticosteroids in COVID-19 https://ClinicalTrials.gov/show/NCT04374071
NCT04374617 Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04374617
NCT04373798 C-reactive Protein Levels Among Individuals With COVID-19 https://ClinicalTrials.gov/show/NCT04373798
NCT04373811 One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting https://ClinicalTrials.gov/show/NCT04373811
NCT04373005 Screening of Cancer Patients to Assess Impact of COVID-19 https://ClinicalTrials.gov/show/NCT04373005
NCT04373148 Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19 https://ClinicalTrials.gov/show/NCT04373148
NCT04373109 Stroke Rehabilitation Outcome During COVID-19 Lockdown https://ClinicalTrials.gov/show/NCT04373109
NCT04372576 Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04372576
NCT04371679 Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04371679
NCT04371692 Prevalence of COVID-19 Infection Among HCW in a French University Hospital https://ClinicalTrials.gov/show/NCT04371692
NCT04371302 Nursing Perspective on Burnout and Medical Errors in the Intensive Care Unit During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04371302
NCT04371315 Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children https://ClinicalTrials.gov/show/NCT04371315
NCT04371250 Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures. https://ClinicalTrials.gov/show/NCT04371250
NCT04371471 Covid-19 Pandemic Triage Score https://ClinicalTrials.gov/show/NCT04371471
NCT04370808 VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04370808
NCT04370275 Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia https://ClinicalTrials.gov/show/NCT04370275
NCT04370197 Covid-19 Epidemic on Acute Stroke Management https://ClinicalTrials.gov/show/NCT04370197
NCT04370210 Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry https://ClinicalTrials.gov/show/NCT04370210
NCT04370171 Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic https://ClinicalTrials.gov/show/NCT04370171
NCT04369690 The Psychological, Social, and Economic Impacts of COVID-19 https://ClinicalTrials.gov/show/NCT04369690
NCT04369859 Obstetric and Perinatal Outcomes of Women With COVID-19 https://ClinicalTrials.gov/show/NCT04369859
NCT04369989 Observational Study of COVID-19 Treatment Efficacy https://ClinicalTrials.gov/show/NCT04369989
NCT04368793 Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge https://ClinicalTrials.gov/show/NCT04368793
NCT04368897 In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity https://ClinicalTrials.gov/show/NCT04368897
NCT04368871 Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study https://ClinicalTrials.gov/show/NCT04368871
NCT04368390 Neuroradiolological Analysis of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04368390
NCT04368312 Psychological Impairment Due to Covid-19 https://ClinicalTrials.gov/show/NCT04368312
NCT04367805 COVID-19 Infection in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04367805
NCT04367363 Social Media and COVID-19 https://ClinicalTrials.gov/show/NCT04367363
NCT04367129 Electrocardiogram Analysis in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04367129
NCT04367337 Health Behavior Change During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04367337
NCT04367064 To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study) https://ClinicalTrials.gov/show/NCT04367064
NCT04363788 Needle Stick Injuries in Emergency Medical Service Practice https://ClinicalTrials.gov/show/NCT04363788
NCT04363489 The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers) https://ClinicalTrials.gov/show/NCT04363489
NCT04363333 Obstructive Sleep Apnea & Covid-19 Outcomes https://ClinicalTrials.gov/show/NCT04363333
NCT04363268 ACCESS A Master Digital Surveillance Protocol for COVID-19 https://ClinicalTrials.gov/show/NCT04363268
NCT04363047 Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19 https://ClinicalTrials.gov/show/NCT04363047
NCT04363099 Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster. https://ClinicalTrials.gov/show/NCT04363099
NCT04362943 Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults https://ClinicalTrials.gov/show/NCT04362943
NCT04362930 Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences) https://ClinicalTrials.gov/show/NCT04362930
NCT04362345 Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04362345
NCT04362267 Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital https://ClinicalTrials.gov/show/NCT04362267
NCT04362150 Long-term Impact of Infection With Novel Coronavirus (COVID-19) https://ClinicalTrials.gov/show/NCT04362150
NCT04360707 Solid Organ Transplant Recipients With SARS-CoV-2 French Registry https://ClinicalTrials.gov/show/NCT04360707
NCT04360733 Precision Immunology to Determine the Immune Response in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04360733
NCT04360863 The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong https://ClinicalTrials.gov/show/NCT04360863
NCT04360538 Long Term Outcomes of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04360538
NCT04359914 Neurocognitive Impairment in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04359914
NCT04359836 A Study to Explore the Role of Gut Flora in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04359836
NCT04359667 Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab https://ClinicalTrials.gov/show/NCT04359667
NCT04359706 Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19 https://ClinicalTrials.gov/show/NCT04359706
NCT04359849 Sequencing and Tracking of Phylogeny in COVID-19 Study https://ClinicalTrials.gov/show/NCT04359849
NCT04358952 Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients https://ClinicalTrials.gov/show/NCT04358952
NCT04368884 Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04368884
NCT04368637 Acute Cardiovascular Events Triggered by COVID-19-Related Stress https://ClinicalTrials.gov/show/NCT04368637
NCT04368026 SARS-CoV-2 (COVID-19) and Surgery https://ClinicalTrials.gov/show/NCT04368026
NCT04368351 Bacteriotherapy in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04368351
NCT04368208 Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women’s Depression https://ClinicalTrials.gov/show/NCT04368208
NCT04367883 Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection https://ClinicalTrials.gov/show/NCT04367883
NCT04367402 COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION) https://ClinicalTrials.gov/show/NCT04367402
NCT04367142 Rapid Detection of COVID-19 by Portable and Connected Biosensor https://ClinicalTrials.gov/show/NCT04367142
NCT04366752 Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy https://ClinicalTrials.gov/show/NCT04366752
NCT04366778 Thrombosis and Covid-19 https://ClinicalTrials.gov/show/NCT04366778
NCT04366921 European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO https://ClinicalTrials.gov/show/NCT04366921
NCT04366934 Study of the Pathogenesis of Olfactory Disorders in COVID-19 https://ClinicalTrials.gov/show/NCT04366934
NCT04366154 Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers https://ClinicalTrials.gov/show/NCT04366154
NCT04365959 The Prone Position in Covid-19 Affected Patients https://ClinicalTrials.gov/show/NCT04365959
NCT04365881 Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology https://ClinicalTrials.gov/show/NCT04365881
NCT04365764 Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study https://ClinicalTrials.gov/show/NCT04365764
NCT04365816 NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30 https://ClinicalTrials.gov/show/NCT04365816
NCT04366024 A Novel Nomogram to Predict Severity of COVID-19 https://ClinicalTrials.gov/show/NCT04366024
NCT04365595 SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir) https://ClinicalTrials.gov/show/NCT04365595
NCT04365166 Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19) https://ClinicalTrials.gov/show/NCT04365166
NCT04365530 Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City https://ClinicalTrials.gov/show/NCT04365530
NCT04363008 COVID 19 Biomarkers https://ClinicalTrials.gov/show/NCT04363008
NCT04362995 St. Jude Tracking of Viral and Host Factors Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04362995
NCT04362319 Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04362319
NCT04361123 Atrium COVID-19 Syndromic and Serologic Surveillance https://ClinicalTrials.gov/show/NCT04361123
NCT04360954 Evaluation of Antibody Tests for COVID-19 https://ClinicalTrials.gov/show/NCT04360954
NCT04359121 COVID-19 and the Developement of Phobic Fears of Disease https://ClinicalTrials.gov/show/NCT04359121
NCT04359212 Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19 https://ClinicalTrials.gov/show/NCT04359212
NCT04358536 Classification of COVID-19 Infection in Posteroanterior Chest X-rays https://ClinicalTrials.gov/show/NCT04358536
NCT04358380 Liver Injury in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04358380
NCT04358029 Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04358029
NCT04357574 Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19 https://ClinicalTrials.gov/show/NCT04357574
NCT04357769 COVID-19 Pandemic Burden in Severe Mental Disease Patients https://ClinicalTrials.gov/show/NCT04357769
NCT04357418 Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives https://ClinicalTrials.gov/show/NCT04357418
NCT04357431 COVID-19 Among Egyptian Health Care Providers https://ClinicalTrials.gov/show/NCT04357431
NCT04358510 COVID-19 Mortality Prediction Model https://ClinicalTrials.gov/show/NCT04358510
NCT04357847 Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04357847
NCT04357834 WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories https://ClinicalTrials.gov/show/NCT04357834
NCT04357938 Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections https://ClinicalTrials.gov/show/NCT04357938
NCT04357535 Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives https://ClinicalTrials.gov/show/NCT04357535
NCT04370249 Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19 https://ClinicalTrials.gov/show/NCT04370249
NCT04356560 COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department https://ClinicalTrials.gov/show/NCT04356560
NCT04356443 Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04356443
NCT04356378 Long Term Physical Functional Limitations in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation https://ClinicalTrials.gov/show/NCT04356378
NCT04355741 Gut Microbiota, “Spark and Flame” of COVID-19 Disease https://ClinicalTrials.gov/show/NCT04355741
NCT04355338 Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA) https://ClinicalTrials.gov/show/NCT04355338
NCT04355481 Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit https://ClinicalTrials.gov/show/NCT04355481
NCT04355507 Computed Tomography for COVID-19 Diagnosis https://ClinicalTrials.gov/show/NCT04355507
NCT04355624 Kidney Involvement in COVID-19 Disease (COVKID) https://ClinicalTrials.gov/show/NCT04355624
NCT04354857 Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04354857
NCT04355611 Epidemiological Characteristics of COVID-19 in Patients With MS or NMO https://ClinicalTrials.gov/show/NCT04355611
NCT04355442 Evolution of Facial Trauma During COVID Containment Measures https://ClinicalTrials.gov/show/NCT04355442
NCT04354766 COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2 https://ClinicalTrials.gov/show/NCT04354766
NCT04354779 Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel. https://ClinicalTrials.gov/show/NCT04354779
NCT04354272 Evaluation of Dental Emergency Treatments During COVID19 Crisis https://ClinicalTrials.gov/show/NCT04354272
NCT04353609 Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases https://ClinicalTrials.gov/show/NCT04353609
NCT04353011 Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04353011
NCT04353141 International Lung UltraSound Analysis (ILUSA) Study https://ClinicalTrials.gov/show/NCT04353141
NCT04352582 COVID-19 and Vaccination Attitudes https://ClinicalTrials.gov/show/NCT04352582
NCT04352491 An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease https://ClinicalTrials.gov/show/NCT04352491
NCT04352842 Echocardiographic Manifestation in Patient With COVID-19 (EARLY-MYO COVID-19) https://ClinicalTrials.gov/show/NCT04352842
NCT04352634 The Covid-19 HEalth caRe wOrkErS (HEROES) Study https://ClinicalTrials.gov/show/NCT04352634
NCT04352556 COVID19-hematological Malignancies: the Italian Hematology Alliance https://ClinicalTrials.gov/show/NCT04352556
NCT04351633 Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04351633
NCT04351711 Immunological Profiling of Patients With COVID-19 in Respiratory Distress https://ClinicalTrials.gov/show/NCT04351711
NCT04351659 Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04351659
NCT04351854 Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room https://ClinicalTrials.gov/show/NCT04351854
NCT04351503 A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19 https://ClinicalTrials.gov/show/NCT04351503
NCT04351399 Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04351399
NCT04351568 Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics; https://ClinicalTrials.gov/show/NCT04351568
NCT04351139 Impact of the COVID-19 Pandemic in Gynecological Oncology https://ClinicalTrials.gov/show/NCT04351139
NCT04350710 Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS https://ClinicalTrials.gov/show/NCT04350710
NCT04350099 Emotional Burden of Healthcare Professionals and Covid Infection 19 https://ClinicalTrials.gov/show/NCT04350099
NCT04349202 Beaumont Health Large-scale Automated Serologic Testing for COVID-19 https://ClinicalTrials.gov/show/NCT04349202
NCT04349163 Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort. https://ClinicalTrials.gov/show/NCT04349163
NCT04348422 Evaluating the Immune Response for COVID-19 https://ClinicalTrials.gov/show/NCT04348422
NCT04348552 Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study https://ClinicalTrials.gov/show/NCT04348552
NCT04348396 Clinical and Biological Predictors of COVID-19 Disease in Older Patients https://ClinicalTrials.gov/show/NCT04348396
NCT04347876 Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis? https://ClinicalTrials.gov/show/NCT04347876
NCT04347850 A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04347850
NCT04347460 Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH https://ClinicalTrials.gov/show/NCT04347460
NCT04347369 A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease https://ClinicalTrials.gov/show/NCT04347369
NCT04347694 Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic. https://ClinicalTrials.gov/show/NCT04347694
NCT04347070 Implementation of Physiotherapy on COVID-19 Patients in ICU https://ClinicalTrials.gov/show/NCT04347070
NCT04346602 A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019 https://ClinicalTrials.gov/show/NCT04346602
NCT04346264 CoVid-19 - Infection and Antibody Formation in the Viennese Population https://ClinicalTrials.gov/show/NCT04346264
NCT04346212 Oropharyngeal Dysphagia in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04346212
NCT04346186 COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff https://ClinicalTrials.gov/show/NCT04346186
NCT04345510 Testing for COVID-19 Infection in Asymptomatic Persons https://ClinicalTrials.gov/show/NCT04345510
NCT04346056 Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19 https://ClinicalTrials.gov/show/NCT04346056
NCT04345640 The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver. https://ClinicalTrials.gov/show/NCT04345640
NCT04344964 Endoscopy-related Phone Consultation During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04344964
NCT04345159 Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease https://ClinicalTrials.gov/show/NCT04345159
NCT04345315 Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent. https://ClinicalTrials.gov/show/NCT04345315
NCT04344925 Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19 https://ClinicalTrials.gov/show/NCT04344925
NCT04344834 Short and Long-term Psychological Impact of Covid-19 on The Egyptians https://ClinicalTrials.gov/show/NCT04344834
NCT04344171 CovidDB: The Covid-19 Inpatient Database https://ClinicalTrials.gov/show/NCT04344171
NCT04344119 Assessment of Chilbains Occuring During Covid-19 Infection https://ClinicalTrials.gov/show/NCT04344119
NCT04343742 Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19 https://ClinicalTrials.gov/show/NCT04343742
NCT04342637 COVID-19 Endoscopy Survey https://ClinicalTrials.gov/show/NCT04342637
NCT04342104 NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure https://ClinicalTrials.gov/show/NCT04342104
NCT04341714 Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04341714
NCT04341792 Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient https://ClinicalTrials.gov/show/NCT04341792
NCT04341506 Non-contact ECG Sensor System for COVID19 https://ClinicalTrials.gov/show/NCT04341506
NCT04341480 The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19 https://ClinicalTrials.gov/show/NCT04341480
NCT04341519 Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers https://ClinicalTrials.gov/show/NCT04341519
NCT04341012 Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases https://ClinicalTrials.gov/show/NCT04341012
NCT04340219 Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04340219
NCT04340921 The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury https://ClinicalTrials.gov/show/NCT04340921
NCT04339634 Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy https://ClinicalTrials.gov/show/NCT04339634
NCT04339998 Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS) https://ClinicalTrials.gov/show/NCT04339998
NCT04339608 Max COVID19- Study https://ClinicalTrials.gov/show/NCT04339608
NCT04339686 Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening. https://ClinicalTrials.gov/show/NCT04339686
NCT04338672 The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients https://ClinicalTrials.gov/show/NCT04338672
NCT04338945 Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy https://ClinicalTrials.gov/show/NCT04338945
NCT04337151 Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment https://ClinicalTrials.gov/show/NCT04337151
NCT04337502 Clinical and Radiomic Model of COVID-19 https://ClinicalTrials.gov/show/NCT04337502
NCT04337424 Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04337424
NCT04337190 Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2) https://ClinicalTrials.gov/show/NCT04337190
NCT04336761 Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France https://ClinicalTrials.gov/show/NCT04336761
NCT04336657 Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease? https://ClinicalTrials.gov/show/NCT04336657
NCT04337047 Distress in Crisis Situations During COVID-19 https://ClinicalTrials.gov/show/NCT04337047
NCT04335747 COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases https://ClinicalTrials.gov/show/NCT04335747
NCT04335630 Cardiovascular Manifestations of COVID-19 https://ClinicalTrials.gov/show/NCT04335630
NCT04335162 Cardiovascular Complications and COVID-19 (CovCardioVasc-Study) https://ClinicalTrials.gov/show/NCT04335162
NCT04335188 COVID-19 Registry Rhineland-Palatinate (Germany) https://ClinicalTrials.gov/show/NCT04335188
NCT04332913 Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia https://ClinicalTrials.gov/show/NCT04332913
NCT04332016 COVID-19 Biological Samples Collection https://ClinicalTrials.gov/show/NCT04332016
NCT04331509 COVID-19 Symptom Tracker https://ClinicalTrials.gov/show/NCT04331509
NCT04331106 Survey of the Anxiety Associated With the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04331106
NCT04330599 Longitudinal Population-based Observational Study of COVID-19 in the UK Population https://ClinicalTrials.gov/show/NCT04330599
NCT04330521 Impact of the Coronavirus (COVID-19) on Patients With Cancer https://ClinicalTrials.gov/show/NCT04330521
NCT04330261 Clinical Characteristics and Outcomes of Pediatric COVID-19 https://ClinicalTrials.gov/show/NCT04330261
NCT04329546 Understanding COVID-19 https://ClinicalTrials.gov/show/NCT04329546
NCT04328454 Clinical Characteristics and Prognostic Factors of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04328454
NCT04327804 A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research https://ClinicalTrials.gov/show/NCT04327804
NCT04326387 Evaluation of Novel Diagnostic Tests for COVID-19 https://ClinicalTrials.gov/show/NCT04326387
NCT04327180 PREdiction of DIagnosed Covid-19 infecTion in IUC Patients https://ClinicalTrials.gov/show/NCT04327180
NCT04325919 Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong https://ClinicalTrials.gov/show/NCT04325919
NCT04326725 Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT04326725
NCT04325646 Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France https://ClinicalTrials.gov/show/NCT04325646
NCT04324736 “COVID-19 and Diabetes Outcomes” https://ClinicalTrials.gov/show/NCT04324736
NCT04323787 Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry https://ClinicalTrials.gov/show/NCT04323787
NCT04323644 Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg) https://ClinicalTrials.gov/show/NCT04323644
NCT04322188 An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications https://ClinicalTrials.gov/show/NCT04322188
NCT04322279 Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19. https://ClinicalTrials.gov/show/NCT04322279
NCT04322487 Simple, Safe, Same: Lung Ultrasound for COVID-19 https://ClinicalTrials.gov/show/NCT04322487
NCT04320017 Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04320017
NCT04319315 Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak https://ClinicalTrials.gov/show/NCT04319315
NCT04316949 Predictors of Respiratory Failure in SARS-Cov-2 Infection https://ClinicalTrials.gov/show/NCT04316949
NCT04314817 Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04314817
NCT04313946 Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays https://ClinicalTrials.gov/show/NCT04313946
NCT04314232 Mechanisms for Covid-19 Disease Complications https://ClinicalTrials.gov/show/NCT04314232
NCT04312464 Myocardial Damage in COVID-19 https://ClinicalTrials.gov/show/NCT04312464
NCT04312100 Sequential Oxygen Therapy Strategy for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04312100
NCT04307459 Acute Respiratory Failure and COVID-19 in Real Life https://ClinicalTrials.gov/show/NCT04307459
NCT04306705 Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19 https://ClinicalTrials.gov/show/NCT04306705
NCT04306497 TCM Differentiation and Treatment Protocol of COVID-19 https://ClinicalTrials.gov/show/NCT04306497
NCT04305574 Social Media Use During COVID-19 https://ClinicalTrials.gov/show/NCT04305574
NCT04302688 Accurate Classification System for Patients With COVID-19 Pneumonitis https://ClinicalTrials.gov/show/NCT04302688
NCT04292340 Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04292340
NCT04284046 CT Scores Predict Mortality in 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04284046
NCT04279899 The Investigation of the Neonates With or With Risk of COVID-19 https://ClinicalTrials.gov/show/NCT04279899
NCT04283396 Study for Novel Coronavirus Pneumonia (NCP) https://ClinicalTrials.gov/show/NCT04283396
NCT04282135 Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling https://ClinicalTrials.gov/show/NCT04282135
NCT04279782 Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04279782
NCT04279795 Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations https://ClinicalTrials.gov/show/NCT04279795
NCT04275947 The COVID-19 Mobile Health Study (CMHS) https://ClinicalTrials.gov/show/NCT04275947
NCT04274322 Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool https://ClinicalTrials.gov/show/NCT04274322
NCT04262921 French COVID Cohort https://ClinicalTrials.gov/show/NCT04262921
NCT04259892 Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19. https://ClinicalTrials.gov/show/NCT04259892
NCT04260308 A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04260308
NCT04255940 2019-nCoV Outbreak and Cardiovascular Diseases https://ClinicalTrials.gov/show/NCT04255940
NCT05076240 FilmArray® and Management of Ventilator Associated Pneumonia in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT05076240
NCT05076227 SARS-CoV-2 (COVID-19) Vaccine Tolerability and Clinical Outcome Among Hospital Staff https://ClinicalTrials.gov/show/NCT05076227
NCT04834869 COVID-19 Vaccines Safety Tracking (CoVaST) https://ClinicalTrials.gov/show/NCT04834869
NCT04854824 A Simple Approach to Prevent Hospitalization for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04854824
NCT05069090 Effect of COVID-19 Lockdown on Alcohol and Tobacco Use in Two Chilean Universities https://ClinicalTrials.gov/show/NCT05069090
NCT05077319 Characteristics and Outcome of Patients With COVID-19 in ICUs in South Tyrol https://ClinicalTrials.gov/show/NCT05077319
NCT05075629 Mental Health in Undergraduate Health Science Students During the Covid-19 Pandemic. https://ClinicalTrials.gov/show/NCT05075629
NCT05080192 Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors - Effect of Fenofibrate https://ClinicalTrials.gov/show/NCT05080192
NCT05077163 Patients With Acute Renal Failure During Severe COVID-19 https://ClinicalTrials.gov/show/NCT05077163
NCT05067400 SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort https://ClinicalTrials.gov/show/NCT05067400
NCT04894448 Immunogenicity of COVID-19 Vaccination in PLWH https://ClinicalTrials.gov/show/NCT04894448
NCT04880720 Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT04880720
NCT04551690 Prevalence of COVID-19 (Coronavirus Disease 19) in Pregnant Women on Labor in a Public Hospital in Chile (COroNavirus diSease Covid-19 pandEmic iN ChilE) https://ClinicalTrials.gov/show/NCT04551690
NCT04366167 Patient Recovery From Heart Surgery During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04366167
NCT04353934 The Ariel University Survey on Dietary Changes and Anxiety During the Coronavirus Pandemic https://ClinicalTrials.gov/show/NCT04353934
NCT04351802 CORonavirus (COVID-19) Diagnostic Lung UltraSound Study https://ClinicalTrials.gov/show/NCT04351802
NCT05080933 ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS https://ClinicalTrials.gov/show/NCT05080933
NCT04336787 Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine https://ClinicalTrials.gov/show/NCT04336787
NCT05082168 Capnodynamic Monitoring of Cardiorespiratory Function in Critically Ill Patients https://ClinicalTrials.gov/show/NCT05082168
NCT05026788 Impact of COVID-19 Pandemic on Orthopaedic Practice https://ClinicalTrials.gov/show/NCT05026788
NCT04666246 Inspiratory Effort in COVID-19 https://ClinicalTrials.gov/show/NCT04666246
NCT05083039 Observational Program, Double-blind, Placebo-controlled to Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19 https://ClinicalTrials.gov/show/NCT05083039
NCT05083026 Neutralizing Antibody Level After COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT05083026
NCT04880447 Special Investigation of COMIRNATY in the Population With Underlying Diseases https://ClinicalTrials.gov/show/NCT04880447
NCT04910243 The Practice of Providing Palliative Care in the Situation of the COVID-19 (Coronavirus Disease 2019) Pandemic in Czech Republic https://ClinicalTrials.gov/show/NCT04910243
NCT04492384 Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients https://ClinicalTrials.gov/show/NCT04492384
NCT04384029 The Geneva Covid-19 CVD Study https://ClinicalTrials.gov/show/NCT04384029
NCT05087277 Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain https://ClinicalTrials.gov/show/NCT05087277
NCT05085652 Spinal Anesthesia Related Hypotension in SARS-CoV-2 (COVID-19) Pregnant Patients https://ClinicalTrials.gov/show/NCT05085652
NCT05085262 Cardiovascular Disease and Outcomes Among Patients With SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT05085262
NCT05084950 Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc) https://ClinicalTrials.gov/show/NCT05084950
NCT05074017 COVAG - Covid-19 Antigen Study - the Diagnostic Efficacy of SARS-CoV-2 Rapid Detection Tests https://ClinicalTrials.gov/show/NCT05074017
NCT05058339 Distress Associated With Coronavirus Disease 2019 and Telehealth on Supportive Care Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT05058339
NCT04669054 Hospital Interns Psychological State During the COVID-19 https://ClinicalTrials.gov/show/NCT04669054
NCT04761913 Paediatric Inflammatory Multisystem Syndrome During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04761913
NCT05089578 Integrative Treatment Methods in COVID-19 https://ClinicalTrials.gov/show/NCT05089578
NCT05089968 Ventilation Associated Pneumonia and Covid-19 https://ClinicalTrials.gov/show/NCT05089968
NCT05088941 Impact of SARSCoV2 on Allogeneic Stem Cell Transplantation Organization : a French Experience https://ClinicalTrials.gov/show/NCT05088941
NCT05070091 The Impact of Pituitary-thyroid and Pituitary-adrenal Axes Function on COVID-19 Clinical Course. https://ClinicalTrials.gov/show/NCT05070091
NCT05065827 Lung Ultrasound Findings in Patients With COVID-19 in a UK ED https://ClinicalTrials.gov/show/NCT05065827
NCT05080231 COVID-19 Immunity Assessment https://ClinicalTrials.gov/show/NCT05080231
NCT04962347 Real World Study of COVID-19 in a Flyover Region https://ClinicalTrials.gov/show/NCT04962347
NCT04866082 Corticosteroids in Severe COVID-19 (ASAP-ESICM/ESAIC Study) https://ClinicalTrials.gov/show/NCT04866082
NCT04379284 Risks of COVID19 in the Pregnant Population https://ClinicalTrials.gov/show/NCT04379284
NCT05074953 Post-COVID-19 Monitoring in Routine Health Insurance Data https://ClinicalTrials.gov/show/NCT05074953
NCT04657263 Impact of the COVID-19 Pandemic on Vaccination https://ClinicalTrials.gov/show/NCT04657263
NCT05067985 SARS-CoV-2 PANDEMIC AND FAILED SPINAL ANESTHESIA https://ClinicalTrials.gov/show/NCT05067985
NCT04974164 Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic https://ClinicalTrials.gov/show/NCT04974164
NCT04798625 Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication https://ClinicalTrials.gov/show/NCT04798625
NCT04590794 SuPAR in Adult Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04590794
NCT04689490 Prospective Study of Persistent Dyspnea in Recovered COVID-19 Patients https://ClinicalTrials.gov/show/NCT04689490
NCT04350073 Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID) https://ClinicalTrials.gov/show/NCT04350073
NCT04322513 Biomarkers for Identification of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04322513
NCT04316884 Mechanisms for Organ Dysfunction in Covid-19 https://ClinicalTrials.gov/show/NCT04316884
NCT04993560 Safety and Efficacy of COVID-19 Prime-boost Vaccine in Bahrain https://ClinicalTrials.gov/show/NCT04993560
NCT04728919 Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04728919
NCT04726176 COVID-19 and the Brain https://ClinicalTrials.gov/show/NCT04726176
NCT04664309 Understanding Immunity to the COVID-19 Vaccines https://ClinicalTrials.gov/show/NCT04664309
NCT04474249 Follow-up of Critical COVID-19 Patients https://ClinicalTrials.gov/show/NCT04474249
NCT04526977 Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis). https://ClinicalTrials.gov/show/NCT04526977
NCT04402827 Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19. https://ClinicalTrials.gov/show/NCT04402827
NCT05096819 Evaluation of the Usefulness of Adopting Remote, Mobile-based 6MWT Among Hospital Outpatients (the 6-APPnow), Within the Constraints Imposed by the SARS-COV2 Pandemic https://ClinicalTrials.gov/show/NCT05096819
NCT05087290 LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR) https://ClinicalTrials.gov/show/NCT05087290
NCT04319172 Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients https://ClinicalTrials.gov/show/NCT04319172
NCT05096858 Continuous Glucose Monitorization in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05096858
NCT05069389 Registry of Management Strategies for Patients With COVID-19 in Healthcare Establishments https://ClinicalTrials.gov/show/NCT05069389
NCT05025514 Retrospective Study of COVID-19 Vaccines in Patients Undergoing Immunotherapy for Cancer. https://ClinicalTrials.gov/show/NCT05025514
NCT04858568 Immune Responses to COVID-19 Vaccination in Lymphoma Patients https://ClinicalTrials.gov/show/NCT04858568
NCT04813328 The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms https://ClinicalTrials.gov/show/NCT04813328
NCT04462393 Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19 https://ClinicalTrials.gov/show/NCT04462393
NCT05097664 Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran https://ClinicalTrials.gov/show/NCT05097664
NCT05069116 The Impact of Covid 19 Pandemic on the Training of General Surgery Residents https://ClinicalTrials.gov/show/NCT05069116
NCT04818164 Prone Position Improves End-Expiratory Lung Volumes in COVID-19 Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04818164
NCT04853004 Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations https://ClinicalTrials.gov/show/NCT04853004
NCT04753242 Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals https://ClinicalTrials.gov/show/NCT04753242
NCT05087355 Health Status Prior and Post Infection With Influenza or COVID 19: a Population Based Retrospective Analysis of 2016-2021 https://ClinicalTrials.gov/show/NCT05087355
NCT05054218 COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients https://ClinicalTrials.gov/show/NCT05054218
NCT04360850 Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04360850
NCT05102656 Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT05102656
NCT04904692 Virological and Immunological Monitoring in Patients (Suspected of/Confirmed With) COVID-19 https://ClinicalTrials.gov/show/NCT04904692
NCT04692779 A Prospective Clinical Study to Explore Response to Prone Positioning in ARDS Patients https://ClinicalTrials.gov/show/NCT04692779
NCT04596098 Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine. https://ClinicalTrials.gov/show/NCT04596098
NCT04637295 Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19 https://ClinicalTrials.gov/show/NCT04637295
NCT04764773 Persistence of Symptoms After Improvement of Acute COVID-19 https://ClinicalTrials.gov/show/NCT04764773
NCT04477473 Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group https://ClinicalTrials.gov/show/NCT04477473
NCT04472013 Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19 https://ClinicalTrials.gov/show/NCT04472013
NCT05060692 Changes of NLF in Serum of Long COVID Patients https://ClinicalTrials.gov/show/NCT05060692
NCT05137249 The Glycocalyx in COVID-19 Patients. A Pilot Study https://ClinicalTrials.gov/show/NCT05137249
NCT05104398 Hemoperfusion With the Efferon CT Extracorporeal Adsorbers in Patients With Severe Covid-19 https://ClinicalTrials.gov/show/NCT05104398
NCT05092529 Psychological Impact of COVID-19 on Intensive Care Survivors https://ClinicalTrials.gov/show/NCT05092529
NCT05079191 Impact of the CT Scan in Patients With Suspected Covid-19 https://ClinicalTrials.gov/show/NCT05079191
NCT05079165 Covid Vaccination in Liver Transplantation https://ClinicalTrials.gov/show/NCT05079165
NCT04568499 Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings https://ClinicalTrials.gov/show/NCT04568499
NCT04847596 A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab https://ClinicalTrials.gov/show/NCT04847596
NCT04611230 A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It’s Affect on Quality of Life in Adult Volunteers in Lake County, Illinois https://ClinicalTrials.gov/show/NCT04611230
NCT04418609 Neuro-COVID-19: Neurological Complications of COVID-19 https://ClinicalTrials.gov/show/NCT04418609
NCT04336215 Rutgers COVID-19 Cohort Study https://ClinicalTrials.gov/show/NCT04336215
NCT05092737 Physiological Response to Prone Position in COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) https://ClinicalTrials.gov/show/NCT05092737
NCT05107258 A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care https://ClinicalTrials.gov/show/NCT05107258
NCT04665245 Symptom-Based Markers for COVID-19 Transmission https://ClinicalTrials.gov/show/NCT04665245
NCT04558320 COVID-19 and Lactating Mothers https://ClinicalTrials.gov/show/NCT04558320
NCT05109585 Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study https://ClinicalTrials.gov/show/NCT05109585
NCT05109572 The Impact of the Covid-19 Pandemic on Schizophrenia Patients Registered With the Community Mental Health Center https://ClinicalTrials.gov/show/NCT05109572
NCT05104411 Rehabilitation in Severely Ill Inpatients With COVID-19: A Retrospective Cohort Study https://ClinicalTrials.gov/show/NCT05104411
NCT04791436 Oral and Olfactory Complications of Recovered COVID-19 Patients https://ClinicalTrials.gov/show/NCT04791436
NCT04821986 Oral Manifestation in Patients With SARS-CoV2 Infection. https://ClinicalTrials.gov/show/NCT04821986
NCT04760639 COVID Breath Test - Ancon https://ClinicalTrials.gov/show/NCT04760639
NCT04697927 A Study of Risk Factors for the COVID-19 Virus Infection https://ClinicalTrials.gov/show/NCT04697927
NCT05110859 QUALITATIVE SURVEY ABOUT NURSES FIRST WORK EXPERIENCE DURING COVID-19 PANDEMIC https://ClinicalTrials.gov/show/NCT05110859
NCT05084976 Parental Perception of COVID-19 Vaccine in Technology Dependent Patients https://ClinicalTrials.gov/show/NCT05084976
NCT04992234 COVID-19 Antibody Responses in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04992234
NCT05087225 Suspicion of Hypoglycemic Effect of mRNA Based Covid-19 Vaccines (Polyethylene Glycol) Will Happen , Observational Study on Diabetic Patients at Saudia Arabia https://ClinicalTrials.gov/show/NCT05087225
NCT04967820 Burn-out Among Chinese Anaesthesiologist After COVID-19 Pandemic Peak and Its Protective Factor: a National Survey https://ClinicalTrials.gov/show/NCT04967820
NCT04586413 Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg) https://ClinicalTrials.gov/show/NCT04586413
NCT05115617 Pregnant and Lactating Individuals & Newborns COVID-19 Vaccination Prospective Cohort Study https://ClinicalTrials.gov/show/NCT05115617
NCT05115526 PEEP Setting in COVID19-related ARDS https://ClinicalTrials.gov/show/NCT05115526
NCT05115370 Vaccination Perception in Inflammatory Conditions https://ClinicalTrials.gov/show/NCT05115370
NCT05102669 Spike-specific Cellular Immune Response After COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT05102669
NCT05113472 Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers https://ClinicalTrials.gov/show/NCT05113472
NCT05104385 Hacettepe University COVID-19 Vaccinated’s Health Cohort- Students of Health Sciences https://ClinicalTrials.gov/show/NCT05104385
NCT05104359 COVID-19 Quantitative Antibody Titers & Booster Vaccinations https://ClinicalTrials.gov/show/NCT05104359
NCT05096962 COVID-19: SARS-CoV-2-CZ-PREVAL-II Study https://ClinicalTrials.gov/show/NCT05096962
NCT05062538 Cancer Patient Perspectives During COVID-19 https://ClinicalTrials.gov/show/NCT05062538
NCT04828460 Monitoring of COVID-19 Vaccine Response in Organ Transplant Patients https://ClinicalTrials.gov/show/NCT04828460
NCT04771624 Assessment of Executive Functions After Covid-19 https://ClinicalTrials.gov/show/NCT04771624
NCT04733105 Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04733105
NCT04583319 Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04583319
NCT04569344 COVID-19 and Venous Thromboembolism Risk https://ClinicalTrials.gov/show/NCT04569344
NCT04506515 Psychological Impact of COVID-19 Pandemic in Healthcare Workers https://ClinicalTrials.gov/show/NCT04506515
NCT05116748 COVID19 Vaccine in SOT Adult Recipients https://ClinicalTrials.gov/show/NCT05116748
NCT05020691 NIV in Covid-19 Respiratory Failure https://ClinicalTrials.gov/show/NCT05020691
NCT05009030 Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients https://ClinicalTrials.gov/show/NCT05009030
NCT04904445 COVID-19 Antibody Responses In Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04904445
NCT04420637 Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases https://ClinicalTrials.gov/show/NCT04420637
NCT04701515 Cardiovascular Manifestations of COVID-19 https://ClinicalTrials.gov/show/NCT04701515
NCT04477889 Methodist Health System COVID-19 Patient Registry https://ClinicalTrials.gov/show/NCT04477889
NCT04667923 Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome https://ClinicalTrials.gov/show/NCT04667923
NCT04407143 Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection https://ClinicalTrials.gov/show/NCT04407143
NCT04457817 Compensatory Reserve Index (CRI) for Management of COVID-19 https://ClinicalTrials.gov/show/NCT04457817
NCT05119738 Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment https://ClinicalTrials.gov/show/NCT05119738
NCT05125510 The Canadian COVID-19 Prospective Cohort Study https://ClinicalTrials.gov/show/NCT05125510
NCT05038475 Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19 https://ClinicalTrials.gov/show/NCT05038475
NCT04385160 Myeloproliferative Neoplasms (MPN) and COVID-19 https://ClinicalTrials.gov/show/NCT04385160
NCT05119543 Refractive Error in Chinese Students https://ClinicalTrials.gov/show/NCT05119543
NCT05119465 COVID-19 Clinical Status Associated With Outcome Severity: An Unsupervised Machine Learning Approach https://ClinicalTrials.gov/show/NCT05119465
NCT05077228 Efficiency of the Imaging Strategy for the Management of Suspected Covid-19 https://ClinicalTrials.gov/show/NCT05077228
NCT04791462 COVID-19 in Osteoarthritis Patients https://ClinicalTrials.gov/show/NCT04791462
NCT04786808 Risk Factors for COVID-19 Mortality https://ClinicalTrials.gov/show/NCT04786808
NCT04542083 Covid-19, Acute Myocardial Infarctions and Strokes in France https://ClinicalTrials.gov/show/NCT04542083
NCT05121662 COVID-19 Vaccine Biomarker Study in Multiple Sclerosis https://ClinicalTrials.gov/show/NCT05121662
NCT05052294 COVID-19 Antibody Responses in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT05052294
NCT05122208 Famotidine in Covid-19 Intensive Care Unit https://ClinicalTrials.gov/show/NCT05122208
NCT04888793 Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort Study https://ClinicalTrials.gov/show/NCT04888793
NCT04497636 Mental Health Impact of the COVID-19 Pandemic Among Migrants in Chile https://ClinicalTrials.gov/show/NCT04497636
NCT04456933 Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study https://ClinicalTrials.gov/show/NCT04456933
NCT05123573 Self-Perceived in Medical Students Undergoing Distance Learning https://ClinicalTrials.gov/show/NCT05123573
NCT05109546 Geriatric COVID-19 Serology https://ClinicalTrials.gov/show/NCT05109546
NCT05124197 Extended Prone Position Duration COVID-19-related ARDS: a Retrospective Study https://ClinicalTrials.gov/show/NCT05124197
NCT04760795 Stress, Personality, Attachment and Coping During the Covid Crisis. https://ClinicalTrials.gov/show/NCT04760795
NCT04377685 Prediction of Clinical Course in COVID19 Patients https://ClinicalTrials.gov/show/NCT04377685
NCT05079178 Newborns in Level III Services in Alsace From Mothers With COVID-19 https://ClinicalTrials.gov/show/NCT05079178
NCT05124613 The Impact of Covid-19 on Patients Waiting for Knee Surgery https://ClinicalTrials.gov/show/NCT05124613
NCT05124587 Prediction for Critical Outcomes of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT05124587
NCT05125770 Study on the Fetal Safety of New Coronavirus Vaccination for Couples During the Peri-pregnancy Period https://ClinicalTrials.gov/show/NCT05125770
NCT04826770 Adaptive Immune Response to COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT04826770
NCT04766645 ACE2 Gender Differences in Stroke With COVID-19 https://ClinicalTrials.gov/show/NCT04766645
NCT04805840 Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen https://ClinicalTrials.gov/show/NCT04805840
NCT04448145 Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence https://ClinicalTrials.gov/show/NCT04448145
NCT04437706 Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling https://ClinicalTrials.gov/show/NCT04437706
NCT04367870 COVID-19 Detection Test in Oncology https://ClinicalTrials.gov/show/NCT04367870
NCT05128695 Public Health Consequences of Covid-19 https://ClinicalTrials.gov/show/NCT05128695
NCT04401371 Distance and Hybrid Learning for Dental Student During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04401371
NCT04400877 Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04400877
NCT05128435 Coronavirus Pediatric Serological Study https://ClinicalTrials.gov/show/NCT05128435
NCT04864535 A Pilot Study for the Collection Of Vocalized, Individual Digital Cough Sound Recordings to Screen for COVID-19 https://ClinicalTrials.gov/show/NCT04864535
NCT04583761 Tobacco and Nicotine Consumption and the Risk of Acquisition of Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04583761
NCT05126641 Analysis of Emergency Department Visits According to Incidence of Covid-19 https://ClinicalTrials.gov/show/NCT05126641
NCT05041764 RNA Sequencing of Individual Versus Wastewater - SARS-CoV2 https://ClinicalTrials.gov/show/NCT05041764
NCT05130320 Severe Asthma Covid Vaccine Response Study https://ClinicalTrials.gov/show/NCT05130320
NCT05131594 Evaluating the Response of the Immune System of People With Long COVID https://ClinicalTrials.gov/show/NCT05131594
NCT05130749 Infection Prevention and Control Practices Regarding COVID-19 https://ClinicalTrials.gov/show/NCT05130749
NCT04918888 COVID-19 Vaccination in Oncologic Patients https://ClinicalTrials.gov/show/NCT04918888
NCT04896957 Perceptions and Representations of Vaccination Against COVID-19 https://ClinicalTrials.gov/show/NCT04896957
NCT04826640 Observational Maternal COVID-19 Vaccination Study https://ClinicalTrials.gov/show/NCT04826640
NCT04757272 Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019? https://ClinicalTrials.gov/show/NCT04757272
NCT04587323 VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease https://ClinicalTrials.gov/show/NCT04587323
NCT04372056 The COVID-ICU Healthcare Professional Study https://ClinicalTrials.gov/show/NCT04372056
NCT04596579 SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida https://ClinicalTrials.gov/show/NCT04596579
NCT04427280 Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04427280
NCT04539834 Electrolyte State in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04539834
NCT05047822 Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in England https://ClinicalTrials.gov/show/NCT05047822
NCT05124223 Analysis of Cardiac Damage Post Infection With SARS-CoV-2 and Post Vaccination Against COVID-19 https://ClinicalTrials.gov/show/NCT05124223
NCT04998799 Practice Variation on Antithrombotics in COVID-19 https://ClinicalTrials.gov/show/NCT04998799
NCT04821908 Consequences of COVID 19 Pandemic on Childhood Asthma https://ClinicalTrials.gov/show/NCT04821908
NCT04655521 Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04655521
NCT04384705 HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital https://ClinicalTrials.gov/show/NCT04384705
NCT04468386 Specimen Collection Study Protocol https://ClinicalTrials.gov/show/NCT04468386
NCT05124145 Primary Care in AURA for COVID-19 https://ClinicalTrials.gov/show/NCT05124145
NCT04992221 Arterial Line Patency in ICU Bound COVID-19 Patients https://ClinicalTrials.gov/show/NCT04992221
NCT04930016 Quality of Life and Survival of Patients With Colorectal Cancer 5 Years After Surgery - Follow-up of the RCT DIQOL https://ClinicalTrials.gov/show/NCT04930016
NCT04970550 Vaccination Against SARS-Cov2 (COVID-19) in Chronic Inflammatory Rheumatism and Factors Determining Its Decision. https://ClinicalTrials.gov/show/NCT04970550
NCT04913948 Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada https://ClinicalTrials.gov/show/NCT04913948
NCT04799834 Genotype and Susceptibility to COVID-19 https://ClinicalTrials.gov/show/NCT04799834
NCT04776005 COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies https://ClinicalTrials.gov/show/NCT04776005
NCT04513210 Reliability of Standardized Protocol of Ultrasound of the Lungs in Prediction of Severity of Covid-19 Infection https://ClinicalTrials.gov/show/NCT04513210
NCT04438863 Daily Home Spirometry for Early Detection of Pulmonary Complications in Patients With COVID19 https://ClinicalTrials.gov/show/NCT04438863
NCT04389684 Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors https://ClinicalTrials.gov/show/NCT04389684
NCT05137535 A Study of the Infection and Transmission of SARS-CoV-2 in Paediatric Patients https://ClinicalTrials.gov/show/NCT05137535
NCT05079373 Study of Neurological Damage From Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT05079373
NCT05137405 THE IMPACT OF COVID-19 AMONG OBESE PATIENTS https://ClinicalTrials.gov/show/NCT05137405
NCT04365348 The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families https://ClinicalTrials.gov/show/NCT04365348
NCT05072496 Study on Antibody Persistence and Immune Memory of Inactivated COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05072496
NCT05068375 Unleash the Mystery of COVID-19 Related Unusual Thrombosis https://ClinicalTrials.gov/show/NCT05068375
NCT05067907 Efficacy of Respiratory Physiotherapy on Severe ICU-admitted COVID-19 Patients. https://ClinicalTrials.gov/show/NCT05067907
NCT05067959 Covid-19 Vaccine Responses in Patients With Inflammatory Bowel Diseases https://ClinicalTrials.gov/show/NCT05067959
NCT05067881 Post-COVID-19 Pneumo-hematocele https://ClinicalTrials.gov/show/NCT05067881
NCT05065788 Ophthalmological Emergencies and COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT05065788
NCT05063812 Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT05063812
NCT05062603 Lung Ultrasound Changes in Covid 19 Patients Discharged From Hospital https://ClinicalTrials.gov/show/NCT05062603
NCT05065658 Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients https://ClinicalTrials.gov/show/NCT05065658
NCT05059080 A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study https://ClinicalTrials.gov/show/NCT05059080
NCT05062525 Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients https://ClinicalTrials.gov/show/NCT05062525
NCT05060926 Intubation Prediction in COVID-19 Patients Treated With Awake Prone Positioning https://ClinicalTrials.gov/show/NCT05060926
NCT05060497 DYNamic Assessment of Multi Organ Level Dysfunction in Patients Recovering From Covid-19 https://ClinicalTrials.gov/show/NCT05060497
NCT05060354 COVID Vaccine Response in MS https://ClinicalTrials.gov/show/NCT05060354
NCT05059184 Long-term Sequelae of COVID-19 (Myalgic Encephalomyelitis): An International Cross-Sectional Study https://ClinicalTrials.gov/show/NCT05059184
NCT05058716 Assessment of Clinical Effects of Coenzyme Q10 Levels in COVID-19 Patients in Intensive Care Unit https://ClinicalTrials.gov/show/NCT05058716
NCT05058729 MS PATHS COVID-19 Questionnaire Data Linkage Sub-Study https://ClinicalTrials.gov/show/NCT05058729
NCT05057962 Tocilizumab in Covid-19 Penumonia in Buenos Aires City https://ClinicalTrials.gov/show/NCT05057962
NCT05057208 Does the COVID-19 Vaccination Rate Change According to the Education, Income, Culture Level, Prosociality ? https://ClinicalTrials.gov/show/NCT05057208
NCT05055479 Nosocomial Outbreak of BHRe in an Intensive Care Unit During SARS-CoV-2 Pandemic https://ClinicalTrials.gov/show/NCT05055479
NCT05055440 Evaluation of Peripheral Muscle With Ultrassonografic of Critical Patients With Covid-19 https://ClinicalTrials.gov/show/NCT05055440
NCT05055466 COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS) https://ClinicalTrials.gov/show/NCT05055466
NCT05054582 COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF https://ClinicalTrials.gov/show/NCT05054582
NCT05054283 Baseline Blood Indices and Prolonged Length of Hospital Stay https://ClinicalTrials.gov/show/NCT05054283
NCT05052008 Management of Migraine Using Enerumab and Traditional Therapy at the Time of COVID-19 https://ClinicalTrials.gov/show/NCT05052008
NCT05051605 Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation https://ClinicalTrials.gov/show/NCT05051605
NCT05052034 Music for Decreasing Dental Anxiety During Oral Surgery in Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT05052034
NCT05047653 RALE Versus CORADS/CT-Severity Score in COVID-19 https://ClinicalTrials.gov/show/NCT05047653
NCT05049187 Characterization and Durability of COVID-19 Vaccine Induced Immune Responses in Healthcare/Frontline Workers https://ClinicalTrials.gov/show/NCT05049187
NCT05047874 High-dose, Short-term Steroid and Low-dose Long-term Steroid Use in ARDS Caused by COVID-19 https://ClinicalTrials.gov/show/NCT05047874
NCT05046652 Effectiveness of Convalescent Plasma Therapy in 8 Non-Intubated COVID-19 Patients in Indonesia: A Case Series https://ClinicalTrials.gov/show/NCT05046652
NCT05047835 Comparison of Prone Position and Standard Electrocardiogram in COVID-19 Patients https://ClinicalTrials.gov/show/NCT05047835
NCT05046769 COVID-19: A Scope Research on Epidemiology and Clinical Course https://ClinicalTrials.gov/show/NCT05046769
NCT05046509 The Clinical Manifestations Of SARS-Cov-2 Disease Not Only Pulmonary https://ClinicalTrials.gov/show/NCT05046509
NCT05046470 SARS-CoV-2 Transmission in Belgian Primary Schools of the Federation Wallonie - Bruxelles: An Epidemiological Pilot Study https://ClinicalTrials.gov/show/NCT05046470
NCT05045924 CirrhoCare in COVID-19: A Pilot, Remote, Home Monitoring Study in Advanced Cirrhosis https://ClinicalTrials.gov/show/NCT05045924
NCT05045846 Diagnostic Accuracy of Rapid Antigen Test Based on Anterior Nasal Swab Compared With RT-PCR for SARS-CoV-2 Detection. https://ClinicalTrials.gov/show/NCT05045846
NCT05043363 LuCID - Investigating the Use of a Novel Digital Rectoscope for Community Examinations During COVID-19 https://ClinicalTrials.gov/show/NCT05043363
NCT05043246 Safety and Immune Response of COVID-19 Vaccination in Middle-aged and Elderly Patients With Basic Disease https://ClinicalTrials.gov/show/NCT05043246
NCT05043129 Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection https://ClinicalTrials.gov/show/NCT05043129
NCT05043155 Strategies to Continue Gynae-oncology Services in the Era of COVID-19 Outbreak: Concerns and Challenges in a Referral Centre in Malaysia https://ClinicalTrials.gov/show/NCT05043155
NCT05043142 Epidemiological Study of the COVID-2019 in Participating Organizations. https://ClinicalTrials.gov/show/NCT05043142
NCT05043272 Safety and Immune Response of COVID-19 Vaccination in Overweight People With Excessive BMI https://ClinicalTrials.gov/show/NCT05043272
NCT05042193 A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19 https://ClinicalTrials.gov/show/NCT05042193
NCT05042232 A Prospective Virtual Study of Patient Reported Behaviors and Health Outcomes in Individuals With COVID-19 https://ClinicalTrials.gov/show/NCT05042232
NCT05042011 Role of mHealth-based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan: Qualitative Study https://ClinicalTrials.gov/show/NCT05042011
NCT05040750 Correlation Between Cardiac Markers and Severity of COVID-19 https://ClinicalTrials.gov/show/NCT05040750
NCT05037214 COVID-19 : Stress Within Hospital Workers https://ClinicalTrials.gov/show/NCT05037214
NCT05037227 Safety Profile Following Inactivated COVID-19 Vaccine in Healthy Adults Aged >18 Years in Indonesia https://ClinicalTrials.gov/show/NCT05037227
NCT05036824 Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT05036824
NCT05034978 Novel SARS-CoV-2 Point-of-care Testing https://ClinicalTrials.gov/show/NCT05034978
NCT05033613 Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease https://ClinicalTrials.gov/show/NCT05033613
NCT05028998 Covid-related Opioid Treatment Policy Evaluation https://ClinicalTrials.gov/show/NCT05028998
NCT05031845 Low-Dose Chest CT (LDCT) COVID-19 Study https://ClinicalTrials.gov/show/NCT05031845
NCT05026840 GDM Screening During COVID Pandemic. IADPSG vs WHO ’99 Criteria https://ClinicalTrials.gov/show/NCT05026840
NCT05028842 Effect of Lockdown During COVID 19 Pandemic on Liver Disease and Metabolic Parameters. https://ClinicalTrials.gov/show/NCT05028842
NCT05028881 COVID-19 Serology in People Living With HIV in Hong Kong https://ClinicalTrials.gov/show/NCT05028881
NCT05027724 Technology Assisted Solutions for the Recognition of Objective Physiological Indicators of Post-Coronavirus-19 Fatigue https://ClinicalTrials.gov/show/NCT05027724
NCT05026879 Adverse Events Report of Inactivated COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT05026879
NCT05025839 Neurological Outcome After SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT05025839
NCT05022407 Impact of COVID-19 Epidemic on Clinical Outcomes and Service Delivery Among People Living With HIV and Health Care Workers in Mozambique https://ClinicalTrials.gov/show/NCT05022407
NCT05022446 The Impact of COVID-19 on Pulmonary Procedures https://ClinicalTrials.gov/show/NCT05022446
NCT05021575 Effects of COVID-19 Pandemic on a Health Care System: Case Study of the CirculatORy System in LiThuania https://ClinicalTrials.gov/show/NCT05021575
NCT05019300 Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors. https://ClinicalTrials.gov/show/NCT05019300
NCT05019313 Diaphragm Ultrasound Evaluation During Weaning From Mechanical Ventilation in the Positive COVID-19 Patient https://ClinicalTrials.gov/show/NCT05019313
NCT05014516 Lung Structure-Function In SurVivors of Mild and SEvere COVID-19 Infection: 129Xe MRI https://ClinicalTrials.gov/show/NCT05014516
NCT05013047 Impact of the COVID-19 Pandemic on the Organization of Healthcare in France https://ClinicalTrials.gov/show/NCT05013047
NCT05012306 Covid-19 Antibody Responses in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT05012306
NCT05012839 Complicated Appendicitis in COVID-19 Era https://ClinicalTrials.gov/show/NCT05012839
NCT05009134 Influences of Allergic Rhinitis and Allergen Immunotherapy on SARS-CoV-2 Vaccination https://ClinicalTrials.gov/show/NCT05009134
NCT05009043 COVID-19 Vaccine Hesitancy and Dental Faculty Staff Members in Egypt https://ClinicalTrials.gov/show/NCT05009043
NCT05008406 E-Learning During COVID-19 Pandemic: Turning a Crisis Into Opportunity https://ClinicalTrials.gov/show/NCT05008406
NCT05008016 Procalcitonin Level and the High Risk of Mortality in 30 Days in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patient , Cases Series. https://ClinicalTrials.gov/show/NCT05008016
NCT05008627 PERSONAL PROTECTION EQUIPMENT AND SARS-CoV-2 CONTAMINATION https://ClinicalTrials.gov/show/NCT05008627
NCT05007665 Safety and Immune Response of COVID-19 Vaccination in Patients With Chronic Liver Diseases https://ClinicalTrials.gov/show/NCT05007665
NCT05004246 Longitudinal Changes in Characteristics of COVID-19 Survivors and Their Long-term Follow-up Study https://ClinicalTrials.gov/show/NCT05004246
NCT05004701 Impact of the Lockdown Due to the COVID Pandemic in French Wilson’s Disease Patients https://ClinicalTrials.gov/show/NCT05004701
NCT05000099 the Role of Technology in Elderly Patients https://ClinicalTrials.gov/show/NCT05000099
NCT05000229 Residual Symptoms After Coronavirus Disease (COVID-19) in Lithuanian Population https://ClinicalTrials.gov/show/NCT05000229
NCT04995289 Prone Position During ECMO in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hypoxaemic Patient https://ClinicalTrials.gov/show/NCT04995289
NCT04993573 Acceptability, Representations and Experiences of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04993573
NCT04992195 Impact of COVID-19 Vaccines on Cerebrovascular Health https://ClinicalTrials.gov/show/NCT04992195
NCT04909476 Tracheal Intubation in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04909476
NCT04989452 Cough Sound Recordings to Understand COVID-19-like Symptom Progression to Understand COVID-19-like Symptom Progression https://ClinicalTrials.gov/show/NCT04989452
NCT04987736 Assessment of Long-term Effects (Complications) of COVID-19 in the Southern Part of Bangladesh - a Retrospective Observational Study. https://ClinicalTrials.gov/show/NCT04987736
NCT04988438 Gastrointestinal Motor Disorders (Esophageal and Anorectal) After COVID-19 https://ClinicalTrials.gov/show/NCT04988438
NCT04988126 Pain, Fatigue and Life Quality in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04988126
NCT04987853 Clinical, Functional, Immunological and Genetic Factors on the Severity of the Course of Coronavirus Infection https://ClinicalTrials.gov/show/NCT04987853
NCT04988269 Assessment of Diurnal Salivary Cortisol Production in COVID-19 https://ClinicalTrials.gov/show/NCT04988269
NCT04987528 Pulmonary Fibrosis During Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04987528
NCT04987606 Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions https://ClinicalTrials.gov/show/NCT04987606
NCT04984564 Cardiovascular Fellow-in-training Feedback on Virtual and Simulator-based Learning Experience in A Low to Middle Income Country https://ClinicalTrials.gov/show/NCT04984564
NCT04982341 HFNC and Prone Positioning in Awake Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04982341
NCT04982263 Blood Coagulation Abnormalities in COVID-19 (Corona Virus Disease-19) Patients https://ClinicalTrials.gov/show/NCT04982263
NCT04982328 COVID-19 and Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04982328
NCT04981405 Real-world Evidence of COVID-19 Vaccines Effectiveness https://ClinicalTrials.gov/show/NCT04981405
NCT04981249 Chronic Multimorbidity Patterns in Relation to COVID-19 Severe Infection https://ClinicalTrials.gov/show/NCT04981249
NCT04980560 Gut Microbiota Profile and Its Impact on Immunity Status in COVID-19 Vaccinated Cohorts https://ClinicalTrials.gov/show/NCT04980560
NCT04979897 Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04979897
NCT04979208 Impact of Changes in the Use of Care and Reorganization of the Healthcare System Linked to the Covid-19 Outbreak on the Quality of Care Pathways of Patients Suffering From Acute Myocardial Infarction and Stroke in Aquitaine (AVICOVID) https://ClinicalTrials.gov/show/NCT04979208
NCT04979091 Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04979091
NCT04978220 Mental and Psychological Problems and Insomnia Disorder of Medical Staff in Hospital With Infected COVID-19 Patients https://ClinicalTrials.gov/show/NCT04978220
NCT04978246 Cognitive Functions After COVID-19 https://ClinicalTrials.gov/show/NCT04978246
NCT04978233 The Opal - COVID-19 Study https://ClinicalTrials.gov/show/NCT04978233
NCT04977934 Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 https://ClinicalTrials.gov/show/NCT04977934
NCT04977050 The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners https://ClinicalTrials.gov/show/NCT04977050
NCT04974177 A Study to Determine the Role of Physician Gestalt in Predicting COVID-19 in Patients https://ClinicalTrials.gov/show/NCT04974177
NCT04970927 The Effect of Pandemic on Children With Cerebral Palsy https://ClinicalTrials.gov/show/NCT04970927
NCT04972591 Follow-up Study of Population Vaccinated With COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04972591
NCT04972708 Genetics of COVID-19 Risks & Resilience in Bipolar Disorder https://ClinicalTrials.gov/show/NCT04972708
NCT04970849 Survey Study About Endoscopy During COVID-19 Pandemic for IBD Doctors https://ClinicalTrials.gov/show/NCT04970849
NCT04967781 Autoimmunity Contributes to the Severe Progression of COVID-19 https://ClinicalTrials.gov/show/NCT04967781
NCT04967586 Medical Students and Risk of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04967586
NCT04967768 The Influence and Effects of the COVID-19 Pandemic on Orthopaedic Resident Training https://ClinicalTrials.gov/show/NCT04967768
NCT04966845 Effect of Face Mask on Exhaled Carbon Monoxide of Smokers https://ClinicalTrials.gov/show/NCT04966845
NCT04961489 Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes https://ClinicalTrials.gov/show/NCT04961489
NCT04961385 Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial https://ClinicalTrials.gov/show/NCT04961385
NCT04961242 Pilot Evaluation of Together for Wellness Website in COVID-19 https://ClinicalTrials.gov/show/NCT04961242
NCT04961372 Socio-psychological Status of Healthcare Workers During SARS-CoV2 Pandemic https://ClinicalTrials.gov/show/NCT04961372
NCT04959734 COVID-19 Impact on RSV Emergency Presentations https://ClinicalTrials.gov/show/NCT04959734
NCT04958681 Changes in Physical Activity Status: Comparison of Older Adults With Versus Without a History of Covid-19 Infection https://ClinicalTrials.gov/show/NCT04958681
NCT04959773 Muscle Weakness in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04959773
NCT04958889 COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV https://ClinicalTrials.gov/show/NCT04958889
NCT04957199 Physiotherapist Awareness in the Community https://ClinicalTrials.gov/show/NCT04957199
NCT04956445 Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development https://ClinicalTrials.gov/show/NCT04956445
NCT04956562 Effect of Sinovac on Survival in Intensive Care Unit https://ClinicalTrials.gov/show/NCT04956562
NCT04954651 Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines https://ClinicalTrials.gov/show/NCT04954651
NCT04954612 Musculoskeletal Problems in School Children During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04954612
NCT04954105 Influence of the COvid-19 Epidemic on STRESS and Heart-Rate Variability in Health-care Workers https://ClinicalTrials.gov/show/NCT04954105
NCT04954235 Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study https://ClinicalTrials.gov/show/NCT04954235
NCT04953247 Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19 https://ClinicalTrials.gov/show/NCT04953247
NCT04953065 Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer Patients https://ClinicalTrials.gov/show/NCT04953065
NCT04953091 Evaluation of the Sofia SARS Antigen FIA Assay for COVID-19 https://ClinicalTrials.gov/show/NCT04953091
NCT04952337 Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ) https://ClinicalTrials.gov/show/NCT04952337
NCT04950673 Open-label, Post-marketing, Prospective Study to Assess Impact of COVID-19 on Cognitive Function in Patients https://ClinicalTrials.gov/show/NCT04950673
NCT04949230 A Retrospective Study of COVID-19 Treatments https://ClinicalTrials.gov/show/NCT04949230
NCT04889326 Collection of the Thrombo-VaxCov Cohort https://ClinicalTrials.gov/show/NCT04889326
NCT04949035 Mental Status and Quality of Life of Post-COVID-19 Patients https://ClinicalTrials.gov/show/NCT04949035
NCT04946175 National Survey Among Egyptian Pain Practitioners https://ClinicalTrials.gov/show/NCT04946175
NCT04948229 Annexin A1 Levels in SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04948229
NCT04948255 Measuring Work-Related Stress in Primary Care in the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04948255
NCT04947943 Geriatric Care for Older People Hospitalised for COVID-19 https://ClinicalTrials.gov/show/NCT04947943
NCT04947046 Carotid Stenosis Management During COVID-19 Era - Pilot Study https://ClinicalTrials.gov/show/NCT04947046
NCT04946565 The Impact of Sinopharm COVID-19 Vaccination on Male Fertility https://ClinicalTrials.gov/show/NCT04946565
NCT04948190 Canine COVID-19 Detection Phase 2 and 3 https://ClinicalTrials.gov/show/NCT04948190
NCT04945863 COVID-19 in Nursing Homes 2020 and 2021 https://ClinicalTrials.gov/show/NCT04945863
NCT04945577 The Relationship Between Vitamin D Levels, Inflammatory Parameters and Disease Severity of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04945577
NCT04944394 Psychological and Ethical Support for Hospital Professionals During the COVID-19 Pandemic: Suitability and Post-crisis Implications for the Experience of All Professionals https://ClinicalTrials.gov/show/NCT04944394
NCT04944433 Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients https://ClinicalTrials.gov/show/NCT04944433
NCT04944329 Hip Fracture and COVID-19 https://ClinicalTrials.gov/show/NCT04944329
NCT04944095 Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations https://ClinicalTrials.gov/show/NCT04944095
NCT04944160 Impact of the Covid-19 on RSV Epidemic https://ClinicalTrials.gov/show/NCT04944160
NCT04944134 COVID-19 Antibody Levels After Vaccines https://ClinicalTrials.gov/show/NCT04944134
NCT04942249 Long COVID in Military Organisations https://ClinicalTrials.gov/show/NCT04942249
NCT04941092 ARDS COVID vs ARDS Influenza https://ClinicalTrials.gov/show/NCT04941092
NCT04941144 Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination https://ClinicalTrials.gov/show/NCT04941144
NCT04941209 imPulseâ„¢ Una Infrasound-to-ultrasound E-stethoscope https://ClinicalTrials.gov/show/NCT04941209
NCT04940208 Chronic Pain in COVID-19 Patients Discharged From Intensive Care Unit https://ClinicalTrials.gov/show/NCT04940208
NCT04939155 Methylation Effects of COV-19 Infection and Vaccinations https://ClinicalTrials.gov/show/NCT04939155
NCT04937621 Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04937621
NCT04937608 Impact of the Coronavirus Disease 2019 (COVID-19) on Sperm Parameters https://ClinicalTrials.gov/show/NCT04937608
NCT04935463 Mucormycosis in COVID-19 https://ClinicalTrials.gov/show/NCT04935463
NCT04937712 Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular Dysfunction https://ClinicalTrials.gov/show/NCT04937712
NCT04935450 Pulmonary Inflammation in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04935450
NCT04934085 COVID-19 Versus Neurological Impairment, Physical Activity, Social Contacts and Education https://ClinicalTrials.gov/show/NCT04934085
NCT04934202 Cohort Follow-up of Survivors of Hospitalization for COVID-19 During the 2nd Wave of the Epidemic in France https://ClinicalTrials.gov/show/NCT04934202
NCT04933981 Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04933981
NCT04932967 Use of nMoABs for the Treatment of COVID-19 in Patients With HM. https://ClinicalTrials.gov/show/NCT04932967
NCT04932954 Immunohematology in COVID-19 Patients: A Hospital-based Retrospective Cohort Study https://ClinicalTrials.gov/show/NCT04932954
NCT04930055 Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC) https://ClinicalTrials.gov/show/NCT04930055
NCT04932863 BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment https://ClinicalTrials.gov/show/NCT04932863
NCT04932889 Musculoskeletal Symptoms in Post Acute Covid-19 Patients https://ClinicalTrials.gov/show/NCT04932889
NCT04932876 The Response of the Immune System of Patients With End Stage Kidney Disease on Dialysis and Kidney Transplant Recipients Vaccinated for COVID-19 https://ClinicalTrials.gov/show/NCT04932876
NCT04930978 Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis https://ClinicalTrials.gov/show/NCT04930978
NCT04930757 Involvement of Polymorphonuclear Neutrophils and Platelets in Severe Form of COVID-19 https://ClinicalTrials.gov/show/NCT04930757
NCT04930120 Assessing the Impact of COVID-19 Patients Long Distance Transfers Between Intensive Care Units https://ClinicalTrials.gov/show/NCT04930120
NCT04928469 Clinical Impact of COVID-19 by P.1 SARS-CoV-2 Lineage https://ClinicalTrials.gov/show/NCT04928469
NCT04928911 Expectations About the COVID-19 Vaccines https://ClinicalTrials.gov/show/NCT04928911
NCT04927078 Analysis of Vital Signs in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04927078
NCT04926571 Dexamethasone and COVID-19 Inpatient Mortality https://ClinicalTrials.gov/show/NCT04926571
NCT04925999 Distance Learning and Neck Problems During Pandemic Period https://ClinicalTrials.gov/show/NCT04925999
NCT04925908 Exclusive Breastfeeding in Infants of Mothers Infected With Novel Coronavirus https://ClinicalTrials.gov/show/NCT04925908
NCT04924816 Awake Prone Position in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04924816
NCT04924829 Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04924829
NCT04924790 The Effect of the COVID-19 on Patient Preferences and Decision Making for Obstructive Urinary Stone Interventions https://ClinicalTrials.gov/show/NCT04924790
NCT04924673 Impact of the COVID-19 Epidemic on Glycemic Balance and the Level of Stress in Diabetic Patients https://ClinicalTrials.gov/show/NCT04924673
NCT04924634 Stress Levels and Mental Well-Being Among Slovak Students During e-Learning https://ClinicalTrials.gov/show/NCT04924634
NCT04922944 Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients https://ClinicalTrials.gov/show/NCT04922944
NCT04923386 mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels https://ClinicalTrials.gov/show/NCT04923386
NCT04921241 In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life https://ClinicalTrials.gov/show/NCT04921241
NCT04920851 Cytokine Hemadsorption in Covid 19 Patients With Bacterial Sepsis https://ClinicalTrials.gov/show/NCT04920851
NCT04918849 WhatsApp in India During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04918849
NCT04916834 Impact of SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and Structure. https://ClinicalTrials.gov/show/NCT04916834
NCT04916873 Rehabilitation Status of Children With Cerebral Palsy and Anxiety of Their Caregivers During the Covid19 Pandemic https://ClinicalTrials.gov/show/NCT04916873
NCT04916275 Post-traumatic Stress, Signs of Depression and Burnout Syndrome Among Nursing Home Staff in Occitanie During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04916275
NCT04915781 Tobacco Use and COVID-19 Incidence in the Finnish General Population https://ClinicalTrials.gov/show/NCT04915781
NCT04914754 Mechanisms Underlying Long-term Fatigue and Exercise Intolerance Following CoV-2 Infection https://ClinicalTrials.gov/show/NCT04914754
NCT04915001 An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province https://ClinicalTrials.gov/show/NCT04915001
NCT04914364 Balance in COVID-19 https://ClinicalTrials.gov/show/NCT04914364
NCT04913701 COVID-19 Epidemiological Surveillance on Healthcare Workers and Patients in a Rehabilitation Medicine Facility https://ClinicalTrials.gov/show/NCT04913701
NCT04912934 The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome https://ClinicalTrials.gov/show/NCT04912934
NCT04912804 Perceived Health After Hospitalization for COVID-19 https://ClinicalTrials.gov/show/NCT04912804
NCT04912778 Profiling of Post Covid-19 Infection Patients: an Online Survey https://ClinicalTrials.gov/show/NCT04912778
NCT04911868 Surgical Management During the Era of COVID-19 https://ClinicalTrials.gov/show/NCT04911868
NCT04912700 The Impact of Vaccination on Severity of Illness in COVID-19 https://ClinicalTrials.gov/show/NCT04912700
NCT04912284 Africa COVID-19 Vaccine Hesitancy https://ClinicalTrials.gov/show/NCT04912284
NCT04910880 Personal Protective Equipment Comfort and User Attitude During COVID-19 https://ClinicalTrials.gov/show/NCT04910880
NCT04910971 Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year https://ClinicalTrials.gov/show/NCT04910971
NCT04910958 Impact of COVID-19 Pandemic on Early Spontaneous Abortions and Early Termination of Pregnancy https://ClinicalTrials.gov/show/NCT04910958
NCT04910334 Long-term Cognitive and Functional Status After COVID-19 Treatment at Danish ICUs https://ClinicalTrials.gov/show/NCT04910334
NCT04910633 Medical Treatment of Solid Tumors at the Lyon University Hospital Cancer Institute During the First Wave of COVID-19 in France: A Conservative Approach https://ClinicalTrials.gov/show/NCT04910633
NCT04910360 Embolism in COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04910360
NCT04910295 Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients https://ClinicalTrials.gov/show/NCT04910295
NCT04908007 COvid Pandemic Institutional maNaGement https://ClinicalTrials.gov/show/NCT04908007
NCT04906850 Evaluation of the New Variant 501Y.V2 of COVID-19 https://ClinicalTrials.gov/show/NCT04906850
NCT04905875 Prone Positioning for Invasively Ventilated Patients With COVID-19 Registry https://ClinicalTrials.gov/show/NCT04905875
NCT04905862 Assessment of Immune Response After Vaccination Against COVID-19 in Patients Treated With Renal Replacement Therapy https://ClinicalTrials.gov/show/NCT04905862
NCT04905823 Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D) https://ClinicalTrials.gov/show/NCT04905823
NCT04904731 Effects of Body Position on Diaphragmatic Activity in Patients Requiring Noninvasive Ventilation for Acute Respiratory Failure COVID-19 Related https://ClinicalTrials.gov/show/NCT04904731
NCT04904523 Blood Markers for Identifying & Investigating Infection With COVID19 & Sepsis in Children. https://ClinicalTrials.gov/show/NCT04904523
NCT04903834 Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study https://ClinicalTrials.gov/show/NCT04903834
NCT04902157 Relationship Between CT- Value With Prognosis in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04902157
NCT04902118 Burnout Determinants Among Pediatric Psychiatry Workers During COVID-19 Crisis https://ClinicalTrials.gov/show/NCT04902118
NCT04900376 Evaluation of Covid-19 Vaccination in Elderly Subjects in Retirement Home (EHPAD) and Long-term Care Units (USLD) in Ile-de-France https://ClinicalTrials.gov/show/NCT04900376
NCT04900441 Tele-assessment in Individuals With COVID-19 https://ClinicalTrials.gov/show/NCT04900441
NCT04900233 Effect of Covid-19 Pandemic in Non Covid-19 Patients at the Emergency Surgical Department https://ClinicalTrials.gov/show/NCT04900233
NCT04898946 Serological Response to mRNA and Inactivated COVID-19 Vaccine in Health Care Workers in Hong Kong https://ClinicalTrials.gov/show/NCT04898946
NCT04900259 The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations https://ClinicalTrials.gov/show/NCT04900259
NCT04898192 Monitoring of Incidence of Mental Discomfort in Pregnant Women During the Serious COVID-19 Pandemic Conditions https://ClinicalTrials.gov/show/NCT04898192
NCT04898985 The Leukemia and Lymphoma Society (LLS) T-cells in Blood Cancer and COVID-19 https://ClinicalTrials.gov/show/NCT04898985
NCT04896762 Extrapulmonary Presentations of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04896762
NCT04898140 The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents https://ClinicalTrials.gov/show/NCT04898140
NCT04898179 Support for COVID19 Patients at Home https://ClinicalTrials.gov/show/NCT04898179
NCT04896944 Is Precariousness a Risk Factor for COVID-19 Mortality in Intensive Care? https://ClinicalTrials.gov/show/NCT04896944
NCT04896983 National Survey of Mental Health After COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04896983
NCT04896918 Tobacco Use and the Risk of COVID-19 https://ClinicalTrials.gov/show/NCT04896918
NCT04897152 Coronavirus Associated Pneumomediastinum and Pneumothorax https://ClinicalTrials.gov/show/NCT04897152
NCT04895007 Comparative Evaluation of Covid-19 Vaccines Response https://ClinicalTrials.gov/show/NCT04895007
NCT04895462 Acute Revascularization Treatment in Ischemic Stroke Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04895462
NCT04895189 Yale COVID-19 Recovery Study https://ClinicalTrials.gov/show/NCT04895189
NCT04894682 Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor https://ClinicalTrials.gov/show/NCT04894682
NCT04893694 the Prevalence of Oral Manifestation in Patients With SARS-CoV2 Infection https://ClinicalTrials.gov/show/NCT04893694
NCT04894331 Telemedicine for SNAS Patients in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04894331
NCT04894214 Flow-controlled Ventilation (FCV) in Moderate Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 https://ClinicalTrials.gov/show/NCT04894214
NCT04892888 Survey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 Symptoms https://ClinicalTrials.gov/show/NCT04892888
NCT04893122 Impact of Pandemic of Presentation to Emergency Department and Admissions https://ClinicalTrials.gov/show/NCT04893122
NCT04892797 Understanding Immunology and Patient Outcomes of COVID-19 in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04892797
NCT04893070 Impact of SARS-CoV-2 (COVID-19) Infection, Treated in Ambulatory Care, on Long-term Quality of Life in a Parisian Military Population https://ClinicalTrials.gov/show/NCT04893070
NCT04891276 Impact of COVID-19 Infection and Confinement on Diabetic Ulcer Management and Amputation Risk https://ClinicalTrials.gov/show/NCT04891276
NCT04890600 COVID-19 and Psycological Well-being in Healthcare Workers https://ClinicalTrials.gov/show/NCT04890600
NCT04887623 Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04887623
NCT04889365 COVID-19 Antigen Rapid Test Kit https://ClinicalTrials.gov/show/NCT04889365
NCT04889313 Post COVID-19 Neurologic Symptoms : a Somatic Spectrum Disorder ? (SOMATiC) https://ClinicalTrials.gov/show/NCT04889313
NCT04889261 External Validation of the CHOD Risk Scale https://ClinicalTrials.gov/show/NCT04889261
NCT04887142 Predictors of Disease Severity in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04887142
NCT04887246 Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of Colombia https://ClinicalTrials.gov/show/NCT04887246
NCT04887220 Persistent Pain and Its Impact on Quality of Life COVID-19 Patients That Required Critical Care https://ClinicalTrials.gov/show/NCT04887220
NCT04885478 Professional’s Health in Epidemiological Crisis Covid-19 https://ClinicalTrials.gov/show/NCT04885478
NCT04885543 COVID-19 STAndard of Care in Sub-Saharan Africa https://ClinicalTrials.gov/show/NCT04885543
NCT04885192 Implementation and Evaluation of a Stepped-Care Mental Health Treatment Program for Patients With Chronic Pain https://ClinicalTrials.gov/show/NCT04885192
NCT04884477 COVID-19 Infection in Patients Receiving Anti-CD20 Therapy https://ClinicalTrials.gov/show/NCT04884477
NCT04884061 Narrow Band Imaging Bronchoscopy During SARS-CoV2 Infection https://ClinicalTrials.gov/show/NCT04884061
NCT04884321 Complementary And Alternative Medicine During The COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04884321
NCT04883164 Immunity After COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT04883164
NCT04883801 Clinical Outcomes of Newborns Born to Pregnant Women With and Without COVID-19 https://ClinicalTrials.gov/show/NCT04883801
NCT04883190 Fatigue a Long COVID-19 Symptom Substudy of FSC19-KN Trial https://ClinicalTrials.gov/show/NCT04883190
NCT04882670 COVID-19 Pandemic on Health Care and Rehabilitation Outcomes https://ClinicalTrials.gov/show/NCT04882670
NCT04883177 Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101) https://ClinicalTrials.gov/show/NCT04883177
NCT04881266 Long-Term Functional, Quality-of-Life, Neuropsychological and Cognitive Outcomes in COVID-19 Critical Illness Survivors https://ClinicalTrials.gov/show/NCT04881266
NCT04881305 Characterizing Long-term Cognitive and Emotional Impairment in Post-COVID-19 Sequelae https://ClinicalTrials.gov/show/NCT04881305
NCT04878822 Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT04878822
NCT04878913 Retrospective Evaluation of Lung Pathology in Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04878913
NCT04879251 The Impact of the COVID-19 Pandemic on Cardiovascular Risk Factors in Patients With Diabetes https://ClinicalTrials.gov/show/NCT04879251
NCT04878796 Effectiveness of mRNA Covid-19 Vaccines on Cancer Patients:Observational Study. (ANTICOV) https://ClinicalTrials.gov/show/NCT04878796
NCT04878900 Effects of COVID-19 in Chronic Pain https://ClinicalTrials.gov/show/NCT04878900
NCT04877808 Bacterial Surinfections in COVID-19 ICU Patients https://ClinicalTrials.gov/show/NCT04877808
NCT04877509 Micronutrient Status Involved in Immunity in Elderly Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04877509
NCT04876898 High Body Mass Index and Severity of Coronavirus https://ClinicalTrials.gov/show/NCT04876898
NCT04876872 Modified Pediatric Early Warning Score and Modified PRISA II During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04876872
NCT04876443 Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD) https://ClinicalTrials.gov/show/NCT04876443
NCT04874792 Clinical Characteristics of Deceased With COVID-19 https://ClinicalTrials.gov/show/NCT04874792
NCT04874753 The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease https://ClinicalTrials.gov/show/NCT04874753
NCT04874740 Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region https://ClinicalTrials.gov/show/NCT04874740
NCT04873388 Early Predictors of Prognostic Course in Patients With COVID-19 in Critical or Semi-intensive Area. https://ClinicalTrials.gov/show/NCT04873388
NCT04874363 The Effects of Smoking on Mortality in Patients With Acute Respiratory Syndrome Coronavirus 2 Infection https://ClinicalTrials.gov/show/NCT04874363
NCT04874779 Acute Kidney Injury Risk in COVID-19 https://ClinicalTrials.gov/show/NCT04874779
NCT04872673 The Professional Values and Ethical Sensitivities During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04872673
NCT04872764 Acute Kidney Injury in Patients With CoVID-19 https://ClinicalTrials.gov/show/NCT04872764
NCT04872751 Immune Response of Haemodialysis Patients Post Covid-19 Vaccination https://ClinicalTrials.gov/show/NCT04872751
NCT04872738 Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment https://ClinicalTrials.gov/show/NCT04872738
NCT04872699 Prevalence of COVID-19 in a French Dependent Care Facility for the Elderly and in a French Long-term Care Unit: Observational Study https://ClinicalTrials.gov/show/NCT04872699
NCT04872049 Assessment of SARS-CoV-2 Effect on Post-traumatic Stress of Patients Hospitalized in Intensive Care Unit https://ClinicalTrials.gov/show/NCT04872049
NCT04871789 Optimization of Patients Long-term Management After the Coronavirus Infection COVID-19 https://ClinicalTrials.gov/show/NCT04871789
NCT04871841 Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan https://ClinicalTrials.gov/show/NCT04871841
NCT04871945 Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis https://ClinicalTrials.gov/show/NCT04871945
NCT04871685 The ECOVITA Study - Validation of LUS Score in SARS-CoV-2 Disease, i.e COVID-19 https://ClinicalTrials.gov/show/NCT04871685
NCT04871932 COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics https://ClinicalTrials.gov/show/NCT04871932
NCT04863534 Ultrasound Grayscale Analysis in ARDS covid19 https://ClinicalTrials.gov/show/NCT04863534
NCT04870411 Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics https://ClinicalTrials.gov/show/NCT04870411
NCT04869202 Covid-19 Infection in Pregnancy https://ClinicalTrials.gov/show/NCT04869202
NCT04868188 Pharmacokinetics of Voriconazole in Adult ECMO Patients https://ClinicalTrials.gov/show/NCT04868188
NCT04867161 Superinfection and Hyperinflammatory Phenotype in COVID-19 (Coronavirus Disease 2019) Pneumonia Patients https://ClinicalTrials.gov/show/NCT04867161
NCT04868448 COVID-19 Vaccine Effectiveness Among Health Workers in Georgia https://ClinicalTrials.gov/show/NCT04868448
NCT04867213 Breath Analysis of Patients Diagnosed With COVID-19 Using Infrared Spectroscopy https://ClinicalTrials.gov/show/NCT04867213
NCT04865913 Venous Thrombosis Virtual Surveillance in COVID https://ClinicalTrials.gov/show/NCT04865913
NCT04865133 Efficacy and Safety of COVID-19 Vaccine in Cancer Patients https://ClinicalTrials.gov/show/NCT04865133
NCT04864938 Recovery After Critical Covid-19 Infection https://ClinicalTrials.gov/show/NCT04864938
NCT04863586 COVID-19 and Multiple Sclerosis Disease Modifying Therapies https://ClinicalTrials.gov/show/NCT04863586
NCT04861272 Risk Perception Associated With Covid-19 Among Anesthetists https://ClinicalTrials.gov/show/NCT04861272
NCT04861402 Non-Invasive Intracranial Pressure in COVID-19 Individuals https://ClinicalTrials.gov/show/NCT04861402
NCT04860908 COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO BETA CELL FUNCTION IN THE FETUS https://ClinicalTrials.gov/show/NCT04860908
NCT04860869 Endocrine, Metabolic and Microbiome Influence on the Post COVID-19 Syndrome https://ClinicalTrials.gov/show/NCT04860869
NCT04860687 Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study. https://ClinicalTrials.gov/show/NCT04860687
NCT04860245 Risks and Outcomes Among COVID-19 Patients Admitted to Assiut University Hospitals. https://ClinicalTrials.gov/show/NCT04860245
NCT04859894 Physiological Studies in Post-COVID-19 Syndrome, and the Association With DNA Methylation https://ClinicalTrials.gov/show/NCT04859894
NCT04859881 Risk Factors for Barotrauma in COVID-19 https://ClinicalTrials.gov/show/NCT04859881
NCT04854785 Neuroinflammation in COVID-19 and Depression https://ClinicalTrials.gov/show/NCT04854785
NCT04860206 Post COVID19 Functional and Cognitive Assessments https://ClinicalTrials.gov/show/NCT04860206
NCT04855539 Coronavirus: Ventilator Outcomes Using Artificial Intelligence Chest Radiographs & Other Evidence-based Co-variates https://ClinicalTrials.gov/show/NCT04855539
NCT04858607 Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals https://ClinicalTrials.gov/show/NCT04858607
NCT04854980 Serologic Response to the SARS-CoV-2 (COVID-19) mRNA-1273 Vaccine in Select Subsets of Oncology Patients https://ClinicalTrials.gov/show/NCT04854980
NCT04854863 Respiratory Muscles After Hospitalisation for COVID-19 https://ClinicalTrials.gov/show/NCT04854863
NCT04854837 Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis https://ClinicalTrials.gov/show/NCT04854837
NCT04854408 Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers’ Menstrual Patterns https://ClinicalTrials.gov/show/NCT04854408
NCT04853940 Respiratory Muscle Function, Dyspnea, Exercise Capacity and Quality of Life in Severe COVID19 Patients https://ClinicalTrials.gov/show/NCT04853940
NCT04853316 Asymptomatic SARS-CoV-2 Detection in Children https://ClinicalTrials.gov/show/NCT04853316
NCT04853108 Remote Monitoring of COVID-19 Positive Outpatients https://ClinicalTrials.gov/show/NCT04853108
NCT04852835 COVID-19 Vaccine Response https://ClinicalTrials.gov/show/NCT04852835
NCT04849624 Body Composition Study in Critically Ill Patients-Extended to COVID-19 https://ClinicalTrials.gov/show/NCT04849624
NCT04851561 Post-coronavirus Disease-2019 Fatigue https://ClinicalTrials.gov/show/NCT04851561
NCT04852718 Rehabilitation Program for the Sequelae of COVID 19 Infection https://ClinicalTrials.gov/show/NCT04852718
NCT04852757 Estimating the Prevalence of Postpartum Anxiety and Depression in the Context of the Coronavirus Disease (COVID-19) Pandemic https://ClinicalTrials.gov/show/NCT04852757
NCT04849546 Staff Physical and Mental Health Assessment in the Aftermath of the First Peak of the Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04849546
NCT04849585 Evaluation of the Impact of Hospitalization in Intensive Care for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04849585
NCT04849611 Covid-19 Fear and Compliance With Protective Measures of Students https://ClinicalTrials.gov/show/NCT04849611
NCT04848610 The Factors That Affect the Infection of COVID-19 https://ClinicalTrials.gov/show/NCT04848610
NCT04848493 National Project on Vaccines, COVID-19 and Frail Patients https://ClinicalTrials.gov/show/NCT04848493
NCT04848584 Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California https://ClinicalTrials.gov/show/NCT04848584
NCT04847804 Large-scale COVID-19 Population Screening https://ClinicalTrials.gov/show/NCT04847804
NCT04847817 Important Data on COVID-19 Profile in Africa https://ClinicalTrials.gov/show/NCT04847817
NCT04847336 Improving MAternal Newborn carE In the in the WHO European Region During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04847336
NCT04847622 Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir. https://ClinicalTrials.gov/show/NCT04847622
NCT04847687 Investigation of Hospitalisation Times and Mortality According to Drug Dose in Patients Given Systemic Methylprednisolone With a Pre-diagnosis of Covid-19 Pneumonia; Retrospective Study https://ClinicalTrials.gov/show/NCT04847687
NCT04845984 Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Four Hospital of the Alpine Region https://ClinicalTrials.gov/show/NCT04845984
NCT04844697 Resilience and Coping in a Rare Skeletal Disease Population to Face Coronavirus (COVID-19) Outbreak Distress: a Longitudinal Study https://ClinicalTrials.gov/show/NCT04844697
NCT04844541 Prophylaxis and Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04844541
NCT04844632 COVID19 Vaccination: Clinical, Laboratory and Cellular Monitoring https://ClinicalTrials.gov/show/NCT04844632
NCT04844242 MISC COVID-19 Study in Pediatric Population https://ClinicalTrials.gov/show/NCT04844242
NCT04843878 COVID-19 Testing Pilot Study https://ClinicalTrials.gov/show/NCT04843878
NCT04843917 Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine https://ClinicalTrials.gov/show/NCT04843917
NCT04841785 Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients https://ClinicalTrials.gov/show/NCT04841785
NCT04839913 Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study https://ClinicalTrials.gov/show/NCT04839913
NCT04840940 Presepsin Biomarker for Ventilator-associated Pneumonia Diagnosis in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04840940
NCT04840966 A Simplified Test to Assess Flavor in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04840966
NCT04839094 Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19. https://ClinicalTrials.gov/show/NCT04839094
NCT04838834 Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children https://ClinicalTrials.gov/show/NCT04838834
NCT04838119 Preop COVID Testing Patterns https://ClinicalTrials.gov/show/NCT04838119
NCT04838093 COVID-19 Testing in Patients With Vascular Disorders https://ClinicalTrials.gov/show/NCT04838093
NCT04837651 Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab https://ClinicalTrials.gov/show/NCT04837651
NCT04836793 COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04836793
NCT04836039 Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04836039
NCT04836065 ESICM UNITE COVID-19 Project (UNITE-COVID) https://ClinicalTrials.gov/show/NCT04836065
NCT04834882 Burnout, Stress and Coping Strategies: Impact of the Covid-19 Epidemic https://ClinicalTrials.gov/show/NCT04834882
NCT04832828 Sensitivity and Specificity of the Roth Test in Patients With COVID-19 Positive https://ClinicalTrials.gov/show/NCT04832828
NCT04834934 Artificial Intelligence - SARS-CoV-2 Risk Evaluation https://ClinicalTrials.gov/show/NCT04834934
NCT04834401 Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis https://ClinicalTrials.gov/show/NCT04834401
NCT04834583 Corona And Manual Professions https://ClinicalTrials.gov/show/NCT04834583
NCT04832867 Pulmonary Rehabilitation in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04832867
NCT04834102 COVID-19 Induced Telogen Effluvium https://ClinicalTrials.gov/show/NCT04834102
NCT04832945 SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study https://ClinicalTrials.gov/show/NCT04832945
NCT04832932 The COVID-19 Back-to-Normal Study https://ClinicalTrials.gov/show/NCT04832932
NCT04832022 Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination https://ClinicalTrials.gov/show/NCT04832022
NCT04832061 Respiratory Supports and COVID-19 Mortality https://ClinicalTrials.gov/show/NCT04832061
NCT04831866 COVID-19 Surveillance and Exposure Testing in School Communities https://ClinicalTrials.gov/show/NCT04831866
NCT04829552 Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units https://ClinicalTrials.gov/show/NCT04829552
NCT04828629 Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity https://ClinicalTrials.gov/show/NCT04828629
NCT04828772 A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan https://ClinicalTrials.gov/show/NCT04828772
NCT04828148 Incidence of Infection and Mortality by COVID-19 in Specialists https://ClinicalTrials.gov/show/NCT04828148
NCT04827160 Prediction of Thrombosis Using D-dimer Trends in COVID-19 https://ClinicalTrials.gov/show/NCT04827160
NCT04826731 Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04826731
NCT04825301 Prognostic Prediction of COVID-19 Clinical Course Through the Development of Machine Learning Based Algorithms https://ClinicalTrials.gov/show/NCT04825301
NCT04824651 Covid-19 Vaccine Cohort in Specific Populations https://ClinicalTrials.gov/show/NCT04824651
NCT04824625 Incidence of Infection Reported by COVID-19 in Attendees of a Commercial Music Concert https://ClinicalTrials.gov/show/NCT04824625
NCT04824664 The ALIGHIERI Survey: an Italian Overview of Global Impact of tHe COVID-19 pandemIc on General surgERy practIce https://ClinicalTrials.gov/show/NCT04824664
NCT04824495 Evaluation of Inflammatory Cytokines During COVID-19 https://ClinicalTrials.gov/show/NCT04824495
NCT04823234 Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women https://ClinicalTrials.gov/show/NCT04823234
NCT04822012 Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid https://ClinicalTrials.gov/show/NCT04822012
NCT04821921 The Impact of the COVID-19 Pandemic on Diabetes Management https://ClinicalTrials.gov/show/NCT04821921
NCT04821570 To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment https://ClinicalTrials.gov/show/NCT04821570
NCT04818697 Effect of Social Isolation on Physical Activity Level, and Kinesophobia in Heart Rhythm Disorders During Pandemic https://ClinicalTrials.gov/show/NCT04818697
NCT04819802 MIcrovascular Dysfunction in CRitically Ill cOVID-19 Patients https://ClinicalTrials.gov/show/NCT04819802
NCT04819165 Healthcare-associated Infections in Severe COVID-19 During 2020 https://ClinicalTrials.gov/show/NCT04819165
NCT04818463 Characterization and Verification of the Intensive Care Standard Operating Procedure (SOP) Adherence of the Treated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04818463
NCT04818853 COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI) https://ClinicalTrials.gov/show/NCT04818853
NCT04817293 Prolonged Symptoms and Reasons for Consultation in Town Medicine Associated With COVID-19 Infection in the Hauts de France Region https://ClinicalTrials.gov/show/NCT04817293
NCT04817280 COVID-19 in Polish Ice Swimmers. https://ClinicalTrials.gov/show/NCT04817280
NCT04817553 Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients https://ClinicalTrials.gov/show/NCT04817553
NCT04816760 Immune Cells Phenotypes During COVID-19 https://ClinicalTrials.gov/show/NCT04816760
NCT04816786 COVID-19 Patients Admitted to the ICU https://ClinicalTrials.gov/show/NCT04816786
NCT04815018 Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04815018
NCT04815850 Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study https://ClinicalTrials.gov/show/NCT04815850
NCT04815135 Effect of Covid-19 Pandemic on Emergency Surgery Practice https://ClinicalTrials.gov/show/NCT04815135
NCT04815759 Dental Anxiety Among Children Pre and Post COVID 19 Pandemic https://ClinicalTrials.gov/show/NCT04815759
NCT04815304 Clinical Features of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04815304
NCT04814914 An Observational Clinical Study to Evaluate COVID-19 Symptoms in “Long Hauler” Patients Who Participated in K031-120 or K032-120 https://ClinicalTrials.gov/show/NCT04814914
NCT04813939 Is Bio-adrenomedullin (Bio-ADM) a Prognostic Factor in Patients With COVID-19 Treated in the ICU? https://ClinicalTrials.gov/show/NCT04813939
NCT04813692 Mechanical Complications of Acute Myocardial Infarction During COVID-19 Pandemics https://ClinicalTrials.gov/show/NCT04813692
NCT04811391 COVID-19 Vaccine Effectiveness in Albanian Health Workers https://ClinicalTrials.gov/show/NCT04811391
NCT04812496 Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV) https://ClinicalTrials.gov/show/NCT04812496
NCT04811781 Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study https://ClinicalTrials.gov/show/NCT04811781
NCT04811885 The Effects of Covid-19 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder https://ClinicalTrials.gov/show/NCT04811885
NCT04811352 Drug Abuse During the COVID-19 Pandemic. https://ClinicalTrials.gov/show/NCT04811352
NCT04810117 Monitoring the IgG/IgM Antibodies in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04810117
NCT04809480 COVID-19 and Acute Invasive Fungal Rhinosinusitis https://ClinicalTrials.gov/show/NCT04809480
NCT04806815 Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19 https://ClinicalTrials.gov/show/NCT04806815
NCT04805970 REsearching Covid-19 Outcomes in Diabetes (RECODE) https://ClinicalTrials.gov/show/NCT04805970
NCT04806867 Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT04806867
NCT04802642 Evaluation of COVID-19 Fear, Anxiety and Their Effects in Physiotherapy Technician Students https://ClinicalTrials.gov/show/NCT04802642
NCT04805632 Immune Response in Dialysis Patients Vaccinated Against COVID-19 https://ClinicalTrials.gov/show/NCT04805632
NCT04805216 Covid-19 Vaccine Response in Immunocompromised Haematology Patients https://ClinicalTrials.gov/show/NCT04805216
NCT04802044 COVID-19, Aging, and Cardiometabolic Risk Factors Study https://ClinicalTrials.gov/show/NCT04802044
NCT04799704 Tear Film SARS-nCoV-2 Detection in Symptomatic and Pauci-symptomatic Patients. https://ClinicalTrials.gov/show/NCT04799704
NCT04800731 Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04800731
NCT04800146 A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study https://ClinicalTrials.gov/show/NCT04800146
NCT04799691 Comparison of 2 Ventilatory Support Strategies During Coronavirus Disease 2019 (Covid-19) Pneumonia https://ClinicalTrials.gov/show/NCT04799691
NCT04799873 Alpha-1-Antitrypsin-Deficiency in COVID-19 https://ClinicalTrials.gov/show/NCT04799873
NCT04799600 The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU https://ClinicalTrials.gov/show/NCT04799600
NCT04799977 COVID-19: Post-covid Olfactory Disorders Assessment https://ClinicalTrials.gov/show/NCT04799977
NCT04799808 Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and Staff https://ClinicalTrials.gov/show/NCT04799808
NCT04799652 Are Surgeons Ready to Get the COVID-19 Vaccine? https://ClinicalTrials.gov/show/NCT04799652
NCT04799132 Association Between Body Mass Index and HFNC Therapy Success https://ClinicalTrials.gov/show/NCT04799132
NCT04797091 Kidney in Coronavirus Disease 2019 Registry https://ClinicalTrials.gov/show/NCT04797091
NCT04797624 Does Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Gastric Cancer Patients? https://ClinicalTrials.gov/show/NCT04797624
NCT04794998 A Simple Approach to Treat COVID-19 Patients at Home. https://ClinicalTrials.gov/show/NCT04794998
NCT04796584 Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication https://ClinicalTrials.gov/show/NCT04796584
NCT04795414 Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers https://ClinicalTrials.gov/show/NCT04795414
NCT04794920 Post-Covid-19 Emotional Aspects of Hospital Staff https://ClinicalTrials.gov/show/NCT04794920
NCT04794361 Management of Patients Suspected of COVID 19 With Ultra Low Dose Thoracic Scanner https://ClinicalTrials.gov/show/NCT04794361
NCT04793269 Characteristics of Long COVID-19 Syndrome https://ClinicalTrials.gov/show/NCT04793269
NCT04794062 Myocardial Injury and Quality of Life After COVID-19 https://ClinicalTrials.gov/show/NCT04794062
NCT04792086 Disease Containment Measures Among Older Adults During the Covid-19 Pandemia https://ClinicalTrials.gov/show/NCT04792086
NCT04790994 COVID-19 Prevalence in UNIVI Geriatric Institutions: Epidemiological Study of Immunological Status With Rapid Serological Tests https://ClinicalTrials.gov/show/NCT04790994
NCT04791085 Investigation of Stress Levels and Lifestyle of a Sample of Greek General Surgeons in Covid-19 https://ClinicalTrials.gov/show/NCT04791085
NCT04789460 Relationship Between Potential Predictors and Mortality in COVID-19 Patients ın Turkey https://ClinicalTrials.gov/show/NCT04789460
NCT04789512 Respiratory Muscle Strength in Volleyball Players Suffered From COVID-19 https://ClinicalTrials.gov/show/NCT04789512
NCT04789447 Initial CT Findings and CO-RADS Stage in COVID-19 https://ClinicalTrials.gov/show/NCT04789447
NCT04789395 Evaluation of Post-covid 19 Patients Who Receive Ozonetheraphy With Thorax CT https://ClinicalTrials.gov/show/NCT04789395
NCT04787614 2019 NSECE COVID-19 Follow-up https://ClinicalTrials.gov/show/NCT04787614
NCT04788433 Registry of Coronavirus Complications - CORRELATION WITH GLYCOMIC PROFILE https://ClinicalTrials.gov/show/NCT04788433
NCT04788394 Renal Involvement in Hospitalized Children With COVID-19 https://ClinicalTrials.gov/show/NCT04788394
NCT04787536 Perioperative Cognitive Trajectories in Deferred Surgery (CoTELE-SURGE) https://ClinicalTrials.gov/show/NCT04787536
NCT04787588 COVID-19 Infection and Epithelial Cell Markers https://ClinicalTrials.gov/show/NCT04787588
NCT04786301 Severe Acute Respiratory Infection - Preparedness (COVID-19 and Influenza) https://ClinicalTrials.gov/show/NCT04786301
NCT04786249 Impact of Rapid Screening for COVID-19 in Delocalized Biology in the Emergency Department https://ClinicalTrials.gov/show/NCT04786249
NCT04786041 the Impact of COVID-19 Pandemic on the Incidence and Outcome of Complicated Appendicitis https://ClinicalTrials.gov/show/NCT04786041
NCT04785157 Neurotropism and Neuroinflammation in COVID-19 Patients With Delirium. https://ClinicalTrials.gov/show/NCT04785157
NCT04784689 Host Immune Response to Novel RNA COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT04784689
NCT04784468 DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04784468
NCT04784403 SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDY https://ClinicalTrials.gov/show/NCT04784403
NCT04782427 COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave https://ClinicalTrials.gov/show/NCT04782427
NCT04782739 Evaluation of the Impact of the COVID-19 Pandemic on Provision and Uptake of Services for the Prevention of Mother-to-child Transmission of HIV and Syphilis in Zimbabwe https://ClinicalTrials.gov/show/NCT04782739
NCT04780295 COvid-19 REgistry on THROMBOSIS Complications https://ClinicalTrials.gov/show/NCT04780295
NCT04780594 Impact of the COVID-19 Pandemic on the Surgical Activity of Bellvitge University Hospital https://ClinicalTrials.gov/show/NCT04780594
NCT04780373 Prognostic Score in Covid-19 https://ClinicalTrials.gov/show/NCT04780373
NCT04780555 Evaluation of Musculoskeletal System Symptoms and Biochemical Parameters in COVID-19 https://ClinicalTrials.gov/show/NCT04780555
NCT04779749 Pregnancy Outcomes According to the Gestational Age of Acquiring COVID-19 https://ClinicalTrials.gov/show/NCT04779749
NCT04779944 Impact of SARS-CoV-2 Pandemic on Psychological State of Health Care Workers https://ClinicalTrials.gov/show/NCT04779944
NCT04780113 Evolution of Perceived Stress in General Practice Residents During COVID-19 Sanitary Crisis https://ClinicalTrials.gov/show/NCT04780113
NCT04779996 Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment https://ClinicalTrials.gov/show/NCT04779996
NCT04779541 National Survey Concerning Vaccination Against COVID-19 in Nursing Homes and Long-Term Care Units https://ClinicalTrials.gov/show/NCT04779541
NCT04779021 Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department https://ClinicalTrials.gov/show/NCT04779021
NCT04778033 Semen Analysis Parameters Following Pfizer’s COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04778033
NCT04775966 CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic https://ClinicalTrials.gov/show/NCT04775966
NCT04775784 Determination of COVID-19 Related Virus in Central Nervous System https://ClinicalTrials.gov/show/NCT04775784
NCT04775563 COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients https://ClinicalTrials.gov/show/NCT04775563
NCT04775407 COVID-19 Serological Testing of Patients With a Mental Disorder From the Catchment Area of the Capital Region of Denmark https://ClinicalTrials.gov/show/NCT04775407
NCT04775134 Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19) https://ClinicalTrials.gov/show/NCT04775134
NCT04775017 Delirium in Covid-19: Germany-wide Covid-19 Intensive Register https://ClinicalTrials.gov/show/NCT04775017
NCT04772703 DNA Damage in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04772703
NCT04772404 Repercussion of the COVID-19 Pandemic on Physical Activity, Psychological State and Sleep https://ClinicalTrials.gov/show/NCT04772404
NCT04772833 Spanish Study to Analyze the Histopathological, Ultrastructural and Microbiological Findings Obtained in Autopsies of Patients Who Died Due to COVID-19 https://ClinicalTrials.gov/show/NCT04772833
NCT04771117 Defiances to Face COVID-19 Pandemic in Mexico https://ClinicalTrials.gov/show/NCT04771117
NCT04772586 Sarcopenia and Mechanical Ventilation in Older Patients Admitted Due to COVID-19 https://ClinicalTrials.gov/show/NCT04772586
NCT04583982 ImmuneSenseâ„¢ COVID-19 Study https://ClinicalTrials.gov/show/NCT04583982
NCT04771052 Minimizing the Effects of COVID-19 Hospitalization With the COVID Rehabilitation Program for the Elderly https://ClinicalTrials.gov/show/NCT04771052
NCT04769700 Post-partum Depression, Breastfeeding Adherence and Fear in COVID-19 https://ClinicalTrials.gov/show/NCT04769700
NCT04769284 Psychological State of Students of Health Sciences During COVID-19 https://ClinicalTrials.gov/show/NCT04769284
NCT04769349 Effectiveness of Supportive Housing on COVID-19 Related Outcomes for People Experiencing Homelessness https://ClinicalTrials.gov/show/NCT04769349
NCT04769245 The Effectiveness of ACB-IP 1.0 Convalescent Plasma in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04769245
NCT04768153 Prioritising Prevention of COVID-19 in Persons With Cancer in the French West Indies https://ClinicalTrials.gov/show/NCT04768153
NCT04768244 Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health https://ClinicalTrials.gov/show/NCT04768244
NCT04766983 Incidence of VAP in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04766983
NCT04766294 Macrophage Activation Markers in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04766294
NCT04764747 Effectiveness of Convalescent Plasma in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04764747
NCT04763213 New Predictors in Determining the Need for Invasive Treatment in Non-STEMI https://ClinicalTrials.gov/show/NCT04763213
NCT04763395 Liver Function Test Abnormalities in COVID-19 https://ClinicalTrials.gov/show/NCT04763395
NCT04765254 COVID-19 Infection in Diabetic Patients https://ClinicalTrials.gov/show/NCT04765254
NCT04764032 Right Ventricular Dysfunction in Ventilated Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04764032
NCT04762056 CPAx for Assessing Functional Status of COVID-19 Patients After Intensive Care Unit Discharge https://ClinicalTrials.gov/show/NCT04762056
NCT04716907 Thymic Function in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04716907
NCT04761107 Impact of COVID-19 on GU Disease https://ClinicalTrials.gov/show/NCT04761107
NCT04760704 Covid-19 Vaccine Response in Elderly Subjects https://ClinicalTrials.gov/show/NCT04760704
NCT04760990 A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort. https://ClinicalTrials.gov/show/NCT04760990
NCT04760184 Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden https://ClinicalTrials.gov/show/NCT04760184
NCT04757792 Back to the Traditional: Anti-COX Drugs Can Improve the Outcome of COVID-19 Patients Admitted to ICU https://ClinicalTrials.gov/show/NCT04757792
NCT04757883 Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients https://ClinicalTrials.gov/show/NCT04757883
NCT04756674 The Impact of Covid-19 on Skeletal Muscle https://ClinicalTrials.gov/show/NCT04756674
NCT04756518 COVID-19 Infection and Machine Learning Using Artificial Intelligence (AI) https://ClinicalTrials.gov/show/NCT04756518
NCT04756869 Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology https://ClinicalTrials.gov/show/NCT04756869
NCT04756479 Mortality Due to COVID-19 in the COVID-AGEBRU Study https://ClinicalTrials.gov/show/NCT04756479
NCT04756817 Immunogenicity of the BNT162b2 Covid-19 Vaccine in Elderly People Aged 85 and Older in Greece https://ClinicalTrials.gov/show/NCT04756817
NCT04756193 Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound https://ClinicalTrials.gov/show/NCT04756193
NCT04754633 Comparison of Chest CT Findings Related to COVID-19 With RSNA and BSTI Guidelines https://ClinicalTrials.gov/show/NCT04754633
NCT04753463 Assessment of the Impact of COVID-19 Pandemic on Residents Training and Mental Health in Poland https://ClinicalTrials.gov/show/NCT04753463
NCT04753346 Comparison of Cardiopulmonary Fitness Level With Normal Values After COVID-19 https://ClinicalTrials.gov/show/NCT04753346
NCT04753762 Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 Infection https://ClinicalTrials.gov/show/NCT04753762
NCT04753632 Status of People With Cerebral Palsy and Their Caregivers During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04753632
NCT04751734 Impact of Maternal COVID-19 Vaccines on Breast Milk https://ClinicalTrials.gov/show/NCT04751734
NCT04750330 Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04750330
NCT04751227 Modafinil for Wakefulness in the Critical Care Units https://ClinicalTrials.gov/show/NCT04751227
NCT04750369 Enhanced Triage for COVID-19 https://ClinicalTrials.gov/show/NCT04750369
NCT04750629 Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDxâ„¢) https://ClinicalTrials.gov/show/NCT04750629
NCT04750356 SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study) https://ClinicalTrials.gov/show/NCT04750356
NCT04748185 Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT04748185
NCT04747769 COVID-19. CT-Scan Modeling in COVID19 Sequelae https://ClinicalTrials.gov/show/NCT04747769
NCT04747782 COVID-19 Longitudinal Biomarkers in Lung Injury https://ClinicalTrials.gov/show/NCT04747782
NCT04747522 Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19) https://ClinicalTrials.gov/show/NCT04747522
NCT04746521 Cellular-Mediated Immunity in COVID-19 https://ClinicalTrials.gov/show/NCT04746521
NCT04746092 The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19 https://ClinicalTrials.gov/show/NCT04746092
NCT04746066 Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19 https://ClinicalTrials.gov/show/NCT04746066
NCT04746443 Effect of Covid-19 Affliction on Psychological and Mental Health Among College Going Students: Cross-Sectional Survey https://ClinicalTrials.gov/show/NCT04746443
NCT04745923 Physical Activity Level in Patients With Chronic Kidney Disease During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04745923
NCT04745377 Responses to COVID-19 Vaccination in Patients With Cancer https://ClinicalTrials.gov/show/NCT04745377
NCT04745416 Clinical Characteristics of Patients With Leukemia and COVID-19 https://ClinicalTrials.gov/show/NCT04745416
NCT04743609 RSV Burden in Outpatient Settings https://ClinicalTrials.gov/show/NCT04743609
NCT04742712 A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 Covid-19 https://ClinicalTrials.gov/show/NCT04742712
NCT04741178 PAtterns and Extension in COVID-19 Related Interstitial Pneumonia: CT Analysis https://ClinicalTrials.gov/show/NCT04741178
NCT04740658 Organizational Measures to Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents https://ClinicalTrials.gov/show/NCT04740658
NCT04740125 SURVEY ABOUT STRESS-COVID IN HEALTH CARE WORKERS IN NORTH AFRICA COUNTRY https://ClinicalTrials.gov/show/NCT04740125
NCT04740372 Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ https://ClinicalTrials.gov/show/NCT04740372
NCT04739345 New Immune-inflammation Index for Predicting Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection https://ClinicalTrials.gov/show/NCT04739345
NCT04738760 Clinical Outcomes of High Dose Vitamin D Versus Standard Dose in COVID-19 Egyptian Patients https://ClinicalTrials.gov/show/NCT04738760
NCT04738032 Stories for Change: Digital Storytelling Intervention for Diabetes Self-Management in the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04738032
NCT04738695 SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19) https://ClinicalTrials.gov/show/NCT04738695
NCT04738331 Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database https://ClinicalTrials.gov/show/NCT04738331
NCT04736732 Institut de Recherche Cliniques de Montreal (IRCM) Post-COVID-19 (IPCO) Research Clinic https://ClinicalTrials.gov/show/NCT04736732
NCT04736901 Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04736901
NCT04736524 Immune Response Following COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT04736524
NCT04736680 Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital https://ClinicalTrials.gov/show/NCT04736680
NCT04735757 Effects of COVID-19 Infection and Critical Illness on Diaphragm Tissue Characteristics and Movement, Visualized With MRI https://ClinicalTrials.gov/show/NCT04735757
NCT04735744 Evaluation of Allied Healthcare in Patients Recovering From COVID-19 https://ClinicalTrials.gov/show/NCT04735744
NCT04734678 Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome https://ClinicalTrials.gov/show/NCT04734678
NCT04734223 Neuroimaging Findings in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04734223
NCT04733807 Antibodies Response to mRNA Vaccine Against Covid-19 https://ClinicalTrials.gov/show/NCT04733807
NCT04732858 Educational Interventions for Surgeons During COVID-19 Pandemic: Cross-sectional, E-survey https://ClinicalTrials.gov/show/NCT04732858
NCT04732663 Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19 https://ClinicalTrials.gov/show/NCT04732663
NCT04732702 Effects of Contact Restrictions During the COVID-19 Pandemic on Newborns and Their Parents https://ClinicalTrials.gov/show/NCT04732702
NCT04729374 COVID-19 Vaccine Induced Adaptive Immune Responses https://ClinicalTrials.gov/show/NCT04729374
NCT04729452 Characterisation of the Immune Response to SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04729452
NCT04728880 Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience https://ClinicalTrials.gov/show/NCT04728880
NCT04728828 COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients https://ClinicalTrials.gov/show/NCT04728828
NCT04727762 Use of the Mask and Current Pandemic https://ClinicalTrials.gov/show/NCT04727762
NCT04727775 Antiviral Drugs on the Treatment of SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04727775
NCT04727294 MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey https://ClinicalTrials.gov/show/NCT04727294
NCT04726865 COVID-19 Pandemic and Medical Students https://ClinicalTrials.gov/show/NCT04726865
NCT04725097 A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection https://ClinicalTrials.gov/show/NCT04725097
NCT04725084 Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04725084
NCT04724642 COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency https://ClinicalTrials.gov/show/NCT04724642
NCT04724434 Follow-up Study of COVID-19 Patients in the District Konstanz https://ClinicalTrials.gov/show/NCT04724434
NCT04724395 Disability Following Hospitalization in People of Working-age Surviving SARS-CoV-2 Infection - COVID-19 https://ClinicalTrials.gov/show/NCT04724395
NCT04723706 Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients https://ClinicalTrials.gov/show/NCT04723706
NCT04721444 Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19) https://ClinicalTrials.gov/show/NCT04721444
NCT04719182 Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04719182
NCT04718519 Migrant Workers’ Responses to the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04718519
NCT04717024 The Nanowear Wearable Covid-19 Observational and Analysis Trend https://ClinicalTrials.gov/show/NCT04717024
NCT04717011 Case Series Study to Detect SARS-CoV-2 in Semen of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04717011
NCT04717089 Extended Post Anaesthetic Care in PACU During COVID-19: Multi-perspective Value-based Analysis https://ClinicalTrials.gov/show/NCT04717089
NCT04716088 Rapid Antigen Testing for SARS-CoV-2 Among Healthcare Workers to Prevent Spread of COVID-19 https://ClinicalTrials.gov/show/NCT04716088
NCT04715919 Long Term Outcomes of Coronavirus Disease-19 (COVID-19) https://ClinicalTrials.gov/show/NCT04715919
NCT04716023 Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19 https://ClinicalTrials.gov/show/NCT04716023
NCT04716465 Dysautonomia in Patients Post COVID-19 Infection https://ClinicalTrials.gov/show/NCT04716465
NCT04715477 Intensive Care Anxiety in SARS-CoV-2 Patients https://ClinicalTrials.gov/show/NCT04715477
NCT04714333 Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath https://ClinicalTrials.gov/show/NCT04714333
NCT04714125 Prognostic Value of Flow-mediated Dilation in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04714125
NCT04714138 Remote Video Consultation for Quality of Life Assessment in Patients Hospitalised After COVID-19 Infection https://ClinicalTrials.gov/show/NCT04714138
NCT04714008 Covid-19 and ONline GAmbling https://ClinicalTrials.gov/show/NCT04714008
NCT04714515 Montelukast - a Treatment Choice for COVID-19 https://ClinicalTrials.gov/show/NCT04714515
NCT04713852 Predictive Value of SOFA and APACHE Scores for In-hospital Mortality in COVID-19 ICU Patients https://ClinicalTrials.gov/show/NCT04713852
NCT04713540 Rehabilitation in Intensive Care Unit https://ClinicalTrials.gov/show/NCT04713540
NCT04712292 Effects of COVID-19 Pandemic on the Diagnosis and Outcomes of Colorectal Cancer (COVID-CRC) https://ClinicalTrials.gov/show/NCT04712292
NCT04388813 Predictors of Severe COVID-19 Outcomes https://ClinicalTrials.gov/show/NCT04388813
NCT04710836 NoRCoRP Assessment Clinic https://ClinicalTrials.gov/show/NCT04710836
NCT04712448 Serum Prevalence of SARS-Cov-2 Antibodies in Pre-pandemic Blood Samples (SPARE) https://ClinicalTrials.gov/show/NCT04712448
NCT04710771 Effect of Prone Positioning in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04710771
NCT04710329 High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04710329
NCT04709744 Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04709744
NCT04708912 Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04708912
NCT04709003 Covid-19 Vaccine Effectiveness in Healthcare Personnel in Clalit Health Services in Israel (CoVEHPI) https://ClinicalTrials.gov/show/NCT04709003
NCT04709068 Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization https://ClinicalTrials.gov/show/NCT04709068
NCT04706390 Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination https://ClinicalTrials.gov/show/NCT04706390
NCT04706325 COVID-19 RELATED KIDNEY DAMAGE https://ClinicalTrials.gov/show/NCT04706325
NCT04706260 Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at Strasbourg University Hospitals https://ClinicalTrials.gov/show/NCT04706260
NCT04706156 Oral Side Effects of COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04706156
NCT04704466 Impact of Covid-19 Pandemic on Management of Head and Neck Cancers https://ClinicalTrials.gov/show/NCT04704466
NCT04704388 Study Project Comparing the Sequelae of COVID-19 Infection in Patients Who Have and Have Not Received Ventilatory Support in Critical Care https://ClinicalTrials.gov/show/NCT04704388
NCT04703777 Relationship Between Social Status and Use of Healthcare Services During the Confinement Period Linked to the COVID-19 Epidemic https://ClinicalTrials.gov/show/NCT04703777
NCT04703452 poSt Covid-19 Infection centraL sENsitisaTion https://ClinicalTrials.gov/show/NCT04703452
NCT04703270 Understanding COVID-19 Infection in Pregnant Women and Their Babies https://ClinicalTrials.gov/show/NCT04703270
NCT04701905 The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19 https://ClinicalTrials.gov/show/NCT04701905
NCT04701892 poSt Covid-19 Infection centraL Sensitisation 2 https://ClinicalTrials.gov/show/NCT04701892
NCT04701944 Clinical Study of Pregnant Women With COVID-19 https://ClinicalTrials.gov/show/NCT04701944
NCT04700254 Anxiety, Depression and Eating Attitudes of Diabetes Mellitus Patients During COVID-19 Lockdown in Greece https://ClinicalTrials.gov/show/NCT04700254
NCT04699578 COVID-19 Infection and Fetal-neonatal Outcomes https://ClinicalTrials.gov/show/NCT04699578
NCT04699903 Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood https://ClinicalTrials.gov/show/NCT04699903
NCT04699058 COVID-19 Sero-prevalence Health Care Workers Kinshasa https://ClinicalTrials.gov/show/NCT04699058
NCT04699097 The Effect of Azithromycin Use on Conduction System of Heart in COVID-19 Positive Children https://ClinicalTrials.gov/show/NCT04699097
NCT04698083 Electrocardiographic QRS Axis Shift ,Rotation and COVÄ°D-19 https://ClinicalTrials.gov/show/NCT04698083
NCT04698837 Understanding Potential Airborne Transmission and the Protective Value of Type II Surgical Masks in SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04698837
NCT04698044 Anxiety and Depression Perceived by Individuals With and Without Cancer During the COVID-19 Pandemic Period https://ClinicalTrials.gov/show/NCT04698044
NCT04698382 Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis https://ClinicalTrials.gov/show/NCT04698382
NCT04697030 Burnout Among Adolescent Population During Covid-19 Lockdown in Pakistan https://ClinicalTrials.gov/show/NCT04697030
NCT04696679 Quality of Life of Very Preterm Children With Dysexecutive Disorders at Elementary School Age During the Confinement-deconfinement Period of Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04696679
NCT04695379 Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection https://ClinicalTrials.gov/show/NCT04695379
NCT04695756 Liver Transplantation and Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04695756
NCT04695457 Correlation Between the Incidence of COVID-19 in Nursing-homes and the Profile of Nursing Homes in the French Alps https://ClinicalTrials.gov/show/NCT04695457
NCT04695678 Epidemiological Multicohort Study of Latent COVID-19 Infections https://ClinicalTrials.gov/show/NCT04695678
NCT04694768 Implementation of Rehabilitation Program for Post COVID-19 https://ClinicalTrials.gov/show/NCT04694768
NCT04695158 Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19 https://ClinicalTrials.gov/show/NCT04695158
NCT04694664 COVID-19 Vaccine Confidence Among Pregnant Women and Mothers https://ClinicalTrials.gov/show/NCT04694664
NCT04694703 Changing of Trace Element, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Covid-19 https://ClinicalTrials.gov/show/NCT04694703
NCT04694742 Ventilatory Efficiency in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04694742
NCT04694482 The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology https://ClinicalTrials.gov/show/NCT04694482
NCT04694716 Determination of Serum Trace Element and Physical Activity Levels in COVID-19 https://ClinicalTrials.gov/show/NCT04694716
NCT04693052 Attitudes Towards Receiving Mental Health Care Using Telehealth During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04693052
NCT04691921 Current Pharmacological Practices in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04691921
NCT04694014 Emotional Intelligence Skills Health Leaders Need During Covid-19 https://ClinicalTrials.gov/show/NCT04694014
NCT04674553 Effect of Obesity Among COVID-19 Patients in Critical Care Settings https://ClinicalTrials.gov/show/NCT04674553
NCT04691934 Obstetric Anesthesia Experiences in COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04691934
NCT04691609 Assiut University Registry for ACS Patients During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04691609
NCT04689672 Predictivity of Hemogasanalysis and Lung UltraSound in Determining COVID-19 Severity https://ClinicalTrials.gov/show/NCT04689672
NCT04688372 Hospital COVID-19 Surge and Associated Mortality Risk https://ClinicalTrials.gov/show/NCT04688372
NCT04689464 COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04689464
NCT04688840 Smartphone Application: A Possible Solution for Follow up of Patients With Hip Arthroplasty https://ClinicalTrials.gov/show/NCT04688840
NCT04686747 COVID - 19 and Advanced Gastro-intestinal Cancer Treatment https://ClinicalTrials.gov/show/NCT04686747
NCT04686565 Covid-19 Pandemic and Cerebral Palsy https://ClinicalTrials.gov/show/NCT04686565
NCT04686578 The Effects of Covid-19 Pandemic on The Patients With Fibromyalgia https://ClinicalTrials.gov/show/NCT04686578
NCT04686708 COVID-19 Pandemic and General Surgery Emergencies https://ClinicalTrials.gov/show/NCT04686708
NCT04684433 Surgery in the Time of COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04684433
NCT04685629 Covid-19 Long-term Revalidation Follow-up https://ClinicalTrials.gov/show/NCT04685629
NCT04684836 Comparative Effectiveness of Telemedicine in Primary Care https://ClinicalTrials.gov/show/NCT04684836
NCT04681950 Assessment of Self-Collected Sample Compared to Clinician Collected Sample in COVID-19 and Influenza Program https://ClinicalTrials.gov/show/NCT04681950
NCT04682912 Blood Types in Children With COVID-19 https://ClinicalTrials.gov/show/NCT04682912
NCT04682548 Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients https://ClinicalTrials.gov/show/NCT04682548
NCT04682093 Risk Stratification of Patients With Suspected COVID-19 Presenting to the ED https://ClinicalTrials.gov/show/NCT04682093
NCT04682132 Polk COVID-19 and Flu Response https://ClinicalTrials.gov/show/NCT04682132
NCT04681755 Rehabilitation Required Due to Clinical Disorders After Severe Covid-19 Infection https://ClinicalTrials.gov/show/NCT04681755
NCT04681157 Retrospective Study on Anosmias and Ageusias Linked to Infection by Covid-19 https://ClinicalTrials.gov/show/NCT04681157
NCT04681040 Risk Stratification of COVID-19 Using Urine Biomarkers https://ClinicalTrials.gov/show/NCT04681040
NCT04679584 COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life https://ClinicalTrials.gov/show/NCT04679584
NCT04679428 Immunological Characteristics of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04679428
NCT04679272 Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT04679272
NCT04677283 Study of Symptoms Linked to Covid-19 in Residents and Professionals in EHPAD, Associated With a Dual Diagnostic Approach by PCR and Serology: a Cohort in ÃŽle-de-France. https://ClinicalTrials.gov/show/NCT04677283
NCT04678024 Sensitivity Evaluation of Serological Tests for Covid-19 https://ClinicalTrials.gov/show/NCT04678024
NCT04675281 Pathological Findings of Fatal COVID-19 https://ClinicalTrials.gov/show/NCT04675281
NCT04673331 Physical Activity, Exercise Capacity and Coronavirus Phobia of Adult Cystic Fibrosis Patients During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04673331
NCT04674410 Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients https://ClinicalTrials.gov/show/NCT04674410
NCT04670328 Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity https://ClinicalTrials.gov/show/NCT04670328
NCT04672343 Prognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04672343
NCT04669509 Effect of Liver Injury on Mortality in Coronavirus Disease-2019 Patients Admitted to Intensive Care Unit https://ClinicalTrials.gov/show/NCT04669509
NCT04669912 COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-management https://ClinicalTrials.gov/show/NCT04669912
NCT04670094 Comorbidities and Risk Score in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04670094
NCT04669938 Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease,COVID-19, in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04669938
NCT04669990 Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study https://ClinicalTrials.gov/show/NCT04669990
NCT04668911 Oral Health, Microbial Burden and COVID-19 https://ClinicalTrials.gov/show/NCT04668911
NCT04668937 Conséquences of the COVID-19 Lockdown Measures on the CHRU Nancy Pediatric Emergency Services https://ClinicalTrials.gov/show/NCT04668937
NCT04667936 Evaluation of Sedation in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04667936
NCT04666753 Retrospective Study of ImmunoFormulation for COVID-19 https://ClinicalTrials.gov/show/NCT04666753
NCT04668196 Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR) https://ClinicalTrials.gov/show/NCT04668196
NCT04667962 Impact of the Change in Hospital Service of Caregivers During COVID-19 Health Crisis on Operational Strain https://ClinicalTrials.gov/show/NCT04667962
NCT04666285 Southampton Women’s Survey COVID-19 Study https://ClinicalTrials.gov/show/NCT04666285
NCT04665960 Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2 https://ClinicalTrials.gov/show/NCT04665960
NCT04666207 Viral Shedding, Symptoms and Exposure of SARS-CoV-2 in Non-hospitalized Children With COVID-19 https://ClinicalTrials.gov/show/NCT04666207
NCT04666064 Validation of COVILUS Score in Patients Suspected of COVID-19 Infection in the Emergency Room https://ClinicalTrials.gov/show/NCT04666064
NCT04666025 SARS-CoV-2 Donor-Recipient Immunity Transfer https://ClinicalTrials.gov/show/NCT04666025
NCT04664049 The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04664049
NCT04664296 COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults (Dyn3CEA_Nosocor) https://ClinicalTrials.gov/show/NCT04664296
NCT04664075 Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) https://ClinicalTrials.gov/show/NCT04664075
NCT04664023 Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution https://ClinicalTrials.gov/show/NCT04664023
NCT04663659 The Effect of Diabetes Mellitus on Mortality of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04663659
NCT04662437 The Status of Parathyroid Hormone Secretion in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04662437
NCT04661462 Health After Covid-19 in Tyrol https://ClinicalTrials.gov/show/NCT04661462
NCT04659889 Clinical and Haematological Phenotypes in Long COVID https://ClinicalTrials.gov/show/NCT04659889
NCT04659876 Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to COVID 19 https://ClinicalTrials.gov/show/NCT04659876
NCT04659356 NOSOcomial COVID-19 in ICU (NOSOCOVID) https://ClinicalTrials.gov/show/NCT04659356
NCT04659759 COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes https://ClinicalTrials.gov/show/NCT04659759
NCT04659252 CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid-19) https://ClinicalTrials.gov/show/NCT04659252
NCT04659200 Thyroid Function Tests and Status of Thyroid Autoantibodies in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04659200
NCT04659187 CORONA Germany- Clinical Outcome and Risk in Hospitalized COVID-19 Patients - An Epidemiological Study From Germany https://ClinicalTrials.gov/show/NCT04659187
NCT04658121 SARS-CoV-2/COVID-19 Prevalence Study https://ClinicalTrials.gov/show/NCT04658121
NCT04657445 EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY https://ClinicalTrials.gov/show/NCT04657445
NCT04657510 Femoral frACturEs and COVID-19. https://ClinicalTrials.gov/show/NCT04657510
NCT04657419 Fatigue and Sleep in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04657419
NCT04654416 Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine https://ClinicalTrials.gov/show/NCT04654416
NCT04653857 Cardiac Assessment After Covid-19 Disease in Elite Altheltic Population https://ClinicalTrials.gov/show/NCT04653857
NCT04654442 Feasibility and Analytic Performance of TestNPass (IVDMD) for CoViD-19 Diagnosis on Saliva Sample https://ClinicalTrials.gov/show/NCT04654442
NCT04653727 Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19 https://ClinicalTrials.gov/show/NCT04653727
NCT04651413 PCR Cycle Threshold Values and COVID-19 Outcomes https://ClinicalTrials.gov/show/NCT04651413
NCT04650178 Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials https://ClinicalTrials.gov/show/NCT04650178
NCT04649931 Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease) https://ClinicalTrials.gov/show/NCT04649931
NCT04650035 The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak https://ClinicalTrials.gov/show/NCT04650035
NCT04649827 A Clinical Trial for Hospitalized Patients With COVID-19 in Ceará: ResCOVID Study https://ClinicalTrials.gov/show/NCT04649827
NCT04649333 COVID-19 and Sports - an Online Survey on the Impact of the Pandemic and Possible Preventive Measures https://ClinicalTrials.gov/show/NCT04649333
NCT04648709 Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19 https://ClinicalTrials.gov/show/NCT04648709
NCT04647994 Exploratory Study: COVID-19 and Pregnancy https://ClinicalTrials.gov/show/NCT04647994
NCT04649996 Variation in Acute Appendicitis During COVID-19 Pandemic in Italy https://ClinicalTrials.gov/show/NCT04649996
NCT04649658 Pronation in COVID-19 Patients Undergoing Non Invasive Respiratory Support https://ClinicalTrials.gov/show/NCT04649658
NCT04649320 Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias https://ClinicalTrials.gov/show/NCT04649320
NCT04648410 Corticosteroids in Severe COVID-19(ASAP-C Study) https://ClinicalTrials.gov/show/NCT04648410
NCT04646525 The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs https://ClinicalTrials.gov/show/NCT04646525
NCT04646642 Psychological Health, Coping Strategies and Preferences of Military COVID-19 Deployers https://ClinicalTrials.gov/show/NCT04646642
NCT04644341 Tele-monitoring of COVID-19 Survivors for Long-Term Impacts https://ClinicalTrials.gov/show/NCT04644341
NCT04645433 Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit https://ClinicalTrials.gov/show/NCT04645433
NCT04645563 Using Whatsapp for the Consultation https://ClinicalTrials.gov/show/NCT04645563
NCT04645368 Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04645368
NCT04644302 Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis https://ClinicalTrials.gov/show/NCT04644302
NCT04644159 Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19] https://ClinicalTrials.gov/show/NCT04644159
NCT04644146 Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection) https://ClinicalTrials.gov/show/NCT04644146
NCT04643548 WHO Covid 19 - Neurological Abnormalities in SARS-CoV-2 ICU Patients https://ClinicalTrials.gov/show/NCT04643548
NCT04643522 Semen Parameters and COVID-19 in Infertile Men https://ClinicalTrials.gov/show/NCT04643522
NCT04643444 Police COVID-19 Serosurvey https://ClinicalTrials.gov/show/NCT04643444
NCT04642703 Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy https://ClinicalTrials.gov/show/NCT04642703
NCT04642196 COVID-19 in Home Healthcare https://ClinicalTrials.gov/show/NCT04642196
NCT04641988 Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04641988
NCT04640428 COVID-19 Stroke Apical Lung Examination Study https://ClinicalTrials.gov/show/NCT04640428
NCT04639427 Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases https://ClinicalTrials.gov/show/NCT04639427
NCT04636294 Borderline COVID-19 PCR Test Result https://ClinicalTrials.gov/show/NCT04636294
NCT04635813 The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study https://ClinicalTrials.gov/show/NCT04635813
NCT04633915 Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19. https://ClinicalTrials.gov/show/NCT04633915
NCT04633941 Impact of Social Distancing on Bariatric Versus Non-Surgical Obese Patients During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04633941
NCT04632615 Sleep Behaviour in Athletes During Home Confinement Due to the Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04632615
NCT04632173 Head and Neck cancERs International cOviD-19 collabOraTion https://ClinicalTrials.gov/show/NCT04632173
NCT04631861 Physical Activity and the Risk of COVID-19 Infection and Mortality https://ClinicalTrials.gov/show/NCT04631861
NCT04631497 Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04631497
NCT04630015 Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth https://ClinicalTrials.gov/show/NCT04630015
NCT04629638 Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women https://ClinicalTrials.gov/show/NCT04629638
NCT04629183 Risk Stratification of COVID-19 Patients Discharged From the Emergency Department https://ClinicalTrials.gov/show/NCT04629183
NCT04629222 Tracheobronchitis in Respiratory Involvement on the Lung SPECT/CT Images of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04629222
NCT04628637 High GRP78 Levels in Covid-19 Infection: A Case-Control Study https://ClinicalTrials.gov/show/NCT04628637
NCT04628195 Cardiac Performance in Mechanically Ventilated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04628195
NCT04628208 Clinical Study Spartan COVID-19 V2 System (Canada Alternate) https://ClinicalTrials.gov/show/NCT04628208
NCT04628000 Baseline Vitamin D Deficiency and COVID-19 Disease Severity https://ClinicalTrials.gov/show/NCT04628000
NCT04627623 Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration https://ClinicalTrials.gov/show/NCT04627623
NCT04627194 Characteristics of COVID-19 Patients in Kazakhstan in Early 2020 https://ClinicalTrials.gov/show/NCT04627194
NCT04624503 Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04624503
NCT04625257 COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19) https://ClinicalTrials.gov/show/NCT04625257
NCT04625075 Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19) https://ClinicalTrials.gov/show/NCT04625075
NCT04623346 Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04623346
NCT04623177 Thromboprophylaxis for Patients in ICU With COVID-19 https://ClinicalTrials.gov/show/NCT04623177
NCT04622748 Neurocognitive Functions of Recovered COVID-19 Patients https://ClinicalTrials.gov/show/NCT04622748
NCT04621084 Influence of the COVId-19 Pandemic on STRESS and Eating Habits https://ClinicalTrials.gov/show/NCT04621084
NCT04621214 Innovation of Audio-Visual Triage System in Combating the Spread of COVID-19 Infection and Its Efficacy: A Novel Strategy https://ClinicalTrials.gov/show/NCT04621214
NCT04619576 Influence of the COVId-19 Pandemic on STRESS of Occupational Health Workers https://ClinicalTrials.gov/show/NCT04619576
NCT04619407 Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers https://ClinicalTrials.gov/show/NCT04619407
NCT04618835 Physical Activity a Vital Sign? 40 Steps to Safety Test for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04618835
NCT04618861 Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study https://ClinicalTrials.gov/show/NCT04618861
NCT04618341 A Clinical Study of Online Active Play Program With Adolescents https://ClinicalTrials.gov/show/NCT04618341
NCT04616976 COVID-19 With Convalescent Plasma https://ClinicalTrials.gov/show/NCT04616976
NCT04615728 MANAGEMENT OF APPENDICITIS DURING THE COVID-19 PANDEMIC https://ClinicalTrials.gov/show/NCT04615728
NCT04615390 Recovery Profiles in Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation https://ClinicalTrials.gov/show/NCT04615390
NCT04615195 Effect of COVID-9 Related COntainment in ChildreN https://ClinicalTrials.gov/show/NCT04615195
NCT04611841 Medical-biological Research of the Pathogenesis of COVID-19 Disease Caused by SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04611841
NCT04610554 Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19 https://ClinicalTrials.gov/show/NCT04610554
NCT04611243 Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04611243
NCT04609774 Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04609774
NCT04609839 FOLLOW-UP OF PATIENTS WITH COVID-19. https://ClinicalTrials.gov/show/NCT04609839
NCT04608383 Laparoscopy and COVID-19 Contamination https://ClinicalTrials.gov/show/NCT04608383
NCT04607941 Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19 https://ClinicalTrials.gov/show/NCT04607941
NCT04605757 Long-term Evolution of Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Follow the Covid Study https://ClinicalTrials.gov/show/NCT04605757
NCT04605952 Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive https://ClinicalTrials.gov/show/NCT04605952
NCT04605172 Lockdown Impact on Spontaneous Premature Birth in a Level III NICU https://ClinicalTrials.gov/show/NCT04605172
NCT04604769 Perceived Stress Among ICU Medical Staff During COVID-19 Crisis https://ClinicalTrials.gov/show/NCT04604769
NCT04605692 Evaluation of Occupational Burnout and Stress Among Dentists in Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04605692
NCT04604249 Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World https://ClinicalTrials.gov/show/NCT04604249
NCT04604080 Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan https://ClinicalTrials.gov/show/NCT04604080
NCT04603755 Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04603755
NCT04603664 Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection https://ClinicalTrials.gov/show/NCT04603664
NCT04602351 Communication in ICU During COVID-19 https://ClinicalTrials.gov/show/NCT04602351
NCT04602481 COVID-19 in People With Primary Ciliary Dyskinesia https://ClinicalTrials.gov/show/NCT04602481
NCT04603677 Northern Colorado COVID-19 Biobank https://ClinicalTrials.gov/show/NCT04603677
NCT04602637 Training Load Management in Three Professional Tennis Players During COVID-19 Lockdown: a Case Series Study https://ClinicalTrials.gov/show/NCT04602637
NCT04602260 Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension Study https://ClinicalTrials.gov/show/NCT04602260
NCT04601415 Point of Care Artificial Intelligence Tool for Heart Failure Diagnosis https://ClinicalTrials.gov/show/NCT04601415
NCT04601012 OCTA Study: Retinal Vascular Changes in Patients With SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04601012
NCT04595123 Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19) https://ClinicalTrials.gov/show/NCT04595123
NCT04599998 Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04599998
NCT04598620 Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate https://ClinicalTrials.gov/show/NCT04598620
NCT04597853 Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04597853
NCT04596943 RGD PET/CT Imaging in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04596943
NCT04595110 Hemostatic Profile in Patients Affected by COVID-19 https://ClinicalTrials.gov/show/NCT04595110
NCT04595240 Semen Analysis Changes in Covid-19 Positivepatients https://ClinicalTrials.gov/show/NCT04595240
NCT04594356 Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist https://ClinicalTrials.gov/show/NCT04594356
NCT04594291 MRI Changes of Acute Kidney Injury in COVID-19 https://ClinicalTrials.gov/show/NCT04594291
NCT04593654 Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04593654
NCT04592055 The Effect of COVID-19 on Diabetes Mellitus https://ClinicalTrials.gov/show/NCT04592055
NCT04592510 Impact of COVID-19 on Pediatric Dental Practice During First, Second And Third Wave. https://ClinicalTrials.gov/show/NCT04592510
NCT04591704 The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04591704
NCT04590352 Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04590352
NCT04590378 Pulmonary Embolism and COVID-19 https://ClinicalTrials.gov/show/NCT04590378
NCT04590170 French Cohort of COVID-19 Patients With Post-intensive Care Syndrome https://ClinicalTrials.gov/show/NCT04590170
NCT04588909 Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy https://ClinicalTrials.gov/show/NCT04588909
NCT04587375 Diagnosis of Endocrine Dysfunctions in Covid-19 https://ClinicalTrials.gov/show/NCT04587375
NCT04587258 Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island https://ClinicalTrials.gov/show/NCT04587258
NCT04586140 Operation of the GHPSJ Clinical Ethical Reflection Assistance Group During the COVID-19 Period https://ClinicalTrials.gov/show/NCT04586140
NCT04585945 COVID-19 on Placental Gene Expression and Pathology https://ClinicalTrials.gov/show/NCT04585945
NCT04584450 Investigation of Validity and Reliability of Post-COVID-19 Functional Status Scale https://ClinicalTrials.gov/show/NCT04584450
NCT04586114 Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19 https://ClinicalTrials.gov/show/NCT04586114
NCT04584658 Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study) https://ClinicalTrials.gov/show/NCT04584658
NCT04584606 Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04584606
NCT04583865 Feasibility and Quality of TeleConsultation in Pediatric Anesthesia https://ClinicalTrials.gov/show/NCT04583865
NCT04583345 Physical Activity Levels of Hypertensive and Healthy Individuals Under Social Isolation During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04583345
NCT04583293 Acute kIDnEy Injury in coviD-19 https://ClinicalTrials.gov/show/NCT04583293
NCT04581928 Patients Reactions Towards Their Diagnosis as Having COVID-19 https://ClinicalTrials.gov/show/NCT04581928
NCT04582331 Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis https://ClinicalTrials.gov/show/NCT04582331
NCT04581577 Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders https://ClinicalTrials.gov/show/NCT04581577
NCT04581889 Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen Children https://ClinicalTrials.gov/show/NCT04581889
NCT04581083 Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04581083
NCT04581070 The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to the 2020 SARS-CoV-2 Pandemic" https://ClinicalTrials.gov/show/NCT04581070
NCT04579471 Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study https://ClinicalTrials.gov/show/NCT04579471
NCT04579588 Understanding Immunity to the Flu Vaccine in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04579588
NCT04579627 Facial Hair, PPE and COVID-19 https://ClinicalTrials.gov/show/NCT04579627
NCT04579289 Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions https://ClinicalTrials.gov/show/NCT04579289
NCT04578197 NeuroCovid - a Study of Intensive Care-requiring Covid-19 Patients https://ClinicalTrials.gov/show/NCT04578197
NCT04578132 Description of the Population With Genitourinary Tumors and COVID-19 https://ClinicalTrials.gov/show/NCT04578132
NCT04577105 Risk Factors and Computed Tomography Findings in COVID-19. https://ClinicalTrials.gov/show/NCT04577105
NCT04576299 Health Care Workers’ Perception of Patient Safety During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04576299
NCT04576351 The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19 https://ClinicalTrials.gov/show/NCT04576351
NCT04575571 MAVIPAN: My Life and the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04575571
NCT04575532 Detection of COVID-19 Decompensation https://ClinicalTrials.gov/show/NCT04575532
NCT04575168 Clinical Study Spartan COVID-19 V2 System https://ClinicalTrials.gov/show/NCT04575168
NCT04572438 A Cohort Study of Mechanically Ventilated COVID-19 Patients Undergoing Tracheostomy https://ClinicalTrials.gov/show/NCT04572438
NCT04570982 Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal https://ClinicalTrials.gov/show/NCT04570982
NCT04570189 Evaluating Auscul-X, a Touch Free Digital Stethoscope https://ClinicalTrials.gov/show/NCT04570189
NCT04573634 A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition https://ClinicalTrials.gov/show/NCT04573634
NCT04573335 Diabetes Outcomes in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04573335
NCT04569851 Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019) https://ClinicalTrials.gov/show/NCT04569851
NCT04569292 COVID-19 Infection in Cancer Pantients https://ClinicalTrials.gov/show/NCT04569292
NCT04568850 Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population https://ClinicalTrials.gov/show/NCT04568850
NCT04568655 The Noninvasive Ventilation to COVID-19 Patients https://ClinicalTrials.gov/show/NCT04568655
NCT04568018 Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19 https://ClinicalTrials.gov/show/NCT04568018
NCT04567927 Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04567927
NCT04567836 Screening of Health-care Workers in an University Hospital for SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04567836
NCT04568044 Evaluation of Humoral Immunity Following COVID-19 in Pregnancy https://ClinicalTrials.gov/show/NCT04568044
NCT04567979 Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico. https://ClinicalTrials.gov/show/NCT04567979
NCT04568148 COVID-19 Biorepository https://ClinicalTrials.gov/show/NCT04568148
NCT04565522 Transmission of COVID-19 Virus Among Patients and Staff in Dialysis Centers https://ClinicalTrials.gov/show/NCT04565522
NCT04565782 Corona Virus Infection Among Liver Transplant Recipients https://ClinicalTrials.gov/show/NCT04565782
NCT04565106 Automatic Oxygen Titration With O2matic® to Patients Admitted With COVID-19 and Hypoxemic Respiratory Failure https://ClinicalTrials.gov/show/NCT04565106
NCT04563247 Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs https://ClinicalTrials.gov/show/NCT04563247
NCT04563156 Follow-up and Rehabilitation of Survivors of Severe Coronavirus Disease 2019 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04563156
NCT04562285 Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays https://ClinicalTrials.gov/show/NCT04562285
NCT04562246 SARS-CoV-2 IgG and IgM Serologic Assays https://ClinicalTrials.gov/show/NCT04562246
NCT04561024 Evaluation of a COVID-19 Pneumonia CXR AI Detection Algorithm https://ClinicalTrials.gov/show/NCT04561024
NCT04560530 The Role of CT Chest Scan in the Pre-anesthetic Assessment of Suspected or Confirmed COVID -19 Patients https://ClinicalTrials.gov/show/NCT04560530
NCT04560855 Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home https://ClinicalTrials.gov/show/NCT04560855
NCT04560413 Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients https://ClinicalTrials.gov/show/NCT04560413
NCT04558749 Anxiety and Depression Among Pregnant Women During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04558749
NCT04559100 Long-term Characterization of Patients With Severe/Critical Infection by COVID-19 Virus https://ClinicalTrials.gov/show/NCT04559100
NCT04559542 Body Weight Regulation, Disordered Eating Behaviour, and Experiences of Sexual Harassment in Female Martial Art Athletes https://ClinicalTrials.gov/show/NCT04559542
NCT04558645 Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04558645
NCT04558307 Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations https://ClinicalTrials.gov/show/NCT04558307
NCT04558385 Seroconversion in COVID-19 Recovered Population https://ClinicalTrials.gov/show/NCT04558385
NCT04558437 COVID-Impact “Psychological IMPACT of Covid-19 on AP-HP Staff” https://ClinicalTrials.gov/show/NCT04558437
NCT04556565 MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain https://ClinicalTrials.gov/show/NCT04556565
NCT04557358 Impact in the Medical Care Among the Rheumatic Diseases Patients in a Tertiary Hospital in México During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04557358
NCT04556604 Surgical Consent During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04556604
NCT04556513 Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status https://ClinicalTrials.gov/show/NCT04556513
NCT04556318 Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04556318
NCT04556149 imPulseâ„¢ Una Full-spectrum, Over Clothing E-stethoscope https://ClinicalTrials.gov/show/NCT04556149
NCT04555187 Cardiovascular Risk Stratification in Covid-19 https://ClinicalTrials.gov/show/NCT04555187
NCT04555954 Determining the Physical Activity Level of Healthy Adults During Pandemic https://ClinicalTrials.gov/show/NCT04555954
NCT04555109 Convalescent Plasma for COVID-19 Research Donor Study https://ClinicalTrials.gov/show/NCT04555109
NCT04554979 COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience https://ClinicalTrials.gov/show/NCT04554979
NCT04554251 Global Impact of COVID-19 on Pulmonology Special Units https://ClinicalTrials.gov/show/NCT04554251
NCT04552340 Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV. https://ClinicalTrials.gov/show/NCT04552340
NCT04551378 The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors https://ClinicalTrials.gov/show/NCT04551378
NCT04550312 The Impact of Lifestyle Changes on Non-COVID Deaths https://ClinicalTrials.gov/show/NCT04550312
NCT04550390 Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19 https://ClinicalTrials.gov/show/NCT04550390
NCT04550403 Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes https://ClinicalTrials.gov/show/NCT04550403
NCT04549831 Genetic Bases of COVID-19 Clinical Variability https://ClinicalTrials.gov/show/NCT04549831
NCT04549350 Sleep Quality Among HCWs https://ClinicalTrials.gov/show/NCT04549350
NCT04549636 COVID-19 Related Lung Ventilation and Perfusion Injury https://ClinicalTrials.gov/show/NCT04549636
NCT04548908 Prevalence Of COVID-19 Among Health-workers in a French General Hospital https://ClinicalTrials.gov/show/NCT04548908
NCT04548895 Non-invasive Biometric Monitoring in Nursing Homes to Fight COVID-19 https://ClinicalTrials.gov/show/NCT04548895
NCT04548505 Recovery of Exertion Ability Following COVID-19 Infection in Military Staff https://ClinicalTrials.gov/show/NCT04548505
NCT04547218 Study on Incidence of Elective Surgery Postponed During COVID-19 Pandemic in Geriatric Population https://ClinicalTrials.gov/show/NCT04547218
NCT04546776 COVID-19 Persistence in Stool https://ClinicalTrials.gov/show/NCT04546776
NCT04547114 Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects https://ClinicalTrials.gov/show/NCT04547114
NCT04544033 IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients https://ClinicalTrials.gov/show/NCT04544033
NCT04544072 Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards https://ClinicalTrials.gov/show/NCT04544072
NCT04544605 Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients https://ClinicalTrials.gov/show/NCT04544605
NCT04544176 COVID-19 Risk From Attending Outpatient Radiology Appointments https://ClinicalTrials.gov/show/NCT04544176
NCT04544150 Gastrointestinal Manifestations Among Patients With COVID19 https://ClinicalTrials.gov/show/NCT04544150
NCT04542226 Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04542226
NCT04542044 Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04542044
NCT04542915 COVID-19-Related Health and Practices Among Dental Hygienists https://ClinicalTrials.gov/show/NCT04542915
NCT04542200 Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built Environment https://ClinicalTrials.gov/show/NCT04542200
NCT04541472 Influence of the COVId-19 Pandemic on the STRESS of Dental Surgeons (COVISTRESS - Dental Surgery) https://ClinicalTrials.gov/show/NCT04541472
NCT04540029 Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure https://ClinicalTrials.gov/show/NCT04540029
NCT04540484 COVID-19 IgG Formation in Physicians at ALGH and Their Household Members https://ClinicalTrials.gov/show/NCT04540484
NCT04538586 Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures (COVISTRESS Screening) https://ClinicalTrials.gov/show/NCT04538586
NCT04538456 Impact of COVID-19 on Lung Cancer Patients https://ClinicalTrials.gov/show/NCT04538456
NCT04537559 Impact of COVID-19 Outbreak on Non-COVID-19 Patients https://ClinicalTrials.gov/show/NCT04537559
NCT04537650 Swallowing Impairment After COVID-19 Infection https://ClinicalTrials.gov/show/NCT04537650
NCT04536285 Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic in Egypt https://ClinicalTrials.gov/show/NCT04536285
NCT04537117 Knowledge, Attitudes and Clinical Practices of Pediatric Dentists Regarding Covid-19 https://ClinicalTrials.gov/show/NCT04537117
NCT04534595 Data Collection on the Model Schools Pediatric Health Initiative at 5 SBHC Sites: COVID-19 Questionnaire https://ClinicalTrials.gov/show/NCT04534595
NCT04535154 Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19 https://ClinicalTrials.gov/show/NCT04535154
NCT04535297 Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke https://ClinicalTrials.gov/show/NCT04535297
NCT04534569 Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF) https://ClinicalTrials.gov/show/NCT04534569
NCT04534608 COVID-19 Child Health Investigation of Latent Disease in Hamburg https://ClinicalTrials.gov/show/NCT04534608
NCT04532411 COVID-19 Testing Sample Acquisition Throughput and Efficiency https://ClinicalTrials.gov/show/NCT04532411
NCT04531345 Cytokine Status of Covid-19 Patients https://ClinicalTrials.gov/show/NCT04531345
NCT04531735 Respiratory Syncytial Virus Infection May be More Dangerous in Neonate https://ClinicalTrials.gov/show/NCT04531735
NCT04531501 COVID-19 Saliva Test Research Study https://ClinicalTrials.gov/show/NCT04531501
NCT04531111 Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt https://ClinicalTrials.gov/show/NCT04531111
NCT04531319 Immune Cell Subgroups in Covid 19 Patients https://ClinicalTrials.gov/show/NCT04531319
NCT04530500 COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression https://ClinicalTrials.gov/show/NCT04530500
NCT04530461 Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases https://ClinicalTrials.gov/show/NCT04530461
NCT04530682 COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs https://ClinicalTrials.gov/show/NCT04530682
NCT04529447 Response of Korean Medicine Hospital to COVID-19 https://ClinicalTrials.gov/show/NCT04529447
NCT04529408 EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up https://ClinicalTrials.gov/show/NCT04529408
NCT04529421 Assocation Between In-person Instruction and COVID-19 Risk https://ClinicalTrials.gov/show/NCT04529421
NCT04528901 Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital) https://ClinicalTrials.gov/show/NCT04528901
NCT04527601 Extremely Premature Births During the Peak of the COVID-19 Pandemic: an International Study of the Active SafeBoosC III Departments https://ClinicalTrials.gov/show/NCT04527601
NCT04527497 Clinical Course and Treatment of COVID-19 Inpatients in Hospital https://ClinicalTrials.gov/show/NCT04527497
NCT04527458 Case Fatalities in Hospitalised COVID-19 Patients in the UK https://ClinicalTrials.gov/show/NCT04527458
NCT05139953 Impact of COVID-19 Infection During Pregnancy https://ClinicalTrials.gov/show/NCT05139953
NCT05085522 Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR) https://ClinicalTrials.gov/show/NCT05085522
NCT05075928 Description of a Cohort of Covid-19 Patients With a Circulating Anticoagulant https://ClinicalTrials.gov/show/NCT05075928
NCT05075915 Transfusion and COVID-19 https://ClinicalTrials.gov/show/NCT05075915
NCT04500600 Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04500600
NCT04335019 Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 + https://ClinicalTrials.gov/show/NCT04335019
NCT04525443 Endothelial Function and COVID-19 https://ClinicalTrials.gov/show/NCT04525443
NCT04526405 Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases https://ClinicalTrials.gov/show/NCT04526405
NCT04524234 Cardiac Dysfunction in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04524234
NCT04525287 Prediction Models for Diagnosis and Prognosis of Severe COVID-19 https://ClinicalTrials.gov/show/NCT04525287
NCT04516928 Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel https://ClinicalTrials.gov/show/NCT04516928
NCT04522310 ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis https://ClinicalTrials.gov/show/NCT04522310
NCT04519372 SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting https://ClinicalTrials.gov/show/NCT04519372
NCT04519307 Evaluation of Newborns Presenting With Suspected COVID 19 https://ClinicalTrials.gov/show/NCT04519307
NCT04519255 Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT https://ClinicalTrials.gov/show/NCT04519255
NCT04517136 Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions https://ClinicalTrials.gov/show/NCT04517136
NCT04514016 Cross Sectional CFAR HIV/COVID-19 Study https://ClinicalTrials.gov/show/NCT04514016
NCT04513847 PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis https://ClinicalTrials.gov/show/NCT04513847
NCT04516486 Coronavirus Studied by Metagenomics in ARDS COVID-19 Patients https://ClinicalTrials.gov/show/NCT04516486
NCT04513561 Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19 https://ClinicalTrials.gov/show/NCT04513561
NCT04514874 Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020 https://ClinicalTrials.gov/show/NCT04514874
NCT04508777 COVID SAFE: COVID-19 Screening Assessment for Exposure https://ClinicalTrials.gov/show/NCT04508777
NCT04514003 The Corona and COVID-19 Study in Telemark and Agder https://ClinicalTrials.gov/show/NCT04514003
NCT04512118 CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients https://ClinicalTrials.gov/show/NCT04512118
NCT04512300 Parental Attitude Toward Children Dental Treatment During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04512300
NCT04508556 Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study https://ClinicalTrials.gov/show/NCT04508556
NCT04507230 COVID-19 Associated Coagulopathy in Egypt https://ClinicalTrials.gov/show/NCT04507230
NCT04491214 Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19) https://ClinicalTrials.gov/show/NCT04491214
NCT04496869 Psychological Impact of COVID19 Among Women Undergoing Infertility Treatment https://ClinicalTrials.gov/show/NCT04496869
NCT04496076 COVID-19 Brain Injury https://ClinicalTrials.gov/show/NCT04496076
NCT04495907 COVID-19 Progression in End-Stage Kidney Disease https://ClinicalTrials.gov/show/NCT04495907
NCT04496128 COVID19 Neurological Manifestation https://ClinicalTrials.gov/show/NCT04496128
NCT04495764 Registry of Sustained Immunity to COVID-19 Among ESKD Patients https://ClinicalTrials.gov/show/NCT04495764
NCT04494776 SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study https://ClinicalTrials.gov/show/NCT04494776
NCT04488588 Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt https://ClinicalTrials.gov/show/NCT04488588
NCT04503447 COVID-19 Seroprevalence Study in ITM Staff https://ClinicalTrials.gov/show/NCT04503447
NCT04494893 ImmuneRACE - Immune Response Action to COVID-19 Events https://ClinicalTrials.gov/show/NCT04494893
NCT04488549 Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19) https://ClinicalTrials.gov/show/NCT04488549
NCT04491227 Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04491227
NCT04480515 Does COVID-19 Pandemic Reduce In-hospital Mortality? https://ClinicalTrials.gov/show/NCT04480515
NCT04487873 COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04487873
NCT04487119 Hematology and Clinical Picture in Pediatric COVID-19 Infection https://ClinicalTrials.gov/show/NCT04487119
NCT04482205 Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures https://ClinicalTrials.gov/show/NCT04482205
NCT04493268 HYPONATREMIA IN COVID-19 PATIENTS https://ClinicalTrials.gov/show/NCT04493268
NCT04492943 To Observe Whether Isoflurane Can Treat COVID-19 Patients https://ClinicalTrials.gov/show/NCT04492943
NCT04480060 Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04480060
NCT04481529 COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector https://ClinicalTrials.gov/show/NCT04481529
NCT04479137 Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul https://ClinicalTrials.gov/show/NCT04479137
NCT04477902 Long-Term Experience and Health Effects of COVID-19 https://ClinicalTrials.gov/show/NCT04477902
NCT04479124 The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul https://ClinicalTrials.gov/show/NCT04479124
NCT04477213 Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers. https://ClinicalTrials.gov/show/NCT04477213
NCT04476914 Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU https://ClinicalTrials.gov/show/NCT04476914
NCT04476823 European Pathology Laboratories and COVID-19 https://ClinicalTrials.gov/show/NCT04476823
NCT04473547 COVID 19 Preventive Measures Among Mansoura Nursing Students https://ClinicalTrials.gov/show/NCT04473547
NCT04473105 Optimising Resource Allocation Via Prediction of Outcomes for Covid-19 https://ClinicalTrials.gov/show/NCT04473105
NCT04473300 Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography https://ClinicalTrials.gov/show/NCT04473300
NCT04473157 COVID-19 in Patients With Anosmia in Egypt https://ClinicalTrials.gov/show/NCT04473157
NCT04468802 Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries? https://ClinicalTrials.gov/show/NCT04468802
NCT04471051 An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04471051
NCT04467008 Covid-19 Rapid Diagnostic Tests on Blood Drop https://ClinicalTrials.gov/show/NCT04467008
NCT04467112 Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols https://ClinicalTrials.gov/show/NCT04467112
NCT04466462 Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel https://ClinicalTrials.gov/show/NCT04466462
NCT04462120 IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study https://ClinicalTrials.gov/show/NCT04462120
NCT04459819 Respiratory Physiotherapy in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04459819
NCT04459403 Psychiatric Disturbances and COVID-19 Infection https://ClinicalTrials.gov/show/NCT04459403
NCT04452617 Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04452617
NCT04456556 Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04456556
NCT04449731 Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int) https://ClinicalTrials.gov/show/NCT04449731
NCT04452422 Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology https://ClinicalTrials.gov/show/NCT04452422
NCT04451993 Physical Activity Level in Patients With OSAS During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04451993
NCT04449094 Emergence of the COVID 19 Epidemic in the City of Nice https://ClinicalTrials.gov/show/NCT04449094
NCT04449081 Knowledge, Attitude and Practice of Dental Students About COVID-19 https://ClinicalTrials.gov/show/NCT04449081
NCT04445441 An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso https://ClinicalTrials.gov/show/NCT04445441
NCT04445233 COVID-19 Household Transmission Study https://ClinicalTrials.gov/show/NCT04445233
NCT04454333 COVID-19 in Pain Perspective https://ClinicalTrials.gov/show/NCT04454333
NCT04448782 Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04448782
NCT04448704 Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04448704
NCT04448418 The Impact of COVID-19 Outbreak on Trans-population’s Health in Italy https://ClinicalTrials.gov/show/NCT04448418
NCT04447638 Percutaneous Tracheostomy With COVID-19 https://ClinicalTrials.gov/show/NCT04447638
NCT04443803 Characterizing the Perioperative Epidemiology of SARS-CoV-2 (COVID-19) Spread for Quality Improvement of Perioperative Infection Control Program https://ClinicalTrials.gov/show/NCT04443803
NCT04444661 Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise https://ClinicalTrials.gov/show/NCT04444661
NCT04444531 Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia https://ClinicalTrials.gov/show/NCT04444531
NCT04442165 Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique https://ClinicalTrials.gov/show/NCT04442165
NCT04441814 FOUND - Ancillary Study to Smile Protocol NCT03654105 https://ClinicalTrials.gov/show/NCT04441814
NCT04441489 Assessment of Lung Inflammation With FDG PET/CT in COVID-19 https://ClinicalTrials.gov/show/NCT04441489
NCT04445961 Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04445961
NCT04446286 Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19 https://ClinicalTrials.gov/show/NCT04446286
NCT04443257 REassessement After Hospitalization for Sars-COV-2 disordER https://ClinicalTrials.gov/show/NCT04443257
NCT04440098 Isolated During COVID-19: Effects of COVID-19’s Social Restrictions on Loneliness and Psychosocial Symptomatology https://ClinicalTrials.gov/show/NCT04440098
NCT04438954 Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels https://ClinicalTrials.gov/show/NCT04438954
NCT04435080 Physical Rehabilitation in ICU in ARDS Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04435080
NCT04435119 Covid-19 and Vitamin D in Nursing-home https://ClinicalTrials.gov/show/NCT04435119
NCT04434157 Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04434157
NCT04432870 Patients’ Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study https://ClinicalTrials.gov/show/NCT04432870
NCT04433039 COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising https://ClinicalTrials.gov/show/NCT04433039
NCT04430023 Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia https://ClinicalTrials.gov/show/NCT04430023
NCT04432961 Natural Language Processing (NLP) Analysis of Free Text Notes to Investigate Coronavirus (COVID-19) https://ClinicalTrials.gov/show/NCT04432961
NCT04436484 Immune Biomarkers of Outcome From COVID-19 https://ClinicalTrials.gov/show/NCT04436484
NCT04432922 Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04432922
NCT04423315 Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04423315
NCT04425213 Obesity and Mortality of Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04425213
NCT04427358 RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population https://ClinicalTrials.gov/show/NCT04427358
NCT04426266 Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population https://ClinicalTrials.gov/show/NCT04426266
NCT04426253 Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19 https://ClinicalTrials.gov/show/NCT04426253
NCT04426071 The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries https://ClinicalTrials.gov/show/NCT04426071
NCT04424446 Saliva as Source of Detection for SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04424446
NCT04423978 Implications of Covid-19 on the Lifestyle Changes https://ClinicalTrials.gov/show/NCT04423978
NCT04420286 Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France https://ClinicalTrials.gov/show/NCT04420286
NCT04420312 Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04420312
NCT04422769 Needs of Persons With Spinal Cord Injury (SCI) https://ClinicalTrials.gov/show/NCT04422769
NCT04422574 COVID 19 Serology in Pulmonologists https://ClinicalTrials.gov/show/NCT04422574
NCT04422873 The Impact of COVID-19 on Dialysis Users https://ClinicalTrials.gov/show/NCT04422873
NCT04418375 Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP) https://ClinicalTrials.gov/show/NCT04418375
NCT04422522 Fibromyalgia During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04422522
NCT04413058 Menstrual Cycle Characteristics of Healthcare Professionals https://ClinicalTrials.gov/show/NCT04413058
NCT04412031 Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient https://ClinicalTrials.gov/show/NCT04412031
NCT04411784 PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04411784
NCT04410939 COVID-19 PCR Test Results in Asymptomatic Pregnants https://ClinicalTrials.gov/show/NCT04410939
NCT04414410 Echocardiography in Critically-ill Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04414410
NCT04412226 Effect of Using Barrier Devices for Intubation in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04412226
NCT04410484 PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04410484
NCT04409249 Prognosis in Pregnant With COVID-19 https://ClinicalTrials.gov/show/NCT04409249
NCT04404270 Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110) https://ClinicalTrials.gov/show/NCT04404270
NCT04409197 Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network https://ClinicalTrials.gov/show/NCT04409197
NCT04408196 QoL and the Emotional-affective Sphere o in Rehabilitation Setting During COVID-19 Quarantine https://ClinicalTrials.gov/show/NCT04408196
NCT04406038 Study of the Spread of COVID-19 in Saint Petersburg, Russia https://ClinicalTrials.gov/show/NCT04406038
NCT04406090 Endovascular Thrombectomy in COVID-19 Infected Patients https://ClinicalTrials.gov/show/NCT04406090
NCT04403932 Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency https://ClinicalTrials.gov/show/NCT04403932
NCT04405232 Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK https://ClinicalTrials.gov/show/NCT04405232
NCT04407572 Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women https://ClinicalTrials.gov/show/NCT04407572
NCT04407598 COPD in the Time of COVID-19 https://ClinicalTrials.gov/show/NCT04407598
NCT04407221 COVID-19 Research in Organ Transplant Recipients https://ClinicalTrials.gov/show/NCT04407221
NCT04407533 Dietary Intake and Eating Habits During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04407533
NCT04407156 Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom https://ClinicalTrials.gov/show/NCT04407156
NCT04407117 Appendicitis During the National Lockdown During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04407117
NCT04406688 Prediction of Acute Kidney Injury in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04406688
NCT04402229 Psychological Impact of the Covid-19 Pandemic on Student Nurses https://ClinicalTrials.gov/show/NCT04402229
NCT04405284 The Use of Disinfectants Among Women in Egypt and the Toxicity by Bleach During the Coronavirus Lock-down. https://ClinicalTrials.gov/show/NCT04405284
NCT04403828 Impact of COVID-19 on Personal Protection Among Dentist in Egypt https://ClinicalTrials.gov/show/NCT04403828
NCT04403061 Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome https://ClinicalTrials.gov/show/NCT04403061
NCT04401241 How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department https://ClinicalTrials.gov/show/NCT04401241
NCT04402905 Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL) https://ClinicalTrials.gov/show/NCT04402905
NCT04397848 Mental Health Outcomes in Healthcare Workers During COVID-19 https://ClinicalTrials.gov/show/NCT04397848
NCT04400812 Attitude and Perception Towards COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04400812
NCT04400461 Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04400461
NCT04400006 Ozone Therapy in the Prevention of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04400006
NCT04396210 Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04396210
NCT04395833 National Survey on the Lockdown of Children With Disabilities https://ClinicalTrials.gov/show/NCT04395833
NCT04397900 Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes https://ClinicalTrials.gov/show/NCT04397900
NCT04395664 Arrhythmias in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04395664
NCT04397237 Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe https://ClinicalTrials.gov/show/NCT04397237
NCT04392245 Proctologic Practice and Covid-19 https://ClinicalTrials.gov/show/NCT04392245
NCT04395391 Home Usability Study of the SARS-CoV-2 (COVID-19) Test https://ClinicalTrials.gov/show/NCT04395391
NCT04385212 Outcomes in Hospitalized Older Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04385212
NCT04389658 Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION) https://ClinicalTrials.gov/show/NCT04389658
NCT04389645 Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04389645
NCT04388579 Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19 https://ClinicalTrials.gov/show/NCT04388579
NCT04387643 Protecting Health Care Workers During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04387643
NCT04391166 Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic https://ClinicalTrials.gov/show/NCT04391166
NCT04386551 Detection of COVID-19 in Saliva Collection https://ClinicalTrials.gov/show/NCT04386551
NCT04386512 Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1) https://ClinicalTrials.gov/show/NCT04386512
NCT04386044 Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04386044
NCT04381273 Oral Health and Psychosocial Factors During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04381273
NCT04381312 Direct and Indirect Impact of COVID-19 In Older Populations https://ClinicalTrials.gov/show/NCT04381312
NCT04384406 COVID-19 Outbreak Consequences for Outpatients Followed in PRM https://ClinicalTrials.gov/show/NCT04384406
NCT04380779 Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses https://ClinicalTrials.gov/show/NCT04380779
NCT04380792 Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital https://ClinicalTrials.gov/show/NCT04380792
NCT04380714 Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19 https://ClinicalTrials.gov/show/NCT04380714
NCT04386395 Immune Changes in Severe COVID-19 Pulmonary Infections https://ClinicalTrials.gov/show/NCT04386395
NCT04385823 Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure https://ClinicalTrials.gov/show/NCT04385823
NCT04379232 Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center https://ClinicalTrials.gov/show/NCT04379232
NCT04379245 COVID-19 Infection in Patients Infected With HIV and/or on PrEP https://ClinicalTrials.gov/show/NCT04379245
NCT04379297 COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE) https://ClinicalTrials.gov/show/NCT04379297
NCT04379466 Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19 https://ClinicalTrials.gov/show/NCT04379466
NCT04383626 Fear Among Dentists During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04383626
NCT04377581 COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior https://ClinicalTrials.gov/show/NCT04377581
NCT04376905 Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04376905
NCT04377074 Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety https://ClinicalTrials.gov/show/NCT04377074
NCT04382495 The Impact of COVID-19 Pandemic on Cancer Care https://ClinicalTrials.gov/show/NCT04382495
NCT04376580 Use of the Nasal Cannula During COVID-19 https://ClinicalTrials.gov/show/NCT04376580
NCT04375644 Impact of the COVID-19 Pandemic on the Quality of Psychological Life (COVID-PRO-IMPACT) https://ClinicalTrials.gov/show/NCT04375644
NCT04375410 Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic https://ClinicalTrials.gov/show/NCT04375410
NCT04382469 Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT https://ClinicalTrials.gov/show/NCT04382469
NCT04382508 Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults. https://ClinicalTrials.gov/show/NCT04382508
NCT04371835 COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings https://ClinicalTrials.gov/show/NCT04371835
NCT04377763 Developement and Evaluation of Serological Assays for COVID-19 https://ClinicalTrials.gov/show/NCT04377763
NCT04377724 Spread and Course of COVID-19 Infections https://ClinicalTrials.gov/show/NCT04377724
NCT04374513 Community Pharmacists Behaviour During Covid-19 https://ClinicalTrials.gov/show/NCT04374513
NCT04371289 Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up https://ClinicalTrials.gov/show/NCT04371289
NCT04374123 COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit https://ClinicalTrials.gov/show/NCT04374123
NCT04373889 COVID-19 Among Healthcare Workers in Belgian Hospitals https://ClinicalTrials.gov/show/NCT04373889
NCT04374097 Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04374097
NCT04373486 Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels https://ClinicalTrials.gov/show/NCT04373486
NCT04371354 Outcomes of Covid-19 Protective Measures in Endoscopy https://ClinicalTrials.gov/show/NCT04371354
NCT04372472 SQuISH-COVID: A Pilot Study https://ClinicalTrials.gov/show/NCT04372472
NCT04371848 Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuébec Sub-study https://ClinicalTrials.gov/show/NCT04371848
NCT04371562 Predicting Death and ICU Admission in COVID-19 Patients in ED https://ClinicalTrials.gov/show/NCT04371562
NCT04367792 Cardiac Injury in COVID-19: a Pathology Study https://ClinicalTrials.gov/show/NCT04367792
NCT04366765 COVID-19 Survival - The COVIVA Study https://ClinicalTrials.gov/show/NCT04366765
NCT04365634 A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04365634
NCT04368221 Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU https://ClinicalTrials.gov/show/NCT04368221
NCT04368338 Lung Ultrasound to Diagnose COVID-19 https://ClinicalTrials.gov/show/NCT04368338
NCT04367896 COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY https://ClinicalTrials.gov/show/NCT04367896
NCT04370678 Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures https://ClinicalTrials.gov/show/NCT04370678
NCT04365725 Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections https://ClinicalTrials.gov/show/NCT04365725
NCT04365335 Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04365335
NCT04361877 Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial) https://ClinicalTrials.gov/show/NCT04361877
NCT04357886 Awareness of COVID-19 in Turkey https://ClinicalTrials.gov/show/NCT04357886
NCT04357314 Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study https://ClinicalTrials.gov/show/NCT04357314
NCT04356950 Analysis of the Coagulopathy Developed by COVID-19 Infected Patients https://ClinicalTrials.gov/show/NCT04356950
NCT04357041 COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being https://ClinicalTrials.gov/show/NCT04357041
NCT04356885 COVID-19 and Psychotic Symptoms in France https://ClinicalTrials.gov/show/NCT04356885
NCT04364698 Observational Cohort of COVID-19 Patients at Raymond-Poincare https://ClinicalTrials.gov/show/NCT04364698
NCT04355871 Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain https://ClinicalTrials.gov/show/NCT04355871
NCT04362956 Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04362956
NCT04361786 Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection https://ClinicalTrials.gov/show/NCT04361786
NCT04361565 Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04361565
NCT04356365 The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI’s) https://ClinicalTrials.gov/show/NCT04356365
NCT04355702 Covid-19 in Lupus Patients https://ClinicalTrials.gov/show/NCT04355702
NCT04355715 Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia https://ClinicalTrials.gov/show/NCT04355715
NCT04359693 Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections https://ClinicalTrials.gov/show/NCT04359693
NCT04354792 Asymptomatic COVID-19 Infection Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04354792
NCT04354753 AiM COVID for Covid 19 Tracking and Prediction https://ClinicalTrials.gov/show/NCT04354753
NCT04353154 The RAPID COVID-19 TRIAGE Algorithm https://ClinicalTrials.gov/show/NCT04353154
NCT04359407 Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04359407
NCT04352699 Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All? https://ClinicalTrials.gov/show/NCT04352699
NCT04354558 French Single Centre Experience of Critically Ill Patients With Covid 19 https://ClinicalTrials.gov/show/NCT04354558
NCT04358640 Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey https://ClinicalTrials.gov/show/NCT04358640
NCT04349540 Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19 https://ClinicalTrials.gov/show/NCT04349540
NCT04352517 Influence Physical Activity Psychological Responses COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04352517
NCT04346342 PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID) https://ClinicalTrials.gov/show/NCT04346342
NCT04346121 Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis https://ClinicalTrials.gov/show/NCT04346121
NCT04344977 Collection of Anti-SARS-CoV-2 Immune Plasma https://ClinicalTrials.gov/show/NCT04344977
NCT04344327 Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF https://ClinicalTrials.gov/show/NCT04344327
NCT04344145 Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population https://ClinicalTrials.gov/show/NCT04344145
NCT04348214 Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals https://ClinicalTrials.gov/show/NCT04348214
NCT04343781 National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04343781
NCT04347928 Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19 https://ClinicalTrials.gov/show/NCT04347928
NCT04347824 Predict Adverse Events by Covid-19 Nephritis https://ClinicalTrials.gov/show/NCT04347824
NCT04343404 Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19 https://ClinicalTrials.gov/show/NCT04343404
NCT04343339 Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment https://ClinicalTrials.gov/show/NCT04343339
NCT04342702 A Study on the Prospective Cohort Library of COVID-19 in Southeran https://ClinicalTrials.gov/show/NCT04342702
NCT04344197 Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey https://ClinicalTrials.gov/show/NCT04344197
NCT04339491 Physical Activity During Social Isolation https://ClinicalTrials.gov/show/NCT04339491
NCT04337320 Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study https://ClinicalTrials.gov/show/NCT04337320
NCT04336384 Impact of Covid-19 in Congenital Heart Disease https://ClinicalTrials.gov/show/NCT04336384
NCT04342195 Acquiring Convalescent Specimens for COVID-19 Antibodies https://ClinicalTrials.gov/show/NCT04342195
NCT04339387 COVID-19 Risk Stratification https://ClinicalTrials.gov/show/NCT04339387
NCT04338932 COVID-19 and Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT04338932
NCT04337983 Hemodynamic Characteristics of Patients With SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04337983
NCT04334252 Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT04334252
NCT04333849 Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19 https://ClinicalTrials.gov/show/NCT04333849
NCT04337762 Beat COVID-19 - Observational Trial https://ClinicalTrials.gov/show/NCT04337762
NCT04327531 Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study https://ClinicalTrials.gov/show/NCT04327531
NCT04329507 Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS) https://ClinicalTrials.gov/show/NCT04329507
NCT04321265 Outcomes and Prognostic Factors in COVID-19 https://ClinicalTrials.gov/show/NCT04321265
NCT04320862 COVID-19 Pandemic Response Network https://ClinicalTrials.gov/show/NCT04320862
NCT04321369 Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals https://ClinicalTrials.gov/show/NCT04321369
NCT04318301 Hypertension in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04318301
NCT04318418 ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19 https://ClinicalTrials.gov/show/NCT04318418
NCT04324684 Prognostic Factors Keeping Track for COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04324684
NCT04324047 Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04324047
NCT04316299 Acute Kidney Injury in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04316299
NCT04292964 Prognostic Factors of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04292964
NCT04292327 Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus https://ClinicalTrials.gov/show/NCT04292327
NCT04285801 Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study https://ClinicalTrials.gov/show/NCT04285801
NCT04256395 Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19 https://ClinicalTrials.gov/show/NCT04256395
NCT05060562 Post Coronavirus Disease (COVID-19) Syndrome Indonesian Population https://ClinicalTrials.gov/show/NCT05060562
NCT04818892 Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT04818892

Registrires

nct_id brief_title link
NCT04898166 Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19). https://ClinicalTrials.gov/show/NCT04898166
NCT04323592 Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome https://ClinicalTrials.gov/show/NCT04323592
NCT05097677 Follow-up of Covid-19 Long Term Sequelae https://ClinicalTrials.gov/show/NCT05097677
NCT05178212 Characteristics and Outcomes of Patients With COVID-19 Treated With High-flow Nasal Oxygen and Awake-prone Position https://ClinicalTrials.gov/show/NCT05178212
NCT05191381 Immune Modulation by Exosomes in COVID-19 https://ClinicalTrials.gov/show/NCT05191381
NCT05188612 International Survey of Acute Coronavirus Syndromes-COVID-19 https://ClinicalTrials.gov/show/NCT05188612
NCT05188482 Using Vibroacoustic Therapy in a Patient With Co-infection and COVID-19 https://ClinicalTrials.gov/show/NCT05188482
NCT05092568 Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service https://ClinicalTrials.gov/show/NCT05092568
NCT04497402 Sex-Informed Data in the COVID-19 Pandemic. https://ClinicalTrials.gov/show/NCT04497402
NCT04778020 International COVID-19 Clinical Evaluation Registry -2 (HOPE-2) https://ClinicalTrials.gov/show/NCT04778020
NCT05198401 The Impact of the Previous Exposure to Covid-19 Virus Infection on the Outcome of ICSI Cycles https://ClinicalTrials.gov/show/NCT05198401
NCT04836767 Evaluation of Physical and Functional Status in Patients With COVID-19 in Long Term https://ClinicalTrials.gov/show/NCT04836767
NCT04391920 Registry of CytoSorb Therapy in COVID-19 ICU Patients https://ClinicalTrials.gov/show/NCT04391920
NCT04334291 International COVID19 Clinical Evaluation Registry, https://ClinicalTrials.gov/show/NCT04334291
NCT05185817 Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant Patients https://ClinicalTrials.gov/show/NCT05185817
NCT04354701 COVID-19 and Cancer Consortium Registry https://ClinicalTrials.gov/show/NCT04354701
NCT04964115 Post Acute Sequelae of COVID-19 https://ClinicalTrials.gov/show/NCT04964115
NCT05074407 Neck Pain in Office Workers During Covid 19 Pandemic https://ClinicalTrials.gov/show/NCT05074407
NCT04625036 NO-mediated Vascular Function in Covid-19 Patient https://ClinicalTrials.gov/show/NCT04625036
NCT04466306 Pediatric Acute Kidney Injury in COVID-19 https://ClinicalTrials.gov/show/NCT04466306
NCT05089565 Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis https://ClinicalTrials.gov/show/NCT05089565
NCT04609332 Endothelial Damage and Angiogenesis Biomarkers During COVID-19 https://ClinicalTrials.gov/show/NCT04609332
NCT04553575 CoViD-19 Patient in Reims University Hospital in March to April 2020 https://ClinicalTrials.gov/show/NCT04553575
NCT04560608 Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19 https://ClinicalTrials.gov/show/NCT04560608
NCT04958304 Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study https://ClinicalTrials.gov/show/NCT04958304
NCT04786353 Long COVID Kids DK - Investigating Long-term Covid-19 https://ClinicalTrials.gov/show/NCT04786353
NCT05067920 Correlation Between Cycle Threshold (Ct) Values in COVID-19, Health Status and Laboratory Biomarkers in the Population of Medellin- Colombia Evaluated in a Specialized Laboratory. https://ClinicalTrials.gov/show/NCT05067920
NCT04367857 ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04367857
NCT04521088 Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic https://ClinicalTrials.gov/show/NCT04521088
NCT04517630 Renal Biomarkers in AKI and COVID-19 https://ClinicalTrials.gov/show/NCT04517630
NCT04515199 Home Management of Adult Egyptian Mild COVID-19 Cases https://ClinicalTrials.gov/show/NCT04515199
NCT04511429 COVID-19 in Immunosuppressed Children https://ClinicalTrials.gov/show/NCT04511429
NCT04508920 A Survey to Assess Effects of Covid-19 on Cardiovascular Patients https://ClinicalTrials.gov/show/NCT04508920
NCT04508959 The McMaster Multi-Regional COVID-19 Hospital Case Registry https://ClinicalTrials.gov/show/NCT04508959
NCT04508712 Long-term Outcomes in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04508712
NCT04506528 The C3I COVID-19 Project https://ClinicalTrials.gov/show/NCT04506528
NCT04503057 Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS) https://ClinicalTrials.gov/show/NCT04503057
NCT04498546 Mask Usage and Exercise During the COVÄ°D-19 Pandemic https://ClinicalTrials.gov/show/NCT04498546
NCT04490837 Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID) https://ClinicalTrials.gov/show/NCT04490837
NCT04481646 Novel Face Mask Sampling for COVID-19: A Diagnostic and Public Health Tool https://ClinicalTrials.gov/show/NCT04481646
NCT04465474 Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP) https://ClinicalTrials.gov/show/NCT04465474
NCT04459689 COVID-19 in PID Survey https://ClinicalTrials.gov/show/NCT04459689
NCT04457505 One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19 https://ClinicalTrials.gov/show/NCT04457505
NCT04456036 Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care https://ClinicalTrials.gov/show/NCT04456036
NCT04455347 Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked https://ClinicalTrials.gov/show/NCT04455347
NCT04453748 The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications https://ClinicalTrials.gov/show/NCT04453748
NCT04453579 Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health https://ClinicalTrials.gov/show/NCT04453579
NCT04451902 COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic https://ClinicalTrials.gov/show/NCT04451902
NCT04445402 Pediatrics HOT COVID-19 Database in NY Tristate https://ClinicalTrials.gov/show/NCT04445402
NCT04441710 Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus https://ClinicalTrials.gov/show/NCT04441710
NCT04441372 Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04441372
NCT04434144 A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh https://ClinicalTrials.gov/show/NCT04434144
NCT04433871 COVID-19 in Pediatric Oncology and Hematology Centers in France https://ClinicalTrials.gov/show/NCT04433871
NCT04433364 COPE - COVID-19 in Pregnancy and Early Childhood https://ClinicalTrials.gov/show/NCT04433364
NCT04430374 Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf https://ClinicalTrials.gov/show/NCT04430374
NCT04425759 Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19) https://ClinicalTrials.gov/show/NCT04425759
NCT04422587 Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea https://ClinicalTrials.gov/show/NCT04422587
NCT04418557 COVID-19 and Obstetric Transmission https://ClinicalTrials.gov/show/NCT04418557
NCT04416009 Extracellular Water in Covid 19 Pneumonia https://ClinicalTrials.gov/show/NCT04416009
NCT04413955 Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA https://ClinicalTrials.gov/show/NCT04413955
NCT04412382 Covid-19: Possible Role of Neutrophil Extracellular Traps https://ClinicalTrials.gov/show/NCT04412382
NCT04412317 Use of PCR-Sars-CoV-2 in Children https://ClinicalTrials.gov/show/NCT04412317
NCT04411563 Epigenetic Tools as Prognostic Predictors in Covid19 https://ClinicalTrials.gov/show/NCT04411563
NCT04410471 Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients https://ClinicalTrials.gov/show/NCT04410471
NCT04408339 COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking https://ClinicalTrials.gov/show/NCT04408339
NCT04403672 Performance Evaluation of RealDetectâ„¢ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus https://ClinicalTrials.gov/show/NCT04403672
NCT04401540 Characteristics of Neonatal Covid-19 in Turkey https://ClinicalTrials.gov/show/NCT04401540
NCT04401033 Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study) https://ClinicalTrials.gov/show/NCT04401033
NCT04398264 Characteristics of COVID-19 Infection Among PREGnant Women https://ClinicalTrials.gov/show/NCT04398264
NCT04395781 Pediatric Acute and Critical Care COVID-19 Registry of Asia https://ClinicalTrials.gov/show/NCT04395781
NCT04395794 SARS-CoV-2 Disguise Study https://ClinicalTrials.gov/show/NCT04395794
NCT04394390 Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients? https://ClinicalTrials.gov/show/NCT04394390
NCT04394000 Impact of an Intensified Thromboprofylaxis Protocol in COVID-19 https://ClinicalTrials.gov/show/NCT04394000
NCT04393324 The Critical Care Response to the COVID-19 Pandemic in Madrid https://ClinicalTrials.gov/show/NCT04393324
NCT04391946 Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04391946
NCT04391686 Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context https://ClinicalTrials.gov/show/NCT04391686
NCT04389996 COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey https://ClinicalTrials.gov/show/NCT04389996
NCT04389554 D-dimer Levels in Pregnant With COVID-19 https://ClinicalTrials.gov/show/NCT04389554
NCT04388631 Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health. https://ClinicalTrials.gov/show/NCT04388631
NCT04387929 Detection of Anti-COVID-19 Antibody Levels in an Hospital Population https://ClinicalTrials.gov/show/NCT04387929
NCT04385797 Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia https://ClinicalTrials.gov/show/NCT04385797
NCT04380766 Covid-19 Pandemic and Pancreatic Surgery in Italy https://ClinicalTrials.gov/show/NCT04380766
NCT04379544 Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 https://ClinicalTrials.gov/show/NCT04379544
NCT04378452 Assessment of the Psycho-social Impact of COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04378452
NCT04374110 Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04374110
NCT04374045 Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study https://ClinicalTrials.gov/show/NCT04374045
NCT04373759 Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs https://ClinicalTrials.gov/show/NCT04373759
NCT04372199 SEVERITY SCORE FOR COVID-19 PNEUMONIA https://ClinicalTrials.gov/show/NCT04372199
NCT04367714 Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19 https://ClinicalTrials.gov/show/NCT04367714
NCT04367207 African Covid-19 Critical Care Outcomes Study https://ClinicalTrials.gov/show/NCT04367207
NCT04367350 Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement https://ClinicalTrials.gov/show/NCT04367350
NCT04365322 Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04365322
NCT04359927 Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry https://ClinicalTrials.gov/show/NCT04359927
NCT04370067 HUNgarian COronaVirus Disease-19 Epidemiological Research https://ClinicalTrials.gov/show/NCT04370067
NCT04368975 ARDS Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04368975
NCT04369300 Anxiety And Depression During COVID-19 IN INDIA https://ClinicalTrials.gov/show/NCT04369300
NCT04368234 Duke COVID-19 Shared Data and Specimen Repository https://ClinicalTrials.gov/show/NCT04368234
NCT04368065 COVID-19 Active Research Experience (CARE) https://ClinicalTrials.gov/show/NCT04368065
NCT04368143 COVID-19 Immune Repertoire Sequencing https://ClinicalTrials.gov/show/NCT04368143
NCT04366986 International Registry of Coronavirus (COVID-19) Exposure in Pregnancy https://ClinicalTrials.gov/show/NCT04366986
NCT04366206 Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est https://ClinicalTrials.gov/show/NCT04366206
NCT04364984 ARB, ACEi, DRi in COVID-19 https://ClinicalTrials.gov/show/NCT04364984
NCT04361591 COVID-19 in Liver Transplant Recipients https://ClinicalTrials.gov/show/NCT04361591
NCT04361500 Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter https://ClinicalTrials.gov/show/NCT04361500
NCT04357639 Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ) https://ClinicalTrials.gov/show/NCT04357639
NCT04357275 The RIsk Stratification in COVID-19 Patients in the ICU Registry https://ClinicalTrials.gov/show/NCT04357275
NCT04352764 ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings https://ClinicalTrials.gov/show/NCT04352764
NCT04351529 Austrian COVID-19 Registry https://ClinicalTrials.gov/show/NCT04351529
NCT04349982 ICU Trial in Critical Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04349982
NCT04348227 How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country’s ICU? https://ClinicalTrials.gov/show/NCT04348227
NCT04347798 IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT https://ClinicalTrials.gov/show/NCT04347798
NCT04347993 A Prospective “Universal” Observational Database for COVID-19 https://ClinicalTrials.gov/show/NCT04347993
NCT04347278 Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry https://ClinicalTrials.gov/show/NCT04347278
NCT04345536 Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital https://ClinicalTrials.gov/show/NCT04345536
NCT04344912 Impact of COVID19 Outbreak in Cardiac Acute Care https://ClinicalTrials.gov/show/NCT04344912
NCT04344002 LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID) https://ClinicalTrials.gov/show/NCT04344002
NCT04344249 Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04344249
NCT04341766 Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19 https://ClinicalTrials.gov/show/NCT04341766
NCT04340466 French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study https://ClinicalTrials.gov/show/NCT04340466
NCT04340479 The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation https://ClinicalTrials.gov/show/NCT04340479
NCT04336956 Covid-19 Pediatric Observatory https://ClinicalTrials.gov/show/NCT04336956
NCT04335773 COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology https://ClinicalTrials.gov/show/NCT04335773
NCT04333953 COVID-19 in Patients With HIV https://ClinicalTrials.gov/show/NCT04333953
NCT04333875 Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis https://ClinicalTrials.gov/show/NCT04333875
NCT04331574 Renin-Angiotensin System Inhibitors and COVID-19 https://ClinicalTrials.gov/show/NCT04331574
NCT04331171 Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients’ Triage https://ClinicalTrials.gov/show/NCT04331171
NCT04327674 The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19 https://ClinicalTrials.gov/show/NCT04327674
NCT04327570 In-depth Immunological Investigation of COVID-19. https://ClinicalTrials.gov/show/NCT04327570
NCT04325412 Cardiac complicAtions in Patients With SARS Corona vIrus 2 (COVID-19) regisTrY https://ClinicalTrials.gov/show/NCT04325412
NCT04325048 Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients https://ClinicalTrials.gov/show/NCT04325048
NCT04321811 Behavior, Environment And Treatments for Covid-19 https://ClinicalTrials.gov/show/NCT04321811
NCT04320472 Acute Encephalopathy in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04320472
NCT04319016 Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy https://ClinicalTrials.gov/show/NCT04319016
NCT04318314 COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04318314
NCT04315870 Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy. https://ClinicalTrials.gov/show/NCT04315870
NCT04314271 The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04314271
NCT04632732 Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19). https://ClinicalTrials.gov/show/NCT04632732
NCT05077202 A New Scoring Model to Diagnose COVID-19 Using Lung Ultrasound in the Emergency Department https://ClinicalTrials.gov/show/NCT05077202
NCT04359602 COVID-19 Recovered Volunteer Research Participant Pool Registry https://ClinicalTrials.gov/show/NCT04359602
NCT04953039 Use of Saliva for COVID-19 Diagnosis https://ClinicalTrials.gov/show/NCT04953039
NCT04709120 Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04709120
NCT05087394 COVID19 Hospitilized in Clinica Pasteur of Neuquen (Argentina) https://ClinicalTrials.gov/show/NCT05087394
NCT05087160 Socioeconomic Inequalities Exacerbated by Mitigation Measures to COVID-19 and Differences in Prematurity Prevalence https://ClinicalTrials.gov/show/NCT05087160
NCT05077189 Temporomandibular Joint and COVID-19 https://ClinicalTrials.gov/show/NCT05077189
NCT04422470 Registry of Patients With Hematologic Disease and COVID-19 in Russia https://ClinicalTrials.gov/show/NCT04422470
NCT04342806 Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19 https://ClinicalTrials.gov/show/NCT04342806
NCT04449042 The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry https://ClinicalTrials.gov/show/NCT04449042
NCT04479488 Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil) https://ClinicalTrials.gov/show/NCT04479488
NCT04610515 Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE) https://ClinicalTrials.gov/show/NCT04610515
NCT05075785 Covid-19 Respiratory Sequelae French Cohort https://ClinicalTrials.gov/show/NCT05075785
NCT04345887 Spironolactone in Covid-19 Induced ARDS https://ClinicalTrials.gov/show/NCT04345887
NCT05049200 Characteristics of Weaning From Mechanical Ventilation in COVID-19 https://ClinicalTrials.gov/show/NCT05049200
NCT04949412 Assessment of Vitamin D Level in COVID-19 https://ClinicalTrials.gov/show/NCT04949412
NCT05008991 Lung Functions in Menopausal Obese Women After COVID 19 Recovery https://ClinicalTrials.gov/show/NCT05008991
NCT04824677 Risk Factors and Prognoses in Patients Hospitalized for COVID-19 https://ClinicalTrials.gov/show/NCT04824677
NCT05113875 Health System Dynamic & Resource Requirement in a South African COVID-19 Field Hospital https://ClinicalTrials.gov/show/NCT05113875
NCT04955587 A Longitudinal Study on Longstanding Complicated Fatigue https://ClinicalTrials.gov/show/NCT04955587
NCT04581096 Mapping COVID-19 Spread in a Tertiary Hospital https://ClinicalTrials.gov/show/NCT04581096
NCT04388605 Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic https://ClinicalTrials.gov/show/NCT04388605
NCT05102630 Ventilator Strategies in ICU Patients With COVID-19 - a National-wide Retrospective Observational Study. https://ClinicalTrials.gov/show/NCT05102630
NCT04435457 Cardiovascular Implications of COVID-19 https://ClinicalTrials.gov/show/NCT04435457
NCT04323839 COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) https://ClinicalTrials.gov/show/NCT04323839
NCT04779268 Large Scale ICU Data Sharing for 1000 Critically Ill Patients With Severe Acute Respiratory Distress Syndrome Coronavirus (SARS.COV19) in Three Distinct Isolation Centers https://ClinicalTrials.gov/show/NCT04779268
NCT04873336 Closed Loop Ventilation in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04873336
NCT05124158 COVID-19 Severity and Psychiatric Morbidity https://ClinicalTrials.gov/show/NCT05124158
NCT05126498 Influence of the COVID-19 Pandemic on Dutch Surgical Patterns of Care https://ClinicalTrials.gov/show/NCT05126498
NCT05094687 Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19). https://ClinicalTrials.gov/show/NCT05094687
NCT04605965 WEAICOR: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19 https://ClinicalTrials.gov/show/NCT04605965
NCT05063214 Muscle Evaluation of Patients Infected by the Coronavirus https://ClinicalTrials.gov/show/NCT05063214
NCT05064501 Impact of COVID19 on Asthma https://ClinicalTrials.gov/show/NCT05064501
NCT05052346 Association of the Neutrophil/Lymphocyte Ratio With Pulmonary Complications and Mortality in COVID-19 Patients https://ClinicalTrials.gov/show/NCT05052346
NCT05048745 Recurrent Appendicitis Following Successful Drainage of Appendicular Abscess in Adult https://ClinicalTrials.gov/show/NCT05048745
NCT05046002 COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry https://ClinicalTrials.gov/show/NCT05046002
NCT05045885 Safety and Feasibility of Percutaneous Dilatational Tracheostomy in Patients With Severe COVID-19 Supported by ECMO https://ClinicalTrials.gov/show/NCT05045885
NCT05026151 Comparing Metabolic Characteristics of Persistent Critically Ill Non-COVID and COVID-19 Patients https://ClinicalTrials.gov/show/NCT05026151
NCT05018052 Early and Late Complications of COVID-19 https://ClinicalTrials.gov/show/NCT05018052
NCT04997928 PAI-1 Levels and Predicting Covid-19 Patients’ Prognosis https://ClinicalTrials.gov/show/NCT04997928
NCT04996784 Pharmacokinetics of Dexamethasone in COVID-19 Obese Patients https://ClinicalTrials.gov/show/NCT04996784
NCT04990570 Telemedicine (Virtual Clinic) for Pediatric Surgery During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04990570
NCT04979195 Acute Kidney Injury Among COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04979195
NCT04979871 SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19 https://ClinicalTrials.gov/show/NCT04979871
NCT04961476 Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19 https://ClinicalTrials.gov/show/NCT04961476
NCT04948515 Gene Polymorphism of IL17 and IL 23 https://ClinicalTrials.gov/show/NCT04948515
NCT04948242 Characteristics of Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04948242
NCT04948216 Management and Healthcare Utilization of Patients With Chronic Airway Disease During the COVID-19 Epidemic https://ClinicalTrials.gov/show/NCT04948216
NCT04945850 Can COVID-19 Persist in Intraocular Fluid? https://ClinicalTrials.gov/show/NCT04945850
NCT04941053 Seroprevalence of COVID-19 https://ClinicalTrials.gov/show/NCT04941053
NCT04933994 Comparison of COVID-19 and H1N1 Influenza Pneumonia https://ClinicalTrials.gov/show/NCT04933994
NCT04929964 COVID-19 Pandemic: Effect on Management of Patients With Breast Cancer https://ClinicalTrials.gov/show/NCT04929964
NCT04924855 Immunity After COVID-19 Vaccination https://ClinicalTrials.gov/show/NCT04924855
NCT04922931 Post-COVID 19 Patients Undergoing Surgery https://ClinicalTrials.gov/show/NCT04922931
NCT04920357 Immune Response to Vaccination Against Covid-19, a Follow up Study https://ClinicalTrials.gov/show/NCT04920357
NCT04917549 Prevalence of Oral Lesions in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04917549
NCT04918901 Comparative Analysis of Clinical Parameters and Radiographic Changes of Severe COVID-19 https://ClinicalTrials.gov/show/NCT04918901
NCT04916561 Detection of Covid-19 in Tissue Samples of Orthopedic Origin https://ClinicalTrials.gov/show/NCT04916561
NCT04907981 Eye Detection to Identify Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04907981
NCT04896905 Rehabilitation After Covid19-Clinical Results and Predictive Factors https://ClinicalTrials.gov/show/NCT04896905
NCT04894253 Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus https://ClinicalTrials.gov/show/NCT04894253
NCT04893031 Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study https://ClinicalTrials.gov/show/NCT04893031
NCT04885504 Post COVID-19 Biorepository https://ClinicalTrials.gov/show/NCT04885504
NCT04883216 Investigation of the Characteristics of Chronic Pain Developing After COVID-19 https://ClinicalTrials.gov/show/NCT04883216
NCT04877496 Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab. https://ClinicalTrials.gov/show/NCT04877496
NCT04873141 Tocilizumab and Cytokine Release Syndrome (CRS) In Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04873141
NCT04872725 The Effect of Covid-19 Process https://ClinicalTrials.gov/show/NCT04872725
NCT04871867 Cardiac and Lung Assessment of Professional Soccer Players Following COVID-19 Disease https://ClinicalTrials.gov/show/NCT04871867
NCT04868864 The Ontario Multi-Regional Hospital COVID-19 Registry (COREG)- Recovery Trajectory Sub-study https://ClinicalTrials.gov/show/NCT04868864
NCT04865900 Prevalence of Perimyocarditis After Covid-19 Vaccine https://ClinicalTrials.gov/show/NCT04865900
NCT04864132 The Investigation Of Exercise Capacity And Exercise-Induced Fatigue in Young Adults Who Survived From Coronavirus https://ClinicalTrials.gov/show/NCT04864132
NCT04863547 Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04863547
NCT04852796 Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients https://ClinicalTrials.gov/show/NCT04852796
NCT04845997 COVID-19 Vaccination in Patients With Rheumatic Diseases https://ClinicalTrials.gov/show/NCT04845997
NCT04844515 The ESPERES Prospective Cohort of Healthcare Workers in France: Study on COVID-19 Vaccine and the COVID-19 Pandemic (ESPERES_COVID19) https://ClinicalTrials.gov/show/NCT04844515
NCT04840953 Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients https://ClinicalTrials.gov/show/NCT04840953
NCT04839107 Institutional Registry on Outpatient and Hospitalized COVID-19 Infected Patients https://ClinicalTrials.gov/show/NCT04839107
NCT04830683 Endothelial Dysfunction in Covid-19 https://ClinicalTrials.gov/show/NCT04830683
NCT04828915 Early Detection of Clinical Deterioration in Patients With COVID-19 Using Machine Learning https://ClinicalTrials.gov/show/NCT04828915
NCT04826718 SARS-CoV-2/COVID-19 Infection Among Health Care Workers https://ClinicalTrials.gov/show/NCT04826718
NCT04823182 Study of HEarT DiseAse and ImmuNiTy After COVID-19 in Ireland https://ClinicalTrials.gov/show/NCT04823182
NCT04824313 Vascular Abnormalities Detected With Chest CT in COVID-19 https://ClinicalTrials.gov/show/NCT04824313
NCT04819282 Mask Usage and Physical Performance During COVID-19 Pandemic in Geriatrics https://ClinicalTrials.gov/show/NCT04819282
NCT04812041 Relationship Between Delirium Severity by CAM-ICU 7 and 4C Mortality Score of the COVID-19 Patients in ICU https://ClinicalTrials.gov/show/NCT04812041
NCT04811456 MultiOrgan Inflammatory Syndromes COVID-19 Related Study https://ClinicalTrials.gov/show/NCT04811456
NCT04806880 Study Evaluating the Olfactory Recovery of Anosmia Post COVID-19 by Olfactory Rehabilitation Assisted by Web-application https://ClinicalTrials.gov/show/NCT04806880
NCT04806620 Comparison of ME/CFS and Long COVID-19 Patients https://ClinicalTrials.gov/show/NCT04806620
NCT04807699 Collaborative Network for Generating Scientific Evidence in COVID-19 For the Unified Health System in Brazil - RECOVER SUS-BRASIL https://ClinicalTrials.gov/show/NCT04807699
NCT04800770 The Effect of COVID-19 Patients’ Serum Phosphate Level on Mortality in ICU https://ClinicalTrials.gov/show/NCT04800770
NCT04799444 LATE-COVID/LATE-COVID-Kids - Observational Study in Children and Adults https://ClinicalTrials.gov/show/NCT04799444
NCT04794387 The Lymphoma and Leukemia Society Amended COVID-19 Registry https://ClinicalTrials.gov/show/NCT04794387
NCT04787510 COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04787510
NCT04780126 Sarco-COVID Study: Measuring the Loss of Skeletal Muscle Mass in the Hospitalized Patient With the Diagnosis of COVID-19 https://ClinicalTrials.gov/show/NCT04780126
NCT04779346 Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Disease (COVID-19) in the Oncology Outpatient Setting https://ClinicalTrials.gov/show/NCT04779346
NCT04769154 Airway Management in the Intensive Care and Regular Hospital Units During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04769154
NCT04768413 Evaluation of a Non-face to Face Multidisciplinary Health Care Model in a Population With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04768413
NCT04758039 Clinical Characteristics and In-hospital Death of a Chilean COVID-19 Prospective Cohort https://ClinicalTrials.gov/show/NCT04758039
NCT04757285 Copeptin and Psychological Stress of Medic During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04757285
NCT04747678 Adverse Effects of Ivermectin Used in Egypt During COVID-19 https://ClinicalTrials.gov/show/NCT04747678
NCT04747366 Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity https://ClinicalTrials.gov/show/NCT04747366
NCT04745611 Neurological and Neuropsychological Sequelae of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04745611
NCT04744415 Hospitalizations During Pandemia in the Italian Coronary Care Unit Network https://ClinicalTrials.gov/show/NCT04744415
NCT04743388 Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System https://ClinicalTrials.gov/show/NCT04743388
NCT04740320 COVID-19 SARS-CoV-2 Screening Protocol https://ClinicalTrials.gov/show/NCT04740320
NCT04741386 The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study https://ClinicalTrials.gov/show/NCT04741386
NCT04741412 Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences https://ClinicalTrials.gov/show/NCT04741412
NCT04738721 Physical Activity and Physical Fitness Parameters in COVID-19 Lockdown https://ClinicalTrials.gov/show/NCT04738721
NCT04733729 Covid-19 in Hematological Malignancies https://ClinicalTrials.gov/show/NCT04733729
NCT04730934 Effects of the COVID-19 Pandemic on Fibromyalgia Patients https://ClinicalTrials.gov/show/NCT04730934
NCT04729075 Associations Between COVID-19 ARDS Treatment, Clinical Trajectories and Liberation From Mechanical Ventilator - an Analysis of the NorthCARDS Dataset https://ClinicalTrials.gov/show/NCT04729075
NCT04727372 Social Acceptability of COVID-19 Vaccines in Pakistan https://ClinicalTrials.gov/show/NCT04727372
NCT04724707 Russian Cardiovascular Registry of COVID-19 https://ClinicalTrials.gov/show/NCT04724707
NCT04720118 Parkinson’s Disease and Experiences Throughout the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04720118
NCT04711954 HIV/COV in Ukraine-NL https://ClinicalTrials.gov/show/NCT04711954
NCT04709302 Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa https://ClinicalTrials.gov/show/NCT04709302
NCT04705116 COVID-19 Vaccines International Pregnancy Exposure Registry https://ClinicalTrials.gov/show/NCT04705116
NCT04705766 KIDney Injury in Times of COVID-19 (KIDCOV) https://ClinicalTrials.gov/show/NCT04705766
NCT04702945 Canadian COVID-19 Emergency Department Registry https://ClinicalTrials.gov/show/NCT04702945
NCT04694651 Potential Acceptance of COVID-19 Vaccines in Healthcare Workers in Egypt https://ClinicalTrials.gov/show/NCT04694651
NCT04694573 Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies https://ClinicalTrials.gov/show/NCT04694573
NCT04693975 Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases https://ClinicalTrials.gov/show/NCT04693975
NCT04691895 Gastrointestinal Symptoms in COVID-19 https://ClinicalTrials.gov/show/NCT04691895
NCT04689477 Non-invasive Characterization of Systemic Microvascular Reactivity by Near-infrared Diffuse Optical Spectroscopy in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04689477
NCT04690114 COVID-10 in the Pediatric Population: SARS-CoV-2 Seropositivity https://ClinicalTrials.gov/show/NCT04690114
NCT04686721 Observational Study for the Evaluation of Tracheal Stenosis in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04686721
NCT04679168 Study on Kidney Disease and EnviromenTal Chemical https://ClinicalTrials.gov/show/NCT04679168
NCT04678193 COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy https://ClinicalTrials.gov/show/NCT04678193
NCT04673279 Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina https://ClinicalTrials.gov/show/NCT04673279
NCT04670003 Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application https://ClinicalTrials.gov/show/NCT04670003
NCT04668404 Study of Coagulation Profile and Role of Heparin Like Effect in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04668404
NCT04668313 COVID-19 Advanced Respiratory Physiology (CARP) Study https://ClinicalTrials.gov/show/NCT04668313
NCT04666779 Access to Chiropractic Care During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04666779
NCT04661657 COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry https://ClinicalTrials.gov/show/NCT04661657
NCT04661631 Surgery and Lung Ultrasound in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04661631
NCT04659135 ASCO Survey on COVID-19 in Oncology (ASCO) Registry https://ClinicalTrials.gov/show/NCT04659135
NCT04650191 Surfactant Protein Genetic Variants in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04650191
NCT04641182 Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure https://ClinicalTrials.gov/show/NCT04641182
NCT04636021 Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era https://ClinicalTrials.gov/show/NCT04636021
NCT04631172 Covid-19 Anxiety and Phobia Levels of the Parents https://ClinicalTrials.gov/show/NCT04631172
NCT04629001 Effect of Covid-19 on Outcomes of Pregnancy https://ClinicalTrials.gov/show/NCT04629001
NCT04626076 International Registry of Healthcare Workers Exposed to COVID-19 Patients https://ClinicalTrials.gov/show/NCT04626076
NCT04623697 Covid-19 Infection and New Onset Type 1 Diabetes https://ClinicalTrials.gov/show/NCT04623697
NCT04619368 Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04619368
NCT04615026 Prevalence of Thrombosis in COVID-Patients https://ClinicalTrials.gov/show/NCT04615026
NCT04615676 Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus https://ClinicalTrials.gov/show/NCT04615676
NCT04615000 SeroCovid<19: A Prospective Covid-19 Seroconversion Study in a Tertiary Pediatric Patient Cohort https://ClinicalTrials.gov/show/NCT04615000
NCT04613817 Sero-prevalence COVID-19 Among Belgian Children https://ClinicalTrials.gov/show/NCT04613817
NCT04613245 Health-Related Quality of Life of Patients With Asthma During the Pandemic of COVID-19 https://ClinicalTrials.gov/show/NCT04613245
NCT04611269 Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina https://ClinicalTrials.gov/show/NCT04611269
NCT04609501 Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship https://ClinicalTrials.gov/show/NCT04609501
NCT04606732 CardioVascular Disease Progression and Prognosis in COVID-19 https://ClinicalTrials.gov/show/NCT04606732
NCT04604119 Anxiety and Burnout in Anesthetists and Intensive Care Unit Nurses During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04604119
NCT04601090 Survival Rates and Longterm Outcomes After COVID-19 https://ClinicalTrials.gov/show/NCT04601090
NCT04598256 Endoscopic Procedures of Children in the Normalization Process of Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04598256
NCT04598347 Evaluation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19 https://ClinicalTrials.gov/show/NCT04598347
NCT04583566 Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian’s Patients https://ClinicalTrials.gov/show/NCT04583566
NCT04583306 The Salivary Raman COVID-19 Fingerprint https://ClinicalTrials.gov/show/NCT04583306
NCT04581187 An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies https://ClinicalTrials.gov/show/NCT04581187
NCT04581135 Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19 https://ClinicalTrials.gov/show/NCT04581135
NCT04573868 National Study “AEC COVID-19” https://ClinicalTrials.gov/show/NCT04573868
NCT04568421 Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection https://ClinicalTrials.gov/show/NCT04568421
NCT04568005 Evaluation of Lymphedema Patients Status During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04568005
NCT04558996 Spanish Registry of Pregnant Women With COVID-19 https://ClinicalTrials.gov/show/NCT04558996
NCT04559009 COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry https://ClinicalTrials.gov/show/NCT04559009
NCT04558203 The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice https://ClinicalTrials.gov/show/NCT04558203
NCT04553055 Antibiotic Misuse During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04553055
NCT04546191 Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland https://ClinicalTrials.gov/show/NCT04546191
NCT04544878 Pediatric Intensive Care and COVID-19 https://ClinicalTrials.gov/show/NCT04544878
NCT04542512 Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic. https://ClinicalTrials.gov/show/NCT04542512
NCT04542954 Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East https://ClinicalTrials.gov/show/NCT04542954
NCT04535128 COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications https://ClinicalTrials.gov/show/NCT04535128
NCT04533360 Prevalence of COVID-19 Antibodies Kingman AZ https://ClinicalTrials.gov/show/NCT04533360
NCT04532632 Taste and Smell Impairment in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04532632
NCT04531202 CORE Study COVID-19 https://ClinicalTrials.gov/show/NCT04531202
NCT04527315 COVID-19 Survivorship Registry https://ClinicalTrials.gov/show/NCT04527315
NCT04505709 Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19 https://ClinicalTrials.gov/show/NCT04505709
NCT04497194 Registry of COVID-19 Patients at AOUI Verona https://ClinicalTrials.gov/show/NCT04497194
NCT04488562 Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands https://ClinicalTrials.gov/show/NCT04488562
NCT04503434 Patients’ Experiences in a Medicalized Hotel for COVID-19 Acute Care Support https://ClinicalTrials.gov/show/NCT04503434
NCT04482361 SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES https://ClinicalTrials.gov/show/NCT04482361
NCT04479150 Complications and Mortality Following Emergency Digestive Surgery During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04479150
NCT04472078 Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina https://ClinicalTrials.gov/show/NCT04472078
NCT04463862 COVID - AirPollution https://ClinicalTrials.gov/show/NCT04463862
NCT04460170 COVID-19 Follow up Intensive Care Studies https://ClinicalTrials.gov/show/NCT04460170
NCT04460196 Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments https://ClinicalTrials.gov/show/NCT04460196
NCT04459364 The Prevalence of Pulmonary Hypertension in Patients With COVID-19. https://ClinicalTrials.gov/show/NCT04459364
NCT04450277 Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04450277
NCT04444310 Antibody Responses in Contacts of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04444310
NCT04443140 Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic? https://ClinicalTrials.gov/show/NCT04443140
NCT04435041 Remote-by-Default Care in the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04435041
NCT04429477 Cerebral Compliance Impairment in COVID-19 https://ClinicalTrials.gov/show/NCT04429477
NCT04431869 In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers https://ClinicalTrials.gov/show/NCT04431869
NCT04426084 Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study https://ClinicalTrials.gov/show/NCT04426084
NCT04423003 Endoscopic Interventions in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04423003
NCT04422444 Post Intensive Care Syndrome in COVID19 Patients https://ClinicalTrials.gov/show/NCT04422444
NCT04412551 Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19 https://ClinicalTrials.gov/show/NCT04412551
NCT04397575 The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients https://ClinicalTrials.gov/show/NCT04397575
NCT04393142 Serologic Testing of Household Contacts of Confirmed Cases of COVID-19 https://ClinicalTrials.gov/show/NCT04393142
NCT04388436 Post Covid-19 Cardiopulmonary and Immunological Changes https://ClinicalTrials.gov/show/NCT04388436
NCT04390555 The Global PCHF-COVICAV Registry https://ClinicalTrials.gov/show/NCT04390555
NCT04380727 Almitrine and COVID-19 Related Hypoxemia https://ClinicalTrials.gov/show/NCT04380727
NCT04379440 Geriatric Population COVID-19 Observational Study (GEROCOVIDobs) https://ClinicalTrials.gov/show/NCT04379440
NCT04386265 Compassionate Use of Hyperbaric Oxygen Therapy https://ClinicalTrials.gov/show/NCT04386265
NCT04379258 Analysis of Mortality of Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04379258
NCT04383457 Covid-19 Triage Using Camera-based AI https://ClinicalTrials.gov/show/NCT04383457
NCT04376398 Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals https://ClinicalTrials.gov/show/NCT04376398
NCT04371744 QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19 https://ClinicalTrials.gov/show/NCT04371744
NCT04371328 Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection https://ClinicalTrials.gov/show/NCT04371328
NCT04370821 COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers https://ClinicalTrials.gov/show/NCT04370821
NCT04358042 PSYCHIATRIC Disorders and Covid-19 https://ClinicalTrials.gov/show/NCT04358042
NCT04356586 Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms https://ClinicalTrials.gov/show/NCT04356586
NCT04363632 Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04363632
NCT04354818 Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) https://ClinicalTrials.gov/show/NCT04354818
NCT04353583 Renal Outcome in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04353583
NCT04354519 The United Kingdom Multiple Sclerosis Register Covid-19 Substudy https://ClinicalTrials.gov/show/NCT04354519
NCT04348942 A COVID-19 Symptom, Exposure and Immune Response Registry https://ClinicalTrials.gov/show/NCT04348942
NCT04339881 NOsocomial Dissemination Risk of SARS-Cov2 https://ClinicalTrials.gov/show/NCT04339881
NCT04336345 Outcomes of Patients With COVID-19 in the Intensive Care Unit https://ClinicalTrials.gov/show/NCT04336345
NCT04337346 Evaluation of Covid 19 Anxiety in Endometriosis Patients https://ClinicalTrials.gov/show/NCT04337346
NCT04329559 COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study https://ClinicalTrials.gov/show/NCT04329559
NCT04327479 Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection https://ClinicalTrials.gov/show/NCT04327479
NCT05012280 Malaria as a Protection Factor Against Severe COVID-19 (Known as SARS-COV-2) in the Democratic Republic of Congo (Palu-COVID) https://ClinicalTrials.gov/show/NCT05012280